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Abstract 
Various studies have sought to determine the typical versus optimal abstinence period after 
which semen samples should be collected, and many have been found to be contradictory. 
Several factors influence the semen microenvironment and subsequent sperm basic and 
functional parameters. In this study we focused on important biomarkers of prostate, seminal 
vesicle and epididymal secretion. Furthermore, extensive proteomic analysis of seminal 
plasma was performed for a more comprehensive understanding of the observations. Semen 
samples were obtained from normozoospermic donors (n = 16) after 4 days and 4 hours of 
ejaculatory abstinence (EA) and standard semen analysis was performed with the assistance 
of computer aided sperm analysis (CASA), while the seminal plasma citric acid, neutral alpha-
glucosidase and fructose concentrations were measured photometrically with commercially 
available assay kits. Protein identification was performed using advanced mass spectrometric 
techniques and pathways were analysed on both Reactome and String databases.  
Results of this study displayed significant decreases in semen volume, sperm concentration, 
total sperm count, and pH after 4 hours of ejaculatory abstinence when compared to 4 days. 
Furthermore, increases in total sperm motility and progressive motility after short EA periods 
were observed, accompanied by significant reductions in all epididymal and accessory sex 
gland biomarker concentrations. However, due to the decreased sperm number, these 
concentrations translated to a significant increase in citric acid and a decrease in fructose 
available per spermatozoon, which, along with the effects on semen pH, could more than likely 
be responsible for increased metabolic function and subsequent increase in the available 
energy for sperm motility. 
Proteomic analysis identified 22 differentially expressed seminal plasma proteins, with 18 
proteins upregulated after 4 days of EA and 3 upregulated after 4 hours of EA. Of the proteins 
differentially expressed, 5 proteins from 4 days of EA and 2 proteins from 4 hours of EA, were 
identified to be related to sperm function and thus selected for pathway analysis. These 
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proteins were found to be prominent components of cellular processes including metabolism, 
apoptosis and cell process regulation, which can be linked directly and indirectly to sperm 
motility parameters. To conclude, the mechanisms by which very short EA improves sperm 





















Verskeie studies het probeer om die tipiese versus optimale onthoudingsperiode te bepaal 
waarna semenmonsters versamel moet word, maar heelwat teenstrydighede is gevind. 
Verskeie faktore beïnvloed die semen mikro-omgewing en daaropvolgende sperm-basiese en 
funksionele parameters. In die huidige studie is daar gefokus op belangrike biomerkers in 
sekresies afkomstig vanaf die prostaat, seminale vesikels en epididimis. Uitgebreide 
proteomiese analises is ook op die seminale plasma uitgevoer om sodoende 'n meer 
omvattende begrip vir die waarnemings te verkry. Semenmonsters is bekom vanaf 
normozoospermiese skenkers (n = 16) na 4 dae en 4 ure van ejakulatoriese onthouding (EO) 
en ŉ standaard semenanalise is uitgevoer met behulp van rekenaargesteunde spermanalise 
(RGSA), terwyl die seminale plasma sitroensuur, neutrale alfa-glukosidase en fruktose 
konsentrasies fotometries bepaal is met kommersieel beskikbare toetsstelle. 
Proteïenidentifikasie is uitgevoer met behulp van gevorderde massa spektrometriese tegnieke 
en proteoompad interaksies is geanaliseer op beide Reactome en String databasisse. 
Die resultate van hierdie studie toon beduidende afnames in semenvolume, 
spermkonsentrasie, totale spermtelling en pH aan ná 4 uur van EO in vergelyking met 4 dae. 
Verder is toenames in totale spermmotiliteit en progressiewe motiliteit na kort EO periodes 
waargeneem. Dit is vergesel van 'n betekenisvolle vermindering in alle epididimale en 
bykomende geslagsklierbiomerkerkonsentrasies. Nietemin, as gevolg van die verminderde 
spermgetal, herlei hierdie konsentrasies egter tot 'n beduidende toename in sitroensuur en 'n 
afname in fruktose beskikbaar per spermatozoon, wat tesame met die effekte op semen pH 
waarskynlik verantwoordelik kan wees vir verhoogde metaboliese funksie en daaropvolgende 
toename in die beskikbare energie vir spermmotiliteit. 
Proteomiese analise het 22 differensiaal uitgedrukte seminale plasma proteïene identifiseer, 
waarvan 18 proteïene opgereguleer was na 4 dae van EO en 3 opgereguleer was na 4 ure 
van EO. Van die proteïene wat differensiaal uitgedruk was, is 5 proteïene vanaf 4 dae EO en 
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2 proteïene vanaf 4 ure EO gekoppel aan spermfunksie en gekies vir verdere proteoompad 
interaksie analise. Daar is bevind dat hierdie proteïne prominente rolspelers is in sellulêre 
prosesse, insluitende metabolisme, sellulêre motiliteit, apoptose en selprosesregulering. Om 
mee af te sluit, die meganismes waardeur baie kort EO spermmotiliteit verbeter berus op 
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The incidence of infertility is approximately 15-20% and is a growing concern in the field of 
reproductive physiology. Among infertile couples, it is projected that causation lies 
predominantly with the female in 38% of the cases, and 20% of the cases can be attributed to 
males. Whereas 27% of observed incidents of infertility among couples have both male and 
female abnormalities (Boivin et al., 2007). Additionally, no evident cause is identified for the 
remaining 15%. Male factor infertility is of particular interest as there are many cases which 
remain unexplained. 
Standardized semen analysis, according to the World Health Organization (WHO), remains 
the initial screening and cornerstone for the evaluation of male sperm quality and patient 
health (van der Horst & du Plessis, 2017). As stated by the prescribed guidelines of the WHO, 
subjects must remain abstinent for a minimum period of 48 hours, but no longer than 7 days 
prior to collecting a sample for a standard semen analysis (WHO, 2010). Various studies have 
sought to determine the typical versus optimal time after which human semen samples should 
be collected for favourable sperm functional parameters, as well as use in assisted 
reproductive techniques (ART), whilst the results are often found to be contradictory. The 
results from studies performed by Bahadur et al. (2016), Alipour et al. (2015, 2017) and Ayad 
et al. (2017), challenge the generally accepted guidelines for length of ejaculatory abstinence 
(EA), since their results show that as little as 40 min, 2  hours and 4 hours of EA  yield 
significantly better sperm samples from a functional perspective. Despite the fact that this 
study was performed on normozoospermic men, future studies on infertile men could possibly 
lead to similar findings, thereby advocating shorter abstinence periods as a strategy to improve 
the outcome of natural conception and ART. Furthermore, ejaculates of both short and long 
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abstinence were collected in quick succession from the same donor, thus eliminating 
confounding variables.  
In the current study we will attempt to further explain the significant results obtained by Ayad 
et al. (2017) by analysing the epididymal and accessory sex gland biomarkers and protein 
changes in seminal plasma and the possible contribution to sperm function from subjects with 
4 hours of EA. Minimizing subject variation by selecting samples from normozoospermic, 
healthy males between the ages of 19 to 25 may reduce variation in physiological conditions 
allowing EA to be the primary intervention. The development of highly accurate mass 
spectrometric techniques, allows for the investigation of a broad array of complex protein and 
peptide profiles of both plasma and cell components. In this study the proteome of the seminal 
plasma will be analysed thus providing a potentially more detailed and comprehensive 
explanation for the functional differences observed between short and long periods of EA. The 
seminal concentrations of three important molecules, namely: fructose, citric acid and alpha-
glucosidase were also measured as markers of epididymal and accessory sex gland function, 
for a more comprehensive comparison into biochemical differences between samples. 
Considering the absolute amount of each of these constituents per spermatozoon, may 
furthermore be considered as a more accurate indicator of their true effect on sperm quality, 
as semen volume and total sperm count (T.S.C.) must be taken into consideration.  
1.2. Motivation for the study 
The optimal period of EA in order to maximise the fertilizing capacity of the male factor has 
been debated for many years. WHO (2010) guidelines state that a minimum of 48 hours, but 
no longer than 7 days of EA are ideal for standard semen analysis. This may also provide a 
guideline for the possible improvement of basic semen parameters with couples experiencing 
difficulties in naturally conceiving, as well as in use in ART. The study by Ayad et al. (2017) 
attempted to explain the differences by means of basic semen analysis as well as functional 
parameters including acrosome reaction (AR), DNA fragmentation, reactive oxygen species 
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(ROS eg. superoxide), thiobarbituric acid reactive substrates (TBARS) and antioxidant activity 
(catalase and superoxide dismutase). There were significant increases in motility parameters 
and expected basic parameters including volume, pH, total sperm count (T.S.C.) and 
concentration observed after 4 hours of EA. Ejaculated spermatozoa are differentiated cells 
and accordingly post-spermatogenesis/post-epididymal, and the main changes/effects are to 
be exerted by the composition and influence of the seminal plasma (Elzanaty et al., 2005; Said 
et al., 2009). Therefore, seminal plasma, and the composition thereof, has been selected as 
a biochemically significant medium for the analysis of the effects of abstinence. Additionally, 
considering how important proteins are to the functioning of all living cells, it was decided that 
it would be greatly beneficial to further explain these differences in the protein composition of 
seminal plasma using advanced liquid chromatography tandem mass spectrometry (LC-
MS/MS) techniques. Furthermore, none of the studies on very short abstinence have 
comprehensively analysed the accessory sex gland secretions as part of the seminal plasma 
as a key attributor to these observations (Alipour et al., 2015; Ayad et al., 2017; Bahadur et 
al., 2016). In this study, focussing on citric acid, fructose and neutral alpha-glucosidase may 
help in elucidating possible mechanisms by which very short EA has on sperm quality.  
1.3. Preliminary study 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was performed on 
2 seminal plasma samples obtained from normozoospermic men having undergone 3 – 4 days 
of EA, in order to identify a suitable range of protein concentrations for an effective proteomic 
analysis. Once isolation of seminal plasma was performed using the double wash technique 
(350g, 15 minutes), increasing volumes of sample were added to each well and allowed to run 
and separate according to their molecular mass (see Figure 1.1). Refer to materials and 
methods for full protocol on SDS-PAGE and LC-MS/MS. 




Figure 1.1. SDS-PAGE Gel end product  
The SDS-PAGE gel displays separated and stained proteins from the largest molecular weight (Top) to 
the lowest Molecular weight (Bottom).Bands were excised from the column containing 91mg/mL of 
protein as indicated by the lines on the figure.  
The column containing 91mg/mL of protein was then excised into 7 fractions, which were 
placed into separate Eppendorf tubes and de-stained. Each fraction was then homogenized 
and LC-MS/MS was performed resulting in a comprehensive proteome. Over 400 proteins at 
1% false discovery rate (FDR), were identified in the seminal plasma which represented a 
multitude of biochemical and physiological functions. The fractions of proteins where 
characterized according to biological processes (see Figure 1.2) as well as cellular 
components. It was noted that a large portion of the proteins identified were intracellular 
proteins from a multitude of cell portions. Although the cellular function of around 60% of 
identified proteins was unknown, nearly 45% are involved in celullar processes and 35% are 
involved in metabolic processes. Furthermore, just less than 10% of the identified proteins are 
known to be involved in reproduction and reproductive processes. 
Stellenbosch University  https://scholar.sun.ac.za
5 
 
Another major hurdle when grouping fractions was the issue of high abundance proteins 
suppressing signals from low abundance proteins. We attempted to reduce the effect of this 
by grouping specific fractions with similar protein ranges in order to obtain a result which the 
proteins of interest are represented with the greatest amount of accuracy. 
 
Figure 1.2. Total number of proteins identified in this pilot study by LC-MS/MS using 
the Uniprot human database related to each stated biological process. 
It was concluded that sufficient protein content may be identified in seminal plasma, and that 
utilizing between 90 and 100 mg/mL of protein per pool of samples, would optimize the protein 
analysis performed with the available techniques and tools. Furthermore, excising each 
column into 7 fractions as illustrated in Figure 1.1, would be adequate for the purpose of 
accurate comparison of expressed proteins between groups. 
1.4. Thesis organization 
An extensive overview of the current literature relating to abstinence, sperm maturation and 
the importance of seminal plasma, seminal proteomics and the composition of seminal plasma 
relating to the secretions from the accessory sex glands will be discussed in chapter 2. 
Chapter 3 will provide the materials and methods utilized in this study. The results will be 
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presented in chapter 4 and will be discussed according to each objective in chapter 5. Chapter 
6 will conclude the study by focusing on the results of each objective and Chapter 7 contains 
appendices including all proteomic data.  
1.5. Setting of the study 
The study was performed at the Stellenbosch University Reproductive Research Group 
(SURRG) laboratory in the Division of Medical Physiology, Faculty of Medicine and Health 
Sciences, Stellenbosch University, Tygerberg. All proteomic analysis was executed at the 
Central Analytics Facility, Faculty of Medicine and Health Sciences, Stellenbosch University. 
1.6. Aims and objectives 
The aim of this study is to provide more comprehensive insight into the biochemical and 
physiological properties of seminal plasma after a short ejaculatory abstinence period of 4 
hours compared to 4 days, in normozoospermic males in order to identify possible 
mechanisms of variations in sperm functional parameters.  
Objective 1: Evaluate the relationship between 4 days and 4 hours of EA by comparing basic 
semen parameters such as pH and volume, as well as sperm parameters including 
concentration, total sperm count (T.S.C.), motility and kinematics. 
Objective 2: Investigate the role of prominent epididymal and accessory sex gland biomarkers 
in abstinence and how they relate to sperm functional parameters.  
Objective 3: Identify differentially expressed proteins in seminal plasma after 4 days and 4 
hours of EA and the subsequently up regulated protein pathways related to sperm 









Male factor infertility has become an increasing concern in the study of human reproduction. 
Further understanding the effects which storage of sperm in the epididymis have on sperm 
functional parameters post-ejaculation may open further avenues for low-cost methods of 
sperm quality improvement, from a functional perspective. Basic and functional semen 
parameters remain key indicators of sperm fertilizing capacity, thus comparing these 
parameters to several epididymal and accessory sex gland secretions may aid in the 
elucidation of EA period and its subsequent role in sperm quality. Furthermore, utilizing 
modern mechanisms of identifying differentially expressed proteins between these two EA 
periods as well as the subsequent pathways which are activated or inhibited, might provide 
additional insight into the physiological mechanisms of very short EA. 
  





2. Literature review 
2.1. Abstinence and fertility 
Standardized semen analysis, according to the WHO, remains the cornerstone of sperm 
quality assessment, yet there are many cases which still require further research in order for 
the pathophysiology of infertility to be more comprehensively understood. As stated by the 
prescribed guidelines of the WHO, subjects must abstain for a minimum period of 48 hours, 
but no longer than seven days prior to collecting a sample for a standard semen analysis. 
Basic semen parameters such as T.S.C., motility, morphology and concentration are still 
considered to be the primary predictive factors when it comes to defining the quality of a semen 
sample, despite variability in sperm production in the same subjects. Approximately 15–20% 
of human couples are affected by infertility and about a third of these cases of infertility can 
be attributed to men (Moore & Reijo-Pera, 2000). Sperm motility in particular is believed to be 
one of the most important parameters when determining the fertilizing ability of ejaculated 
sperm (Bongso et al., 1989; Donnelly et al., 1989). Furthermore, computer-aided sperm 
analyses (CASA) has been proven as an accurate and reliable method of motility analysis in 
clinical and research settings (Hirano et al., 2001; Larsen et al., 2000)   
The negative effects of prolonged EA on basic semen parameters such as motility, 
morphology and viability have been widely reported but the most effective abstinence period 
is still under debate (Bedford, 1994; Turner, 2008). In the final stage of spermatogenesis, 
whereby the spermatozoa are subsequently released into the epididymis, they lose the ability 
of biosynthesis, repair, growth and cell division, and are extremely simple in their metabolic 
functions (Hammerstedt, 1993). The spermatozoa must then pass through the length of the 
epididymis where they undergo a series of biochemical and physiological changes which 
mature the cells before they are ejaculated (Robaire et al., 2006). There are variations in the 
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time in which the spermatozoa spend in the testis, caput, corpus and cauda of the epididymis 
(Bishop & Walton, 1960). This epididymal transit time has been estimated to be between 2 to 
11 days and can be influenced by ejaculatory frequency which affects the rate of passage 
through the cauda (Amann, 1981; Johnson & Varner, 1988). Prolonged EA could increase 
exposure of spermatozoa to the damaging effects of ROS in these areas, primarily generated 
by abnormal spermatozoa and granulocytes (Ayad et al., 2018). This contribution from these 
spermatozoa to the ejaculate is known to impair semen quality unless regularly ejaculated 
(Mortimer, 1994). A large recent study which investigated the influence of abstinence on male 
fertility of over 2000 samples, attributed the decrease in sperm quality after extended periods 
of EA to ROS-associated DNA damage (Comar et al., 2017). It is generally agreed that sperm 
concentration will increase with increased EA, yet it has been shown to have a negative impact 
on other sperm parameters such as motility and viability (De Jonge et al., 2004; Magnus et 
al., 1991; Pellestor et al., 1994). The variation in total and progressive motility of sperm after 
different periods of EA has previously been attributed to the exposure to varying 
concentrations of accessory sex gland secretions in the semen microenvironment (Elzanaty 
et al., 2005). 
Another question arises regarding whether these ideal abstinence periods apply to 
normozoospermic men or those with sub-quality sperm samples. Many studies have shown 
conflicting results attributable to this predicament. One study has shown that as little as one 
hour of EA could increase volume, concentration and motility of spermatozoa in patients with 
unacceptable ejaculate quality (Bar-Hava et al., 2000). Another, much larger study found that 
in oligozoospermic men, morphology and motility were inversely proportional to the length of 
EA (Levitas et al., 2005).  Furthermore, in a clinical study on couples with male factor infertility, 
increased chances of successful ART were observed with as little as two hours of EA (Alipour 
et al., 2015). It was presumed that these results were due to the observed increase in sperm 
motility, but further analysis of biochemical factors in the seminal plasma may help us to 
elucidate the reasons for these findings. Similarly, a study with an abstinence period of 40 
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minutes found significantly improved motility parameters in the chosen cohort of 
oligozoospermic men (Bahadur et al., 2016).  
With regard to variations in the sperm quality diagnosis of individuals, it is generally accepted, 
as shown in early and recent studies on healthy normozoospermic men, sample quality 
gradually increases with increased abstinence but sharply decreases between 11 and 14 
days, yet does not decrease when the EA is shortened (Agarwal et al., 2016; Levitas et al., 
2005). Another study performed on both oligozoospermic and normozoospermic donors 
providing multiple successive samples after an extended EA (up to 10 days) found that motility 
significantly increased for oligozoospermic donors (Cooper et al., 1993). This reiterates the 
belief that even though this study will focus on normozoospermic men, the findings may help 
in providing more insight into a cost effective method to increase the success rate of ART and 
natural conception in oligozoospermic men.  
 
2.2. Spermatogenesis, sperm capacitation and motility  
Spermatogenesis is a complex growth, cell division and maturation process composed of 3 
distinct stages occurring within the walls of the seminiferous tubules of the testis. Firstly mitotic 
proliferation and maturation of stem cell-derived spermatogonia; secondly, two meiotic 
cleavages form haploid spermatocytes, and finally, spermiogenesis occurs which consists of 
the maturation of round spermatids into elongated spermatids and subsequent spermatozoa 
with condensed and elongated genetic material (Stukenborg et al., 2014). Each individual 
germ cell undergoes intermittent resting phases during cell growth and maturation. 
Spermatogenesis is highly dependent on optimal conditions in the testis, and has been found 
to be regulated by several factors including DNA methylation and histone replacement by 
protamines (Song et al., 2011).  
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The significance of sperm motility parameters has been extensively studied and found to be 
positively correlated with sperm fertilizing capacity in several human and animal models (Davis 
et al., 1991; Hirano et al., 2001; Larsen et al., 2000; Rhemrev et al., 2001; Terriou et al., 1994).  
The guidelines for assessment of sperm presented by the WHO (2010) identify 4 key 
variations of motile sperm to be considered as adequate categories of sperm motion namely, 
rapid progressive motility (type a), slow progressive motility (type b), non-progressive motility 
(type c) and immotile (see Figure 2.1).  
 
     Rapid progressive motility (type a)       Non-progressive motility (type c) 
     Slow progressive motility (type b)                             Immotile 
Figure 2.1. Photomicrograph displaying the various types of progressive motility of 
spermatozoa assessed using Computer-aided Sperm Analysis (CASA).  
Utilizing CASA to determine the intricacies of sperm hyperactivation has been identified as an 
effective method of determining changes in sperm fertilizing capacity as these parameters are 
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known to be directly related to fertility (Larsen et al., 2000). Generally, the trajectories of 
spermatozoa are smooth arcs due to the symmetrical waveform of the flagellum (Alavi et al., 
2009).  The velocity values that are determined are: curvilinear velocity (VCL), straight-line 
velocity (VSL), and average path velocity (VAP) (see Figure 2.2). The VCL refers to the total 
distance that the sperm head covers in the observation period, and is always the highest of 
the 3 velocity values. The VSL is determined from the straight-line distance between the first 
and last points of the trajectory, and provides the net space gain in the observation period. 
This is always the lowest of the 3 velocity values for any spermatozoon. The VAP is the 
distance the spermatozoon has travelled in the average direction of movement during the 
observation period. Furthermore, due the fact that trajectory shape influences velocity values, 
these values must be compared (Mortimer, 1994). This is performed by considering the ratios 
of these velocities, they are as follows:  linearity (LIN = (VSL/VCL) x 100), straightness (STR 
= (VSL/VAP) x 100) and oscillation index (WOB = (VAP/VCL) x 100). 
 
Figure 2.2. Diagram illustrating the typical trajectory of progressively motile sperm and 
the various parameters which are assessed using the SCA® 




Once stored spermatozoa are ejaculated, the main physiological changes which occur are 
attributed by influencing factors in seminal plasma released by the epididymis, accessory sex 
glands and other tissues (Elzanaty et al., 2005; Said et al., 2009). Ejaculated spermatozoa, 
primarily bathing in cauda epididymal fluid are exposed to most, if not all secretions from the 
accessory sex glands in vitro. In vivo, however, not all sperm are necessarily exposed to the 
majority of the secretions from these glands, since sperm fractions are delivered in differential 
order and are exposed to seminal plasma with different concentrations of constituents, 
including metabolites, peptides and proteins (Rodríguez‐Martínez et al., 2011). Apart from 
differential order of sex gland secretion, once ejaculated, sperm must move out of the seminal 
plasma and travel through the cervix within minutes. As soon as sperm are moving out of the 
ejaculate and passing the cervical mucus, they are rapidly but passively transported in the 
uterus (oxytocin) and then enter fallopian tubes where they undergo several biochemical 
changes, collectively called capacitation (Gadella & Visconti 2006).  
Sperm capacitation and motility are closely related. Sperm undergo several changes as they 
travel through the male and female reproductive system and these changes involve molecules 
integrating into the sperm plasma membrane during epididymal maturation (Ickowicz et al., 
2012). The removal or alteration of these molecules prepares the sperm toward successful 
binding to the egg and subsequent fertilization (Ickowicz et al., 2012). 
The process of capacitation can be divided into two prominent signalling events: fast and slow. 
These events take place during the passage of sperm from the epididymis to the female 
reproductive tract. The fast events include activation of the vigorous and asymmetric 
movement of the flagella and these happen as soon as the sperm leave the epididymis 
(Visconti, 2009).  The slow events include changes in the pattern of movement 
(hyperactivation) and subsequent metabolic changes involved (Visconti, 2009). Eventually, all 
these changes will lead to the capacitation of the sperm and as a final point, the following 
events occur: hyperactivation, the ability to carry out the acrosome reaction (AR) induced by 
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biological agonists, zona pellucida (ZP), or progesterone; exhibition of chemotactic behaviour 
and the ability to fertilize an oocyte. 
2.3. Important seminal plasma components 
Seminal plasma is made up of secretions from several sources i.e. the accessory sex glands 
namely the seminal vesicles (65%–75%), prostate (25%–30%), bulbourethral glands (1%); the 
testicular Sertoli cells (2-5%); and the epididymis (~`1%). These contributions create a nutrient 
and mineral rich fluid containing a multitude of signalling molecules vital to sperm function and 
vitality (Mann & Mann, 1982). The importance of these accessory glands is highlighted 
whenever they lose their functionality, resulting from underlying pathophysiological conditions 
leading to an unfavourable seminal plasma environment which has a subsequent deleterious 
impact on fertilizing capacity (Lewis, 2007). The seminal plasma microenvironment is 
important as the spermatozoon is the only cell that performs its functions outside the body of 
the organism it originates from (Baccetti, 1984). In addition to acting as a medium transporting 
spermatozoa to the oocyte, seminal plasma fulfils three pivotal roles in ensuring that 
fertilization occurs (Poiani, 2006):  
 It contributes to the process of sperm capacitation (Khan et al., 1992). 
 It influences sperm competition through allospermicidal properties and modification of 
spermatozoa velocity parameters (Charlesworth & Charlesworth, 1999; Fichtner et al., 
1996). 
 It influences the process of fertilisation through facilitating sperm motility, controlling 
pH, providing nutrients for sperm, the AR and sperm immune defence in the female 
reproductive tract (Arienti et al., 1999; Bencic et al., 2000; Birkhead et al., 1993; 
Buckett & Lewis-Jones, 2002; Camiña et al., 2002; O'Mahony et al., 2000; Vitali et al., 
1995; Wallach et al., 1987;). 
 Sperm competition or sperm selection totally under estimated 
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A large portion of men who are undergoing infertility treatment are oligozoospermic, and this 
has diminished the effectiveness of using sperm as a diagnostic source in the clinical setting, 
especially if the semen sample will be further used in ART. Utilizing seminal plasma as a 
medium for research into possible methods of diagnosis along with improvement of the male 
factor seems only fitting as it contains contributions from various glands and tissues that have 
been consistently demonstrated to have observable effects on sperm characteristics.  
The prostate gland is a heterogeneous, multilobulated gland, consisting of four 
morphologically different zones (Lu et al., 2007). The gland is anatomically located between 
the urogenital diaphragm and the neck of the bladder, and completely envelops both 
ejaculatory ducts and the urethra (Pienta & Esper, 1993). It is a prominent accessory sex gland 
and its main function is to produce and release large amounts (up to 180 mM) of ionized 
derivatives of citric acid in the form of citrate into prostatic fluid as well as several hydrolytic 
enzymes (Kavanagh, 1994). Furthermore, the following compounds are also secreted: zinc, 
prostate-specific antigen (PSA), spermine, cholesterol, magnesium, phospholipids, 
muraminidase, fibrinolysin fibrinogenase and acid phosphatase (Ganong, 1981). Accordingly, 
the amount of citric acid in semen provides an accurate measure of prostate gland secretion 
(Moellering & Gruber, 1966; WHO, 2010). These secretions make up approximately 25% of 
the seminal plasma volume and it has been speculated that citric acid may play a role in 
maintaining the osmotic equilibrium of semen as well as playing a role in sperm energy 
metabolism (Medrano et al., 2006). Reductions in citric acid concentration in the seminal 
plasma, may cause a minor increase in pH which has been found to increase sperm motility 
(Zhou et al., 2015). Prostate specific antigen is a glycoprotein enzyme capable of liquefying 
the seminal coagulum thereby allowing sperm to swim freely (Balk et al., 2003). Zinc released 
by the prostate aids in sperm DNA stabilization and low levels of seminal zinc are correlated 
with low fertility rates (Canale et al., 1986). 
The seminal vesicles are a pair of membranous sacs situated between the rectum and the 
posterior surface of the bladder (Wilson et al., 1997). Their secretions make up approximately 
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65% of the seminal plasma volume. There are a multitude of compounds released by the 
secretory cells found in the epithelial lining of the seminal vesicles, including a variety of 
proteins, prostaglandins, fibrinogen, ascorbic acid, flavins, phosphorycholine (Hafex, 1977; 
Harvey, 1948; WHO, 2010). Fructose is produced primarily by the seminal vesicles with a 
small contribution from the ampulla of the vas deferens (WHO, 2010), and is essential to the 
function of sperm, as well as being a major source of glycolyzable energy necessary for sperm 
motility (Mann, 1946; Schoenfeld et al., 1979). Fructose levels in semen are regularly 
measured in laboratories to diagnose retrograde ejaculation as well as obstructive and non-
obstructive azoospermia (Lu et al., 2007).  Seminal vesicle secretion is also proportional to 
the amount of seminal fructose measured in the ejaculate and it may serve as a marker for 
seminal vesicule function (Gonzales, 2001; WHO, 2010). Extended periods of sperm storage 
cause seminal fructose levels to progressively decrease and lactic acid build-up to occur 
(Mann 1946). Although sperm primarily utilize fructose as their energy source, the enzymatic 
machinery at their disposal allow for equally efficient metabolism of glucose and mannose 
substrates (Mann, 1946). The spermatozoon is highly specialized for motility, capacitation, 
hyperactivation and acrosome reaction which are all highly dependent on the energy state of 
the cell. This state is determined by the ratio between AMP and ATP. In a patient with a low 
ejaculate volume, the absence of fructose indicates ejaculatory duct obstruction, seminal 
vesicle dysfunction or hypoplasia (Aumüller & Riva, 1992). The lower reference limit for 
fructose is 13 µmol per ejaculate (Cooper et al., 1990).   




Figure 2.4. Lateral view of the male reproductive system and accessory sex glands 
(Forbes, 2015). 
The epididymis is a narrow, tightly-coiled tube connecting the posterior part of the testicles to 
the vas deferens. It is anatomically divided into three main zones: the caput, corpus and 
cauda. As mentioned previously, the epididymis plays a crucial role in the maturation of 
spermatozoa and their acquisition of progressive motility and fertilizing capacity. It does this 
by storing and providing passage for immature and immotile spermatozoa to be released 
through the vas deferens and eventually allowing for capacitation post ejaculation (Cooper, 
1996; Haidl & Schill, 1997).  A simple photometric measurement of its activity is conventionally 
useful in assessment of epididymal secretion and function (Mahmoud et al., 1998). Seminal 
neutral alpha-glucosidase (NAG) levels have been observed to be significantly correlated with 
semen volume and pH (Said et al., 2009).  In addition, strong positive correlations between 
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NAG activity and motility development have also been observed (Loko et al., 1997; Viljoen et 
al., 1990).  
Studies analysing an array of epididymal markers such as NAG, carnitine and 
glycerolphosphocholine have been found to be significantly reduced in sub-fertile patients 
(Zöpfgen et al., 2000).  As the length of EA increases, as does the concentration of NAG 
(Elzanaty et al., 2005). This however does not necessarily relate to an increase in the 
enzyme’s activity and requires further investigation.  The levels of seminal alpha-glucosidase 
may also be useful in the differentiation of causes of various cases of azoospermia (Lu et al., 
2006; Mahmoud et al., 1998).  
The percentage change in the concentrations of the selected epididymal and accessory sex 
gland biomarkers, have been widely utilized as clinical reflections of the global changes in the 
volume of secretions from each component (WHO, 2010). Many studies have attempted to 
formulate a specific ratio, which causes variations in these secretions, but there are multitude 
of variables to consider effecting secretion volumes (Elzanaty et al., 2005; Wong et al., 2001; 
Zöpfgen et al., 2000). 
A useful approach to further evaluate the effects which varying concentrations of molecules in 
the semen have on individual sperm, would be to analyse concentrations on a micro scale.  
Considering the total amount of a specific molecule in the ejaculate, and dividing that value by 
the T.S.C., would provide a more representative view of the actual availability of important 
biomolecules to individual sperm. 
2.4. Proteomics  
The broad definition of proteomics can be stated as “The collection of all the proteins 
expressed from the genome in all isoforms, polymorphisms and post-translational 
modifications” (Graham et al., 2005). In human seminal plasma, approximately 10% of the 
proteins are of testicular or epididymal origin, while the rest originate from accessory sex 
glands and other parts of the body (Batruch et al., 2011). Studies have shown that epididymal 
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proteins play a key role in sperm quality and that proteins directly associated with testicular 
function may be found in seminal plasma (Intasqui et al., 2013; Milardi et al., 2012; Pilch & 
Mann, 2006; Wang et al., 2009).  
Due to the wide variation of seminal plasma protein functions and origin, seminal proteins 
have the potential for diagnosis and monitoring of pathways and interactions affecting male 
fertility, such as non-obstructive azoospermia, obstructive azoospermia, asthenozoospermia, 
varicocele and vasectomy (Batruch et al., 2011; Drabovich et al., 2011; Heshmat et al., 2008; 
Intasqui et al., 2013; Wang et al., 2009; Zylbersztejn et al., 2013). Within the rapidly evolving 
field of proteomics, the establishment of extensive databases of a large number of proteins 
specific to the spermatozoa and seminal plasma can allow for research into male fertility, 
extending to scenarios such as diagnostics and subsequent treatment modalities (Oliva et al., 
2009). 
Among the main physiological features necessary for sperm to perform their function, they 
possess vital components which must be considered when assessing protein function and 
origin. Firstly, the presence of active mitochondria and glycolysis, which are important for 
sustaining motility and important for sperm transit through the female reproductive tract to the 
oocyte (Ferramosca et al., 2012). Secondly, an intact and functional acrosome structure which 
is essential for sperm penetration of the zona pellucida (Hsu et al., 1999). Finally, sperm DNA 
integrity of sufficient quality for the production of a viable embryo void of genomic 
imperfections and negative mutations, ideally leading to the development of a healthy baby 
(Shamsi et al., 2008).  
Furthermore, apart from reflecting abnormalities such as, acrosome damage, DNA 
fragmentation and reduction in sperm mitochondrial activity, the seminal plasma proteome 
directly reflects status of important components of spermatogenesis including Sertoli cell 
secretions, as well as agonists/antagonists of epididymal maturation status in 
normozoospermic men (Intasqui et al., 2016).   
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Experimentally, seminal plasma proteins have displayed the ability to regulate sperm function, 
which is substantiated by both human and bovine studies whereby the addition of seminal 
plasma from an ejaculate with highly motile sperm, to sperm with low motility, may improve 
functional sperm parameters (Milardi et al., 2012; Henault & Killian, 1996; Brackett et al., 1996; 
Barbonetti et al., 2013). Furthermore, it was also found that proteins from damaged and 
abnormal sperm may also present throughout the male reproductive tract and were thus 
secreted in seminal plasma (Henault & Killian, 1996).  
The average protein concentration of human seminal plasma ranges from 35 to 55 mg/mL, 
making it an extremely rich source for protein analysis. Specialized methods for proteomic 
analysis of seminal plasma have been developed and a multitude of high-abundance seminal 
proteins have been identified using one-dimensional gel electrophoresis as well as mass 
spectrometry (MS) (Du Plessis et al., 2011). Nonetheless, seminal plasma shares a feature 
with many other body fluids, that it is characterized by a highly dynamic range of proteins, 
making low-abundance components difficult to analyse. Strategic selection of separated 
fractions of the seminal plasma samples may help in preventing large abundance proteins 
from overshadowing the detection of low abundance proteins in MS analysis.  
Thousands of distinct proteins have been identified in human seminal plasma, where 
approximately 25% are secretory. Interestingly, the physiological roles of seminal plasma 
proteins among mammals are highly conserved (Rodríguez‐Martínez et al., 2011). Research 
which has focused on the sperm-specific protein profile has constructed an extensive list of 
cellular maintenance proteins, which contribute to crucial metabolic pathways such as 
glycolysis and oxidative phosphorylation (Johnston et al., 2005). This has linked seminal 
plasma proteins to several vital processes preceding fertilization including capacitation, 
establishment of the oviductal sperm reservoir, modulation of the uterine immune response, 
and sperm transport in the female genital tract, as well as in gamete interaction and fusion 
(Calvete et al., 1994). The most abundant proteins found in seminal plasma are the gel-
forming adhesion proteins: fibronectin, semenogelin I, semenogelin II and laminin (Lilja et al., 
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1987). Lactoferrin, known for displaying antimicrobial properties, is also highly expressed. 
From a preliminary proteomic analysis on seminal plasma from normozoospermic donors, 
prostatic acid phosphatase and prostate-specific antigen were detected in large amounts 
compared to the rest of the spectrum. Prostate specific antigen is a protease released into 
seminal plasma which targets gel forming proteins (Lilja, 1985), whereas prostatic acid 
phosphatase has been found to have a role in the development of cancer in prostate cells 
(Muniyan et al., 2013).  
Similarly to other bodily fluids, serum albumin is found in relatively high amounts in seminal 
plasma. It functions as a transport protein and cholesterol sink which is removed from the 
sperm membrane during capacitation (Pilch & Mann, 2006). Two other proteins of interest are 
alpha-1-antitrypsin and zinc-alpha-2-glycoprotein (ZAG), which have been found to be 
involved in sperm maturation and forward motility (Ding et al., 2007). A study performed by 
Martinez-Heridia et al. (2006) on the sperm proteome found that transcription factors were 
present at the time of the analysis which may insinuate that mature sperm are able to 
synthesize and secrete proteins themselves. 
An extremely important property of proteins is protein phosphorylation. This form of post-
translational modification has the ability to regulate many cellular processes via signal 
transduction pathways. These pathways are generally reversibly controlled by protein 
phosphorylation and require both protein kinases (phosphorylation) and protein phosphatases 
(dephosphorylation). Target proteins are phosphorylated at specific sites by one or more 
protein kinases, and these phosphates are then removed by specific phosphatases (see 
Figure 2.5).  




Figure 2.5. Diagrammatic representation of the mechanism for propagation of a cellular 
signal via phosphorylation of proteins.  
An inactive enzyme is activated by the transfer of a phosphate group from a nucleoside triphosphate 
(usually ATP) to either a serine, threonine or tyrosine side chain of the enzyme. This transfer is 
facilitated by specialized protein kinases (PK) (Burnett & Kennedy, 1954). Reversing the activation and 
reverting the enzyme to its inactive state is achieved by protein phosphatases (PP) which 
dephosphorylate the enzyme (Fischer & Krebs, 1955).  
Many signalling pathways have been comprehensively investigated in somatic cells. However, 
limited information is available on their characterization in spermatozoa, furthermore, there 
have been no comprehensive proteomic analysis to elucidate the mechanisms of very short 
EA in the improvement of semen/sperm quality.  
  




3. Materials and methods  
3.1. Ethical clearance 
The volunteer donors were informed and ensured anonymity by signing a detailed SURRG 
consent form, guaranteeing that the sample donated was to be used solely for research 
purposes and disposed of accordingly following experimental use. Ethical clearance for the 
use of semen samples was granted by the Stellenbosch University Health Research Ethics 
Committee (Ethics Reference: S15/02/045A). 
3.2. Basic semen analysis 
3.2.1. Volunteers 
Freshly ejaculated semen samples were collected from healthy donors with scheduled 
abstinence durations and between the ages of 20 and 25. Information about donor 
identification and age, date of semen collection, time of semen collection, abstinence duration, 
sample volume, pH, appearance, colour, odour, liquefaction, viscosity and agglutination were 
reported. Standard parameters of each sampled were also analyzed including motility, 
morphology and viability. With regards to sample size, a study performed by Yamakawa et al. 
(2007) on the proteomic profiles of 10 donors was able to identify significant protein differences 
between these men. Accordingly, it was decided that the current study was to be performed 
on a slightly larger cohort of 16 normozoospermic donors. 
3.2.2.  Semen sample collection  
All samples were collected according to the WHO guidelines (2010). The first sample from 
each donor was collected after an EA period of exactly 4 days. The second sample was 
collected from the same donor exactly 4 hours subsequent to the first collection. Semen was 
collected by means of masturbation into a labelled sterile wide mouth plastic container in a 
separate room close to the SURRG laboratory. The sample was placed in an incubator (37°C, 
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5% CO2, 30 minutes) within 10 minutes of collection and allowed to fully liquefy before further 
processing.  
3.2.3. Motility  
The sperm concentration and motility/kinematic parameters were determined using CASA and 
the Sperm Class Analyser (SCA) version 5.4, (Microptic, S.L, Barcelona, Spain). The settings 
of the analyzer were as follows: optics, Ph+; contrast, 435; brightness, 100; objective, 10x; 
and 50 images (one second); temperature, 37ºC. The components of the SCA® consist of the 
following: Basler A312fc digital colour camera (Microptic, S.L., Barcelona, Spain), Nikon 
Eclipse 50i Microscope (IMP, Cape Town, South Africa) and a temperature-regulated 
microscope stage (Wirsam Scientific, Cape Town, South Africa). To assess the motility, 2μl of 
semen was pipetted into a single chamber of a four-chamber disposable Leja slide (depth 
20μm; length 21mm) (Leja, Nieuw-Vennep, Netherlands). The motility status of at least 1000 
motile spermatozoa per sample was examined under photo-microscopic capture in at least 5 
randomly selected representative fields (10x objectives). The following motility parameters 
were analysed: Type A, Type B, Type C, Type D as well as a number of kinematic parameters 
including VCL, VSL, VAP, LIN, STR, WOB, ALH and BCF.   
3.2.4. Viability 
Sperm viability was assessed by means of a dye exclusion staining technique (WHO, 2010), 
which is based on the microscopic visualization of dye that has passed through the 
compromised plasma membrane, using the Eosin-Nigrosin stain (Sigma-Aldrich, MO, USA). 
A mixture of 10 μl of 5x106 spermatozoa/ml, 20 μl Eosin and 30 μl Nigrosin was smeared 
across the length of a microscope slide and allowed to air dry at room temperature. The slide 
was then mounted with a coverslip using DPX as a mounting medium (Sigma-Aldrich, MO, 
USA). Thereafter, 100 spermatozoa were counted in duplicate from each sample using the 
SCA counter module of the SCA® system whereby the number of pink-stained (non-viable) 
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spermatozoa and those unstained (viable) were counted in various randomly selected fields. 
Results were expressed as a percentage of viable spermatozoa. 
3.2.5. Storage of samples 
Spermatozoa were isolated from seminal plasma immediately after basic semen analysis, by 
centrifugation where-after the seminal plasma and remaining spermatozoa were separately 
cryopreserved in liquid nitrogen (LN) (-196°C) until further analysis. 
3.3. Epididymal and accessory sex gland biomarkers 
All parameters of samples were analyzed on a FLUOstar™ Omega micro plate reader (BMG 
Labtech, Offenburg, Germany) using commercially available kits. For each kit, a Greiner 96 










Figure 3.1. Summarized procedure for analysis of key epididymal and accessory sex 
gland biomarkers in the seminal plasma. 
 
Removal of aliquots of seminal 
plasma from LN, thawed at room 
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100µL seminal plasma: 
Citric acid assay 
100µL seminal plasma: 
Fructose assay 
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3.3.1. Citric acid assay:  
Seminal plasma citric acid was measured using a commercially available Citric Acid Assay Kit 
(FertiPro, N.V., Belgium). A standard was prepared by mixing 100μL of citric acid standard 
with 100μL of isopropanol. 100µL of isopropanol was added to 100µL of thawed seminal 
plasma from each sample and then centrifuged (2500g, 20 minutes). Following centrifugation, 
25µL of supernatant from each sample pipetted into wells and 200µL of ferric chloride was 
gently added to each well. The Fe3+-ions form a complex with citrate that turns the solution 
into a yellow colour. The intensity of the colour is directly related to the amount of citrate and 
was measured photometrically at wavelength 405nm using the microplate reader. The normal 
citric acid value is 10mg or more per ejaculate. The measured optical density (OD) for the 
sample was divided by the OD from the standard and multiplied by the concentration of the 
standard (4mg/ml). Citric Acid mg/ml = 
OD Sample
OD Standard
 x 4mg/ml (see Appendix A, Table 7.1) To 
obtain total citric acid amounts, we multiplied the result with the total volume of the semen 
sample or seminal plasma. To obtain the absolute amount of citric acid per sperm, the citric 
acid content per ejaculate was divided by the T.S.C.  
3.3.2. Fructose assay 
Seminal plasma fructose was measured using a commercially available Fructose Assay Kit 
(FertiPro N.V., Belgium). 100µL of thawed seminal plasma from each sample was 
deproteinized by the addition of 500µL of a Trichloroacetic (TCA) solution and centrifuged 
(x1000 g, 10 minutes). A standard curve with a range of fructose concentrations from 0 to 
5mg/mL was calculated according to the set instructions. Following centrifugation, 20μL of the 
resultant supernatant that formed was pipetted into an Eppendorf tube. At 37°C and low pH 
(addition of 200µL 32% HCl), 20µL of indole was added to the isolated seminal plasma where 
it formed a colorimetric complex with fructose. The samples were left in the water bath for 30 
minutes when 200µL of 0.5M NaOH was added to each tube stop the colour reaction. All 
samples, blanks and standards were prepared in duplicate.  
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This complex was measured photometrically at a wavelength 470nm. All absorbance values 
were transferred to an excel sheet supplied by the manufacturer which converts absorbance 
values into fructose concentration (mg/mL) (see Appendix A, Table 7.2). Normal values 
according to the WHO laboratory manual (fifth edition) are 2.4mg/ejaculate or more and 
13µmol/ejaculate or more.  
3.3.3. Episcreen plus™- Neutral alpha-glucosidase assay: 
Seminal plasma neutral α-glucosidase was quantified using the EpiScreen Plus™ (FertiPro 
N.V., Belgium) assay. Under specified conditions (pH = 6.8; 37°C), 1IU of alpha-glucosidase 
liberates 1µM Para (4)-Nitrophenol (PNP) per minute from substrate Para (4)-Nitrophenyl-
alpha-D-glucopyranoside (PNPG7). For each thawed seminal plasma sample, a reaction 
solution and an inhibitor solution was prepared in separate Eppendorf tubes with 20µL of 
seminal plasma in each. The reaction solution contained 3µL of 50x substrate solution (Para 
(4)-Nitrophenyl-alpha-D-glucopyranoside (PNPG) in Dimethyl sulfoxide (DMSO)) in 147µL of 
reaction buffer (pH 6.8), supplemented with sodium dodecyl sulfate (SDS). The inhibitor 
solution contained 3µL of 50x substrate solution in 147µL inhibitor solution (reaction buffer 
containing glucose) which acted as a negative control. The reaction and inhibitor solutions for 
each sample were vortexed and then incubated in a warm water bath (37oC, 120 min). During 
incubation, para (4)-nitrophenol standard dilutions were made using 5mM standard stock 
solution and standard dilution buffer (0.03M NaOH + 0.1% SDS) as directed in the provided 
instructions.  
After incubation, 1mL of stopping buffer (0.02M NaOH) was added to each tube. The tubes 
were vortexed and 200µL of each tube (including standards) were pipetted into separate wells 
on the 96-well plates. The amount of yellow colour was measured spectrophotometrically at 
405nm. Alpha-glucosidase activity is expressed as IU/Litre (or mIU/mL). The lower and upper 
detection limit for total alpha-glucosidase is 12 - 100 mIU/mL, and 2 - 15mIU/mL for NAG. All 
absorbance values were transferred to an excel sheet supplied by the manufacturer which 
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converts absorbance values into alpha-glucosidase concentration (mIU/mL) and total alpha-
glucosidase values (see Appendix A, Table 7.3).  
Once the amounts of all 3 epididymal and accessory sex gland biomarkers per ejaculate were 
calculated, these values were then divided by the corresponding T.S.C. values to provide an 
amount per sperm.  
3.4. Statistical analysis of basic semen parameters and epididymal and accessory 
sex gland biomarkers. 
Comparisons between parameters measured after long and short EA were performed using 
the Students paired t-test  for normally distributed data sets and Mann-Whitney U-tests for 
nonparametric data sets, on GraphPad Prism© version 7.00 for Windows (GraphPad Software, 
La Jolla California, USA).  All values are presented as mean ± SE. Statistical significance was 
set at p<0.05. 
3.5. Proteomic Analysis 
Proteomic analysis was performed with the aid of the Central Analytics Facility 
Proteomics unit, following the protocol provided by an expert in the field of protein 
analysis and LC-MS/MS. 
3.5.1. Sample preparation and SDS-PAGE 
The protein concentration of each of the 16 samples was measured using the Direct Detect® 
Infrared Spectrometer where 2 µl of sample made up in Laemmli sample buffer were spotted 
on specialized strips which were inserted into the Spectrometer and values were calculated. 
Samples were then pooled randomly in 4 groups consisting of 4 samples each, where each 
sample contributed an equal amount of protein (60µg). The combined volumes of each pool 
were made to be 25µL by addition of 1X Phosphate-buffered saline (PBS).   
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Thereafter, 25 µL of each sample pool was loaded onto 12% Criterion TGX precast gels (Bio-
Rad, CA, USA) and run for 45 min at 200 volts in Laemmli electrophoresis running buffer (Bio-
Rad, CA, USA).  After the run, gels were fixed in a fixative (40% Methanol; 7% Acetic acid) 
while gently shaken for 60 min at room temperature. This was followed by staining with 
“Brilliant Blue G –Colloidal Concentrate” (Sigma-Aldrich, MO, USA) for 30 minutes at room 
temperature using gentle shaking; (40 mL stain + 10 mL Methanol). The gels were then de-
stained in 25% Methanol with gentle shaking at room temperature, until the protein bands 
became visible and the background clear (± 4 hours). Gels were stored in milli-Q water at 4°C 
until processed.  
3.5.2. In-gel Digestion 
All reagents used were analytical grade or equivalent and all H2O was Milli-Q filtered. Each 
pooled protein column was excised into 7 pieces which each clearly displaying a concentrated 
band of proteins (see Figure1.1), with a new surgical - grade scalpel and placed into separate 
marked Eppendorf 1.5 mL tube. Gel slices were de-stained with 200 mM NH4HCO3:acetonitrile 
50:50 (Sigma-Aldrich, MO, USA) until clear. Samples were dehydrated and desiccated before 
reduction with 2 mM triscarboxyethyl phosphine (TCEP; Fluka® Analytical, St. Gallen, 
Switzerland) in 25 mM NH4HCO3 for 15 minutes at room temperature with agitation. Excess 
TCEP were removed and the gel pieces again dehydrated. Cystein residues were 
thiomethylated with 20 mM S-Methyl methanethiosulfonate (Sigma-Aldrich, MO, USA) in 25 
mM NH4HCO3 for 30 minutes at room temperature. After thiomethylation the gel pieces were 
dehydrated and washed with 25 mM NH4HCO3 followed by another dehydration step. Proteins 
were digested by rehydrating the gel pieces in trypsin (Pierce MS grade, Thermo Fisher 
Scientific, MS, USA) solution (20ng/µL) and incubating at 37 °C overnight. Peptides were 
extracted from the gel pieces once with 50µL water and once with 50% acetonitrile. The 
samples were dried down and re-suspended in 30µL 2% acetonitrile:milli-Q water; 0.1% formic 
acid (Sigma-Aldrich, MO, USA). 
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Residual digest reagents were removed using an in-house manufactured C18 stage tip 
(Empore Octadecyl C18 extraction discs placed in a pipette tip; Supelco® Analytical, MO, 
USA). The samples were loaded onto the stage tip after activating the C18 membrane with 
30µL methanol (Sigma-Aldrich, MO, USA) and equilibration with 30µL 2% acetonitrile: milli-Q 
water; 0.05% TFA. The bound sample was washed with 30µL 2% acetonitrile: milli-Q water; 
0.1% TFA before elution with 30 µL 50% acetonitrile: milli-Q water 0.05% TFA. The eluate 
was evaporated to dryness using a SpeedVac (Eppendorff, HH, Germany). The dried peptides 
were dissolved in 2% acetonitrile: milli-Q water; 0.1% FA for LC-MS/MS analysis. 
3.5.3. Liquid chromatography 
Liquid chromatography was performed on a Thermo Scientific Ultimate 3000 RSLC (Thermo 
Fisher Scientific, MS, USA) equipped with a 2cm x 100µm C18 trap column and a 35cm x 
75µm C18 (Luna C18, 5µm; Phenomenex Inc., CA, USA) analytical column. The solvent 
system employed was loading: 2% acetonitrile: milli-Q water; 0.1% FA; Solvent A: 2% 
acetonitrile: milli-Q water; 0.1% FA and Solvent B: 100% acetonitrile: milli-Q water. The 
samples were loaded onto the trap column using loading solvent at a flow rate of 15µL/min 
from a temperature controlled auto-sampler set at 7°C. Loading was performed for 5 min 
before the sample was eluted onto the analytical column. Flow rate was set to 500nL/min and 
the gradient generated as follows: 2.0% - 10% B over 5 min; 5% - 25% B from 5 - 50 minutes 
using Chromeleon non-linear gradient 6, 25%-45% from 50 - 65 minutes, using Chromeleon 
non-linear gradient 6. Chromatography was performed at 50°C and the outflow delivered to 
the mass spectrometer through a stainless steel nano-bore emitter. 
3.5.4. Mass spectrometry 
Mass spectrometry was performed using a Thermo Scientific Orbitrap Fusion mass 
spectrometer (Thermo Fisher Scientific, MS, USA) equipped with a Nanospray Flex ionization 
source. The sample was introduced through a stainless steel emitter. Data was collected in 
positive mode with spray voltage set to 2kV and ion transfer capillary set to 275°C. Spectra 
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were internally calibrated using polysiloxane ions at m/z = 445.12003 and 371.10024. MS1 
scans were performed using the Orbitrap detector set at 120 000 resolution over the scan 
range 350-1650 with AGC target at 3 E5 and maximum injection time of 40ms. Data was 
acquired in profile mode. 
The second mass spectrometry acquisitions were performed using monoisotopic precursor 
selection for ion with charges +2 - +6 with error tolerance set to +/- 0.02ppm. Precursor ions 
were excluded from fragmentation once for a period of 30 seconds. Precursor ions were 
selected for fragmentation in Higher-energy collisional dissociation (HCD) mode using the 
quadrupole mass analyzer with HCD energy set to 32.5%. Ion fragments were detected in the 
Orbitrap mass analyzer set to 15 000 resolution. The autmomatic gain control (AGC) target 
was set to 1E4 and the maximum injection time to 45 milliseconds. The data was acquired in 
centroid mode. 
3.5.5. Bioinformatics 
The raw files generated by the mass spectrometer were imported into Proteome Discoverer 
v1.4 (Thermo Fisher Scientific, MA, USA) and processed using Sequest algorithm. Database 
interrogation was performed against a concatenated database created using the Uniprot 
human database with semi-tryptic cleavage allowing for 2 missed cleavages. Precursor mass 
tolerance was set to 10ppm and fragment mass tolerance set to 0.02 Da. Protein N-terminal 
acetylation, deamidation (NQ) and oxidation (M) was allowed as dynamic modifications and 
thiomethyl of C as static modification. Peptide validation was performed using the peptide 
validator node set to search against a decoy database with strict FDR 1%.  The results files 
were imported into Scaffold 1.4.4 and identified peptides validated using the X!Tandem search 
algorithm included in Scaffold. Peptide and protein validation was performed using the Peptide 
and Protein Prophet algorithms. Protein quantitation was done using a t-test on the paired 
data with the Hochberg-Benjamini correction applied. Pathway analysis was then performed 
using Reactome.org database and string-db.org to formulate extensive networks of 
intracellular and extracellular protein interactions. 





Figure 3.2. Summarized procedure for analysis of seminal plasma proteome 
  
Removal of aliquots of 
seminal plasma from liquid 
N+, thawed at room 
temperature. N = 16 
1D-Gel Electrophoresis 






Pool samples randomly and 
measure protein content 
using Direct Detect© 












The results will be presented in 3 distinct stages, the first being the assessment of basic semen 
parameters accompanied by extensive motility and kinematic analysis of samples provided 
after both EA periods. Secondly, the measurement of the epididymal and accessory sex gland 
biomarkers in the seminal plasma and how they are influenced by T.S.C will be presented. 
Finally, the identification of proteins differentially expressed after each EA period and the 
cellular processes in which they are involved will be highlighted in great detail.  
4.1. Objective 1: Basic semen analysis and sperm motility parameters 
As displayed in Table 4.1, basic semen parameters were mostly aligned with previous 
literature showing significant decreases in semen volume, sperm concentration and T.S.C. 
after 4 hours of EA when compared with 4 days. Semen pH was slightly, yet significantly 
increased after 4 hours of EA, accompanied by significant improvements in both total motility 
and progressive motility. Viability slightly decreased after 4 hours of EA and no significant 
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Table 4.1. Representative summary of the differences observed amongst the macro- 
and microscopic semen and spermatozoa parameters (mean ± SEM). 
Conc. = Concentration, EA = Ejaculatory abstinence, T.S.C. = Total sperm count, WHO = World Health 
Organisation 
Significant increases in rapid swimming sperm, curvilinear velocity, straight line velocity and 
average path velocity were observed in sperm after short EA when compared to long EA. The 
increase in the percentage of rapid swimming sperm was accompanied by a significant 
decrease in the percentage of slow swimming sperm (see Table 4.2).  Figure 4.1 displays the 
relationships between each of the measured kinematic parameters after 4 days and 4 hours 

























2.56 ± 0.33 1.74 ± 0.22 No - 0.025 -32% 1.5 or more 
Sperm conc. 
(x106/mL) 
57.35 ± 7.2 36.83 ± 4.51 No - 0.018 -36% 15 or more 
T.S.C. 
(x106/ejaculate) 
144.68 ± 22.77 58.01  ± 6.43 Yes 0.0007 - -77% 39 or more 
pH 7.68 ± 0.029 7.76 ± 0.038 No - 0.046 1% 7.2 - 8 
Viability (%) 73.06 ± 1.57 69.94 ± 1.67 Yes 0.032 - -4% 58 or more 
Total motility (%) 64.71 ± 13.94 71.84 ± 3.85 Yes 0.033 - 14% 40 or more 
Progressive 
motility (%) 
47.73 ± 14.33 58.54 ± 13.38 Yes 0.001 - 30% 32 or more 
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Rapid (%) 47.09 ± 3.61 57.53 ± 3.44 Yes 0.023 - 
Medium (%) 5.74 ± 0.61 5.15 ± 0.5 No - 0.25 
Slow (%) 11.69 ± 0.73 9.15 ± 0.68 Yes 0.0005 - 
VCL (µm/s) 78.61 ± 4.03 91.78 ± 6.23 No - 0.137 
VSL (µm/s) 29.66 ± 1.2 34.95 ± 1.41 No - 0.006 
VAP (µm/s) 49.71 ± 2.05 57.89 ± 2.72 No - 0.018 
LIN (%) 38.28 ± 1.07 39.53 ± 1.77 Yes 0.476 - 
STR (%) 60.04 ±  1.39 61.11 ± 1.81 Yes 0.318 - 
WOB (%) 63.73 ± 1.0 64.27 ± 1.3 Yes 0.571 - 
BCF (Hz) 13.34 ± 0.62 14.89 ± 0.64 Yes 0.068 - 
ALH (µm) 2.23 ±  0.11 2.27 ±  0.15 Yes 0.865 - 
CASA = Computer aided sperm analysis, EA = Ejaculatory abstinence, Rapid = Rapid swimming sperm, 
Medium = Medium swimming sperm, Slow = Slow swimming sperm, VCL = Curvilinear velocity, VSL = 
Straight line velocity, VAP = Average path velocity, LIN = Linearity index, STR = Straightness index, 
WOB = Oscillation index, BCF = Beat cross frequency, ALH = Amplitude of lateral head displacement, 
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Figure 4.1: Radar plots of kinematic parameters from individual samples (N=16) for 4 days and 
4 hours of EA. 
Sample numbers are represented on the perimeters, and the radii demonstrate the percentage of 
sperm, velocity (µm/s) or displacement (µm) in the respective group. VAP = Average path velocity, 
VSL = Straight line velocity, VCL = Curvilinear velocity, LIN = Linearity index, WOB = Oscillation 
index, STR = Straightness index, BCF = Beat cross frequency, ALH = Amplitude of lateral head 
displacement EA = Ejaculatory abstinence. 
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4.2. Objective 2: Epididymal and accessory sex gland biomarker analysis 
Citric acid, NAG and fructose concentrations were all significantly reduced after 4 hours of EA 
when compared to 4 days (see Table 4.3). As expected, all epididymal and accessory sex 
gland biomarkers significantly reduced per ejaculate after 4 hours. On the contrary, when 
considering T.S.C., the absolute amount of citric acid per sperm was significantly increased 
after 4 hours of EA and fructose per sperm significantly decreased. There was no observed 
change in alpha-glucosidase per sperm. 
Table 4.3: Summary of accessory gland biomarkers as measured using commercially 
available kits (mean ± SEM) 













8.01 ± 1.352 5.96 ± 1.232 No - 0.032 -25% 6.7 or more 
Citric acid per 
sperm (ng) 
0.141 ± 0.025 0.254 ± 0.056 No - 0.034 110% - 
Total citric acid 
(mg/ejaculate) 
14.68 ± 1.317 10.22 ± 1.042 Yes 0.005 - -27% - 
Fructose 
(mg/mL) 
4.07 ± 0.77 1.66 ± 0.52 No - 0.015 -54% 1.6 or more 
Fructose per 
sperm (ng) 
0.045 ± 0.016 0.036 ± 0.011 Yes 0.037 - -38% - 
Total fructose 
(mg/ejaculate) 
8.478 ± 2.011 2.242 ± 0.707 No - 0.001 -63% - 
NAG (mIU/mL) 29.32 ± 3.53 19.92 ± 3.61 Yes 0.005 - -33% 2 – 15 
NAG per sperm 
(nIU) 
0.563 ± 0.08 0.145 ± 0.128 No - 0.638 6% - 
Total NAG 
(mIU/ejaculate) 
71.41 ± 13.30 28.18 ± 3.536 No - 0.001 -53% - 
EA = Ejaculatory abstinence, NAG = Neutral alpha-glucosidase, WHO = World Health Organisation.
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4.3. Objective 3: Proteomic analysis  
LC-MS/MS analysis was successful in identifying a total of 1765 proteins expressed in the seminal plasma of all of the samples which 
originate from a multitude of cells, tissues and glands in the male reproductive system. A total of 19 proteins were identified to be significantly 
upregulated after 4 days of EA when compared to 4 hours, and 3 proteins significantly upregulated after 4 hours of EA compared to 4 days (see 
Tables 4.3 and 4.4).  














Q9UM22 EPDR1 25.4 0.0015  Extracellular (secreted) 
Possible role in calcium dependent cell adhesion (Gregorio-
king et al., 2002) 
Transforming growth factor beta-1 P01137 TGFB1 44.3 0.0045  Extracellular (matrix) 
Controls proliferation, differentiation and other functions in 
many cell types (Chang et al., 2015) 
26S proteasome non-ATPase 
regulatory subunit 8 
P48556 PSMD8 39.6 0.0068  
Cytosol, extracellular 
(exosome), nucleus and 
various proteasome 
complexes 
ATP-dependent degradation of ubiquitinated proteins 
(Kanayama et al., 1992) 
Tandem C2 domains nuclear 
protein 
Q8N9U0 TC2N 58.3 0.0068  Nucleus 
Regulation of blood coagulation and gene expression (Antoni 
et al., 2011) 
Ras-related protein Rab-13 P51153 RAB13 22.8 0.0087  
Plasma membrane, Golgi 
apparatus (trans-Golgi 
network membrane), 
endosome and tight 
junctions. 
Key regulators of intracellular membrane trafficking (Marzesco 
et al., 2002) 
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Ig lambda chain V-I region P04208 IGLV1-47 12.3 0.01  
Extracellular (secreted) 
and plasma membrane 
Participates in antigen recognition (Lefranc, 2014) 
Limbic system-associated 
membrane protein 
Q13449 LSAMP 37.3 0.013  Plasma membrane 
Mediates selective neuronal growth and axon targeting 
(Pimenta et al., 1995) 
Transketolase-like protein 1 P51854 TKTL1 37.4 0.015  Nucleus and cytoplasm 
Catalyzes the transfer of a two-carbon ketol group from a 
ketose donor to an aldose acceptor (Coy et al., 2005) 
Phosphatidylethanolamine-binding 
protein 4 
Q96S96 PEBP4 25.7 0.021  Lysosome 
Postulated as having several roles in the male reproductive 
system 
(Frayne et al., 1988) 
Rho GTPase-activating protein 1 Q07960 ARHGAP1 50.4 0.029  Cytoplasm 
Able to induce dynamic rearrangements of the plasma 
membrane-associated actin cytoskeleton (Aspenstrom et al, 
2004) 
Ubiquitin-conjugating enzyme E2 
K 
P61086 UBE2K 17.1 0.029  Cytoplasm 
Accepts ubiquitin from the E1 complex and catalyzes its 
covalent attachment to other proteins (Kalchman et al., 1996) 
Heat shock-related protein A2 P54652 HSPA2 70 0.03  Cytoskeleton (spindle) 
Molecular chaperone involved in a wide variety of cellular 
processes related to male fertility (Radons, 2016). 
2,4-dienoyl-CoA reductase, 
mitochondrial 
B7Z6B8 DECR1 35 0.031  Mitochondrion 





Q9UBQ7 GRHPR 35.7 0.033  
Cytosol, extracellular 
(exosome) and peroxisome 
(matrix)  
Hydroxy-pyruvate reductase, glyoxylate reductase and D-
glycerate dehydrogenase enzymatic activities (Mdluli et al., 
2005). 
14 kDa phosphohistidine 
phosphatase 
Q9NRX4 PHPT1 14 0.036  Cytoplasm 
Phosphohistidine phosphatase activity affecting metabolic and 
immune system functioning (Krieglstein et al., 2008; Srivastava 
et al., 2008) 
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Ropporin-1B (Fragment) D6RCR2 ROPN1B 15 0.041  Unknown Unknown  
Isoform 7 of Complement decay-
accelerating factor 
P08174-7 CD55 41.4 0.044  Plasma membrane 
Virus receptor activity and complement activation (Ward et al., 
1994)  
Sperm protein associated with the 
nucleus on the X chromosome B1 
Q9NS25 SPANXB1 11.8 0.045  Nucleus and cytoplasm Spermatid development (Westbrook et al., 2000) 
Transmembrane protease serine O15393 TMPRSS2 53.8 0.050 
Plasma membrane and 
extracellular (secreted) 
Serine protease that proteolytically cleaves and activates the 
viral spike glycoproteins which facilitate virus-cell membrane 
fusions (Shulla et al., 2011) 
Metalloproteinase inhibitor P01033 TIMP1 23.2 0.054 Extracellular (secreted) 
May act as a growth factor to regulates cell differentiation, 
migration and cell death (Chesler et al., 1995) 
 









Cellular localization  
(via Uniprot.org) 
Description 
Isoform 5 of Tropomyosin alpha-3 
chain  
P06753-5 TPM3 29  0.04  Cytoskeleton 
Central role, in association with the troponin complex, in 
the calcium dependent regulation of vertebrate striated 
muscle contraction (Janco et al., 2012) 
Calcium-binding protein 39  Q9Y376 CAB39 39.9 0.036  Cytoplasm 
Stabilized the LKB1-STRAD-MO25 complex which  has 
cellular signalling ramifications (Zeqiraj et al., 2009) 
Deoxyribonuclease-1  P24855 DNASE1 31.4 0.047  
Extracellular (secreted), 
nucleus (envelope) 
Involved in cell death by apoptosis 
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As illustrated in Figure 4.3 a), 60% of proteins identified are involved cellular processes and 
40% and 45% are involved in metabolic processes and biological regulation respectively. 
Furthermore, 8% of the identified proteins play roles in both reproduction and reproductive 
processes. Additionally, of the 2 differentially expressed proteins between the two EA periods, 
a similar trend of cellular processes is displayed with 76% of proteins involved in cellular 
processes and 45% and 52% involved in metabolism and biological regulation respectively 
(see Figure 4.3 b). Interestingly, a large proportion (40%) of the differentially expressed 








Figure 4.2: Venn diagram of proteins displaying number of differentially expressed 
proteins in each cohort  





























Figure 4.3: Proteomic data and significantly upregulated proteins from each cohort. 
a) Total number of proteins identified in this study related to each biological process. b) Number of 
differentially expressed proteins identified in this study related to each biological process.  
a) 
b) 





The discussion will be divided into three objectives as presented in the results of Chapter 4. 
Firstly, the evaluation of basic and functional sperm parameters measured after 4 days and 4 
hours of EA, followed by the biochemical analysis of important epididymal and accessory sex 
gland biomarkers in seminal plasma after both EA periods covered in objective 2 will be 
discussed. Lastly, proteomic analysis of the seminal plasma of both cohorts as well as the 
results of pathway analysis of differentially expressed proteins will be explored.  
5.1. Objective 1: Evaluate the relationship between 4 days and 4 hours of EA 
by comparing basic semen parameters such as pH and volume, as well as 
sperm parameters including concentration, total sperm count (T.S.C.), 
motility and kinematics. 
The results of this study shows that conventional and functional semen parameters were 
influenced significantly by different lengths of EA. A short period of EA (4 hours) produced 
significant reductions in semen volume, T.S.C. sperm concentration accompanied by 
significant increases in both sperm motility and progressive motility. Furthermore, the 
percentage of viable sperm slightly yet significantly reduced after short EA and no significant 
morphological abnormalities were observed in either cohort.  
Two substantially larger studies than indicated above and performed by Comar et al. (2017) 
and Levitas et al.  (2005), also observed a significant positive relationship between EA period 
and sperm T.S.C., sperm concentration and semen volume. In the case of the shorter EA 
period, the sperm reserves were depleted and T.S.C. decreased (Rao et al., 2015), which may 
be attributed to the insufficient time for the epididymis and accessory sex glands to produce 
their respective secretions, resulting in reduction in semen volume associated with short 
abstinence (Levitas et al., 2004). 
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After 4 hours of EA, the release of spermatozoa may reduce exposure to the above-proposed 
motility-inhibiting factors which may therefore reduce the severity of the adverse effects on 
sperm functional parameters. Since spermatogenesis takes approximately 74 days and 
epididymal maturation a further 2 to 11 days, the sperm released after 4 days and 4 hours of 
EA are of relatively similar age which is confirmed in the morphological assessment, as no 
significant morphological differences were observed, thus implying similar developmental 
conditions. This would indicate that no major differences in spermatogenesis have occurred, 
which can influence sperm development and subsequent sperm function once ejaculated. 
Likewise, the lack of significant effects of short EA periods on sperm morphology have been 
widely reported (Choavaratana et al., 2014; Mayorga-Torres et al., 2016; Mayorga-Torres et 
al., 2015; Sunanda et al., 2014) 
These effects are ascribed to the fact that sperm reserves were available and stored in the 
cauda epididymis or that sperm morphology is not necessarily a good reflection of sperm 
functionality. As mentioned above, sperm transit time through the epididymis takes between 
2 and 11 days (Yanagimachi et al., 1994) yet frequent ejaculations have been noted to reduce 
this transit time. Decreasing sperm stagnancy in the epididymis may lead to recently mature 
sperm to dominate the ejaculate and prevent them from being exposed for prolonged periods 
to harmful ROS released by immature spermatozoa, which is known to cause extensive 
adverse effects on sperm function and vitality (Argarwal et al., 2014).  
Motility reductions after prolonged EA have been attributed to increased levels of reactive 
oxygen species (ROS) and subsequent DNA damage in stored sperm (Comar et al., 2017 and 
Levitas et al., 2005). Both damaged spermatozoa (Iwasaki et al., 1992) and infiltrating 
leukocytes (Kessopoulou et al., 1994) were suggested as sources of ROS amongst these 
latent sperm yet increased ROS and subsequent oxidative stress, may originate from both 
endogenous (pathophysiology’s and physiological events in sperm) and exogenous 
(chemicals, toxins and environmental factors) sources, which subsequently lead to damaging 
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reactions in the spermatozoon including, lipid peroxidation, DNA damage and initiation of 
apoptosis (see Figure 5.1).  
 
Figure 5.1: Oxidative stress in male reproduction (adapted from Kothari et al., 2010). 
In the current study, progressive motility increased by 30%, which is nearly double that of the 
increase observed in total motility. This supports the assumption that very short EA periods 
increase sperm functionally, thus potentially increasing fertilizing capacity (Alipour et al., 2015; 
Ayad et al., 2017; Bhahadur et al., 2016). The reduced time in which the 4 hour EA sperm are 
exposed to epididymal fluid, along with fewer sperm and thus more energy available for 
motility, may be reasons for these observations. As the epididymal media surrounding sperm 
is regularly renewed, the constant interactions between secreted molecules by sperm and 
tubular epithelia have direct effects on sperm stored in the epididymis (Yanagimachi et al., 
1994). In the context of this study, the rate at which this epididymal media is renewed is of 
particular interest and will undoubtedly play a large role in how sperm are affected by 
epididymal transit durations and EA in general.  
Furthermore, velocity and kinematic parameters provided by CASA, the percentage of rapidly 
swimming sperm significantly increased after 4 hours of EA, whereas the percentage of slow 
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swimming sperm significantly decreased (see Table 4.2). Studies have shown that VCL and 
VSL of spermatozoa can be correlated with improved rate of fertilisation (Liu et al., 2004), 
while ALH has previously been correlated with the efficacy of cervical mucus penetration 
(Aiken et al., 1986).  The observed increase in rapid swimming and decrease in slow 
swimming sperm (with no change in the percentage of medium velocity swimming sperm) 
equates to an improvement in sperm motility which was accompanied by significant increases 
in VSL and VAP. These are all highly useful parameters for assessing sperm motion (Hatef et 
al., 2013).  
Sperm hyperactivation (HA) assessment must ideally be performed using CASA and relies on 
reference limits explicitly stated by Mortimer et al. (2015). VCL must be greater than 150 µm/s; 
LIN must be less than 50% and ALH must be greater than 3.5 µm. The causation for these 
velocity results must then lie with either intrinsic activation of flagellar movement after 4 hours 
of EA via signalling molecules, or variations in seminal plasma conditions (e.g. pH and 
available energy).  
  




5.2. Objective 2: Investigate the role of prominent accessory sex gland 
biomarkers in abstinence and how they relate to sperm functional 
parameters. 
The WHO (2010) explicitly state normal ranges and lower reference limits of the 3 biomarkers 
measured in this study. Concentration measurements revealed citric acid to fall below the 
lower reference limit after 4 hours of EA (see Table 4.3) and both fructose and NAG remained 
above the lower reference limits. Interestingly, once T.S.C. was considered for each 
epididymal and accessory sex gland secretion, a substantial increase in citric acid available 
per sperm was observed accompanied by a slight decrease in the amount of available 
fructose.  
The results of this study bring citric acid to the fore, due to the fact that per sperm, citric acid 
increased by 110% after short EA when compared to long EA, whereas fructose decreased 
by 38% after short EA.  
Seminal fructose is considered to be the primary source of energy with direct effects on sperm 
motility (Mann, 1946), and interestingly, did not increase to account for the observed 
enhancement of sperm motility after 4 hours of EA. It however significantly decreased which 
would further reiterate the assumption that an alternative source of energy must be 
responsible for increased sperm motility. Patel et al. (1988) found direct positive correlations 
between seminal fructose levels and the percentage of motile sperm and this has been 
explained by the presence of glycolytic enzymes concentrated in the principal piece in the 
sperm flagellum (Eddy et al., 2003; Storey & Kayne, 1975; Travis et al., 1998) therefore the 
breakdown of fructose in glycolysis could produce ATP adjacent to the site where it is required. 
Furthermore, it has been suggested that glycolysis in the principal piece of the flagellum, is 
critical for normal sperm motility (Turner, 2003).  Therefore, the observed increases in sperm 
motility cannot be ascribed to fructose and alternative energy sources should be responsible. 
This proposes citric acid as a possible source of energy due to its significant increase seen 
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after short EA. Second to this, an alternative explanation might be related to the change 
observed in pH. 
The fragile microenvironment created by the testes, epididymis and accessory sex glands has 
been found to actively manipulate the basic and functional sperm parameters including semen 
pH and volume, as well as sperm motility and fertilizing capacity. Studies have found EA of 2 
days, to be associated with decreased prostatic secretions and increased epididymal 
secretions (Elzanaty, et al., 2005). However, little is known about the variations in seminal 
accessory gland secretions after EA periods of less than 1 day. 
A previous study performed by Medrano et al. (2006), found that citric acid acts as a substrate 
for energy metabolism in sperm in addition to causing slight variations in seminal plasma pH. 
However, its relationship with, and role in abstinence has not been elucidated.  
Considering our paradoxical results, there are two possible mechanisms by which citric acid 
may affect sperm motility. Either the influence of sperm metabolism providing energy for 
flagellar movement via increased mitochondria processing utilizing the citric acid cycle, or the 
indirect increase of seminal pH which, according to various studies, has positive effects on 
sperm motility within the range of 7.2 – 8.2.  
The direct mechanism mentioned above, consists of the increase in available amount of 
citrates per sperm, for utilization in the citric acid cycle to provide energy for sperm motility, 
seeing that there is more citric acid per sperm available after short EA. Sperm are capable of 
producing ATP by glycolysis and by oxidative phosphorylation; however, the glycolytic 
pathway is found to dominate ATP production (Visconti et al., 2012). As mentioned previously, 
spermatozoa primarily utilize fructose originating from the seminal vesicles, as a source of 
carbohydrates however, other glycolyzable substrates including glucose, mannose and 
sorbitol are also effective in sustaining sperm motility through glycolysis (Visconti, 2012). Once 
absorbed by sperm, it is then broken down into glucose and converted to acetyl-coenzyme A 
(CoA), which drives the citric acid cycle ultimately leading to the production of utilizable energy 
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in the form of Adenosine Triphosphate (ATP) produced by the electron transport chain (Figure 
5.1). Furthermore, it has been shown that spermatozoa pre-incubated in citrate increase their 
ATP production without the addition of fructose (Medrano et al., 2006). It is believed that this 
occurs when excess extracellular citrates are converted to malate or pyruvate by a series of 
enzymes, which are subsequently utilized in the citric acid cycle in sperm mitochondria 
(Visconti, 2012).  
On the other hand, the potential role of citric acid in improving sperm motility after short EA 
might also be explained through a more indirect mechanism. The decrease in citric acid after 
4 hours of EA was also accompanied by an overall increase in pH of the seminal plasma. As 
citric acid is acidic (1mM citric acid solution pH = 2.2, Silva et al., 2009), the reduction in 
concentration in the semen may cause pH to increase, and it has been reported that this 
increase in alkalinity creates a more conducive environment for spermatozoa, which has been 
shown to enhance their motility (Zhou et al., 2015). The exact mechanism by which pH alters 
sperm motility is not clear, yet it is well recognized (Makler et al., 1981; Carr et al., 1985; 
Ingermann et al., 2002). However, it has been speculated that pH affects the activity of the 
alpha-4-isoform of the Na+/K+-ATPase, which controls the transmembrane Na+ gradient in 
sperm flagella by keeping the intracellular Na+ concentration low which is crucial to many 
general and cell-specific processes (Zhou et al., 2015). In support of this, α4-isoform knockout 
mice have been reported to produce predominantly immotile sperm (Jimenez et al., 2011). 
This may explain the observed increases in total sperm motility and progressive motility when 
sperm are exposed to increasing alkalinity. The ideal pH for sperm to function adequately is 
between 7.2 and 8.2 yet motility increases as the pH increases in this range (Zhou et al., 
2015). 




Figure 5.2: Glycolysis and Citric acid cycle in sperm mitochondria 
Fructose enters the glycolytic pathway after phosphorylation by hexokinase and is subsequently 
converted to pyruvate via glycolysis to be used in the citric acid cycle. The entire citric acid cycle occurs 
within the inner mitochondrial wall. Pyruvate can enter the mitochondria through specific transporters 
where it can be oxidized to acetyl-coenzyme A (CoA) and CO2. Acetyl-CoA then enters the citric acid 
cycle, which generates one high-energy bond in the form of GTP and four reduced compounds (3 NADH 
and 1 FADH2), to be used in the oxidative phosphorylation process. Regarding citrate, when it is 
obtained from oxaloacetate inside the mitochondria as part of the citric acid cycle, exogenous citrate 
cannot permeate the inner mitochondrial membrane. Thus, before entering the cycle, it should be first 
converted to malate and to pyruvate by a series of enzymes with the use of ATP. Malate and pyruvate 
are then utilized in the citric acid cycle to produce NADH and FADH2, which are then used to reduce 
oxygen in the oxidative phosphorylation process (adapted from Visconti, 2012). ADP = Adenosine 
diphosphate; ATP = Adenosine triphosphate.  
Alpha-glucosidase, and particularly its neutral isoenzyme, is secreted mostly in the corpus and 
cauda of the epididymis (Yeung, Cooper & Senge, 1990). It appears to be a sensitive indicator 
of epididymal function, but the subsequent effects it has on sperm functional parameters has 
not been thoroughly investigated. Although contradictory to this current study, Said et al. 
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(2009) and Viljoen et al. (1990) both observed positive correlations between seminal 
concentrations of NAG and percentage of motile sperm. 
As mentioned above, citric acid, NAG and fructose are all effective biomarkers of the secretion 
and function of glands or tissues from which they originate. It may be beneficial to note 
variations in the secretions of these glands after the two different EA periods and how these 
variations may reflect on semen quality as a whole. Elzanaty et al. (2005) observed increases 
in both prostatic and epididymal secretion after longer EA periods whereas no significant 
differences were observed in seminal vesicle secretions. Our observations however paint a 
different picture. All 3 secretions were greater after 4 days of EA whereas the greatest 
percentage difference was observed in seminal vesicle secretion. Disproportionate reductions 
in epididymal and accessory sex gland secretions may be an important avenue to explore 
when attempting to understand the mechanisms of very short EA. 
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5.3. Objective 3: Identify differentially expressed proteins as well as subsequently 
upregulated protein pathways in seminal plasma after 4 days and 4 hours of 
ejaculatory abstinence. 
In this study we used advanced techniques to extensively investigate how seminal plasma 
proteins differ after different EA periods. A total of 1765 proteins were identified in seminal 
plasma derived from pooled samples of donors. As shown in Figure 4.3, most of these proteins 
are involved in cellular, metabolic and regulatory processes. A total of 18 proteins were 
significantly upregulated after 4 days of EA and 3 proteins upregulated after 4 hours of EA. 
Pathway and network analysis was performed on selected proteins using the search tools 
Reactome (https://www.reactome.org) and String 10.5 (https://string-db.org). As illustrated in 
Figure 4.2, the 1765 identified proteins are involved in a multitude of cellular processes 
including reproduction, metabolism and cellular regulation. Many of these classifications are 
based on somatic cells, yet spermatozoa do share certain important cellular components and 
life cycle processes with somatic cells. For example, reproductive proteins identified in the 
seminal plasma are involved in mitotic proliferation during spermatogenesis as well as 
proliferation of the zygote after fertilization. As the sperm are evaluated shortly after ejaculation 
and the seminal plasma was isolated shortly thereafter, our ability to make observations on 
protein markers and their relationship with sperm functional parameters is sufficient.  
When comparing levels of proteins expressed between 4 days and 4 hours of EA, 4 days of 
EA is essentially a control, as normal values are based on samples collected between 2 and 
7 days. Thus, the upregulation of proteins after 4 days of EA may be viewed as downregulation 
after 4 hours of EA as they are directly compared to one another.  
5.3.1. Proteins upregulated after 4 days of EA 
Of the 19 proteins which were found to be upregulated after 4 days of EA, 5 proteins were 
specifically selected for further pathway analysis based on cellular location and involved 
processes. These 5 proteins are known to participate in important cellular processes including 
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metabolism and apoptosis. All 5 proteins selected for further analysis, have been previously 
identified in human cells and are found in the cytoplasm or mitochondria. The identification of 
these proteins in the seminal plasma may be due to lysis of spermatozoa during processing 
(centrifugation) or due to their secretion via exosomes in the male reproductive system in 
response to extracellular conditions or intercellular signalling.  
5.3.1.1. Heat-shock protein A2  
Heat-shock proteins (HSPs), are highly conserved cellular stress proteins, present in every 
organism from bacteria to man (Neuer et al., 2000), and are recognised for playing a critical 
role in the cellular defence mechanism of spermatozoa by serving two central functions. 
Firstly, they are involved in protein folding, translocation across membranes and the 
compilation of multi-protein structures (Bukau et al., 2006). Secondly, HSPs maintain cellular 
homeostasis and function as “molecular chaperones”, subsequently regulating apoptosis and 
cell division (Eggert-Kruse et al., 2002). 
Heat-shock protein A2 (HSPA2) is a 70kDa protein identified to be located in the spindle 
component of the cytoskeleton in many cell types. Spindle fibre formation and centrosome 
integrity is critically important for successful fertilization and embryo development. In most 
systems, the sperm centrosome contributes the dominant nucleating seed consisting of the 
proximal centriole surrounded by pericentriolar components onto which the oocyte's 
centrosomal material is assembled (Manandhar et al., 2005; Sun and Schatten, 2006, 2007). 
The sperm centrosome is primarily responsible for nucleating and organizing the sperm aster, 
which pushes the sperm head toward the oocyte centre and guides migration of the female 
pro-nucleus for union with the male pro-nucleus, completing the fertilization process. Reduced 
or abnormal centrosomal material leads to fertilization or developmental failures (Schatten et 
al., 2009). 
 These proteins are synthesized in testicular seminiferous tubule cells and have been 
observed to be significantly downregulated in asthenozoospermic samples (Siva et al., 2010; 
Stellenbosch University  https://scholar.sun.ac.za
54 
 
Martínez-Heredia et al., 2008). HSPA2 is a member of the 70-kDa HSPs family, and is a 
molecular chaperone that assists in the folding, transport and assembly of proteins in the 
cytoplasm, mitochondria and endoplasmic reticulum (Georgopoulos & Welch, 1993). Feng et 
al. (2001) and Dix et al. (1996) both observed highly detrimental effects on male fertility when 
the expression of heat shock proteins were disrupted. In both studies, these reductions in 
sperm motility and concentration were ascribed to dramatic increases in spermatocyte 
apoptosis and failures in proper meiosis occurring in the seminiferous epithelium.  
5.3.1.2. 26S proteasome non-ATPase regulatory subunit 8 and proteasomes in 
protein ubiquitination. 
A study on the human spermatozoon proteome identified that variable expression proteasome 
subunits may hold importance in sperm capacitation and motility (Kong et al., 2009). 
Proteasomes are protein complexes which degrade cytosolic and nuclear proteins that have 
been previously marked with ubiquitin molecules (Sutovsky, 2003). Reduced levels of 
proteasomes may result in increased amounts of ubiquinated proteins which has been 
correlated with sperm motility (Sutovsky et al., 2004). Ubiquitin-conjugating enzyme E2 K 
(UBE2K) was also upregulated after 4 days of EA. This protein is involved in the biochemical 
process of ubiquinitation where it accepts ubiquitin from the E1 complex and catalyzes its 
covalent attachment to other proteins (Kikuchi et al., 2000). 
Ubiquitination of proteins serves a multitude of functions in the human cell including controlling 
events as diverse as cell cycle progression (Glotzer et al., 1991), protein degradation and 
recycling (Ciechanover et al., 1984), membrane receptor endocytosis (Strous & Govers, 
1999), and even retroviral infection (Ott et al., 1998). Once the protein or peptide is marked 
with ubiquitin, the poly-ubiquitin chain is then removed by ubiquitin C-terminal hydrolases and 
the substrate is hydrolysed into smaller peptides and individual amino acids (Wilkinson & 
Hochstrasser, 1998). Proteasomal subunits have been identified inside or near the sperm 
centriole (Bialy et al., 2001; Mochida et al., 2000) which has been proposed as either inactive 
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by-products of dismantled proteasomes and ubiquitinated centrosomes or important 
proteolytic components required for release of the centriole at fertilization (Sutovsky, 2003). 
Ubiquitin has been identified in human seminal plasma (Lippert et al., 1993) as well as during 
epididymal passage when defective spermatozoa become ubiquitinated (Sutovsky et al., 
2001), thus variations in prevalence of the proteins associated with ubiquitination (i.e. 
proteasomes) are likely to be observed in different semen samples. 
Sperm proteome studies on asthenozoospermic samples have revealed that some 
components of the proteasome complex are differentially expressed, suggesting an 
importance of the proteasome complex in sperm motility. Nevertheless, there are 
contradictions as to which subunits are variably expressed. For example, Martinex-Heredia et 
al. (2008) reported that 26S proteasome non-ATPase regulatory subunit 3 (PSMB3) was 
increased in asthenozoospermic patients, whereas Zhao et al. (2007) found that the 26S 
protease regulatory subunit 7 is significantly reduced in asthenozoospermic patients. In this 
study, 26S proteasome non-ATPase regulatory subunit 8 (PSMD8) was significantly 
upregulated after 4 days of EA when compared to 4 hours. This protein forms part of a large 
proteasome complex by binding to several other subunits to form the 26S proteasome (see 
Figure 5.2). The upregulation of this protein has been observed in samples after 4 days of EA, 
accompanied by lower sperm motility parameters, yet greater T.S.C., sperm concentration 
and volume. Reactome pathway analysis identified a multitude of protein pathways which are 
influenced by the 26S proteasome, primarily revolving around the ATP-dependent degradation 
of proteins in cytosol and nucleus, which subsequently affects numerous cellular processes 
including various metabolic and genetic signalling cascades (Kanyama et al., 1992) (see 
Figure 5.3).  
A balance between apoptosis and cell survival is important in multicellular organisms yet 
sperm also require functional apoptotic signals in order to remove unhealthy and dysfunctional 
sperm (Matsuzawa, 2001). In adult males, germ cell death during normal spermatogenesis 
plays an important role in the process of sperm production. Approximately 25%–75% of 
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potential spermatozoa degenerate and die in the mammalian (adult) testis (Hikim & Swerdloff, 
1999; Sakkas et al., 1999). Defects in control of this balance may contribute to low fertility and 
increases in pathologies in the male reproductive system. Protein ubiquitination and 
degradation is one of the major mechanisms that regulate apoptotic cell death (Yang and Yu 
2003). This ubiquitination thus removes proteins which inhibit the initiation of cell death. This 
is curiously not reflected in the basic semen analysis of the cohorts in this study, although it 
does raise the question that the ubiquitination of proteins in the spermatozoon, and 
subsequent degradation of these proteins occurs at different levels between 4 hours and 4 
days of EA. 
Further insight into these mechanisms of interaction between sperm the 26S proteasome is 











Figure 5.3:  Diagram of the protein interaction network revealed by String 10.5 of the multiprotein 
26S Proteasome complex.  
Protein interactions consisting of the binding of a multitude of subunits to form the biologically active 
complex. Blue lines represent binding interactions between nodes. The highest confidence view (score 
0.9) of the interaction between these proteins was prepared. SMD8 = Proteasome 26S subunit, non-
ATPase, 8; PSMD4 = Proteasome 26S subunit, non-ATPase, 4; PSMD6 = Proteasome 26S subunit, 
non-ATPase, 6; PSMA4 = Proteasome subunit, alpha type, 4; PSMD3 = Proteasome 26S subunit, non-
ATPase, 3; PSMB1 = Proteasome subunit, beta type, 1; PSMC6 = Proteasome 26S subunit, ATPase, 
6; PSMA5 = Proteasome subunit, alpha type, 5; PSMC4 = Proteasome 26S subunit, ATPase, 4; PSMB4 











Figure 5.4. Extensive Reactome.org identification of all protein pathways influenced by the 26S Proteasome complex.  
Several processes including metabolism of proteins, cell cycle, apoptosis  and cellular responses to external stimuli may have direct impacts on sperm 
physiology thus influences observed basic and functional semen parameters. 
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5.3.1.3. 14 kDa phosphohistidine phosphatase and ATP-citrate synthase inhibition 
Increased 14 kDa phosphohistidine phosphatase expression is associated with the 
inactivation of ATP-citrate synthase (ACLY) activity (Krieglstein et al., 2008).  ACLY is a 
reliable enzymatic marker of mitochondrial volume and ACLY catalyses the formation of 
acetyl-CoA and oxaloacetate in the cytosol from citrate and CoA with the hydrolysis of ATP to 
ADP and phosphate. This step is the major source of cytosolic acetyl-CoA which is used in 
the biosynthetic pathways of carbohydrates, fatty acids, cholesterol and acetyl-choline 
(Amaral et al., 2013) (see Figure 5.4). The upregulation of this enzyme may have an active 
role in reducing available energy for sperm motility. ACLY catalyses the formation of acetyl-
CoA and oxaloacetate in the cytosol from citrate and CoA with the hydrolysis of ATP to ADP 
and phosphate (Krieglstein et al., 2008). This step is the major source of cytosolic acetyl-CoA 
which is used in the biosynthetic pathways of carbohydrates, fatty acids, cholesterol and acetyl 
choline. The inhibition of ACLY leads to reduced amounts of cytosolic acetyl-CoA and 
oxaloacetate available for the citric acid cycle. This may ultimately result in less glycolyzable 
substrates available to provide energy for sperm motility. PHPT1 is expressed at significantly 
lower levels after 4 hours of EA, this may result in less ACLY-facilitated reduction in 
glycolyzable substrates for subsequent sperm motility. Therefore, this provides further 
explanation for the observed increases in sperm motility after 4 hours of EA. 




Figure 5.5: 14 kDa phosphohistidine phosphatase and subsequent ATP-citrate synthase 
inhibition 
Mitochondrial Ac-CoA is transported to the cytosol as citrate to participate in fatty acid biosynthesis. 
Cytosolic ATP-citrate synthase (ACLY), in tetrameric form, catalyses the transformation of citrate to Ac-
CoA and oxaloacetate (OA) (Elshourbagy et al., 1992). Cytosolic MORC family CW-type zinc finger 
protein 2 (MORC2) positively regulates the activity of ACLY (Sánchez-Solana et al., 2014). 
Phosphohistidine phosphatase (PHPT1) inactivates the ACYL thus inhibiting the conversion of citrate 
utilizable energy substrates.  
5.3.1.4. Human Phosphatidylethanolamine-binding protein 4 and apoptosis 
Although the function of human phosphatidylethanolamine-binding protein 4  (hPEBP4) is not 
clear in human sperm, in a study by Wang et al. (2004), hPEBP4 was observed to promote 
cellular resistance to TNF-induced apoptosis by inhibiting activation of the Raf-1/MEK/ERK 
pathway, c-Jun N-terminal kinases (JNKs) and phosphatidylethanolamine externalization. 
These same mechanisms may influence resistance to apoptotic signals in sperm during 
storage which may explain the higher percentage of viable cells observed in samples after 4 
days of EA. As illustrated by the String network in Figure 5.5, hPEBP4 interacts with several 
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mitochondrial ribosomal proteins which form structural constituents of those ribosomes and 
are thus involved in RNA binding in the mitochondria (Suzuki et al., 2001).  
Frayne et al., (1997) found that hPEBP may be involved in the organisation of sperm 
membranes during spermatogenesis. The presence of hPEBP was observed in Leydig cells 
and testes using western blotting and immunohistochemistry. They concluded that this 
localization suggests diverse roles for this protein as a lipid carrier or binding constituent. 
Therefore further analyses is required to fully understand the possible role which human 
phosphatidylethanolamine-binding proteins play in the male reproductive system and in 
particular, variations in EA periods. 
Figure 5.6. Diagram of the protein interaction network revealed by String 10.5.  
Human PEBP4 interacts with several genetically important proteins involved in ribosomal function and 
initiation of apoptosis in cells. The thickness of the lines connecting different nodes represent the 
strength of the data report. A confidence view of score 0.4 was prepared for the interaction between 
these proteins. PEBP4 = Phosphatidylethanolamine-binding protein 4; MRPLA47 = Mitochondrial 
ribosomal protein L47; MRPL23 = Mitochondrial ribosomal protein L23; MRPL27 = Mitochondrial 
ribosomal protein L27; MRPL17 = Mitochondrial ribosomal protein L17; MRPL47 = Mitochondrial 
ribosomal protein L46; AKT1 = V-akt murine thymoma viral oncogene homolog 1; MAP2K11 = Mitogen-
activated protein kinase kinase 1. 
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5.3.1.5. 2,4-dienoyl-CoA reductase, mitochondrial 
Mitochondrial 2,4-dienoyl-CoA reductase (DECR1) is an auxiliary enzyme of beta-oxidation 
and participates in the metabolism of unsaturated fatty enoyl-CoA (Alphey et al., 2005). 
Although human sperm are predominantly known to produce ATP from the breakdown of 
sugars, a study by Amaral et al. (2012) suggests an endogenous mechanism of mitochondrial 
beta-oxidation of lipids as well as several other mechanisms of lipid metabolism in sperm 
mitochondria. These observations were made based on the identification of various enzymes 
specifically involved in a host of lipid metabolic processes. This would mean that sperm may 
be adapted to exogenous fluctuations in primary glycolyzable energy sources.  Noting that the 
upregulation of DECR1 after 4 days of EA equates to its downregulation after 4 hours of EA, 
this may indicate decreased beta-oxidation in the mitochondria-containing midpiece after 4 
hours of EA, as it aids enzymes directly involved in beta-oxidation, which cannot process all 
the different double bond conformations occurring naturally. It does this by catalysing the 
NADP-dependent reduction of 2,4-dienoyl-CoA to yield trans-3-enoyl-CoA. String network 
analysis revealed DECR1 to interact with several important mitochondrial proteins (see Figure 
5.6). DECR1 binds to Cytochrome b-245, beta polypeptide (CYBB), a vital component of a 
respiratory chain that transfers single electrons from cytoplasmic NADPH across the plasma 
membrane to molecular oxygen on the exterior and participates in the regulation of cellular 
pH. DECR1 interacts with several other known enzymes involved in the management of ROS, 
via antioxidant activation and production.   
Therefore, after 4 hours of EA, decreased DECR1 may indicate that less beta-oxidation of 
fatty acids is occurring, thus glycolytic phosphorylation is the primary mechanism of energy 
production for flagellar movement. 





Figure 5.7. Diagram of the protein interaction network revealed using String 10.5.  
Relationships are identified between DECR1 and several other proteins involved in beta oxidation of 
fatty acids. DECR1 is a central component of the interaction network revealed, which illustrates the 
activation, post-translational modification and binding of DECR1 to several other proteins. Several of 
the proteins identified in this network are important in immune response and apoptosis. DECR1 = 2,4-
dienoyl CoA reductase 1, mitochondrial; CYP2B2 =  Cytochrome P450, family 2, subfamily B; CRYZ = 
Crystallin, zeta (quinone reductase); PRKCA = Protein kinase C, alpha; PRKCB = Protein kinase C, 
beta; NCF1 = Neutrophil cytosolic factor 1; NCF2 = Neutrophil cytosolic factor 2; CYBB = Cytochrome 
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5.3.2. Proteins upregulated after 4 hours of EA 
Only 3 proteins were observed to be upregulated after 4 hours of EA. Of these only 2 were 
involved in cellular metabolism and apoptosis and thus selected for further analysis. Both 
proteins are expressed at higher levels after 4 hours of EA due to lysis of cells during 
processing or release via exocytosis as they are both cytoplasmic proteins effecting cellular 
processes.   
5.3.2.1. Calcium-binding protein 39 and energy-dependent inhibition of mTOR 
Calcium-binding protein 39 (CAB39) activates protein serine/threonine kinase 11 (STK11) 
(Naz, 1999) by forming a complex with STK11 and enhances the formation of complexes 
between STE20-Related adaptor protein (STRAD) and STK11 (see Figure 5.7). These 
complexes have increased catalytic activity, where CAB39 acts as a scaffolding protein in 
addition to being a component of cellular localization. Furthermore, once the trimeric 
STK11:STRAD:CAB39 complex is formed, STK11 phosphorylates 5' AMP-activated protein 
kinase (AMPK), activating it (Hardie, 2007). This phosphorylation is immediately removed in 
basal conditions by protein phosphatase 2c (PP2C), but if the cellular AMP:ATP ratio rises, 
this activation is maintained and AMPK binding to AMP inhibits the dephosphorylation. As 
shown in table 4.5, fructose, the primary source of energy for spermatozoa, decreased in 
concentration which may be a marker for a lower amount of available energy thus leading to 
a higher AMP:ATP ratio.  
At a molecular level, once energy abundance reduces (ie. high AMP:ATP ratio), excess AMP 
directly binds to tandem repeats of cystathionine-beta-synthase (CBS) domains in the AMPK 
gamma subunit. Binding of AMP is thought to prevent dephosphorylation of the critical 
activation loop-threonine in the alpha subunit (Hardie, 2007). The phosphorylation of the 
activation loop-threonine is unequivocally required for AMPK activation. 
Biochemical and genetic analyses in worms, flies, and mice have revealed that the 
serine/threonine kinase STK11 (LKB1) represents the major kinase in the phosphorylation of 
Stellenbosch University  https://scholar.sun.ac.za
65 
 
the AMPK activation loop under conditions of energy stress across metazoans (Sakamoto et 
al. 2005, Lee et al. 2007). LKB1 phosphorylates AMPK on Thr174 of the alpha 1 subunit (or 
Thr172 on the alpha 2 subunit) leading to activation of AMPK if the cellular AMP/ATP ratio is 
sufficiently high. 
This will allow AMPK to activate the STK11:STRAD:CAB39 complex during the build-up of 
AMP, which activates the intrinsic GTPase activity of Ras homolog enriched in brain (Rheb), 
thus resulting in GDP-loaded Rheb and the inhibition of the mammalian target of rapamycin 
(mTOR) pathway. The mTOR signalling pathway integrates both intracellular and extracellular 
signals, and serves as a central regulator of cell metabolism, growth, proliferation and survival.  
Figure 5.8: Diagram of the protein interaction network revealed by String 10.5 considering 
CAB39 (MO25) and the formation of the trimeric STK11:STRAD:CAB39 complex 
The diagram includes the interaction between CAB39 and two other upstream proteins, STK11 (LKB1) 
and STRADA, which leads to the formation of the trimeric STK11:STRAD:CAB39 complex and  the 
subsequent AMPK phosphorylation of various kinases and other protein interactions. The highest 
confidence view (score 0.9) of the interaction between these proteins was prepared. CAB39 = Calcium 
binding protein 39, STRADB = STE20-related kinase adaptor beta, MST4 = mammalian STE20-like 
protein kinase 4, STK11 = Serine/threonine kinase 11, STK24 = Serine/threonine kinase 24, STK25 = 
Serine/threonine kinase 25, STRADA = STE20 - related kinase adaptor alpha, STRADB = STE20 - 
related kinase adaptor beta, PTEN = Phosphatase and tensin homolog. 
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MTOR is a highly conserved multifunctional serine/threonine protein kinase that coordinates 
and integrates signals that manipulate essential processes of cellular physiology, including 
protein synthesis, cellular growth, proliferation, motility, survival, and autophagy. It responds 
to multiple signals to control processes stemming from the direct or indirect regulation of the 
phosphorylation of hundreds of proteins (Laplante, 2009). It associates with different proteins 
such as Regulatory-associated protein of mTOR (RPTOR) and Rapamycin-insensitive 
companion of mammalian target of rapamycin (RICTOR), to form two distinct complexes, 
mTORC1 and mTORC2, respectively. These two complexes display different sensitivity to the 
inhibitor rapamycin; with mTORC1 being acutely inhibited by rapamycin, whereas mTORC2 
inhibition requires prolonged treatment and is cell/tissue dependent.  
Activated mTORC1 up-regulates protein synthesis, by phosphorylating key regulators of 
mRNA translation and ribosome synthesis. While mTORC2, regulates cytoskeletal function 
and insulin signalling (Laplante & Sabatini, 2009). Despite the extensive work already done 
on mTOR signalling, particularly in somatic cells, its functions and activity in germ cells remain 
mostly unknown.  
A study by Silva et al. found a negative correlation between the amount of activated mTOR 
and sperm motility yet the exact mechanism by which this occurs is not clear (Silva et al., 
2015). Rapamycin induced inhibition of mTOR have been found to have negative effects on 
male fertility (Zuber et al., 2008). Conditional deletion of RPTOR in mouse skeletal muscle has 
been shown to reduce the expression of genes involved in mitochondrial biogenesis 
(Bentzinger et al., 2008).  Another study by Cunningham et al. discovered that mTORC1 
controls the transcriptional activity of PPARγ coactivator 1 (PGC1-α), a nuclear cofactor that 
plays an important role in mitochondrial biogenesis and oxidative metabolism, by altering its 
physical interaction with another transcription factor, yin-yang 1 (YY1) (Cunningham et al., 
2007). This would mean that the proposed effects of mTOR after 4 hours of EA must occur 
during transit of sperm through the epididymis and not during spermatogenesis.  
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This aligns with the results of this current study, where sperm motility was observed to be 
significantly higher in samples which contain proteins known for the inhibition of mTOR. 
CAB39s ability to indirectly impact sperm capacitation and metabolism is of particular interest.  
This may serve as a possible mechanism for the observed impact of short EA on semen 
quality. It can be postulated that an upregulation of the CAB39 protein may elicit improved 
motility in conditions of reduced seminal glycolyzable molecules, and may be used as a 
biomarker for this particular sperm parameter.
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Figure 5.9. Energy dependent 
inhibition of mTOR 
Formation of the trimeric 
STK11:STRAD:CAB39 complex leads to 
further kinase activity subsequently 
phosphorylating the AMP-activated protein 
kinase (AMPK) activation loop. The AMPK is 
a highly conserved heterotrimeric kinase 
complex consisting of a catalytic (alpha) 
subunit and two regulatory (beta and 
gamma) subunits. Once the AMP:ATP ratio 
elevates (ie. Energy stress conditions), AMP 
bind to the AMPK gamma subunit. This 
binding is thought to prevent the 
dephosphorylation of AMPK at the critical 
activation loop threonine by PP2C which 
occurs under normal conditions (Hardie, 
2007). The activation loop threonine is 
essential in its phosphorylated state for 
AMPK activation (Sakamoto et al., 2005; 
Lee et al., 2007). Activated AMPK 
(phosphorylated on Thr172 or Thr174 and 
AMP bound) phosphorylates RPTOR on 
Ser722 and Ser792. This step is pivotal in the energy-dependent inhibition of mTORC1 (Gwinn et al., 2008). Furthermore, activated AMPK phosphorylates TSC2 on Ser-1387 
which subsequently activates GTPase activating protein (GAP) activity in the Tuberous Sclerosis Complex (TSC). TSC is a critical upstream inhibitor of mTORC1 and does this 
by stimulating the intrinsic GTPase activity of the small G-protein Rheb. This then inactivates Rheb which subsequently leads to the inability of the GDP-bound form of Rheb to 
activate mTORC1 (Sancak et al., 2007). 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
69 
 
5.3.2.2. Deoxyribonuclease I and sperm apoptosis: 
Deoxyribonuclease-1 (DNase I) is an enzyme predominantly found in the liver, kidneys and 
pancreas (Kishi et al., 1990), and is primarily involved in cell apoptosis (Peitsch et al., 1992). 
However, previous studies had found DNase I activity in seminal plasma and semen 
(Zamenhof et al., 1957; Quinn, 1968). Peitsch et al. (1992) speculated that DNase I may be a 
role-player in the continuous apoptosis of differentiating spermatogonia in the testes. DNAse.I 
may interact selectively and non-covalently with monomeric or multimeric forms of actin, 
including actin filaments, and can possibly prevent damage of genetic material, yet the function 
is unclear. 
This initiation of apoptosis may be responsible for decreases in the output of viable sperm in 
the ejaculate. The early study by Quinn (1968) also suggested that increased activity of 
DNase.I was linked to significant decreases in sperm motility parameters, yet the exact 
mechanisms are not yet clear.  Shen and Ong (2000) utilized DNase I to initiate apoptosis in 
human sperm and used this as a positive control when comparing DNA damage amongst 
cohorts. Therefore, considering the significant reduction in the percentage of viable sperm 
after 4 hours of EA when compared to 4 days, an upregulation of DNase I may be a sign of 
increased apoptosis. This apoptosis may be linked to the proposed mechanism of shorter EA 
by Ayad et al. (2018) whereby it is speculated that increased sperm motility parameters were 
at the cost of weaker and improper functioning sperm.  
This would support the possibility that an intrinsic mechanism of improving observed sperm 
motility was occurring after 4 hours of EA, allowing for damaged sperm to be destroyed and 
highly motile sperm to be prevalent as observed in the reduction of viable sperm accompanied 
by improved motility after shot EA. In order to substantiate this theory, a study which further 
analysed levels of leukocytes and DNA damage at a highly accurate level would be beneficial.  
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5.4. Limitations of the study/recommendations 
By and large this study attained its objectives, but several shortcomings and limitations were 
inevitable from the beginning of the study. As mentioned, the entire cohort of donors were 
healthy normozoospermic and potentially fertile males between the ages of 19 and 25. For 
further comprehensive analysis, subjects with sub-fertile conditions such as oligozoospermia, 
teratozoospermia and asthenozoospermia should be included in the study. Secondly, the 
cohort size was relatively small (N=16) due to the huge costs of different analyses. If financially 
possible, future studies on shorter EA periods should incorporate larger cohorts for further 
research into differentialy expressed proteins and signalling pathways, to provide a deeper 
insight into the mechanisms by which EA may improve sperm functional characteristics. Two-
dimensional gel electrophoresis for more accurate separation of proteins should be utilized if 
financially feasible in order to further reduce any sensitivity issues when LC-MS/MS is 
performed as larger abundance proteins may reduce the chances of identifying much smaller 
abundance proteins.  
Furthermore, metabolomic analysis would prove highly useful in the context of mitochondrial 
metabolism and energy availability for sperm motility. Nuclear magnetic resonance 
spectroscopy (NMR) has been utilized as an effective identifier of metabolites and would 
provide a more comprehensive analysis of the seminal plasma constituents released by the 
accessory sex glands.  
As with all biological samples, results may be influenced by donor-specific factors which could 
sway our results. Larger cohorts are required and further investigation into how differing 
epididymal transit times may alter the mechanisms which are known to influence sperm 
motility. 
The results of this study emphasize the general consensus that male reproduction requires a 
multi-factoral approach to understanding how EA may manipulate sperm functional 
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parameters. There are clearly a multitude of contributing factors to observable sperm 
functional characteristics, and as many as possible should be considered.  
  





Several recent publications have contradicted the official WHO guidelines for ejaculatory 
abstinence and this raises doubts about the true importance of EA period and how this 
influences sperm function. This study was performed on a relatively small cohort yet 
significantly better sperm motility based on total motility, progressive motility and several 
kinematic parameters including rapid swimming sperm, VSL and VAP was observed after 4 
hours of EA when compared to 4 days, yet the reasoning for these changes are relatively 
ambiguous. Short EA has repeatedly been associated with reductions in T.S.C., sperm 
concentration and semen volume, however the controversial results of increased motility 
remain. Significant reductions in observed viability after 4 hours of EA may be part of the 
reason for the observed increases in motility as favourable sperm were observed at the cost 
of weaker, abnormal sperm that may have impaired membrane integrity after being marked 
for apoptosis. 
Most previous studies have not systematically assessed the contributory role of accessory sex 
gland secretions and citric acid in particular. This includes citric acids ability to influence sperm 
functional characteristics directly or indirectly in relation to EA. This study found that citric acid 
may be a viable candidate in the justification of the observed improvements in sperm motility 
after an EA period of 4 hours, through acting as a possible alternative source of energy in the 
citric acid cycle. An additive effect via the increased availability of citric acid per sperm might 
occur which furthermore compensates for the reduction in fructose per sperm.  This highlights 
a possible oversight of the metabolic significance of citric acid as well as being partially 
responsible for an increase in semen pH. Further comprehensive biochemical pathway 
analysis is required to better understand the role that epididymal and accessory sex glands 
play in the improvement of sperm motility after very short EA. Another avenue of research 
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may be the ratios of secretions from these glands and tissues, plus the subsequent effects on 
basic and functional sperm parameters. 
Despite the considerable advances in proteomics, there remains a lack of research into 
spermatozoa and seminal proteins isolated from ejaculates after very short EA periods. The 
utilisation of a high-output approach such as LC-MS/MS, as adopted in this study, allows for 
a considerable majority of the seminal plasma proteome to be identified. With 21 differentially 
expressed proteins between 4 hours and 4 days of EA. Changes in protein expression and 
the corresponding impact on the spermatozoa’s functional capacity were discussed. With only 
3 significantly upregulated proteins identified after 4 hours of EA, several  proteins upregulated 
after 4 days of EA seem to influence sperm functional parameters negatively besides for the 
positive impact of sperm viability.  
Amongst the proteins upregulated after 4 days of EA, various proteins were selected for 
relevant influence in metabolism, apoptosis and cellular stress management. All having 
proposed direct and indirect effects on sperm motility according to available literature. The 
upregulation of the 26S proteasome requires further attention as the ubiquitination of proteins 
plays an important role in every mammalian cell.               
Calcium binding protein 39 may have an indirect mechanism of sperm motility improvement 
by the energy-dependent inhibition of mTOR in seminal conditions of reduced available 
energy. Deoxyribonuclease I is involved induction of apoptosis of many somatic cells, and 
similar effects have been observed in male germ cells (Shen & Ong, 2000), which may 
elucidate the reduced percentages of viable cells after 4 hours of EA. It has been speculated 
that apoptosis may increase motility and kinematic parameters at the cost of dysfunctional 
sperm. 
It can be stated with reasonable certainty, that this is the first study into the proteomic profile 
and key epididymal and accessory sex gland secretions of seminal plasma from semen 
samples obtained after 4 hours of EA in order to explain improved sperm function. Further 
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understanding of the influence of proteins, metabolites and intrinsic anatomical components 
on sperm characteristics after very short EA, might serve as an important tool for increasing 
the success rates of ART and natural conception, thus reducing cost as well as enriching 
sperm research in general.   
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Appendix A: Epididymal and accessory sex gland secretion optical densities 
Table 7.1. Citric acid assay results 
Donor ID Long EA OD Short EA OD 
Standard  0.14375  0.14375 
1A 4.05 0.15 3.95 0.14 
1B 7.01 0.25 3.93 0.14 
1C 4.86 0.18 4.22 0.15 
1D 18.89 0.68 19.91 0.72 
2A 9.89 0.36 9.16 0.33 
2B 11.55 0.42 14.62 0.53 
2C 5.15 0.19 3.81 0.14 
2D 4.61 0.17 6.48 0.23 
3A 5.04 0.18 3.91 0.14 
3B 4.94 0.18 10.57 0.38 
3C 3.76 0.14 2.27 0.08 
3D 3.34 0.12 4.02 0.15 
4A 4.40 0.16 4.15 0.15 
4B 8.93 0.32 6.32 0.23 
4C 4.83 0.17 7.80 0.28 
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Table 7.2. Fructose assay results 
 OD (470-
492nm) 
Mean Stdev RSD Corrected 
Fructose concentration 
(mg/ml) 
blanc  0.113 0.104 0.11 0.01 0.06 0.00 0 
standard 1 0.261 0.248 0.25 0.01 0.04 0.15 1 
standard 2 0.138 0.091 0.11 0.03 0.29 0.01 2.5 
standard 3 0.089 0.081 0.09 0.01 0.07 -0.02 5 
1A1 0.104 0.113 0.11 0.01 0.06 0.00 4.11 
1A2 0.074 0.096 0.09 0.02 0.18 -0.02 5.56 
1B1 0.153 0.18 0.17 0.02 0.11 0.06 0.53 
1B2 0.109 0.077 0.09 0.02 0.24 -0.02 5.07 
1C1 0.092 0.071 0.08 0.01 0.18 -0.03 5.78 
1C2 0.121 0.12 0.12 0.00 0.01 0.01 3.37 
1D1 0.096 0.097 0.10 0.00 0.01 -0.01 4.85 
1D2 0.134 0.143 0.14 0.01 0.05 0.03 2.26 
2A1 0.137 0.135 0.14 0.00 0.01 0.03 2.41 
2A2 0.114 0.109 0.11 0.00 0.03 0.00 3.92 
2B1 0.139 0.134 0.14 0.00 0.03 0.03 2.38 
2B2 0.148 0.145 0.15 0.00 0.01 0.04 1.76 
2C1 0.126 0.113 0.12 0.01 0.08 0.01 3.43 
2C2 0.094 0.085 0.09 0.01 0.07 -0.02 5.28 
2D1 0.111 0.006 0.06 0.07 1.27 -0.05 7.20 
2D2 0.106 0.108 0.11 0.00 0.01 0.00 4.20 
3A1 0.132 0.114 0.12 0.01 0.10 0.01 3.21 
3A2 0.118 0.179 0.15 0.04 0.29 0.04 1.64 
3B1 0.206 0.218 0.21 0.01 0.04 0.10 -2.29 
3B2 0.104 0.087 0.10 0.01 0.13 -0.01 4.91 
3C1 0.12 0.129 0.12 0.01 0.05 0.02 3.12 
3C2 0.122 0.133 0.13 0.01 0.06 0.02 2.94 
3D1 0.097 0.081 0.09 0.01 0.13 -0.02 5.32 
3D2 0.103 0.179 0.14 0.05 0.38 0.03 2.10 
4A1 0.249 0.278 0.26 0.02 0.08 0.16 -5.47 
4A2 0.1 0.08 0.09 0.01 0.16 -0.02 5.25 
4B1 0.144 0.158 0.15 0.01 0.07 0.04 1.48 
4B2 0.176 0.193 0.18 0.01 0.07 0.08 -0.59 
4C1 0.13 0.114 0.12 0.01 0.09 0.01 3.28 
4C2 0.124 0.154 0.14 0.02 0.15 0.03 2.23 
4D1 0.179 0.144 0.16 0.02 0.15 0.05 0.83 




Coefficient of determination (R2): 0.208957226 
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Coefficient of determination (R2): 1.000 
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Improved sperm motility after short abstinence: A possible role of accessory sex gland 
secretions 
Various studies have sought to determine the typical versus optimal abstinence period 
after which semen samples should be collected and many have been found to be 
contradictory. Several factors influence the semen microenvironment and thus sperm 
parameters. In this study we focused on the secretions of the prostate, seminal vesicles 
and the epididymis. Semen samples were obtained from normozoospermic subjects (n 
= 16) after long (4 days) and short (4 hours) periods of ejaculatory abstinence and 
standard semen analysis was performed with the assistance of computer aided sperm 
analysis, while the seminal plasma citric acid, neutral alpha-glucosidase and fructose 
concentrations were measured with commercially available assay kits. Results of this 
study displayed significant decreases in total sperm count (p<0.001), sperm 
concentration (p<0.05), semen volume (p<0.05) and pH (p<0.05) after 4 hours of 
ejaculatory abstinence when compared to 4 days. Furthermore, increases in total sperm 
motility (p<0.05) and sperm progressive motility (p<0.01) after short ejaculatory 
abstinence periods were observed, accompanied by a significant reduction in total citric 
acid (p<0.05), alpha-glucosidase (P<0.01) and fructose (P<0.05) concentrations. 
However, due to the decreased sperm number, these concentrations translated to a 
significant increase in citric acid (P<0.05) and a decrease in fructose (P<0.05) per 
spermatozoon, which, along with the effects on semen pH, could more than likely be 
responsible for increased metabolic function and subsequent increase in the available 
energy for sperm motility. 




Basic semen parameters, including sperm concentration, motility, morphology and viability, 
remain the primary predictive factors for male infertility diagnosis, despite inter-individual 
variations in semen characteristics. Ejaculatory abstinence (EA) has been suggested to be a 
cost-effective approach to improve sperm quality (Levitas et al., 2004). 
As stated by the prescribed guidelines of the World Health Organisation (WHO), 
subjects must remain abstinent for a minimum period of 48 hours, but not longer than 7 days 
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prior to collecting a sample for a standard semen analysis (WHO, 2010), yet many studies 
referring to these recommendations are often contradictory (Comar et al., 2017; Padova et al., 
1988; Raziel et al., 2001). Recent studies have suggested very short abstinence as a preferable 
measure for better quality sperm from a functional perspective. In a previous study conducted 
in our laboratory, we observed enhanced sperm total motility and progressive motility after 
only 4 hours of abstinence when compared to an EA period of 4 days (Ayad et al., 2017). 
Similarly, Bahadur et al. (2016) found that only 40 minutes of EA improved sperm quality. 
Furthermore, Alipour et al. (2015) observed increases in sperm motility after only 2 hours of 
EA. Interestingly, none of these studies have comprehensively analysed the accessory sex 
gland secretions in the seminal plasma as a key attributor to these observations.  
Ejaculated spermatozoa are terminally differentiated cells post-spermatogenesis, 
therefore the main functional changes are to be exerted by the composition and influence of 
the seminal plasma (Elzanaty et al., 2005; Said et al., 2009). The seminal plasma 
microenvironment is imperative as the spermatozoon is the only cell that performs its functions 
outside the body of the organism it originates from (Baccetti, 1984). Consequently, epididymal 
and accessory sex gland secretions, which constitute seminal plasma, are of particular interest 
in this study. The prostate gland’s main function is to produce and release large amounts of 
ionized derivatives of citric acid in the form of citrate into prostatic fluid (Kavanagh, 1994). 
Furthermore, the prostate also releases a variety of other molecules, which are of importance 
to the process of fertilization. Prostate specific antigen is a glycoprotein enzyme, capable of 
liquefying the seminal coagulum thereby allowing sperm to swim freely (Balk et al., 2003). 
Zinc released by the prostate, aids in sperm DNA stabilization and low levels of seminal zinc 
are correlated with low fertility rates (Canale et al., 1986). The seminal vesicles are the highest 
producers of fructose, which is the main source of energy for spermatozoa (Mann, 1946). 
Seminal vesicles also release amino acids, flavins, phosphorylcholine, prostaglandins, vitamin 
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C and a range of proteins and enzymes (Schoenfeld et al., 1979; Mann, 1946). These molecules 
released by the seminal vesicles have a variety of contributory roles in sperm maturation and 
acquisition of fertilizing potential. The epididymis is primarily responsible for the release of 
neutral alpha-glucosidase (NAG) (Cooper et al., 1990) as well as proteins which prevent 
premature onset of capacitation during epididymal transit and storage (Fraser et al., 1990).  
The Percentage change in the concentrations of the selected epididymal and accessory 
sex gland biomarkers, have been widely utilized as clinical reflections of the global changes in 
the volume of secretions from each component (WHO, 2010). Many studies have attempted to 
formulate a specific ratio which causes variations in these secretions, but there are a multitude 
of variables to consider which effect secretion volumes. Therefore, minimizing subject 
variation by selecting samples from normozoospermic, healthy males between the ages of 19 
to 25, may minimize variation in physiological conditions allowing EA to be the primary 
intervention. 
A useful approach to further evaluating the effects of which varying concentrations of 
molecules in the semen, have on individual sperm, would be to analyse concentrations on a 
micro scale.  Considering the total amount of a specific molecule in the ejaculate, and dividing 
that value by the total sperm count (T.S.C.), would provide a more representative view of the 
absolute bioavailability of these biomolecules per individual sperm. 
Elzanaty et al. (2005) evaluated the semen from patients undergoing fertility 
assessment and measured motility parameters in addition to several accessory gland markers, 
including both fructose and NAG. However, citric acid was not measured, since prostate 
specific antigen (PSA) was chosen as a prostate secretion marker instead. Reductions in 
motility parameters were observed after shorter abstinence periods of 2 to 3 days. Additionally, 
all markers of epididymal and accessory gland secretions were higher after 4 to 7 days of 
abstinence. Although they found significant differences in the contributions of these glands, 
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they did not focus on very short abstinence periods (1 – 4 hours) as their lowest EA period was 
2-3 days.  
For the purpose of this study, basic semen parameters were selected as an adequate 
measure of semen and sperm quality. Furthermore, citric acid, neutral alpha-glucosidase and 
fructose have been selected as key biomarkers of prostatic, epididymal and seminal vesicular 
secretion and function. Furthermore, the possible direct role related to the concentrational 
variations concerning sperm functional improvements were also explored.  
Therefore, the aim of this study was to determine the effect of short (4 hours) and 
long (4 days) periods of EA on key epididymal and accessory sex gland secretions, and the 
subsequent relationship with semen basic and functional parameters.  
Methods 
Before the commencement of the study, ethical approval was obtained from the 
Health Research Ethics Committee of the Faculty of Medicine and Health Sciences at 
Stellenbosch University. Informed written consent was provided by all subjects and the study 
was performed in accordance with the Declaration of Helsinki (2013). Freshly ejaculated 
semen samples were collected from 16 consecutive healthy donors (19 to 25 years) attending 
the SURRG laboratories. All samples were collected according to the WHO guidelines 
(WHO, 2010) in a location close to the laboratory and received within 10 minutes of 
collection. The first sample from each donor was collected after an abstinence period of 4 
days. The second sample was collected from the same donor 4 hours subsequent to the first 
collection. Samples were immediately placed in an incubator (37°C, 5% CO2, 30 minutes) 
and allowed to fully liquefy before further processing. Information about donor identification 
and age, date of semen collection, time of semen collection, abstinence duration, sample 
volume, pH, appearance, colour, odour, liquefaction, viscosity and agglutination were 
reported. The sperm concentration and motility parameters were determined with Computer-
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Aided Sperm Analysis (CASA) using the Sperm Class Analyser version 5.4 - SCA®, 
(Microptic, S.L, Barcelona, Spain). 
Seminal plasma citric acid, fructose and NAG concentrations were measured with 
commercially available assay kits (Citric Acid, Fructose and Episcreen plus™ Assay Kits, 
FertiPro N.V., Belgium) respectively according to the manufacturers guidelines.  Absorbance 
values were measured photometrically for citric acid and NAG at 405nm and for fructose at 
470nm, using a FLUOstar Omega micro plate reader (BMG Labtech, Germany). Results for 
citric acid and fructose concentrations were expressed in mg/mL, while NAG activity was 
expressed as milli-international units per millilitre (mIU/mL). 
Statistical analyses 
Comparisons between parameters measured after long and short EA were performed 
using the Students paired t-test for normally distributed data sets and Mann-Whitney U-tests 
for nonparametric data sets, on GraphPad Prism© version 7.00 for Windows (GraphPad 
Software, La Jolla California, USA).  All values are presented as mean ± SE. Statistical 
significance was set at p<0.05. 
 
Results 
As presented in Table 1, semen volume, sperm concentration and subsequent T.S.C. 
were significantly decreased after short EA when compared to long abstinence, while semen 
pH was slightly yet significantly increased after short EA. A significant increase in the 
percentage of sperm total motility and progressive motility was observed after short EA. 
Citric acid, NAG and fructose concentrations were all significantly reduced after short EA 
when compared to long EA. On the contrary, when considering T.S.C. in these cohorts, the 
absolute amount of citric acid per sperm was significantly higher after short EA. 
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Interestingly, the absolute amount of fructose per sperm was significantly decreased after 
short EA, while NAG per spermatozoon was not significantly affected (Table 2).  
 
Discussion 
The results of this study shows that conventional and functional semen parameters 
were influenced significantly by EA periods. A short period of EA (4 hours) produced 
significant increases in both sperm total motility and progressive motility yet highly 
significant reductions in T.S.C., sperm concentration and semen volume. These results are in 
accordance with two large studies performed by Comar et al. (2017) and Levitas et al.  
(2005) where the duration of EA had a significant positive relationship with sperm 
concentration and semen volume, yet a significant negative influence on sperm motility. 
These effects are ascribed to the fact that sperm reserves were available and stored in the 
epididymis. Motility changes were attributed to increased levels of reactive oxygen species 
(ROS) and subsequent DNA damage in stored sperm over longer EA periods. Damaged 
spermatozoa (Iwasaki et al., 1992) or infiltrating leukocytes (Kessopoulou et al., 1994) are 
the sources of ROS, which is correlated with decreased sperm motility. In the case of the 
lower EA period, the sperm reserves were depleted and T.S.C. decreased (Rao et al., 2015). 
Significant reductions in citric acid, NAG and fructose concentrations were observed after 4 
hours of EA, which may be attributed to the insufficient time for the epididymis and 
accessory sex glands to produce their respective secretions resulting in reduction in semen 
volume associated with short abstinence (Levitas et al., 2004). The results of this study bring 
citric acid to the fore, due to the fact that per sperm, citric acid drastically increased compared 
to the other two accessory gland secretions, with an increase of 110% after short EA when 
compared to long EA. NAG slightly increased by only 6%, whereas fructose decreased by 
38% after short EA. Furthermore, progressive motility increased by 30% which is nearly 
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double that of the increase observed in total motility. This supports the assumption that very 
short EA periods may produce functionally favourable sperm, thus increasing fertilizing 
capacity (Bhahadur et al., 2016; Alipour et al., 2015; Ayad et al., 2017).  
Seminal fructose is considered to be the primary source of energy with direct effects 
on sperm motility (Mann, 1946). Patel et al. (1988) found direct positive correlations between 
seminal fructose levels and the percentage of motile sperm and this has been explained by the 
presence of glycolytic enzymes concentrated in the principal piece in the sperm flagellum 
(Storey and Kayne, 1975; Travis et al., 1998; Eddy et al., 2003), therefore the breakdown of 
fructose during glycolysis could produce ATP adjacent to the site where it is required. 
Furthermore, it has been suggested that glycolysis in the principal piece of the flagellum, is 
critical for normal sperm motility (Turner, 2003).  Therefore, the observed increases in sperm 
motility cannot be ascribed to fructose and alternative energy sources should be responsible. 
This proposes citric acid as a possible source of energy due to its significant increase 
observed after short EA. Second to this, an alternative explanation might be related to the 
change observed in pH. 
The fragile microenvironment created by the testes, epididymis and accessory sex 
glands has been found to actively manipulate the basic and functional sperm parameters 
including semen pH and volume, as well as sperm motility and fertilizing capacity. Studies 
have found short abstinence of 2 days, to be associated with decreased prostatic secretions 
and increased epididymal secretions (Elzanaty, et al., 2005). However, little is known about 
the variations in seminal accessory gland secretions after EA periods of less than 1 day. 
A previous study performed by Medrano et al. (2006), found that citric acid acts as a 
substrate for energy metabolism in sperm in addition to causing slight variations in seminal 
plasma pH. However, its relationship with, and role in abstinence has not been elucidated. 
Considering our paradoxical results, there are two possible mechanisms by which citric acid 
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may affect sperm motility. The direct mechanism, which consists of the increase in available 
amount of citrates per sperm for utilization in the citric acid cycle to provide energy for 
sperm motility, seeing that there is more citric acid per sperm available after short EA. As 
mentioned previously, spermatozoa primarily utilize fructose originating from the seminal 
vesicles, as a source of carbohydrates. Once absorbed by sperm, it is then broken down into 
glucose and converted to acetyl-coenzyme A (CoA), which drives the citric acid cycle 
ultimately leading to the production of utilizable energy in the form of Adenosine 
Triphosphate (ATP) produced by the electron transport chain (Figure 1). Furthermore, it has 
been shown that spermatozoa pre-incubated in citrate increase their ATP production without 
the addition of fructose (Medrano et al., 2006). It is believed that this occurs when citrates are 
converted to malate, an intermediary, which is subsequently utilized in the citric acid cycle in 
sperm mitochondria (Visconti, 2012).  
On the other hand, the potential role of citric acid in improving sperm motility after 
short EA might also be explained through a more indirect mechanism. Short abstinence-
related decrease in citric acid was also accompanied by an overall increase in pH of the 
seminal plasma. It has previously been reported that this increase in alkalinity, creates a more 
conducive environment for spermatozoa, which has been shown to enhance their motility 
(Zhou et al., 2015).  The exact mechanism by which pH alters sperm motility is not clear, yet 
it is well recognized (Makler et al., 1981; Carr et al., 1985; Ingermann et al., 2002). 
However, it has been speculated that pH affects the activity of the alpha-4-isoform of the 
Na+/K+-ATPase, which controls the transmembrane Na+ gradient in sperm flagella by 
keeping the intracellular Na+ concentration low which is crucial to many general and cell-
specific processes (Zhou et al., 2015). In support of this, α4-isoform knockout mice have 
been reported to produce predominantly immotile sperm (Jimenez et al., 2011). This may 
explain the observed increases in total sperm motility and progressive motility when sperm 
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are exposed to increasing alkalinity. The ideal pH for sperm to function adequately is 
between 7.2 and 8.2, yet motility increases as the pH increases in this range (Zhou et al., 
2015). 
Most previous studies have not systematically assessed the contributory role of citric 
acid in particular, and its ability to possibly influence sperm functional characteristics directly 
or indirectly in relation to abstinence. This study found that citric acid may be a viable 
candidate in the justification of the observed improvements in sperm motility after an 
abstinence period of 4 hours, as well as being partially responsible for an increase in semen 
pH. An additive effect via the increased availability of citric acid per sperm might occur 
which furthermore compensates for the reduction in fructose per sperm.  This highlights a 
possible oversight of the metabolic significance of citric acid. Further comprehensive 
biochemical pathway analysis is required to better understand the role that accessory sex 
glands play in the improvement of sperm motility in the ejaculates collected after very short 
abstinence. 
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Table 1: Summary of the SCA® motility parameters as measured by CASA. Values are expressed as mean 
± SE  
























pH 7.68 ± 0.029 7.76 ± 0.038 No - 0.046 1% 7.2 - 8 
Sperm concentration 
(x106/mL) 
57.35 ± 7.2 36.83 ± 4.51 No - 0.018 -36% 15 or more 
Semen volume (mL) 2.56 ± 0.33 1.74 ± 0.22 No - 0.025 -32% 1.5 or more 
Total Sperm count 
(x106/ejaculate) 
144.68 ± 22.77 58.01  ± 6.43 Yes 0.0007 - -77% 39 or more 
Total motility (%) 64.71 ± 13.94 71.84 ± 3.85 Yes 0.033 - 14% 40 or more 
Progressive motility (%) 47.73 ± 14.33 58.54 ± 13.38 Yes 0.001 - 30% 32 or more 
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Table 2: Summary of specific epididymal and accessory sex gland kits. Values are expressed as mean ± 
SE  








% change Normal range 
Citric acid 
(mg/mL) 




0.141 ± 0.025 0.254 ± 0.056 No - 0.034 110% - 
Fructose 
(mg/mL) 
4.07 ± 0.77 1.66 ± 0.52 No - 0.015 -54% 1.6 or more 
Fructose per 
sperm (ng) 
0.045 ± 0.016 0.036 ± 0.011 Yes 0.037 - -38% - 
NAG 
(mIU/mL) 
29.32 ± 3.53 19.92 ± 3.61 Yes 0.005 - -33% 2 – 15 
NAG per 
sperm (nIU) 
0.563 ± 0.08 0.145 ± 0.128 No - 0.638 6% - 





















Figure 1: Fructose enters the glycolytic pathway after phosphorylation by hexokinase and is subsequently 
converted to pyruvate via glycolysis to be used in the citric acid cycle. The entire citric acid cycle occurs within 
the inner mitochondrial wall. Pyruvate can enter the mitochondria through specific transporters where it can be 
oxidized to acetyl-coenzyme A (CoA) and CO2. Acetyl-CoA then enters the citric acid cycle, which generates one 
high-energy bond in the form of GTP and four reduced compounds (3 NADH and 1 FADH2), to be used in the 
oxidative phosphorylation process. Regarding citrate, when it is obtained from oxaloacetate inside the 
mitochondria as part of the citric acid cycle, exogenous citrate cannot permeate the inner mitochondrial membrane. 
Thus, before entering the cycle, it should be first converted to malate and to pyruvate by a series of enzymes with 
the use of ATP. The electrons conserved in NADH and FADH2 are then used to reduce oxygen in the oxidative 
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Appendix C: Proteomic results of LC-MS/MS analysis. 
 
Identified Protein Accession Number T-Test (P-value): 2 (1) 1 (1) 3 (1) 4 (1) 2 4 3 1 
Prostatic acid phosphatase 
OS=Homo sapiens GN=ACPP PE=1 
SV=3 
sp|P15309|PPAP_HUMAN 0.36 3610 3968 3430 3579 3579 4662 3616 4108 
Prostate-specific antigen OS=Homo 
sapiens GN=KLK3 PE=1 SV=2 
sp|P07288|KLK3_HUMAN 0.37 3040 3350 1957 3712 3712 4057 3474 3548 
sp|Q02383|SEMG2_HUMAN 
Semenogelin-2 OS=Homo sapiens 
GN=SEMG2 PE=1 SV=1 
sp|Q02383|SEMG2_HUMANSemenogelin-2 
OS=Homo sapiens GN=SEMG2 PE=1 SV=1 
0.25 3387 2945 916 3256 3256 312 3690 3498 
sp|TRYP_PIG| sp|TRYP_PIG| 0.37 2957 2832 2090 3520 3520 3346 3367 3311 
Serum albumin OS=Homo sapiens 
GN=ALB PE=1 SV=2 
sp|P02768|ALBU_HUMAN 0.38 1738 2417 1777 2499 2499 2817 2301 2234 
Isoform 15 of Fibronectin OS=Homo 
sapiens GN=FN1 
sp|P02751-15|FINC_HUMAN 0.32 2005 2802 1399 2056 2056 1949 2072 2735 
sp|P04279|SEMG1_HUMAN 
Semenogelin-1 OS=Homo sapiens 
GN=SEMG1 PE=1 SV=2 
sp|P04279|SEMG1_HUMANSemenogelin-1 
OS=Homo sapiens GN=SEMG1 PE=1 SV=2 
0.18 2445 2497 554 2758 2758 38 2297 2544 
Isoform DeltaLf of Lactotransferrin 
OS=Homo sapiens GN=LTF 
sp|P02788-2|TRFL_HUMAN 0.41 1446 2212 1442 1866 1866 2237 2209 2440 
Isoform 2 of Clusterin OS=Homo 
sapiens GN=CLU 
sp|P10909-2|CLUS_HUMAN 0.32 1519 1896 1072 1553 1553 1312 1543 1883 
Prolactin-inducible protein OS=Homo 
sapiens GN=PIP PE=1 SV=1 
PIP_HUMAN 0.35 1281 964 803 1112 1112 1138 1053 1148 
sp|ALBU_BOVIN| sp|ALBU_BOVIN| 0.32 1306 1359 2641 1655 1655 996 775 697 
Zinc-alpha-2-glycoprotein OS=Homo 
sapiens GN=AZGP1 PE=1 SV=2 
ZA2G_HUMAN 0.36 1177 1393 1287 1311 1311 1396 1324 1475 
Isoform 2 of Carboxypeptidase E 
OS=Homo sapiens GN=CPE 
sp|P16870-2|CBPE_HUMAN (+1) 0.37 678 606 466 702 702 851 666 783 
sp|P49221|TGM4_HUMAN Protein-
glutamine gamma-
glutamyltransferase 4 OS=Homo 
sapiens... 
sp|P49221|TGM4_HUMAN Protein-glutamine 
gamma-glutamyltransferase 4 OS=Homo 
sapiens... 
0.29 584 983 456 464 464 311 562 730 
sp|P05154|IPSP_HUMAN Plasma 
serine protease inhibitor OS=Homo 
sapiens GN=SERPINA5... 
sp|P05154|IPSP_HUMAN Plasma serine protease 
inhibitor OS=Homo sapiens GN=SERPINA5... 
0.34 422 464 396 452 452 428 439 462 
sp|K1C10_HUMAN| sp|K1C10_HUMAN| 0.35 436 427 398 671 671 519 514 432 
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Proactivator polypeptide OS=Homo 
sapiens GN=PSAP PE=2 SV=1 
C9JIZ6_HUMAN 0.33 411 438 345 512 512 449 397 425 
Mucin-6 OS=Homo sapiens 
GN=MUC6 PE=1 SV=3 
MUC6_HUMAN 0.36 384 456 392 391 391 338 392 603 
Aminopeptidase N OS=Homo sapiens 
GN=ANPEP PE=1 SV=4 
AMPN_HUMAN 0.37 472 420 307 408 408 541 314 605 
sp|K1C9_HUMAN| sp|K1C9_HUMAN| 0.38 495 311 310 372 372 469 556 367 
Actin, cytoplasmic 2 OS=Homo 
sapiens GN=ACTG1 PE=1 SV=1 
ACTG_HUMAN 0.33 503 359 272 303 303 410 387 409 
Alpha-1-antitrypsin OS=Homo 
sapiens GN=SERPINA1 PE=1 SV=3 
sp|P01009|A1AT_HUMAN 0.41 287 372 310 367 367 404 450 378 
Keratin, type II cytoskeletal 1 
OS=Homo sapiens GN=KRT1 PE=1 
SV=6 
K2C1_HUMAN 0.41 4 6 377 575 580 2 614 7 
Beta-microseminoprotein OS=Homo 
sapiens GN=MSMB PE=1 SV=1 
sp|P08118|MSMB_HUMAN 0.33 269 317 245 253 253 206 255 249 
Creatine kinase B-type OS=Homo 
sapiens GN=CKB PE=1 SV=1 
KCRB_HUMAN 0.34 353 385 358 243 243 351 329 312 
sp|TRFE_HUMAN| sp|TRFE_HUMAN| 0.48 205 384 196 240 240 327 487 339 
sp|Q08380|LG3BP_HUMAN 
Galectin-3-binding protein OS=Homo 
sapiens GN=LGALS3BP PE=1 SV=1 
sp|Q08380|LG3BP_HUMANGalectin-3-binding 
protein OS=Homo sapiens GN=LGALS3BP PE=1 
SV=1 
0.63 287 297 138 4 319 3 357 311 
Lipoprotein lipase OS=Homo sapiens 
GN=LPL PE=1 SV=1 
LIPL_HUMAN 0.33 197 225 145 231 231 189 198 210 
sp|K22E_HUMAN| sp|K22E_HUMAN| 0.34 194 223 170 341 341 245 226 183 
Sorbitol dehydrogenase OS=Homo 
sapiens GN=SORD PE=1 SV=4 
DHSO_HUMAN 0.33 219 292 224 224 224 234 211 247 
Fatty acid synthase OS=Homo 
sapiens GN=FASN PE=1 SV=3 
FAS_HUMAN 0.34 205 221 227 121 121 210 185 174 
Peptidyl-prolyl cis-trans isomerase B 
OS=Homo sapiens GN=PPIB PE=1 
SV=2 
PPIB_HUMAN 0.37 163 147 183 207 207 194 194 221 
sp|Q16610|ECM1_HUMAN 
Extracellular matrix protein 1 
OS=Homo sapiens GN=ECM1 PE=1... 
sp|Q16610|ECM1_HUMAN Extracellular matrix 
protein 1 OS=Homo sapiens GN=ECM1 PE=1... 
0.56 143 216 122 219 219 323 263 244 
Glycodelin OS=Homo sapiens 
GN=PAEP PE=1 SV=2 
sp|P09466|PAEP_HUMAN 0.44 120 175 95 163 163 220 223 214 
Cathepsin D OS=Homo sapiens 
GN=CTSD PE=1 SV=1 
CATD_HUMAN 0.33 192 209 160 188 188 176 224 185 
Gastricsin OS=Homo sapiens 
GN=PGC PE=1 SV=1 
sp|P20142|PEPC_HUMAN 0.32 106 70 99 47 47 46 94 58 
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Laminin subunit alpha-5 OS=Homo 
sapiens GN=LAMA5 PE=1 SV=8 
sp|O15230|LAMA5_HUMANLaminin subunit 
alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 
0.33 81 127 131 125 125 0 149 131 
Alpha-1-antichymotrypsin OS=Homo 
sapiens GN=SERPINA3 PE=1 SV=2 
sp|P01011|AACT_HUMAN 0.28 138 270 105 142 142 185 112 203 
Isoform 12 of Titin OS=Homo sapiens 
GN=TTN 
sp|Q8WZ42-12|TITIN_HUMAN 0.47 3 0 0 5 5 4 0 6 
sp|P80303|NUCB2_HUMAN 
Nucleobindin-2 OS=Homo sapiens 
GN=NUCB2 PE=1 SV=2 
sp|P80303|NUCB2_HUMANNucleobindin-2 
OS=Homo sapiens GN=NUCB2 PE=1 SV=2 
0.28 167 219 127 213 213 2 243 226 
sp|P30041|PRDX6_HUMAN 
Peroxiredoxin-6 OS=Homo sapiens 
GN=PRDX6 PE=1 SV=3 
sp|P30041|PRDX6_HUMANPeroxiredoxin-6 
OS=Homo sapiens GN=PRDX6 PE=1 SV=3 
0.27 243 238 138 184 184 1 197 216 
Neprilysin OS=Homo sapiens 
GN=MME PE=1 SV=2 
NEP_HUMAN 0.36 176 208 100 162 162 206 179 213 
Hornerin OS=Homo sapiens 
GN=HRNR PE=1 SV=2 
HORN_HUMAN 0.16 4 2 1 6 6 15 12 5 
sp|O00391|QSOX1_HUMAN 
Sulfhydryl oxidase 1 OS=Homo 
sapiens GN=QSOX1 PE=1 SV=3 
sp|O00391|QSOX1_HUMANSulfhydryl oxidase 1 
OS=Homo sapiens GN=QSOX1 PE=1 SV=3 
0.2 164 233 112 201 201 1 162 210 
sp|P55268|LAMB2_HUMAN Laminin 
subunit beta-2 OS=Homo sapiens 
GN=LAMB2 PE=1 SV=2 
sp|P55268|LAMB2_HUMANLaminin subunit 
beta-2 OS=Homo sapiens GN=LAMB2 PE=1 SV=2 
0.31 107 133 90 126 126 0 133 173 
Alpha-enolase OS=Homo sapiens 
GN=ENO1 PE=1 SV=2 
sp|P06733|ENOA_HUMAN 0.33 187 185 158 128 128 177 196 147 
Cystatin-C OS=Homo sapiens 
GN=CST3 PE=1 SV=1 
CYTC_HUMAN 0.35 129 266 120 120 120 221 164 176 
sp|P01857|IGHG1_HUMAN Ig 
gamma-1 chain C region OS=Homo 
sapiens GN=IGHG1 PE=1 SV=1 
sp|P01857|IGHG1_HUMANIg gamma-1 chain C 
region OS=Homo sapiens GN=IGHG1 PE=1 SV=1 
0.4 139 169 178 161 161 225 191 169 
sp|P54107|CRIS1_HUMAN Cysteine-
rich secretory protein 1 OS=Homo 
sapiens GN=CRISP1... 
sp|P54107|CRIS1_HUMANCysteine-rich 
secretory protein 1 OS=Homo sapiens GN=CRISP1 
PE=1 SV=1 
0.25 173 255 3 3 311 3 254 381 
sp|P62258|1433E_HUMAN 14-3-3 
protein epsilon OS=Homo sapiens 
GN=YWHAE PE=1 SV=1 
sp|P62258|1433E_HUMAN14-3-3 protein 
epsilon OS=Homo sapiens GN=YWHAE PE=1 SV=1 
0.36 157 151 104 128 128 201 134 142 
sp|P07900|HS90A_HUMAN Heat 
shock protein HSP 90-alpha 
OS=Homo sapiens GN=HSP90AA1... 
sp|P07900|HS90A_HUMANHeat shock protein 
HSP 90-alpha OS=Homo sapiens GN=HSP90AA1 
PE=1 SV=5 
0.27 1 346 3 1 232 3 319 309 
Dipeptidyl peptidase 4 OS=Homo 
sapiens GN=DPP4 PE=1 SV=2 
DPP4_HUMAN 0.41 143 152 93 131 131 162 120 234 
sp|P61916|NPC2_HUMAN 
Epididymal secretory protein E1 
OS=Homo sapiens GN=NPC2 PE=1... 
sp|P61916|NPC2_HUMAN Epididymal secretory 
protein E1 OS=Homo sapiens GN=NPC2 PE=1... 
0.4 114 149 107 132 132 148 228 201 
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ADP-ribosyl cyclase 1 OS=Homo 
sapiens GN=CD38 PE=1 SV=2 
sp|P28907|CD38_HUMAN 0.35 89 112 74 93 93 107 84 109 
Angiotensin-converting enzyme 
OS=Homo sapiens GN=ACE PE=1 
SV=1 
ACE_HUMAN 0.3 100 123 90 103 103 0 120 152 
Isoform 2 of 72 kDa type IV 
collagenase OS=Homo sapiens 
GN=MMP2 
sp|P08253-2|MMP2_HUMAN 0.41 89 116 80 137 137 124 170 128 
Ig kappa chain C region OS=Homo 
sapiens GN=IGKC PE=1 SV=1 
IGKC_HUMAN 0.36 111 114 106 110 110 131 121 115 
Carboxypeptidase M OS=Homo 
sapiens GN=CPM PE=1 SV=2 
CBPM_HUMAN 0.47 84 93 113 130 130 229 188 111 
sp|P04406-2|G3P_HUMAN Isoform 
2 of Glyceraldehyde-3-phosphate 
dehydrogenase OS=Homo... 
sp|P04406-2|G3P_HUMANIsoform 2 of 
Glyceraldehyde-3-phosphate dehydrogenase 
OS=Homo sapiens GN=GAPDH 
0.76 205 261 53 1 137 207 175 220 
Complement C3 OS=Homo sapiens 
GN=C3 PE=1 SV=2 
CO3_HUMAN 0.34 72 137 91 96 96 124 83 100 
Isoform 3 of Laminin subunit alpha-3 
OS=Homo sapiens GN=LAMA3 
sp|Q16787-3|LAMA3_HUMAN 0.31 3 6 0 3 3 4 5 6 
Cathepsin B OS=Homo sapiens 
GN=CTSB PE=1 SV=3 
CATB_HUMAN 0.39 103 120 91 111 111 146 145 112 
sp|P68104|EF1A1_HUMAN 
Elongation factor 1-alpha 1 
OS=Homo sapiens GN=EEF1A1 PE=1 
SV=1 
sp|P68104|EF1A1_HUMANElongation factor 1-
alpha 1 OS=Homo sapiens GN=EEF1A1 PE=1 SV=1 
0.63 259 162 36 7 111 134 170 145 
Lysosomal alpha-glucosidase 
OS=Homo sapiens GN=GAA PE=1 
SV=4 
LYAG_HUMAN 0.45 89 121 56 98 98 113 121 162 
sp|P41222|PTGDS_HUMAN 
Prostaglandin-H2 D-isomerase 
OS=Homo sapiens GN=PTGDS PE=1... 
sp|P41222|PTGDS_HUMANProstaglandin-H2 D-
isomerase OS=Homo sapiens GN=PTGDS PE=1 
SV=1 
0.34 110 160 4 0 146 0 184 213 
sp|ANXA5_HUMAN| sp|ANXA5_HUMAN| 0.3 152 158 110 133 133 125 139 104 
Isoform 2 of Protein dopey-2 
OS=Homo sapiens GN=DOPEY2 
sp|Q9Y3R5-2|DOP2_HUMAN 0.3 83 90 79 72 72 77 46 84 
Isoform 3 of Cartilage acidic protein 
1 OS=Homo sapiens GN=CRTAC1 
sp|Q9NQ79-3|CRAC1_HUMAN 0.29 102 170 81 123 123 90 122 130 
Phosphoglycerate kinase 1 OS=Homo 
sapiens GN=PGK1 PE=1 SV=3 
PGK1_HUMAN 0.28 181 124 103 85 85 105 106 109 
Low-density lipoprotein receptor-
related protein 2 OS=Homo sapiens 
GN=LRP2 PE=1 SV=3 
LRP2_HUMAN 0.8 0 6 0 0 0 2 0 2 
sp|GSTP1_HUMAN| sp|GSTP1_HUMAN| 0.33 145 177 166 61 61 102 111 124 
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shock cognate 71 kDa protein 
OS=Homo sapiens GN=HSPA8... 
sp|P11142|HSP7C_HUMANHeat shock cognate 
71 kDa protein OS=Homo sapiens GN=HSPA8 
PE=1 SV=1 
0.15 137 159 0 0 105 172 158 116 
Prolow-density lipoprotein receptor-
related protein 1 OS=Homo sapiens 
GN=LRP1 PE=1 SV=2 
LRP1_HUMAN 0.17 0 0 0 0 0 7 1 2 
sp|P01033|TIMP1_HUMAN 
Metalloproteinase inhibitor 1 
OS=Homo sapiens GN=TIMP1 PE=1 
SV=1 
sp|P01033|TIMP1_HUMANMetalloproteinase 
inhibitor 1 OS=Homo sapiens GN=TIMP1 PE=1 
SV=1 
0.054 119 145 12 0 175 135 178 176 
Isoform M1 of Pyruvate kinase PKM 
OS=Homo sapiens GN=PKM 
sp|P14618-2|KPYM_HUMAN 0.3 131 156 107 84 84 109 106 93 
Myosin-9 OS=Homo sapiens 
GN=MYH9 PE=1 SV=4 
sp|P35579|MYH9_HUMAN 0.34 89 112 120 57 57 108 83 77 
Plastin-2 OS=Homo sapiens GN=LCP1 
PE=1 SV=6 
PLSL_HUMAN 0.51 88 155 72 115 115 167 145 148 
Endoplasmin OS=Homo sapiens 
GN=HSP90B1 PE=1 SV=1 
ENPL_HUMAN 0.46 83 94 50 66 66 127 123 103 
sp|Q9Y6R7|FCGBP_HUMAN IgGFc-
binding protein OS=Homo sapiens 
GN=FCGBP PE=1 SV=3 
sp|Q9Y6R7|FCGBP_HUMANIgGFc-binding 
protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 
0.3 58 100 59 55 55 0 81 102 
Isoform 6 of Agrin OS=Homo sapiens 
GN=AGRN 
sp|O00468-6|AGRIN_HUMAN 0.36 65 89 65 54 54 93 67 70 
sp|O95716|RAB3D_HUMAN Ras-
related protein Rab-3D OS=Homo 
sapiens GN=RAB3D PE=1 SV=1 
sp|O95716|RAB3D_HUMANRas-related protein 
Rab-3D OS=Homo sapiens GN=RAB3D PE=1 SV=1 
0.4 88 72 52 75 75 108 90 121 
sp|Q6PCB0|VWA1_HUMAN von 
Willebrand factor A domain-
containing protein 1 OS=Homo... 
sp|Q6PCB0|VWA1_HUMAN von Willebrand 
factor A domain-containing protein 1 OS=Homo... 
0.31 121 148 97 137 137 108 145 124 
Ribonuclease T2 OS=Homo sapiens 
GN=RNASET2 PE=1 SV=2 
sp|O00584|RNT2_HUMAN 0.31 100 114 64 80 80 81 90 114 
sp|Q96KP4|CNDP2_HUMAN 
Cytosolic non-specific dipeptidase 
OS=Homo sapiens GN=CNDP2 PE=1 
SV=2 
sp|Q96KP4|CNDP2_HUMANCytosolic non-
specific dipeptidase OS=Homo sapiens 
GN=CNDP2 PE=1 SV=2 
0.11 142 155 7 1 111 174 181 158 
sp|P11047|LAMC1_HUMAN Laminin 
subunit gamma-1 OS=Homo sapiens 
GN=LAMC1 PE=1 SV=3 
sp|P11047|LAMC1_HUMANLaminin subunit 
gamma-1 OS=Homo sapiens GN=LAMC1 PE=1 
SV=3 
0.31 69 93 82 69 69 0 85 106 
sp|Q13510|ASAH1_HUMAN Acid 
ceramidase OS=Homo sapiens 
GN=ASAH1 PE=1 SV=5 
sp|Q13510|ASAH1_HUMANAcid ceramidase 
OS=Homo sapiens GN=ASAH1 PE=1 SV=5 
0.23 122 126 76 126 126 1 115 129 
Lactoylglutathione lyase OS=Homo 
sapiens GN=GLO1 PE=1 SV=4 
sp|Q04760|LGUL_HUMAN 0.34 79 80 60 70 70 64 75 77 
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Isoform 2 of Triosephosphate 
isomerase OS=Homo sapiens 
GN=TPI1 
sp|P60174-1|TPIS_HUMAN 0.34 118 121 75 84 84 106 105 117 
Isoform 2 of ATP-citrate synthase 
OS=Homo sapiens GN=ACLY 
sp|P53396-2|ACLY_HUMAN 0.25 84 81 36 28 28 67 57 36 
Tripeptidyl-peptidase 1 OS=Homo 
sapiens GN=TPP1 PE=1 SV=2 
sp|O14773|TPP1_HUMAN 0.39 66 98 72 95 95 117 119 65 
sp|Q99497|PARK7_HUMAN Protein 
DJ-1 OS=Homo sapiens GN=PARK7 
PE=1 SV=2 
sp|Q99497|PARK7_HUMANProtein DJ-1 
OS=Homo sapiens GN=PARK7 PE=1 SV=2 
0.67 69 70 0 73 73 2 103 103 
Polyubiquitin-C (Fragment) 
OS=Homo sapiens GN=UBC PE=2 
SV=1 
F5GXK7_HUMAN 0.37 68 71 69 71 71 91 64 91 
sp|Q9NR99|MXRA5_HUMAN 
Matrix-remodeling-associated 
protein 5 OS=Homo sapiens 
GN=MXRA5 PE=2 SV=3 
sp|Q9NR99|MXRA5_HUMANMatrix-remodeling-
associated protein 5 OS=Homo sapiens 
GN=MXRA5 PE=2 SV=3 
0.43 37 113 0 0 61 42 63 61 
Rab GDP dissociation inhibitor beta 
OS=Homo sapiens GN=GDI2 PE=1 
SV=2 
sp|P50395|GDIB_HUMAN 0.41 63 79 106 54 54 105 76 98 
Hemopexin OS=Homo sapiens 
GN=HPX PE=1 SV=2 
HEMO_HUMAN 0.51 34 94 46 74 74 105 86 66 
A disintegrin and metalloproteinase 
with thrombospondin motifs 1 
OS=Homo sapiens GN=ADAMTS1 
PE=1 SV=4 
ATS1_HUMAN 0.49 31 65 42 59 59 118 74 47 
sp|Q5JQC9|AKAP4_HUMAN A-
kinase anchor protein 4 OS=Homo 
sapiens GN=AKAP4 PE=1 SV=1 
sp|Q5JQC9|AKAP4_HUMANA-kinase anchor 
protein 4 OS=Homo sapiens GN=AKAP4 PE=1 
SV=1 
0.66 1 1 30 53 53 3 249 122 
sp|P04083|ANXA1_HUMAN Annexin 
A1 OS=Homo sapiens GN=ANXA1 
PE=1 SV=2 
sp|P04083|ANXA1_HUMANAnnexin A1 
OS=Homo sapiens GN=ANXA1 PE=1 SV=2 
0.34 117 101 72 82 82 120 98 98 
sp|P11021|GRP78_HUMAN 78 kDa 
glucose-regulated protein OS=Homo 
sapiens GN=HSPA5 PE=1... 
sp|P11021|GRP78_HUMAN78 kDa glucose-
regulated protein OS=Homo sapiens GN=HSPA5 
PE=1 SV=2 
0.32 144 107 0 0 71 131 131 84 
sp|Q06830|PRDX1_HUMAN 
Peroxiredoxin-1 OS=Homo sapiens 
GN=PRDX1 PE=1 SV=1 
sp|Q06830|PRDX1_HUMANPeroxiredoxin-1 
OS=Homo sapiens GN=PRDX1 PE=1 SV=1 
0.49 139 114 47 0 88 110 137 114 
Tubulin alpha-1C chain OS=Homo 
sapiens GN=TUBA1C PE=2 SV=1 
F5H5D3_HUMAN 0.37 66 78 62 52 52 77 83 65 
Isoform 2 of Extracellular matrix 
protein FRAS1 OS=Homo sapiens 
GN=FRAS1 
sp|Q86XX4-2|FRAS1_HUMAN 0.47 0 1 1 1 1 2 1 0 
Ezrin OS=Homo sapiens GN=EZR 
PE=1 SV=4 
EZRI_HUMAN 0.28 82 112 65 72 73 73 81 66 
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containing protein 2 OS=Homo 
sapiens GN=TACC2 PE=2 SV=1 
E9PBC6_HUMAN 0.74 1 10 2 4 4 4 5 11 
Alpha-2-antiplasmin OS=Homo 
sapiens GN=SERPINF2 PE=1 SV=3 
sp|P08697|A2AP_HUMAN 0.35 72 93 67 97 97 73 93 102 
sp|P01859|IGHG2_HUMAN Ig 
gamma-2 chain C region OS=Homo 
sapiens GN=IGHG2 PE=1 SV=2 
sp|P01859|IGHG2_HUMANIg gamma-2 chain C 
region OS=Homo sapiens GN=IGHG2 PE=1 SV=2 
0.38 76 104 62 96 96 82 97 100 
sp|Q96S96|PEBP4_HUMAN 
Phosphatidylethanolamine-binding 
protein 4 OS=Homo sapiens 
GN=PEBP4 PE=1 SV=3 
sp|Q96S96|PEBP4_HUMANPhosphatidylethanol
amine-binding protein 4 OS=Homo sapiens 
GN=PEBP4 PE=1 SV=3 
0.021 68 80 2 0 107 70 141 129 
sp|O15230|LAMA5_HUMAN 
Laminin subunit alpha-5 OS=Homo 
sapiens GN=LAMA5 PE=1 SV=8 
sp|O15230|LAMA5_HUMANLaminin subunit 
alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 
SV=8-DECOY 
0.36 0 0 0 0 0 0 3 0 
Pro-cathepsin H OS=Homo sapiens 
GN=CTSH PE=1 SV=4 
CATH_HUMAN 0.36 78 66 74 63 63 66 84 76 
sp|P04075|ALDOA_HUMAN 
Fructose-bisphosphate aldolase A 
OS=Homo sapiens GN=ALDOA 
PE=1... 
sp|P04075|ALDOA_HUMANFructose-
bisphosphate aldolase A OS=Homo sapiens 
GN=ALDOA PE=1 SV=2 
0.96 142 172 4 2 96 4 119 125 
sp|P04792|HSPB1_HUMAN Heat 
shock protein beta-1 OS=Homo 
sapiens GN=HSPB1 PE=1 SV=2 
sp|P04792|HSPB1_HUMANHeat shock protein 
beta-1 OS=Homo sapiens GN=HSPB1 PE=1 SV=2 
0.21 234 82 63 58 58 0 82 96 
Trypsin-1 OS=Homo sapiens 
GN=PRSS1 PE=2 SV=1 
E7EQ64_HUMAN 0.33 39 43 21 49 49 44 36 40 
sp|P68371|TBB4B_HUMAN Tubulin 
beta-4B chain OS=Homo sapiens 
GN=TUBB4B PE=1 SV=1 
sp|P68371|TBB4B_HUMANTubulin beta-4B 
chain OS=Homo sapiens GN=TUBB4B PE=1 SV=1 
0.23 139 103 56 86 86 0 144 112 
sp|P08107|HSP71_HUMAN Heat 
shock 70 kDa protein 1A/1B 
OS=Homo sapiens GN=HSPA1A 
PE=1... 
sp|P08107|HSP71_HUMANHeat shock 70 kDa 
protein 1A/1B OS=Homo sapiens GN=HSPA1A 
PE=1 SV=5 
0.65 108 156 3 0 108 0 150 94 
sp|P32119|PRDX2_HUMAN 
Peroxiredoxin-2 OS=Homo sapiens 
GN=PRDX2 PE=1 SV=5 
sp|P32119|PRDX2_HUMANPeroxiredoxin-2 
OS=Homo sapiens GN=PRDX2 PE=1 SV=5 
0.56 78 78 3 66 66 66 74 79 
Isoform 2 of Amiloride-sensitive 
amine oxidase [copper-containing] 
OS=Homo sapiens GN=AOC1 
sp|P19801-2|AOC1_HUMAN 0.45 51 72 66 50 50 101 104 65 
Beta-hexosaminidase OS=Homo 
sapiens GN=HEXA PE=2 SV=1 
H3BP20_HUMAN 0.41 51 71 43 66 66 80 81 69 
Complement C4-B OS=Homo sapiens 
GN=C4B PE=1 SV=2 
CO4B_HUMAN 0.32 47 84 31 67 67 79 55 54 
Alpha-2-macroglobulin OS=Homo 
sapiens GN=A2M PE=1 SV=3 
A2MG_HUMAN 0.47 43 44 33 45 45 36 88 59 
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Aldose reductase OS=Homo sapiens 
GN=AKR1B1 PE=1 SV=3 
ALDR_HUMAN 0.29 55 120 37 36 36 63 81 57 
sp|O43707|ACTN4_HUMAN Alpha-
actinin-4 OS=Homo sapiens 
GN=ACTN4 PE=1 SV=2 
sp|O43707|ACTN4_HUMANAlpha-actinin-4 
OS=Homo sapiens GN=ACTN4 PE=1 SV=2 
0.27 51 73 43 48 48 0 53 73 
sp|P20337|RAB3B_HUMAN Ras-
related protein Rab-3B OS=Homo 
sapiens GN=RAB3B PE=1 SV=2 
sp|P20337|RAB3B_HUMANRas-related protein 
Rab-3B OS=Homo sapiens GN=RAB3B PE=1 SV=2 
0.34 102 101 53 54 54 84 77 92 
sp|P02647|APOA1_HUMAN 
Apolipoprotein A-I OS=Homo sapiens 
GN=APOA1 PE=1 SV=1 
sp|P02647|APOA1_HUMANApolipoprotein A-I 
OS=Homo sapiens GN=APOA1 PE=1 SV=1 
0.32 112 104 56 78 78 91 88 108 
Maltase-glucoamylase, intestinal 
OS=Homo sapiens GN=MGAM PE=4 
SV=2 
E7ER45_HUMAN 0.57 1 2 34 77 77 3 100 1 
Isoform 2 of Adenylyl cyclase-
associated protein 1 OS=Homo 
sapiens GN=CAP1 
sp|Q01518-2|CAP1_HUMAN 0.31 102 53 40 35 35 62 56 54 
Kallikrein-2 OS=Homo sapiens 
GN=KLK2 PE=2 SV=1 
sp|P20151|KLK2_HUMAN 0.41 55 52 61 63 63 85 72 80 
Isoform 4 of CD109 antigen 
OS=Homo sapiens GN=CD109 
sp|Q6YHK3-4|CD109_HUMAN 0.83 35 49 13 66 66 66 43 58 
Serpin B6 OS=Homo sapiens 
GN=SERPINB6 PE=1 SV=3 
SPB6_HUMAN 0.3 57 73 37 45 45 62 52 50 
Isoform 3 of Golgi apparatus protein 
1 OS=Homo sapiens GN=GLG1 
sp|Q92896-3|GSLG1_HUMAN 0.31 25 27 18 22 22 14 17 34 
Matrilin-2 OS=Homo sapiens 
GN=MATN2 PE=2 SV=1 
J3KN08_HUMAN 0.32 32 68 27 46 46 39 64 38 
Isoform 2 of Filamin-B OS=Homo 
sapiens GN=FLNB 
sp|O75369-2|FLNB_HUMAN 0.35 36 64 63 12 12 55 42 31 
Glucose-6-phosphate isomerase 
OS=Homo sapiens GN=GPI PE=1 
SV=4 
sp|P06744|G6PI_HUMAN 0.42 56 79 58 57 57 75 102 67 
Carboxypeptidase Z OS=Homo 
sapiens GN=CPZ PE=1 SV=2 
sp|Q66K79|CBPZ_HUMAN 0.37 57 82 58 76 76 70 80 90 
Proprotein convertase 
subtilisin/kexin type 5 (Fragment) 
OS=Homo sapiens GN=PCSK5 PE=2 
SV=1 
Q5JSG7_HUMAN 0.84 0 2 1 1 1 5 1 0 
sp|Q02818|NUCB1_HUMAN 
Nucleobindin-1 OS=Homo sapiens 
GN=NUCB1 PE=1 SV=4 
sp|Q02818|NUCB1_HUMANNucleobindin-1 
OS=Homo sapiens GN=NUCB1 PE=1 SV=4 
0.37 61 74 51 61 61 56 91 77 
Kallistatin OS=Homo sapiens 
GN=SERPINA4 PE=1 SV=3 
KAIN_HUMAN 0.32 74 106 57 97 97 85 95 88 
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shock protein HSP 90-beta OS=Homo 
sapiens GN=HSP90AB1... 
sp|P08238|HS90B_HUMANHeat shock protein 
HSP 90-beta OS=Homo sapiens GN=HSP90AB1 
PE=1 SV=4 
0.57 95 120 0 0 77 0 135 97 
sp|Q9NZR2|LRP1B_HUMAN Low-
density lipoprotein receptor-related 
protein 1B OS=Homo sapiens 
GN=LRP1B PE=1 SV=2 
sp|Q9NZR2|LRP1B_HUMANLow-density 
lipoprotein receptor-related protein 1B 
OS=Homo sapiens GN=LRP1B PE=1 SV=2 
0.8 0 4 0 1 1 0 1 2 
Attractin OS=Homo sapiens 
GN=ATRN PE=1 SV=2 
sp|O75882|ATRN_HUMAN 0.33 16 16 10 15 15 19 13 14 
sp|O00560|SDCB1_HUMAN 
Syntenin-1 OS=Homo sapiens 
GN=SDCBP PE=1 SV=1 
sp|O00560|SDCB1_HUMANSyntenin-1 
OS=Homo sapiens GN=SDCBP PE=1 SV=1 
0.17 62 66 15 51 51 1 59 69 
Fibronectin OS=Homo sapiens 
GN=FN1 PE=1 SV=4 
sp|P02751|FINC_HUMAN 0.31 80 89 65 64 64 59 64 83 
Phospholipase A1 member A 
OS=Homo sapiens GN=PLA1A PE=2 
SV=1 
G5E9W0_HUMAN 0.31 45 82 35 51 51 42 54 74 
Cysteine-rich secretory protein LCCL 
domain-containing 2 OS=Homo 
sapiens GN=CRISPLD2 PE=2 SV=1 
H3BTI0_HUMAN 0.73 62 82 0 0 0 89 0 103 
Beta-galactosidase OS=Homo 
sapiens GN=GLB1 PE=1 SV=2 
sp|P16278|BGAL_HUMAN 0.36 54 75 30 56 56 52 70 80 
sp|Q8WVQ1|CANT1_HUMAN 
Soluble calcium-activated 
nucleotidase 1 OS=Homo sapiens 
GN=CANT1 PE=1 SV=1 
sp|Q8WVQ1|CANT1_HUMANSoluble calcium-
activated nucleotidase 1 OS=Homo sapiens 
GN=CANT1 PE=1 SV=1 
0.1 78 2 8 0 69 72 84 71 
Isoform 2 of Receptor-type tyrosine-
protein phosphatase S OS=Homo 
sapiens GN=PTPRS 
sp|Q13332-6|PTPRS_HUMAN 0.36 0 0 0 0 0 0 0 2 
Elongation factor 2 OS=Homo 
sapiens GN=EEF2 PE=1 SV=4 
EF2_HUMAN 0.4 65 67 45 37 37 93 59 60 
Isoform 2 of Cysteine-rich secretory 
protein 3 OS=Homo sapiens 
GN=CRISP3 
sp|P54108-2|CRIS3_HUMAN 0.4 0 2 42 87 87 2 76 1 
sp|P10586|PTPRF_HUMAN 
Receptor-type tyrosine-protein 
phosphatase F OS=Homo sapiens... 
sp|P10586|PTPRF_HUMANReceptor-type 
tyrosine-protein phosphatase F OS=Homo 
sapiens GN=PTPRF PE=1 SV=2 
0.67 38 58 0 1 35 1 44 44 
Cystatin-S OS=Homo sapiens 
GN=CST4 PE=1 SV=3 
CYTS_HUMAN 0.42 47 65 66 52 52 96 154 42 
sp|O75874|IDHC_HUMAN Isocitrate 
dehydrogenase [NADP] cytoplasmic 
OS=Homo sapiens... 
sp|O75874|IDHC_HUMAN Isocitrate 
dehydrogenase [NADP] cytoplasmic OS=Homo 
sapiens... 
0.35 28 36 41 36 36 30 29 56 
CD9 antigen OS=Homo sapiens 
GN=CD9 PE=2 SV=1 
A6NNI4_HUMAN 0.35 87 60 55 82 82 84 63 80 
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Isoform PSMA-7 of Glutamate 
carboxypeptidase 2 OS=Homo 
sapiens GN=FOLH1 
sp|Q04609-7|FOLH1_HUMAN 0.45 46 69 22 45 45 77 47 70 
sp|Q9NZR2|LRP1B_HUMAN Low-
density lipoprotein receptor-related 
protein 1B OS=Homo sapiens 
GN=LRP1B PE=1 SV=2 
sp|Q9NZR2|LRP1B_HUMANLow-density 
lipoprotein receptor-related protein 1B 
OS=Homo sapiens GN=LRP1B PE=1 SV=2-DECOY 
0.35 0 0 3 2 2 0 0 0 
Isoform 3 of A-kinase anchor protein 
12 OS=Homo sapiens GN=AKAP12 
sp|Q02952-3|AKA12_HUMAN 0.43 2 5 4 4 4 5 6 4 
Mucin-5B OS=Homo sapiens 
GN=MUC5B PE=2 SV=1 
E9PBJ0_HUMAN 0.38 5 3 12 0 0 3 11 0 
Beta-hexosaminidase subunit beta 
OS=Homo sapiens GN=HEXB PE=1 
SV=3 
HEXB_HUMAN 0.41 0 0 92 107 107 0 111 5 
Uncharacterized protein OS=Homo 
sapiens GN=P4HB PE=3 SV=1 
F5H8J2_HUMAN 0.36 40 70 60 24 24 56 60 46 
sp|P12429|ANXA3_HUMAN Annexin 
A3 OS=Homo sapiens GN=ANXA3 
PE=1 SV=3 
sp|P12429|ANXA3_HUMANAnnexin A3 
OS=Homo sapiens GN=ANXA3 PE=1 SV=3 
0.22 87 116 67 85 85 1 86 71 
sp|P35556|FBN2_HUMAN Fibrillin-2 
OS=Homo sapiens GN=FBN2 PE=1 
SV=3 
sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo 
sapiens GN=FBN2 PE=1 SV=3-DECOY 
0.24 0 0 0 1 1 1 5 0 
Isoform APP751 of Amyloid beta A4 
protein OS=Homo sapiens GN=APP 
sp|P05067-8|A4_HUMAN 0.33 17 25 14 23 23 17 22 22 
sp|O00462|MANBA_HUMAN Beta-
mannosidase OS=Homo sapiens 
GN=MANBA PE=1 SV=3 
sp|O00462|MANBA_HUMANBeta-mannosidase 
OS=Homo sapiens GN=MANBA PE=1 SV=3 
0.36 40 63 25 53 53 51 48 64 
Fibrillin-2 OS=Homo sapiens 
GN=FBN2 PE=1 SV=3 
sp|P35556|FBN2_HUMAN 0.75 2 0 0 0 0 1 0 2 
sp|O00194|RB27B_HUMAN Ras-
related protein Rab-27B OS=Homo 
sapiens GN=RAB27B PE=1 SV=4 
sp|O00194|RB27B_HUMANRas-related protein 
Rab-27B OS=Homo sapiens GN=RAB27B PE=1 
SV=4 
0.21 84 71 0 0 68 68 67 71 
Sucrase-isomaltase, intestinal 
OS=Homo sapiens GN=SI PE=1 SV=6 
SUIS_HUMAN 0.88 1 14 3 7 7 16 5 13 
sp|P16035|TIMP2_HUMAN 
Metalloproteinase inhibitor 2 
OS=Homo sapiens GN=TIMP2 PE=1 
SV=2 
sp|P16035|TIMP2_HUMANMetalloproteinase 
inhibitor 2 OS=Homo sapiens GN=TIMP2 PE=1 
SV=2 
0.25 64 53 0 0 52 36 57 57 
Legumain OS=Homo sapiens 
GN=LGMN PE=1 SV=1 
LGMN_HUMAN 0.44 29 45 27 64 64 61 57 47 
Isoform 2 of Multiple epidermal 
growth factor-like domains protein 6 
OS=Homo sapiens GN=MEGF6 
MEGF6_HUMAN 0.77 2 0 0 0 0 0 1 2 
Semaphorin-3C OS=Homo sapiens 
GN=SEMA3C PE=2 SV=1 
F5H1Z7_HUMAN 0.29 48 29 18 37 37 41 22 26 
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carboxypeptidase OS=Homo sapiens 
GN=SCPEP1 PE=1 SV=1 
sp|Q9HB40|RISC_HUMAN 0.35 43 62 29 45 45 49 68 42 
sp|P39060|COIA1_HUMAN Collagen 
alpha-1(XVIII) chain OS=Homo 
sapiens GN=COL18A1 PE=1... 
sp|P39060|COIA1_HUMANCollagen alpha-
1(XVIII) chain OS=Homo sapiens GN=COL18A1 
PE=1 SV=5 
0.34 53 51 0 0 56 0 71 64 
sp|Q14204|DYHC1_HUMAN 
Cytoplasmic dynein 1 heavy chain 1 
OS=Homo sapiens GN=DYNC1H1... 
sp|Q14204|DYHC1_HUMANCytoplasmic dynein 
1 heavy chain 1 OS=Homo sapiens GN=DYNC1H1 
PE=1 SV=5 
0.58 29 53 0 0 27 0 45 47 
sp|P30086|PEBP1_HUMAN 
Phosphatidylethanolamine-binding 
protein 1 OS=Homo sapiens 
GN=PEBP1 PE=1 SV=3 
sp|P30086|PEBP1_HUMANPhosphatidylethanola
mine-binding protein 1 OS=Homo sapiens 
GN=PEBP1 PE=1 SV=3 
0.41 99 84 0 0 54 62 71 85 
Complement factor B OS=Homo 
sapiens GN=CFB PE=2 SV=1 
B4E1Z4_HUMAN 0.4 16 39 21 24 24 36 25 32 
Tissue alpha-L-fucosidase OS=Homo 
sapiens GN=FUCA1 PE=1 SV=4 
FUCO_HUMAN 0.41 29 34 39 35 35 55 42 34 
Serum amyloid P-component 
OS=Homo sapiens GN=APCS PE=1 
SV=2 
SAMP_HUMAN 0.4 28 38 28 29 29 39 58 31 
sp|P63104|1433Z_HUMAN 14-3-3 
protein zeta/delta OS=Homo sapiens 
GN=YWHAZ PE=1 SV=1 
sp|P63104|1433Z_HUMAN14-3-3 protein 
zeta/delta OS=Homo sapiens GN=YWHAZ PE=1 
SV=1 
0.28 58 73 50 67 67 0 73 84 
Isoform 2 of Clathrin heavy chain 1 
OS=Homo sapiens GN=CLTC 
sp|Q00610-2|CLH1_HUMAN 0.48 17 42 43 24 24 70 39 47 
Ceruloplasmin OS=Homo sapiens 
GN=CP PE=1 SV=1 
CERU_HUMAN 0.55 17 35 18 23 23 55 28 31 
Thrombospondin-1 OS=Homo 
sapiens GN=THBS1 PE=1 SV=2 
TSP1_HUMAN 0.38 12 22 16 29 29 26 21 19 
Isoform 6 of Myoferlin OS=Homo 
sapiens GN=MYOF 
sp|Q9NZM1-6|MYOF_HUMAN 0.28 26 27 17 11 11 14 15 27 
Calsyntenin-1 (Fragment) OS=Homo 
sapiens GN=CLSTN1 PE=2 SV=1 
Q5SR54_HUMAN 0.29 23 32 13 26 26 28 20 27 
sp|P08294|SODE_HUMAN 
Extracellular superoxide dismutase 
[Cu-Zn] OS=Homo sapiens 
GN=SOD3... 
sp|P08294|SODE_HUMAN Extracellular 
superoxide dismutase [Cu-Zn] OS=Homo sapiens 
GN=SOD3... 
0.37 70 56 85 70 70 94 71 78 
Sialate O-acetylesterase OS=Homo 
sapiens GN=SIAE PE=1 SV=1 
sp|Q9HAT2|SIAE_HUMAN 0.43 32 49 33 46 46 50 49 55 
sp|Q92597|NDRG1_HUMAN Protein 
NDRG1 OS=Homo sapiens 
GN=NDRG1 PE=1 SV=1 
sp|Q92597|NDRG1_HUMANProtein NDRG1 
OS=Homo sapiens GN=NDRG1 PE=1 SV=1 
0.26 35 64 35 49 49 0 49 55 
sp|P07195|LDHB_HUMAN L-lactate 
dehydrogenase B chain OS=Homo 
sapiens GN=LDHB PE=1... 
sp|P07195|LDHB_HUMAN L-lactate 
dehydrogenase B chain OS=Homo sapiens 
GN=LDHB PE=1... 
0.37 51 72 59 59 59 60 64 75 
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antigen OS=Homo sapiens 
GN=CD177 PE=1 SV=2 
sp|Q8N6Q3|CD177_HUMANCD177 antigen 
OS=Homo sapiens GN=CD177 PE=1 SV=2 
0.43 17 44 50 51 51 33 57 58 
Synaptic vesicle membrane protein 
VAT-1 homolog OS=Homo sapiens 
GN=VAT1 PE=1 SV=2 
VAT1_HUMAN 0.34 49 55 64 57 57 48 44 67 
Transitional endoplasmic reticulum 
ATPase OS=Homo sapiens GN=VCP 
PE=1 SV=4 
TERA_HUMAN 0.9 74 83 3 0 0 97 1 60 
sp|Q8WUM4|PDC6I_HUMAN 
Programmed cell death 6-interacting 
protein OS=Homo sapiens... 
sp|Q8WUM4|PDC6I_HUMANProgrammed cell 
death 6-interacting protein OS=Homo sapiens 
GN=PDCD6IP PE=1 SV=1 
0.58 80 48 0 0 67 0 54 63 
sp|Q02809|PLOD1_HUMAN 
Procollagen-lysine,2-oxoglutarate 5-
dioxygenase 1 OS=Homo sapiens... 
sp|Q02809|PLOD1_HUMANProcollagen-lysine,2-
oxoglutarate 5-dioxygenase 1 OS=Homo sapiens 
GN=PLOD1 PE=1 SV=2 
0.42 42 52 0 1 43 0 64 51 
Neutral alpha-glucosidase AB 
OS=Homo sapiens GN=GANAB PE=2 
SV=1 
E9PKU7_HUMAN 0.82 31 52 0 0 0 56 0 42 
Desmoplakin OS=Homo sapiens 
GN=DSP PE=1 SV=3 
sp|P15924|DESP_HUMAN 0.44 14 1 8 16 16 7 23 5 
sp|Q5D862|FILA2_HUMAN Filaggrin-
2 OS=Homo sapiens GN=FLG2 PE=1 
SV=1 
sp|Q5D862|FILA2_HUMANFilaggrin-2 OS=Homo 
sapiens GN=FLG2 PE=1 SV=1 
0.31 0 0 0 4 4 1 3 3 
Annexin OS=Homo sapiens 
GN=ANXA6 PE=2 SV=3 
A6NN80_HUMAN 0.23 58 71 32 31 31 52 47 36 
Endothelial lipase OS=Homo sapiens 
GN=LIPG PE=1 SV=1 
sp|Q9Y5X9|LIPE_HUMAN 0.4 30 52 24 52 52 43 55 56 
Biotinidase OS=Homo sapiens 
GN=BTD PE=1 SV=2 
BTD_HUMAN 0.4 40 55 32 45 45 70 50 43 
sp|PPIA_HUMAN| sp|PPIA_HUMAN| 0.22 155 35 28 45 45 58 40 40 
sp|Q13438-4|OS9_HUMAN Isoform 
4 of Protein OS-9 OS=Homo sapiens 
GN=OS9 
sp|Q13438-4|OS9_HUMANIsoform 4 of Protein 
OS-9 OS=Homo sapiens GN=OS9 
0.28 44 51 42 45 45 0 56 50 
sp|P30101|PDIA3_HUMAN Protein 
disulfide-isomerase A3 OS=Homo 
sapiens GN=PDIA3 PE=1... 
sp|P30101|PDIA3_HUMANProtein disulfide-
isomerase A3 OS=Homo sapiens GN=PDIA3 PE=1 
SV=4 
0.87 1 59 54 1 51 90 98 67 
Isoform 2 of Slit homolog 2 protein 
OS=Homo sapiens GN=SLIT2 
sp|O94813-2|SLIT2_HUMAN 0.91 2 1 1 2 2 3 4 3 
Nephronectin (Fragment) OS=Homo 
sapiens GN=NPNT PE=2 SV=1 
D6RH31_HUMAN 0.33 15 21 20 16 16 22 6 11 
Collagen alpha-1(XII) chain OS=Homo 
sapiens GN=COL12A1 PE=2 SV=1 
D6RGG3_HUMAN 0.4 3 4 0 0 0 7 0 9 
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Plasma protease C1 inhibitor 
OS=Homo sapiens GN=SERPING1 
PE=2 SV=1 
E9PGN7_HUMAN 0.96 89 97 0 0 0 81 0 110 
Nucleotide exchange factor SIL1 
OS=Homo sapiens GN=SIL1 PE=1 
SV=1 
SIL1_HUMAN 0.87 58 88 0 1 1 56 3 66 
sp|P12830|CADH1_HUMAN 
Cadherin-1 OS=Homo sapiens 
GN=CDH1 PE=1 SV=3 
sp|P12830|CADH1_HUMANCadherin-1 
OS=Homo sapiens GN=CDH1 PE=1 SV=3 
0.26 41 42 16 36 36 44 35 29 
sp|P35555|FBN1_HUMAN Fibrillin-1 
OS=Homo sapiens GN=FBN1 PE=1 
SV=3 
sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo 
sapiens GN=FBN1 PE=1 SV=3-DECOY 
0.38 0 2 2 0 0 0 0 3 
sp|P02533|K1C14_HUMAN Keratin, 
type I cytoskeletal 14 OS=Homo 
sapiens GN=KRT14 PE=1 SV=4 
sp|P02533|K1C14_HUMANKeratin, type I 
cytoskeletal 14 OS=Homo sapiens GN=KRT14 
PE=1 SV=4 
0.51 71 53 0 0 81 0 131 0 
Nesprin-1 OS=Homo sapiens 
GN=SYNE1 PE=2 SV=1 
E9PEL9_HUMAN 0.56 1 0 0 0 0 0 3 0 
Isoform 2 of Transmembrane 
protease serine 2 OS=Homo sapiens 
GN=TMPRSS2 
TMPS2_HUMAN 0.98 31 39 0 1 1 26 0 41 
Proteasome subunit alpha type-5 
OS=Homo sapiens GN=PSMA5 PE=1 
SV=3 
sp|P28066|PSA5_HUMAN 0.38 18 19 25 21 21 25 29 22 
Growth arrest-specific protein 6 
OS=Homo sapiens GN=GAS6 PE=1 
SV=2 
sp|Q14393|GAS6_HUMAN 0.2 37 50 10 28 28 45 33 29 
sp|P18669|PGAM1_HUMAN 
Phosphoglycerate mutase 1 
OS=Homo sapiens GN=PGAM1 PE=1 
SV=2 
sp|P18669|PGAM1_HUMANPhosphoglycerate 
mutase 1 OS=Homo sapiens GN=PGAM1 PE=1 
SV=2 
0.86 47 58 3 47 47 2 54 70 
Sortilin-related receptor OS=Homo 
sapiens GN=SORL1 PE=2 SV=1 
E9PP43_HUMAN 0.67 4 1 0 1 1 2 3 2 
Isoform 3 of Malate dehydrogenase, 
cytoplasmic OS=Homo sapiens 
GN=MDH1 
sp|P40925-3|MDHC_HUMAN 0.39 36 52 29 22 22 44 52 44 
Latent-transforming growth factor 
beta-binding protein 3 (Fragment) 
OS=Homo sapiens GN=LTBP3 PE=2 
SV=1 
E9PKW1_HUMAN 0.33 2 2 1 0 0 1 0 3 
Phosphoglycerate kinase 2 OS=Homo 
sapiens GN=PGK2 PE=1 SV=3 
PGK2_HUMAN 0.35 20 41 24 28 28 46 46 32 
Isoform 2 of Vitamin D-binding 
protein OS=Homo sapiens GN=GC 
sp|P02774-2|VTDB_HUMAN 0.33 25 31 36 37 37 35 22 26 
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related protein Rab-27A OS=Homo 
sapiens GN=RAB27A PE=1 SV=3 
sp|P51159|RB27A_HUMANRas-related protein 
Rab-27A OS=Homo sapiens GN=RAB27A PE=1 
SV=3 
0.27 90 62 0 0 75 69 42 86 
Basal cell adhesion molecule 
OS=Homo sapiens GN=BCAM PE=1 
SV=2 
BCAM_HUMAN 0.41 24 19 22 31 31 33 26 26 
sp|Q8IZJ3|CPMD8_HUMAN C3 and 
PZP-like alpha-2-macroglobulin 
domain-containing protein... 
sp|Q8IZJ3|CPMD8_HUMANC3 and PZP-like 
alpha-2-macroglobulin domain-containing 
protein 8 OS=Homo sapiens GN=CPAMD8 PE=1 
SV=2 
0.85 1 23 2 2 18 2 22 28 
Leucine-rich alpha-2-glycoprotein 
OS=Homo sapiens GN=LRG1 PE=1 
SV=2 
A2GL_HUMAN 0.8 49 89 0 0 0 84 0 83 
Calpain-1 catalytic subunit OS=Homo 
sapiens GN=CAPN1 PE=1 SV=1 
CAN1_HUMAN 0.37 18 51 15 8 8 31 27 31 
Carboxypeptidase D OS=Homo 
sapiens GN=CPD PE=1 SV=2 
sp|O75976|CBPD_HUMAN 0.31 12 19 8 10 10 11 11 18 
Isoform 5 of Voltage-dependent 
calcium channel subunit alpha-
2/delta-1 OS=Homo sapiens 
GN=CACNA2D1 
sp|P54289-5|CA2D1_HUMAN 0.96 9 17 2 1 1 29 2 21 
Bifunctional epoxide hydrolase 2 
OS=Homo sapiens GN=EPHX2 PE=1 
SV=2 
sp|P34913|HYES_HUMAN 0.36 27 31 31 15 15 31 28 26 
Calreticulin OS=Homo sapiens 
GN=CALR PE=1 SV=1 
CALR_HUMAN 0.45 38 28 24 27 27 33 48 42 
Adenosylhomocysteinase OS=Homo 
sapiens GN=AHCY PE=1 SV=4 
sp|P23526|SAHH_HUMAN 0.37 43 52 43 36 36 56 50 49 
Carbonic anhydrase 2 OS=Homo 
sapiens GN=CA2 PE=1 SV=2 
CAH2_HUMAN (+1) 0.32 64 50 41 28 28 44 34 46 
sp|P07355|ANXA2_HUMAN Annexin 
A2 OS=Homo sapiens GN=ANXA2 
PE=1 SV=2 
sp|P07355|ANXA2_HUMANAnnexin A2 
OS=Homo sapiens GN=ANXA2 PE=1 SV=2 
0.5 68 1 63 0 70 0 77 71 
CD63 antigen (Fragment) OS=Homo 
sapiens GN=CD63 PE=2 SV=1 
F8VWK8_HUMAN 0.37 34 40 23 28 28 41 29 47 
Antithrombin-III OS=Homo sapiens 
GN=SERPINC1 PE=1 SV=1 
ANT3_HUMAN 0.4 26 37 49 29 29 46 33 43 
Apolipoprotein D (Fragment) 
OS=Homo sapiens GN=APOD PE=2 
SV=1 
C9JF17_HUMAN 0.37 28 38 39 45 45 45 34 44 
sp|Q7Z7M0|MEGF8_HUMAN 
Multiple epidermal growth factor-
like domains protein 8 OS=Homo 
sapiens GN=MEGF8 PE=1 SV=2 
sp|Q7Z7M0|MEGF8_HUMANMultiple epidermal 
growth factor-like domains protein 8 OS=Homo 
sapiens GN=MEGF8 PE=1 SV=2 
0.75 5 9 0 1 2 0 9 8 
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Hypoxia up-regulated protein 1 
OS=Homo sapiens GN=HYOU1 PE=1 
SV=1 
sp|Q9Y4L1|HYOU1_HUMANHypoxia up-
regulated protein 1 OS=Homo sapiens 
GN=HYOU1 PE=1 SV=1 
0.51 30 37 12 0 37 0 44 29 
sp|P20618|PSB1_HUMAN 
Proteasome subunit beta type-1 
OS=Homo sapiens GN=PSMB1 
PE=1... 
sp|P20618|PSB1_HUMAN Proteasome subunit 
beta type-1 OS=Homo sapiens GN=PSMB1 PE=1... 
0.36 45 48 51 41 41 55 52 45 
Carbonyl reductase [NADPH] 1 
OS=Homo sapiens GN=CBR1 PE=1 
SV=3 
CBR1_HUMAN 0.33 34 47 42 28 28 36 37 28 
AP-2 complex subunit beta 
OS=Homo sapiens GN=AP2B1 PE=2 
SV=1 
K7EJT8_HUMAN 0.38 15 12 16 8 8 19 12 14 
sp|Q96RW7|HMCN1_HUMAN 
Hemicentin-1 OS=Homo sapiens 
GN=HMCN1 PE=1 SV=2 
sp|Q96RW7|HMCN1_HUMANHemicentin-1 
OS=Homo sapiens GN=HMCN1 PE=1 SV=2 
0.36 9 0 0 0 0 0 0 0 
sp|P58499|FAM3B_HUMAN Protein 
FAM3B OS=Homo sapiens 
GN=FAM3B PE=1 SV=2 
sp|P58499|FAM3B_HUMANProtein FAM3B 
OS=Homo sapiens GN=FAM3B PE=1 SV=2 
0.89 38 71 0 35 35 36 34 50 
sp|Q7Z7M0|MEGF8_HUMAN 
Multiple epidermal growth factor-
like domains protein 8 OS=Homo 
sapiens GN=MEGF8 PE=1 SV=2 
sp|Q7Z7M0|MEGF8_HUMANMultiple epidermal 
growth factor-like domains protein 8 OS=Homo 
sapiens GN=MEGF8 PE=1 SV=2-DECOY 
0.3 0 2 1 0 0 0 0 0 
Isoform 2 of Selenium-binding 
protein 1 OS=Homo sapiens 
GN=SELENBP1 
sp|Q13228-2|SBP1_HUMAN 0.34 21 49 45 31 31 28 38 32 
Keratin, type II cytoskeletal 5 
OS=Homo sapiens GN=KRT5 PE=1 
SV=3 
K2C5_HUMAN 0.81 52 54 0 0 0 80 0 59 
sp|P21266|GSTM3_HUMAN 
Glutathione S-transferase Mu 3 
OS=Homo sapiens GN=GSTM3 PE=1 
SV=3 
sp|P21266|GSTM3_HUMANGlutathione S-
transferase Mu 3 OS=Homo sapiens GN=GSTM3 
PE=1 SV=3 
0.16 45 59 0 0 40 44 77 45 
sp|Q04721|NOTC2_HUMAN 
Neurogenic locus notch homolog 
protein 2 OS=Homo sapiens 
GN=NOTCH2 PE=1 SV=3 
sp|Q04721|NOTC2_HUMANNeurogenic locus 
notch homolog protein 2 OS=Homo sapiens 
GN=NOTCH2 PE=1 SV=3 
0.058 0 0 0 0 0 2 3 1 
sp|P02763|A1AG1_HUMAN Alpha-
1-acid glycoprotein 1 OS=Homo 
sapiens GN=ORM1 PE=1 SV=1 
sp|P02763|A1AG1_HUMANAlpha-1-acid 
glycoprotein 1 OS=Homo sapiens GN=ORM1 
PE=1 SV=1 
0.49 37 49 42 33 33 87 57 53 
Gelsolin OS=Homo sapiens GN=GSN 
PE=1 SV=1 
sp|P06396|GELS_HUMAN 0.31 36 29 9 20 20 21 27 41 
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Cathelicidin antimicrobial peptide 
OS=Homo sapiens GN=CAMP PE=1... 
sp|P49913|CAMP_HUMAN Cathelicidin 
antimicrobial peptide OS=Homo sapiens 
GN=CAMP PE=1... (+1) 
0.6 31 23 15 61 61 59 50 77 
sp|Q86VP6|CAND1_HUMAN Cullin-
associated NEDD8-dissociated 
protein 1 OS=Homo sapiens... 
sp|Q86VP6|CAND1_HUMANCullin-associated 
NEDD8-dissociated protein 1 OS=Homo sapiens 
GN=CAND1 PE=1 SV=2 
0.46 14 43 0 0 28 0 48 22 
sp|Q06323|PSME1_HUMAN 
Proteasome activator complex 
subunit 1 OS=Homo sapiens 
GN=PSME1... 
sp|Q06323|PSME1_HUMANProteasome 
activator complex subunit 1 OS=Homo sapiens 
GN=PSME1 PE=1 SV=1 
0.67 55 60 0 0 32 54 34 21 
sp|P07998|RNAS1_HUMAN 
Ribonuclease pancreatic OS=Homo 
sapiens GN=RNASE1 PE=1 SV=4 
sp|P07998|RNAS1_HUMANRibonuclease 
pancreatic OS=Homo sapiens GN=RNASE1 PE=1 
SV=4 
0.94 22 29 0 56 56 0 52 0 
Actin, alpha skeletal muscle 
OS=Homo sapiens GN=ACTA1 PE=1 
SV=1 
ACTS_HUMAN 0.32 35 31 14 19 19 39 32 32 
Isoform 2 of Nesprin-2 OS=Homo 
sapiens GN=SYNE2 
sp|Q8WXH0-2|SYNE2_HUMAN 0.36 0 0 0 0 0 0 5 0 
sp|Q96DA0|ZG16B_HUMAN 
Zymogen granule protein 16 
homolog B OS=Homo sapiens 
GN=ZG16B PE=1 SV=3 
sp|Q96DA0|ZG16B_HUMANZymogen granule 
protein 16 homolog B OS=Homo sapiens 
GN=ZG16B PE=1 SV=3 
0.15 0 67 0 0 64 0 109 69 
sp|Q9BZQ8|NIBAN_HUMAN Protein 
Niban OS=Homo sapiens 
GN=FAM129A PE=1 SV=1 
sp|Q9BZQ8|NIBAN_HUMANProtein Niban 
OS=Homo sapiens GN=FAM129A PE=1 SV=1 
0.25 24 29 12 23 23 0 26 34 
Angiotensinogen OS=Homo sapiens 
GN=AGT PE=1 SV=1 
ANGT_HUMAN 0.35 43 37 23 50 50 58 26 40 
sp|P48723|HSP13_HUMAN Heat 
shock 70 kDa protein 13 OS=Homo 
sapiens GN=HSPA13 PE=1 SV=1 
sp|P48723|HSP13_HUMANHeat shock 70 kDa 
protein 13 OS=Homo sapiens GN=HSPA13 PE=1 
SV=1 
0.094 29 43 2 0 29 35 50 46 
Isoform 3 of Amyloid-like protein 2 
OS=Homo sapiens GN=APLP2 
sp|Q06481-3|APLP2_HUMAN 0.33 6 10 8 8 8 5 4 11 
Cofilin-1 OS=Homo sapiens GN=CFL1 
PE=1 SV=3 
COF1_HUMAN 0.25 115 24 23 20 20 48 21 31 
N-acetylglucosamine-6-sulfatase 
OS=Homo sapiens GN=GNS PE=1 
SV=3 
GNS_HUMAN 0.45 8 13 17 16 16 25 15 16 
Fibromodulin OS=Homo sapiens 
GN=FMOD PE=1 SV=2 
FMOD_HUMAN 0.33 42 39 42 48 48 52 23 40 
Carbonic anhydrase 4 OS=Homo 
sapiens GN=CA4 PE=1 SV=2 
CAH4_HUMAN 0.48 19 29 17 24 24 43 44 39 
Beta-2-microglobulin OS=Homo 
sapiens GN=B2M PE=1 SV=1 
B2MG_HUMAN (+1) 0.35 19 42 20 34 34 28 39 30 
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IQGAP1 OS=Homo sapiens 
GN=IQGAP1 PE=1 SV=1 
sp|P46940|IQGA1_HUMANRas GTPase-
activating-like protein IQGAP1 OS=Homo sapiens 
GN=IQGAP1 PE=1 SV=1 
0.79 19 35 0 0 12 0 22 30 
sp|P22314|UBA1_HUMAN 
Ubiquitin-like modifier-activating 
enzyme 1 OS=Homo sapiens... 
sp|P22314|UBA1_HUMAN Ubiquitin-like 
modifier-activating enzyme 1 OS=Homo sapiens... 
0.34 41 64 46 16 16 50 38 33 
Isoform 2 of Glutamine--fructose-6-
phosphate aminotransferase 
[isomerizing] 1 OS=Homo sapiens 
GN=GFPT1 
GFPT1_HUMAN 0.39 14 35 27 23 23 35 36 16 
Isoform 3 of Mesothelin OS=Homo 
sapiens GN=MSLN 
sp|Q13421-2|MSLN_HUMAN 0.34 21 33 21 39 39 31 21 33 
sp|P30043|BLVRB_HUMAN Flavin 
reductase (NADPH) OS=Homo 
sapiens GN=BLVRB PE=1 SV=3 
sp|P30043|BLVRB_HUMANFlavin reductase 
(NADPH) OS=Homo sapiens GN=BLVRB PE=1 
SV=3 
0.23 43 56 16 42 42 0 50 46 
Dipeptidyl peptidase 2 OS=Homo 
sapiens GN=DPP7 PE=1 SV=3 
DPP2_HUMAN 0.23 38 34 25 31 31 19 24 33 
L-lactate dehydrogenase OS=Homo 
sapiens GN=LDHC PE=2 SV=1 
F5H245_HUMAN 0.96 20 33 15 15 15 56 67 37 
Neogenin OS=Homo sapiens 
GN=NEO1 PE=1 SV=2 
sp|Q92859|NEO1_HUMAN 0.79 7 3 5 12 12 18 10 10 
Isoform 2 of Cytosol aminopeptidase 
OS=Homo sapiens GN=LAP3 
sp|P28838-2|AMPL_HUMAN 0.37 24 29 35 17 17 35 30 20 
sp|Q16651|PRSS8_HUMAN 
Prostasin OS=Homo sapiens 
GN=PRSS8 PE=1 SV=1 
sp|Q16651|PRSS8_HUMANProstasin OS=Homo 
sapiens GN=PRSS8 PE=1 SV=1 
0.77 43 47 24 0 58 52 42 62 
sp|Q9UHC6|CNTP2_HUMAN 
Contactin-associated protein-like 2 
OS=Homo sapiens GN=CNTNAP2 
PE=1 SV=1 
sp|Q9UHC6|CNTP2_HUMANContactin-
associated protein-like 2 OS=Homo sapiens 
GN=CNTNAP2 PE=1 SV=1 
0.24 2 3 0 2 7 0 5 4 
Alpha-galactosidase A OS=Homo 
sapiens GN=GLA PE=1 SV=1 
AGAL_HUMAN 0.34 26 32 30 28 28 24 27 30 
Myosin-7 OS=Homo sapiens 
GN=MYH7 PE=1 SV=5 
MYH7_HUMAN 0.55 17 82 0 2 2 0 43 0 
sp|P19652|A1AG2_HUMAN Alpha-
1-acid glycoprotein 2 OS=Homo 
sapiens GN=ORM2 PE=1 SV=2 
sp|P19652|A1AG2_HUMANAlpha-1-acid 
glycoprotein 2 OS=Homo sapiens GN=ORM2 
PE=1 SV=2 
0.53 44 40 50 0 38 73 46 50 
Neutrophil gelatinase-associated 
lipocalin OS=Homo sapiens GN=LCN2 
PE=2 SV=1 
H9KV70_HUMAN (+1) 0.35 43 28 45 26 26 39 22 38 
sp|Q5CZC0|FSIP2_HUMAN Fibrous 
sheath-interacting protein 2 
OS=Homo sapiens GN=FSIP2 PE=2 
SV=4 
sp|Q5CZC0|FSIP2_HUMANFibrous sheath-
interacting protein 2 OS=Homo sapiens GN=FSIP2 
PE=2 SV=4 
0.36 0 0 0 0 5 0 0 0 
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OS=Homo sapiens GN=B4GALT1 
PE=1 SV=5 
sp|P15291|B4GT1_HUMANBeta-1,4-
galactosyltransferase 1 OS=Homo sapiens 
GN=B4GALT1 PE=1 SV=5 
0.35 55 59 0 0 40 46 36 54 
Kielin/chordin-like protein OS=Homo 
sapiens GN=KCP PE=2 SV=2 
KCP_HUMAN 0.33 4 0 1 0 0 0 3 0 
sp|P19021-5|AMD_HUMAN Isoform 
5 of Peptidyl-glycine alpha-amidating 
monooxygenase... 
sp|P19021-5|AMD_HUMANIsoform 5 of 
Peptidyl-glycine alpha-amidating monooxygenase 
OS=Homo sapiens GN=PAM 
0.47 9 0 3 0 8 14 15 11 
sp|P98095-2|FBLN2_HUMAN 
Isoform 2 of Fibulin-2 OS=Homo 
sapiens GN=FBLN2 
sp|P98095-2|FBLN2_HUMAN Isoform 2 of 
Fibulin-2 OS=Homo sapiens GN=FBLN2-DECOY 
0.94 0 0 0 2 2 0 0 0 
sp|P09467|F16P1_HUMAN 
Fructose-1,6-bisphosphatase 1 
OS=Homo sapiens GN=FBP1 PE=1... 
sp|P09467|F16P1_HUMANFructose-1,6-
bisphosphatase 1 OS=Homo sapiens GN=FBP1 
PE=1 SV=5 
0.2 32 61 0 0 39 49 38 44 
T-complex protein 1 subunit delta 
OS=Homo sapiens GN=CCT4 PE=2 
SV=1 
B7Z9L0_HUMAN 0.38 23 25 22 11 11 27 31 20 
Homogentisate 1,2-dioxygenase 
OS=Homo sapiens GN=HGD PE=1 
SV=2 
HGD_HUMAN 0.24 19 34 13 19 19 19 13 28 
Carboxypeptidase Q OS=Homo 
sapiens GN=CPQ PE=1 SV=1 
CBPQ_HUMAN 0.36 25 35 20 30 30 32 33 32 
Neuropilin-1 OS=Homo sapiens 
GN=NRP1 PE=1 SV=3 
sp|O14786|NRP1_HUMAN 0.33 12 37 17 27 27 19 28 24 
Vitronectin OS=Homo sapiens 
GN=VTN PE=1 SV=1 
VTNC_HUMAN 0.31 28 33 19 29 29 33 24 26 
Isoform 3 of Alpha-actinin-1 
OS=Homo sapiens GN=ACTN1 
sp|P12814-3|ACTN1_HUMAN 0.39 20 20 8 9 9 29 11 23 
Isoform 3 of Importin-5 OS=Homo 
sapiens GN=IPO5 
sp|O00410-3|IPO5_HUMAN (+1) 0.79 1 16 3 5 5 12 13 9 
sp|O43175|SERA_HUMAN D-3-
phosphoglycerate dehydrogenase 
OS=Homo sapiens GN=PHGDH... 
sp|O43175|SERA_HUMAN D-3-phosphoglycerate 
dehydrogenase OS=Homo sapiens GN=PHGDH... 
0.34 39 46 51 24 24 34 30 42 
Isoform B of Ras-related C3 
botulinum toxin substrate 1 
OS=Homo sapiens GN=RAC1 
sp|P63000-2|RAC1_HUMAN 0.36 32 35 17 33 33 47 38 22 
Isoform 4 of Carboxylesterase 5A 
OS=Homo sapiens GN=CES5A 
sp|Q6NT32-4|EST5A_HUMAN 0.2 7 33 4 19 19 33 33 34 
sp|P29401-2|TKT_HUMAN Isoform 2 
of Transketolase OS=Homo sapiens 
GN=TKT 
sp|P29401-2|TKT_HUMANIsoform 2 of 
Transketolase OS=Homo sapiens GN=TKT 
0.23 29 32 32 25 25 1 21 23 
Synaptotagmin-7 OS=Homo sapiens 
GN=SYT7 PE=2 SV=1 
F5H126_HUMAN 0.34 17 22 27 17 17 28 7 15 
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Neuroserpin OS=Homo sapiens 
GN=SERPINI1 PE=1 SV=1 
NEUS_HUMAN 0.35 18 22 23 28 28 25 18 23 
Di-N-acetylchitobiase OS=Homo 
sapiens GN=CTBS PE=1 SV=1 
DIAC_HUMAN 0.42 17 30 26 40 40 36 28 32 
Isoform 1 of Kallikrein-11 OS=Homo 
sapiens GN=KLK11 
sp|Q9UBX7-1|KLK11_HUMAN 0.4 20 27 27 20 20 33 51 29 
sp|Q9BRK5|CAB45_HUMAN 45 kDa 
calcium-binding protein OS=Homo 
sapiens GN=SDF4 PE=1... 
sp|Q9BRK5|CAB45_HUMAN45 kDa calcium-
binding protein OS=Homo sapiens GN=SDF4 PE=1 
SV=1 
0.28 24 37 7 0 25 36 55 57 
Polymeric immunoglobulin receptor 
OS=Homo sapiens GN=PIGR PE=1 
SV=4 
PIGR_HUMAN 0.93 32 40 0 0 0 39 0 37 
sp|P01876|IGHA1_HUMAN Ig alpha-
1 chain C region OS=Homo sapiens 
GN=IGHA1 PE=1 SV=2 
sp|P01876|IGHA1_HUMANIg alpha-1 chain C 
region OS=Homo sapiens GN=IGHA1 PE=1 SV=2 
0.4 22 42 47 28 28 41 46 31 
ADAMTS-like protein 1 OS=Homo 
sapiens GN=ADAMTSL1 PE=1 SV=4 
sp|Q8N6G6|ATL1_HUMAN 0.41 0 3 5 2 2 3 5 1 
Antileukoproteinase OS=Homo 
sapiens GN=SLPI PE=1 SV=2 
SLPI_HUMAN 0.24 64 89 42 20 20 7 8 24 
Isoform 2 of Fibulin-2 OS=Homo 
sapiens GN=FBLN2 
FBLN2_HUMAN 0.4 4 10 0 3 3 6 34 2 
Isoform 2 of Nucleoside diphosphate 
kinase A OS=Homo sapiens 
GN=NME1 
sp|P15531-2|NDKA_HUMAN 0.37 36 13 45 18 18 41 26 27 
Isoform 2 of Teneurin-2 OS=Homo 
sapiens GN=TENM2 
sp|Q9NT68-2|TEN2_HUMAN 0.57 0 5 1 1 1 1 4 3 
sp|P06727|APOA4_HUMAN 
Apolipoprotein A-IV OS=Homo 
sapiens GN=APOA4 PE=1 SV=3 
sp|P06727|APOA4_HUMANApolipoprotein A-IV 
OS=Homo sapiens GN=APOA4 PE=1 SV=3 
0.52 28 1 19 41 41 35 25 31 
sp|Q13162|PRDX4_HUMAN 
Peroxiredoxin-4 OS=Homo sapiens 
GN=PRDX4 PE=1 SV=1 
sp|Q13162|PRDX4_HUMANPeroxiredoxin-4 
OS=Homo sapiens GN=PRDX4 PE=1 SV=1 
0.36 29 32 30 36 36 30 50 36 
sp|Q99519|NEUR1_HUMAN 
Sialidase-1 OS=Homo sapiens 
GN=NEU1 PE=1 SV=1 
sp|Q99519|NEUR1_HUMANSialidase-1 
OS=Homo sapiens GN=NEU1 PE=1 SV=1 
0.23 33 30 13 28 28 1 35 34 
sp|P62820|RAB1A_HUMAN Ras-
related protein Rab-1A OS=Homo 
sapiens GN=RAB1A PE=1 SV=3 
sp|P62820|RAB1A_HUMANRas-related protein 
Rab-1A OS=Homo sapiens GN=RAB1A PE=1 SV=3 
0.25 28 23 13 23 23 0 30 14 
sp|P07711|CATL1_HUMAN 
Cathepsin L1 OS=Homo sapiens 
GN=CTSL PE=1 SV=2 
sp|P07711|CATL1_HUMANCathepsin L1 
OS=Homo sapiens GN=CTSL PE=1 SV=2 
0.17 23 35 15 26 26 0 14 23 
Dystroglycan OS=Homo sapiens 
GN=DAG1 PE=1 SV=2 
DAG1_HUMAN 0.37 11 24 13 11 11 15 20 20 
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Glutathione S-transferase theta-1 
OS=Homo sapiens GN=GSTT1 PE=1 
SV=4 
sp|P30711|GSTT1_HUMANGlutathione S-
transferase theta-1 OS=Homo sapiens GN=GSTT1 
PE=1 SV=4 
0.79 49 69 0 0 34 0 16 42 
Peptidase inhibitor 15 OS=Homo 
sapiens GN=PI15 PE=1 SV=1 
PI15_HUMAN 0.37 23 19 27 25 25 35 25 26 
sp|Q8IYJ3|SYTL1_HUMAN 
Synaptotagmin-like protein 1 
OS=Homo sapiens GN=SYTL1 PE=1... 
sp|Q8IYJ3|SYTL1_HUMANSynaptotagmin-like 
protein 1 OS=Homo sapiens GN=SYTL1 PE=1 SV=1 
0.75 37 30 0 0 26 0 37 19 
Kinesin-1 heavy chain OS=Homo 
sapiens GN=KIF5B PE=1 SV=1 
KINH_HUMAN 0.43 19 18 15 5 5 26 10 29 
Low-density lipoprotein receptor-
related protein 8 OS=Homo sapiens 
GN=LRP8 PE=1 SV=4 
sp|Q14114|LRP8_HUMAN 0.59 2 2 0 3 3 1 1 0 
Galectin-3 OS=Homo sapiens 
GN=LGALS3 PE=1 SV=5 
LEG3_HUMAN 0.33 43 27 29 36 36 34 25 28 
Protein tyrosine phosphatase, 
receptor type, D, isoform CRA_f 
OS=Homo sapiens GN=PTPRD PE=2 
SV=1 
G3XAE2_HUMAN 0.4 1 1 0 0 0 5 0 6 
sp|Q8NBJ4|GOLM1_HUMAN Golgi 
membrane protein 1 OS=Homo 
sapiens GN=GOLM1 PE=1 SV=1 
sp|Q8NBJ4|GOLM1_HUMANGolgi membrane 
protein 1 OS=Homo sapiens GN=GOLM1 PE=1 
SV=1 
0.78 5 9 2 9 9 14 18 0 
sp|P52565|GDIR1_HUMAN Rho 
GDP-dissociation inhibitor 1 
OS=Homo sapiens GN=ARHGDIA... 
sp|P52565|GDIR1_HUMANRho GDP-dissociation 
inhibitor 1 OS=Homo sapiens GN=ARHGDIA PE=1 
SV=3 
0.18 47 37 0 0 34 38 43 40 
Superoxide dismutase [Cu-Zn] 
OS=Homo sapiens GN=SOD1 PE=1 
SV=2 
SODC_HUMAN 0.36 21 11 18 25 25 19 25 15 
Annexin OS=Homo sapiens 
GN=ANXA11 PE=2 SV=1 
B4DVE7_HUMAN 0.41 21 30 43 21 21 42 24 35 
T-complex protein 1 subunit gamma 
OS=Homo sapiens GN=CCT3 PE=1 
SV=4 
sp|P49368|TCPG_HUMAN 0.39 13 12 14 7 7 19 13 11 
Isoform 3 of Inositol 
monophosphatase 1 OS=Homo 
sapiens GN=IMPA1 
sp|P29218-3|IMPA1_HUMAN 0.62 10 29 10 19 19 42 31 31 
Purine nucleoside phosphorylase 
OS=Homo sapiens GN=PNP PE=1 
SV=2 
PNPH_HUMAN 0.61 0 0 12 44 44 0 65 0 
Anosmin-1 OS=Homo sapiens 
GN=KAL1 PE=1 SV=3 
KALM_HUMAN 0.37 14 11 13 13 13 14 13 17 
Cartilage oligomeric matrix protein 
OS=Homo sapiens GN=COMP PE=1 
SV=2 
COMP_HUMAN 0.36 0 0 0 0 0 4 0 0 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
131 
 
Isocitrate dehydrogenase [NADP] 
cytoplasmic OS=Homo sapiens 
GN=IDH1 PE=1 SV=2 
IDHC_HUMAN 0.76 0 2 1 0 0 1 1 5 
sp|Q8NHP8|PLBL2_HUMAN Putative 
phospholipase B-like 2 OS=Homo 
sapiens GN=PLBD2 PE=1... 
sp|Q8NHP8|PLBL2_HUMANPutative 
phospholipase B-like 2 OS=Homo sapiens 
GN=PLBD2 PE=1 SV=2 
0.69 19 13 10 0 15 12 22 22 
Cathepsin F OS=Homo sapiens 
GN=CTSF PE=1 SV=1 
CATF_HUMAN 0.33 5 14 8 25 25 7 16 6 
L-xylulose reductase (Fragment) 
OS=Homo sapiens GN=DCXR PE=3 
SV=1 
J3QS36_HUMAN 0.39 1 1 38 46 46 1 55 0 
Thrombospondin-4 OS=Homo 
sapiens GN=THBS4 PE=1 SV=2 
TSP4_HUMAN 0.37 11 10 22 13 13 24 10 14 
sp|P50502|F10A1_HUMAN Hsc70-
interacting protein OS=Homo 
sapiens GN=ST13 PE=1 SV=2 
sp|P50502|F10A1_HUMANHsc70-interacting 
protein OS=Homo sapiens GN=ST13 PE=1 SV=2 
0.38 27 18 10 9 9 29 29 0 
Transthyretin OS=Homo sapiens 
GN=TTR PE=1 SV=1 
TTHY_HUMAN 0.37 34 21 29 33 33 37 26 37 
Isoform 3 of Cytoskeleton-associated 
protein 5 OS=Homo sapiens 
GN=CKAP5 
sp|Q14008-3|CKAP5_HUMAN 0.28 0 5 2 0 0 1 1 1 
Glycogen debranching enzyme 
OS=Homo sapiens GN=AGL PE=1 
SV=3 
GDE_HUMAN 0.3 1 6 8 2 2 0 2 0 
sp|P27348|1433T_HUMAN 14-3-3 
protein theta OS=Homo sapiens 
GN=YWHAQ PE=1 SV=1 
sp|P27348|1433T_HUMAN14-3-3 protein theta 
OS=Homo sapiens GN=YWHAQ PE=1 SV=1 
0.33 27 35 19 24 24 39 36 25 
Monocyte differentiation antigen 
CD14 OS=Homo sapiens GN=CD14 
PE=1 SV=2 
CD14_HUMAN 0.61 17 31 15 22 22 36 34 31 
sp|P54802|ANAG_HUMAN Alpha-N-
acetylglucosaminidase OS=Homo 
sapiens GN=NAGLU PE=1... 
sp|P54802|ANAG_HUMAN Alpha-N-
acetylglucosaminidase OS=Homo sapiens 
GN=NAGLU PE=1... 
0.35 24 42 24 41 41 38 23 41 
sp|CATA_HUMAN| sp|CATA_HUMAN| 0.17 95 13 9 11 11 15 12 10 
PRKAR2A protein OS=Homo sapiens 
GN=PRKAR2A PE=2 SV=1 
Q9BUB1_HUMAN 0.37 32 24 36 17 17 27 31 32 
sp|P49189|AL9A1_HUMAN 4-
trimethylaminobutyraldehyde 
dehydrogenase OS=Homo sapiens... 
sp|P49189|AL9A1_HUMAN4-
trimethylaminobutyraldehyde dehydrogenase 
OS=Homo sapiens GN=ALDH9A1 PE=1 SV=3 
0.36 35 43 31 0 44 0 0 43 
Isoform 2 of Coatomer subunit alpha 
OS=Homo sapiens GN=COPA 
sp|P53621-2|COPA_HUMAN 0.4 3 0 5 6 6 3 5 2 
Deoxyribonuclease-2-alpha 
OS=Homo sapiens GN=DNASE2 PE=2 
SV=1 
B7Z4K6_HUMAN 0.4 13 12 19 13 13 17 14 20 
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Lipid phosphate phosphohydrolase 1 
OS=Homo sapiens GN=PPAP2A PE=1 
SV=1 
sp|O14494|LPP1_HUMAN 0.86 18 20 2 5 5 24 5 29 
sp|P61019|RAB2A_HUMAN Ras-
related protein Rab-2A OS=Homo 
sapiens GN=RAB2A PE=1 SV=1 
sp|P61019|RAB2A_HUMANRas-related protein 
Rab-2A OS=Homo sapiens GN=RAB2A PE=1 SV=1 
0.78 42 38 0 2 23 35 37 0 
sp|Q02790|FKBP4_HUMAN 
Peptidyl-prolyl cis-trans isomerase 
FKBP4 OS=Homo sapiens 
GN=FKBP4... 
sp|Q02790|FKBP4_HUMANPeptidyl-prolyl cis-
trans isomerase FKBP4 OS=Homo sapiens 
GN=FKBP4 PE=1 SV=3 
0.49 14 26 15 0 4 21 25 17 
sp|P51149|RAB7A_HUMAN Ras-
related protein Rab-7a OS=Homo 
sapiens GN=RAB7A PE=1 SV=1 
sp|P51149|RAB7A_HUMANRas-related protein 
Rab-7a OS=Homo sapiens GN=RAB7A PE=1 SV=1 
0.49 21 32 6 22 22 29 30 34 
Ganglioside GM2 activator OS=Homo 
sapiens GN=GM2A PE=1 SV=4 
SAP3_HUMAN 0.3 9 24 2 12 12 15 11 17 
Peroxidasin homolog OS=Homo 
sapiens GN=PXDN PE=1 SV=2 
sp|Q92626|PXDN_HUMAN 0.72 8 7 0 4 4 9 2 8 
sp|Q13275|SEM3F_HUMAN 
Semaphorin-3F OS=Homo sapiens 
GN=SEMA3F PE=2 SV=2 
sp|Q13275|SEM3F_HUMANSemaphorin-3F 
OS=Homo sapiens GN=SEMA3F PE=2 SV=2 
0.5 11 26 7 14 14 19 23 19 
Annexin OS=Homo sapiens 
GN=ANXA4 PE=2 SV=1 
Q6P452_HUMAN 0.32 26 35 15 28 28 33 32 21 
Ferritin heavy chain OS=Homo 
sapiens GN=FTH1 PE=1 SV=2 
FRIH_HUMAN 0.33 27 26 17 12 12 19 23 19 
Isoform 2 of Phosphoglucomutase-1 
OS=Homo sapiens GN=PGM1 
sp|P36871-2|PGM1_HUMAN 0.48 4 14 15 17 17 20 19 10 
Isoform 2 of Ribosome-binding 
protein 1 OS=Homo sapiens 
GN=RRBP1 
sp|Q9P2E9-3|RRBP1_HUMAN 0.19 5 12 5 3 3 2 4 5 
Metalloreductase STEAP4 OS=Homo 
sapiens GN=STEAP4 PE=2 SV=1 
C9JS50_HUMAN 0.54 18 17 7 15 15 28 10 21 
Beta-2-glycoprotein 1 OS=Homo 
sapiens GN=APOH PE=1 SV=3 
APOH_HUMAN 0.67 4 20 16 21 21 27 18 36 
sp|P54652|HSP72_HUMAN Heat 
shock-related 70 kDa protein 2 
OS=Homo sapiens GN=HSPA2... 
sp|P54652|HSP72_HUMANHeat shock-related 
70 kDa protein 2 OS=Homo sapiens GN=HSPA2 
PE=1 SV=1 
0.03 10 25 0 0 29 38 58 29 
Isoform 2 of Glucosidase 2 subunit 
beta OS=Homo sapiens GN=PRKCSH 
GLU2B_HUMAN 0.45 5 10 0 4 4 0 14 15 
Macrophage-capping protein 
OS=Homo sapiens GN=CAPG PE=1 
SV=2 
sp|P40121|CAPG_HUMAN 0.26 31 30 19 18 18 16 16 16 
Paragranulin (Fragment) OS=Homo 
sapiens GN=GRN PE=4 SV=1 
K7EKL3_HUMAN 0.42 8 14 14 14 14 18 16 14 
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Cysteine-rich secretory protein LCCL 
domain-containing 1 OS=Homo 
sapiens GN=CRISPLD1 PE=1 SV=1 
sp|Q9H336|CRLD1_HUMANCysteine-rich 
secretory protein LCCL domain-containing 1 
OS=Homo sapiens GN=CRISPLD1 PE=1 SV=1 
0.18 0 28 0 0 20 39 30 0 
Latent-transforming growth factor 
beta-binding protein 2 OS=Homo 
sapiens GN=LTBP2 PE=2 SV=1 
G3V3X5_HUMAN 0.5 0 1 0 1 1 0 0 4 
UDP-glucose 6-dehydrogenase 
OS=Homo sapiens GN=UGDH PE=1 
SV=1 
sp|O60701|UGDH_HUMAN 0.38 19 21 18 25 25 26 32 13 
NAD(P)H-hydrate epimerase 
OS=Homo sapiens GN=APOA1BP 
PE=1 SV=2 
sp|Q8NCW5|NNRE_HUMAN 0.33 17 23 22 16 16 12 18 17 
sp|Q14515|SPRL1_HUMAN SPARC-
like protein 1 OS=Homo sapiens 
GN=SPARCL1 PE=1 SV=2 
sp|Q14515|SPRL1_HUMANSPARC-like protein 1 
OS=Homo sapiens GN=SPARCL1 PE=1 SV=2 
0.4 2 12 6 0 3 9 7 0 
sp|P12109|CO6A1_HUMAN 
Collagen alpha-1(VI) chain OS=Homo 
sapiens GN=COL6A1 PE=1 SV=3 
sp|P12109|CO6A1_HUMANCollagen alpha-1(VI) 
chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 
0.34 13 0 9 17 17 0 4 14 
sp|B9A064|IGLL5_HUMAN 
Immunoglobulin lambda-like 
polypeptide 5 OS=Homo sapiens 
GN=IGLL5 PE=2 SV=2 
sp|B9A064|IGLL5_HUMANImmunoglobulin 
lambda-like polypeptide 5 OS=Homo sapiens 
GN=IGLL5 PE=2 SV=2 
0.45 32 39 2 0 45 45 35 0 
Cathepsin Z OS=Homo sapiens 
GN=CTSZ PE=1 SV=1 
CATZ_HUMAN 0.37 20 16 26 16 16 15 16 33 
Alkaline phosphodiesterase I 
OS=Homo sapiens GN=ENPP3 PE=2 
SV=1 
F8W6H5_HUMAN 0.52 7 13 1 0 0 9 0 8 
sp|Q13449|LSAMP_HUMAN Limbic 
system-associated membrane 
protein OS=Homo sapiens 
GN=LSAMP PE=1 SV=2 
sp|Q13449|LSAMP_HUMANLimbic system-
associated membrane protein OS=Homo sapiens 
GN=LSAMP PE=1 SV=2 
0.013 0 31 0 0 44 38 27 37 
sp|O00299|CLIC1_HUMAN Chloride 
intracellular channel protein 1 
OS=Homo sapiens GN=CLIC1 PE=1 
SV=4 
sp|O00299|CLIC1_HUMANChloride intracellular 
channel protein 1 OS=Homo sapiens GN=CLIC1 
PE=1 SV=4 
0.69 77 58 0 0 51 0 0 38 
T-complex protein 1 subunit theta 
OS=Homo sapiens GN=CCT8 PE=1 
SV=4 
TCPQ_HUMAN 0.32 39 34 26 12 12 35 25 19 
Integrin beta-like protein 1 
OS=Homo sapiens GN=ITGBL1 PE=2 
SV=1 
B4DQ02_HUMAN 0.55 0 2 0 0 0 3 0 1 
Ig lambda-3 chain C regions 
OS=Homo sapiens GN=IGLC3 PE=1 
SV=1 
LAC3_HUMAN 0.36 20 15 19 21 21 28 25 18 
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Proteasome subunit beta type-5 
OS=Homo sapiens GN=PSMB5 PE=1 
SV=3 
sp|P28074|PSB5_HUMAN 0.41 17 16 25 23 23 29 43 25 
Probable serine carboxypeptidase 
CPVL OS=Homo sapiens GN=CPVL 
PE=1 SV=2 
CPVL_HUMAN 0.69 13 27 10 30 30 35 13 33 
Importin subunit beta-1 OS=Homo 
sapiens GN=KPNB1 PE=2 SV=1 
F5H4R7_HUMAN 0.48 4 5 5 5 5 7 5 10 
sp|Q14508|WFDC2_HUMAN WAP 
four-disulfide core domain protein 2 
OS=Homo sapiens GN=WFDC2 PE=1 
SV=2 
sp|Q14508|WFDC2_HUMANWAP four-disulfide 
core domain protein 2 OS=Homo sapiens 
GN=WFDC2 PE=1 SV=2 
0.27 22 39 0 0 31 0 83 37 
sp|Q9H4B8|DPEP3_HUMAN 
Dipeptidase 3 OS=Homo sapiens 
GN=DPEP3 PE=2 SV=2 
sp|Q9H4B8|DPEP3_HUMANDipeptidase 3 
OS=Homo sapiens GN=DPEP3 PE=2 SV=2 
0.55 22 0 8 22 22 32 38 34 
sp|P49721|PSB2_HUMAN 
Proteasome subunit beta type-2 
OS=Homo sapiens GN=PSMB2 
PE=1... 
sp|P49721|PSB2_HUMAN Proteasome subunit 
beta type-2 OS=Homo sapiens GN=PSMB2 PE=1... 
0.42 13 25 11 15 15 35 28 16 
Atrial natriuretic peptide-converting 
enzyme, 180 kDa soluble fragment 
OS=Homo sapiens GN=CORIN PE=2 
SV=1 
J3KR90_HUMAN 0.36 0 0 0 0 0 2 0 0 
Dipeptidyl peptidase 3 OS=Homo 
sapiens GN=DPP3 PE=2 SV=1 
G3V1D3_HUMAN 0.27 8 22 6 10 10 11 16 8 
Protein-L-isoaspartate O-
methyltransferase OS=Homo sapiens 
GN=PCMT1 PE=2 SV=1 
J3KP72_HUMAN 0.59 16 22 6 17 17 34 34 10 
Histone H4 OS=Homo sapiens 
GN=HIST1H4A PE=1 SV=2 
H4_HUMAN 0.12 126 38 12 21 21 32 23 20 
Isoform Long of Proteasome subunit 
alpha type-1 OS=Homo sapiens 
GN=PSMA1 
sp|P25786-2|PSA1_HUMAN 0.73 47 30 0 0 0 27 2 27 
Protein NAMPTL (Fragment) 
OS=Homo sapiens GN=NAMPTL PE=2 
SV=1 
Q5SYT8_HUMAN 0.33 21 12 17 5 5 10 18 12 
sp|Q12841|FSTL1_HUMAN 
Follistatin-related protein 1 
OS=Homo sapiens GN=FSTL1 PE=1... 
sp|Q12841|FSTL1_HUMANFollistatin-related 
protein 1 OS=Homo sapiens GN=FSTL1 PE=1 SV=1 
0.63 0 51 1 0 31 31 18 0 
6-phosphogluconate dehydrogenase, 
decarboxylating OS=Homo sapiens 
GN=PGD PE=2 SV=1 
F5H7U0_HUMAN 0.37 20 26 20 9 9 26 32 9 
Valine--tRNA ligase OS=Homo 
sapiens GN=VARS PE=1 SV=4 
SYVC_HUMAN 0.91 2 5 4 2 2 10 12 10 
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Ras-related protein Ral-B OS=Homo 
sapiens GN=RALB PE=2 SV=1 
B4E040_HUMAN 0.39 20 30 25 40 40 29 34 43 
sp|P01769|HV308_HUMAN Ig heavy 
chain V-III region GA OS=Homo 
sapiens PE=1 SV=1 
sp|P01769|HV308_HUMANIg heavy chain V-III 
region GA OS=Homo sapiens PE=1 SV=1-DECOY 
0.63 2 1 0 2 2 2 3 0 
sp|Q13217|DNJC3_HUMAN DnaJ 
homolog subfamily C member 3 
OS=Homo sapiens GN=DNAJC3... 
sp|Q13217|DNJC3_HUMANDnaJ homolog 
subfamily C member 3 OS=Homo sapiens 
GN=DNAJC3 PE=1 SV=1 
0.88 35 23 6 0 18 0 41 26 
Puromycin-sensitive aminopeptidase 
OS=Homo sapiens GN=NPEPPS PE=2 
SV=1 
B7Z463_HUMAN 0.52 17 22 0 0 0 42 0 29 
sp|P48668|K2C6C_HUMAN Keratin, 
type II cytoskeletal 6C OS=Homo 
sapiens GN=KRT6C PE=1... 
sp|P48668|K2C6C_HUMANKeratin, type II 
cytoskeletal 6C OS=Homo sapiens GN=KRT6C 
PE=1 SV=3 
0.37 0 12 7 1 29 1 37 32 
Mannose-6-phosphate isomerase 
OS=Homo sapiens GN=MPI PE=1 
SV=2 
MPI_HUMAN 0.12 12 21 6 12 12 0 12 9 
sp|P80723|BASP1_HUMAN Brain 
acid soluble protein 1 OS=Homo 
sapiens GN=BASP1 PE=1 SV=2 
sp|P80723|BASP1_HUMANBrain acid soluble 
protein 1 OS=Homo sapiens GN=BASP1 PE=1 
SV=2 
0.81 50 24 0 0 27 30 28 0 
Lysosome-associated membrane 
glycoprotein 1 OS=Homo sapiens 
GN=LAMP1 PE=2 SV=1 
B4DWL3_HUMAN 0.4 0 1 23 14 14 0 22 0 
6-phosphofructokinase type C 
OS=Homo sapiens GN=PFKP PE=1 
SV=2 
sp|Q01813|K6PP_HUMAN 0.89 1 18 5 2 2 14 23 14 
sp|O14818|PSA7_HUMAN 
Proteasome subunit alpha type-7 
OS=Homo sapiens GN=PSMA7 
PE=1... 
sp|O14818|PSA7_HUMAN Proteasome subunit 
alpha type-7 OS=Homo sapiens GN=PSMA7 
PE=1... 
0.4 13 27 22 27 27 32 31 24 
Alpha-2-HS-glycoprotein OS=Homo 
sapiens GN=AHSG PE=2 SV=1 
C9JV77_HUMAN 0.46 10 19 21 19 19 20 17 32 
Isoform 1 of Vinculin OS=Homo 
sapiens GN=VCL 
sp|P18206-2|VINC_HUMAN (+1) 0.32 16 7 17 3 3 11 3 8 
Bile salt-activated lipase OS=Homo 
sapiens GN=CEL PE=1 SV=3 
CEL_HUMAN 0.82 6 24 6 9 9 23 41 0 
Alpha-1B-glycoprotein OS=Homo 
sapiens GN=A1BG PE=1 SV=4 
sp|P04217|A1BG_HUMAN 0.45 13 30 20 9 9 28 25 23 
Isoform CNPI of 2',3'-cyclic-
nucleotide 3'-phosphodiesterase 
OS=Homo sapiens GN=CNP 
sp|P09543-2|CN37_HUMAN 0.39 0 0 23 25 25 0 22 0 
Isoform 2 of Neural cell adhesion 
molecule L1-like protein OS=Homo 
sapiens GN=CHL1 
sp|O00533-2|CHL1_HUMAN 0.55 0 4 0 11 11 8 3 4 
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Isoform 2 of Melanophilin OS=Homo 
sapiens GN=MLPH 
sp|Q9BV36-2|MELPH_HUMAN 0.28 30 13 12 17 17 16 17 18 
Myosin light polypeptide 6 OS=Homo 
sapiens GN=MYL6 PE=2 SV=1 
B7Z6Z4_HUMAN 0.27 31 23 14 15 15 16 11 13 
Thymosin beta-4 OS=Homo sapiens 
GN=TMSB4X PE=1 SV=2 
TYB4_HUMAN 0.36 230 0 0 0 0 0 0 0 
Secretogranin-1 OS=Homo sapiens 
GN=CHGB PE=1 SV=2 
SCG1_HUMAN 0.36 13 17 7 14 14 12 13 22 
sp|Q9NZ08|ERAP1_HUMAN 
Endoplasmic reticulum 
aminopeptidase 1 OS=Homo sapiens 
GN=ERAP1 PE=1 SV=3 
sp|Q9NZ08|ERAP1_HUMANEndoplasmic 
reticulum aminopeptidase 1 OS=Homo sapiens 
GN=ERAP1 PE=1 SV=3 
0.76 12 13 5 0 17 0 20 12 
sp|P14550|AK1A1_HUMAN Alcohol 
dehydrogenase [NADP(+)] OS=Homo 
sapiens GN=AKR1A1 PE=1... 
sp|P14550|AK1A1_HUMANAlcohol 
dehydrogenase [NADP(+)] OS=Homo sapiens 
GN=AKR1A1 PE=1 SV=3 
0.13 42 0 0 0 27 32 34 54 
Nidogen-1 OS=Homo sapiens 
GN=NID1 PE=1 SV=3 
sp|P14543|NID1_HUMAN 0.068 2 6 0 7 7 6 12 14 
Zinc finger MYM-type protein 4 
(Fragment) OS=Homo sapiens 
GN=ZMYM4 PE=4 SV=1 
H7C1I7_HUMAN 0.94 0 0 0 5 5 0 0 0 
sp|P07737|PROF1_HUMAN Profilin-
1 OS=Homo sapiens GN=PFN1 PE=1 
SV=2 
sp|P07737|PROF1_HUMANProfilin-1 OS=Homo 
sapiens GN=PFN1 PE=1 SV=2 
0.86 69 38 0 0 19 30 20 23 
Isoform 8 of Fibronectin OS=Homo 
sapiens GN=FN1 
sp|P02751-8|FINC_HUMAN 0.31 25 29 11 36 36 23 23 25 
sp|Q15907|RB11B_HUMAN Ras-
related protein Rab-11B OS=Homo 
sapiens GN=RAB11B PE=1... 
sp|Q15907|RB11B_HUMANRas-related protein 
Rab-11B OS=Homo sapiens GN=RAB11B PE=1 
SV=4 
0.13 44 28 0 0 35 46 34 35 
Isoform 17 of CD44 antigen 
OS=Homo sapiens GN=CD44 
sp|P16070-17|CD44_HUMAN 0.87 5 10 1 3 3 5 9 8 
Fibrinogen beta chain OS=Homo 
sapiens GN=FGB PE=1 SV=2 
FIBB_HUMAN 0.34 8 7 16 4 4 6 2 10 
G-protein-coupled receptor family C 
group 5 member C (Fragment) 
OS=Homo sapiens GN=GPRC5C PE=4 
SV=2 
A8MXZ4_HUMAN 0.83 15 15 4 15 15 26 13 25 
sp|Q13200|PSMD2_HUMAN 26S 
proteasome non-ATPase regulatory 
subunit 2 OS=Homo sapiens 
GN=PSMD2 PE=1 SV=3 
sp|Q13200|PSMD2_HUMAN26S proteasome 
non-ATPase regulatory subunit 2 OS=Homo 
sapiens GN=PSMD2 PE=1 SV=3 
0.52 16 0 19 0 7 18 19 21 
Unconventional myosin-Ic OS=Homo 
sapiens GN=MYO1C PE=2 SV=1 
F5H6E2_HUMAN (+1) 0.24 8 13 5 8 8 6 4 12 
Isoform 1 of Unconventional myosin-
VI OS=Homo sapiens GN=MYO6 
sp|Q9UM54-1|MYO6_HUMAN 0.51 2 2 4 6 6 6 4 6 
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dehydrogenase 1 OS=Homo sapiens 
GN=ALDH1A1 PE=1 SV=2 
sp|P00352|AL1A1_HUMANRetinal 
dehydrogenase 1 OS=Homo sapiens 
GN=ALDH1A1 PE=1 SV=2 
0.24 16 40 18 7 7 0 19 26 
Bifunctional glutamate/proline--
tRNA ligase OS=Homo sapiens 
GN=EPRS PE=1 SV=5 
SYEP_HUMAN 0.79 6 2 0 0 0 4 0 2 
Spermine synthase OS=Homo 
sapiens GN=SMS PE=1 SV=2 
sp|P52788|SPSY_HUMAN 0.35 15 31 16 23 23 28 16 25 
Calpain small subunit 1 OS=Homo 
sapiens GN=CAPNS1 PE=2 SV=1 
K7ELJ7_HUMAN 0.19 25 11 2 10 10 11 17 8 
Isoform 2 of 14-3-3 protein sigma 
OS=Homo sapiens GN=SFN 
1433S_HUMAN 0.21 19 33 0 0 33 52 30 30 
Lactotransferrin OS=Homo sapiens 
GN=LTF PE=1 SV=6 
sp|P02788|TRFL_HUMAN 0.42 3 19 25 22 22 37 26 16 
sp|O14497|ARI1A_HUMAN AT-rich 
interactive domain-containing 
protein 1A OS=Homo sapiens 
GN=ARID1A PE=1 SV=3 
sp|O14497|ARI1A_HUMANAT-rich interactive 
domain-containing protein 1A OS=Homo sapiens 
GN=ARID1A PE=1 SV=3 
0.36 2 0 0 0 0 0 0 0 
Vesicle-fusing ATPase OS=Homo 
sapiens GN=NSF PE=1 SV=3 
NSF_HUMAN 0.3 13 14 8 6 6 12 11 8 
Histone H2A type 1 OS=Homo 
sapiens GN=HIST1H2AG PE=1 SV=2 
H2A1_HUMAN 0.23 107 9 2 11 11 11 6 7 
Brevican core protein OS=Homo 
sapiens GN=BCAN PE=1 SV=2 
sp|Q96GW7|PGCB_HUMAN 0.43 9 28 1 13 13 15 17 33 
Glypican-1 OS=Homo sapiens 
GN=GPC1 PE=1 SV=2 
GPC1_HUMAN 0.91 12 6 5 10 10 38 13 9 
Beta-glucuronidase OS=Homo 
sapiens GN=GUSB PE=1 SV=2 
sp|P08236|BGLR_HUMAN 0.45 10 26 11 15 15 21 20 25 
sp|Q14914|PTGR1_HUMAN 
Prostaglandin reductase 1 OS=Homo 
sapiens GN=PTGR1 PE=1 SV=2 
sp|Q14914|PTGR1_HUMANProstaglandin 
reductase 1 OS=Homo sapiens GN=PTGR1 PE=1 
SV=2 
0.37 10 47 16 0 16 22 13 17 
5'-nucleotidase OS=Homo sapiens 
GN=NT5E PE=1 SV=1 
sp|P21589|5NTD_HUMAN 0.96 6 5 3 15 15 11 7 11 
sp|Q96BH3|ESPB1_HUMAN 
Epididymal sperm-binding protein 1 
OS=Homo sapiens GN=ELSPBP1 PE=1 
SV=2 
sp|Q96BH3|ESPB1_HUMANEpididymal sperm-
binding protein 1 OS=Homo sapiens GN=ELSPBP1 
PE=1 SV=2 
0.18 7 23 2 3 20 16 38 22 
sp|P06702|S10A9_HUMAN Protein 
S100-A9 OS=Homo sapiens 
GN=S100A9 PE=1 SV=1 
sp|P06702|S10A9_HUMANProtein S100-A9 
OS=Homo sapiens GN=S100A9 PE=1 SV=1 
0.49 23 29 2 0 28 23 13 17 
sp|O75969|AKAP3_HUMAN A-
kinase anchor protein 3 OS=Homo 
sapiens GN=AKAP3 PE=1 SV=2 
sp|O75969|AKAP3_HUMANA-kinase anchor 
protein 3 OS=Homo sapiens GN=AKAP3 PE=1 
SV=2 
0.13 0 11 0 7 7 6 25 16 
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2 of Lysosomal Pro-X 
carboxypeptidase OS=Homo 
sapiens... 
sp|P42785-2|PCP_HUMANIsoform 2 of 
Lysosomal Pro-X carboxypeptidase OS=Homo 
sapiens GN=PRCP 
0.53 11 29 18 0 19 0 30 27 
Galactoside 3(4)-L-fucosyltransferase 
OS=Homo sapiens GN=FUT3 PE=2 
SV=1 
FUT3_HUMAN 0.37 17 24 9 21 21 20 25 22 
Glycogen phosphorylase, brain form 
OS=Homo sapiens GN=PYGB PE=1 
SV=5 
PYGB_HUMAN 0.43 0 0 18 16 16 0 25 0 
Glutathione synthetase OS=Homo 
sapiens GN=GSS PE=1 SV=1 
sp|P48637|GSHB_HUMAN 0.37 8 23 21 13 13 18 13 19 
sp|P31948|STIP1_HUMAN Stress-
induced-phosphoprotein 1 OS=Homo 
sapiens GN=STIP1 PE=1 SV=1 
sp|P31948|STIP1_HUMANStress-induced-
phosphoprotein 1 OS=Homo sapiens GN=STIP1 
PE=1 SV=1 
0.42 17 13 0 0 13 0 24 15 
Haptoglobin OS=Homo sapiens 
GN=HP PE=1 SV=1 
HPT_HUMAN 0.3 33 27 33 22 22 4 29 23 
Isoform 3 of L-lactate dehydrogenase 
A chain OS=Homo sapiens GN=LDHA 
sp|P00338-3|LDHA_HUMAN 0.51 0 0 20 40 40 0 49 0 
sp|Q15435|PP1R7_HUMAN Protein 
phosphatase 1 regulatory subunit 7 
OS=Homo sapiens... 
sp|Q15435|PP1R7_HUMANProtein phosphatase 
1 regulatory subunit 7 OS=Homo sapiens 
GN=PPP1R7 PE=1 SV=1 
0.37 13 22 13 0 9 0 22 13 
Isoform 2 of Ras-related protein Rab-
5C OS=Homo sapiens GN=RAB5C 
RAB5C_HUMAN 0.42 17 25 0 19 19 25 16 24 
Elongation factor 1-gamma 
OS=Homo sapiens GN=EEF1G PE=1 
SV=3 
EF1G_HUMAN 0.63 1 17 13 3 3 26 30 19 
sp|P01617|KV204_HUMAN Ig kappa 
chain V-II region TEW OS=Homo 
sapiens PE=1 SV=1 
sp|P01617|KV204_HUMANIg kappa chain V-II 
region TEW OS=Homo sapiens PE=1 SV=1 
0.22 4 3 0 0 1 6 4 4 
T-complex protein 1 subunit beta 
OS=Homo sapiens GN=CCT2 PE=2 
SV=1 
F8VQ14_HUMAN 0.98 32 21 0 0 0 29 0 22 
Transforming protein RhoA 
OS=Homo sapiens GN=RHOA PE=1 
SV=1 
RHOA_HUMAN 0.31 25 20 7 12 12 16 16 22 
T-complex protein 1 subunit zeta 
OS=Homo sapiens GN=CCT6A PE=2 
SV=1 
B4DPJ8_HUMAN 0.3 11 20 11 5 5 10 12 10 
ADP-ribosylation factor 3 OS=Homo 
sapiens GN=ARF3 PE=1 SV=2 
ARF3_HUMAN 0.38 25 11 24 17 17 33 25 18 
Lipase member I OS=Homo sapiens 
GN=LIPI PE=1 SV=2 
sp|Q6XZB0|LIPI_HUMAN 0.44 7 9 1 3 3 15 6 10 
Aminopeptidase B OS=Homo sapiens 
GN=RNPEP PE=1 SV=2 
AMPB_HUMAN 0.35 17 26 18 11 11 21 19 20 
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dioxygenase 3 OS=Homo sapiens 
GN=PLOD3 PE=1 SV=1 
sp|O60568|PLOD3_HUMANProcollagen-lysine,2-
oxoglutarate 5-dioxygenase 3 OS=Homo sapiens 
GN=PLOD3 PE=1 SV=1 
0.51 19 30 5 0 29 0 22 0 
Isoform 3 of Interleukin-6 receptor 
subunit beta OS=Homo sapiens 
GN=IL6ST 
sp|P40189-3|IL6RB_HUMAN 0.44 0 0 10 5 5 0 13 0 
Isoform 2 of Niban-like protein 1 
OS=Homo sapiens GN=FAM129B 
NIBL1_HUMAN 0.83 3 5 1 4 4 3 7 5 
sp|P20336|RAB3A_HUMAN Ras-
related protein Rab-3A OS=Homo 
sapiens GN=RAB3A PE=1 SV=1 
sp|P20336|RAB3A_HUMANRas-related protein 
Rab-3A OS=Homo sapiens GN=RAB3A PE=1 SV=1 
0.38 22 21 18 24 24 24 22 28 
sp|P11717|MPRI_HUMAN Cation-
independent mannose-6-phosphate 
receptor OS=Homo sapiens... 
sp|P11717|MPRI_HUMAN Cation-independent 
mannose-6-phosphate receptor OS=Homo 
sapiens... 
0.4 16 15 17 34 34 27 13 38 
sp|P34932|HSP74_HUMAN Heat 
shock 70 kDa protein 4 OS=Homo 
sapiens GN=HSPA4 PE=1 SV=4 
sp|P34932|HSP74_HUMANHeat shock 70 kDa 
protein 4 OS=Homo sapiens GN=HSPA4 PE=1 
SV=4 
0.22 11 26 14 9 9 0 17 0 
sp|P17987|TCPA_HUMAN T-
complex protein 1 subunit alpha 
OS=Homo sapiens GN=TCP1 PE=1... 
sp|P17987|TCPA_HUMAN T-complex protein 1 
subunit alpha OS=Homo sapiens GN=TCP1 PE=1... 
0.26 37 30 21 22 22 37 23 15 
4F2 cell-surface antigen heavy chain 
OS=Homo sapiens GN=SLC3A2 PE=2 
SV=1 
J3KPF3_HUMAN 0.97 9 14 0 0 0 12 0 11 
Isoform PTPS-MEA of Receptor-type 
tyrosine-protein phosphatase S 
OS=Homo sapiens GN=PTPRS 
sp|Q13332-2|PTPRS_HUMAN 0.4 11 22 13 15 15 21 28 17 
sp|Q9UNW1|MINP1_HUMAN 
Multiple inositol polyphosphate 
phosphatase 1 OS=Homo sapiens... 
sp|Q9UNW1|MINP1_HUMANMultiple inositol 
polyphosphate phosphatase 1 OS=Homo sapiens 
GN=MINPP1 PE=1 SV=1 
0.74 11 13 13 0 30 20 18 0 
6-phosphogluconolactonase 
OS=Homo sapiens GN=PGLS PE=1 
SV=2 
6PGL_HUMAN 0.34 26 19 26 19 19 22 15 21 
Alanine--tRNA ligase, cytoplasmic 
OS=Homo sapiens GN=AARS PE=1 
SV=2 
SYAC_HUMAN 0.35 3 20 14 1 1 10 3 13 
sp|Q9NQX4|MYO5C_HUMAN 
Unconventional myosin-Vc 
OS=Homo sapiens GN=MYO5C PE=1 
SV=2 
sp|Q9NQX4|MYO5C_HUMANUnconventional 
myosin-Vc OS=Homo sapiens GN=MYO5C PE=1 
SV=2 
0.62 0 0 2 1 1 0 1 6 
sp|P52907|CAZA1_HUMAN F-actin-
capping protein subunit alpha-1 
OS=Homo sapiens GN=CAPZA1 PE=1 
SV=3 
sp|P52907|CAZA1_HUMANF-actin-capping 
protein subunit alpha-1 OS=Homo sapiens 
GN=CAPZA1 PE=1 SV=3 
0.67 56 28 0 0 28 0 25 0 
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Isoform 4 of Leukotriene A-4 
hydrolase OS=Homo sapiens 
GN=LTA4H 
sp|P09960-4|LKHA4_HUMAN 0.44 12 15 16 13 13 21 19 15 
Multifunctional protein ADE2 
OS=Homo sapiens GN=PAICS PE=1 
SV=3 






dimethylarginine dimethylaminohydrolase 1 
OS=Homo sapiens GN=DDAH1 PE=1 SV=3 
0.98 29 50 3 0 22 21 26 28 
sp|P08779|K1C16_HUMAN Keratin, 
type I cytoskeletal 16 OS=Homo 
sapiens GN=KRT16 PE=1... 
sp|P08779|K1C16_HUMANKeratin, type I 
cytoskeletal 16 OS=Homo sapiens GN=KRT16 
PE=1 SV=4 
0.37 9 6 9 0 21 0 54 47 
sp|Q9BUD6|SPON2_HUMAN 
Spondin-2 OS=Homo sapiens 
GN=SPON2 PE=1 SV=3 
sp|Q9BUD6|SPON2_HUMANSpondin-2 
OS=Homo sapiens GN=SPON2 PE=1 SV=3 
0.91 15 20 0 24 24 0 21 22 
Otogelin OS=Homo sapiens 
GN=OTOG PE=1 SV=3 
sp|Q6ZRI0|OTOG_HUMAN 0.94 0 0 0 3 3 0 0 0 
sp|Q9GZX9|TWSG1_HUMAN 
Twisted gastrulation protein 
homolog 1 OS=Homo sapiens 
GN=TWSG1 PE=2 SV=1 
sp|Q9GZX9|TWSG1_HUMANTwisted 
gastrulation protein homolog 1 OS=Homo 
sapiens GN=TWSG1 PE=2 SV=1 
0.43 12 8 0 0 11 9 0 13 
Proteasome subunit beta type-3 
OS=Homo sapiens GN=PSMB3 PE=1 
SV=2 
PSB3_HUMAN 0.39 0 0 25 16 16 1 36 0 
Plastin-3 OS=Homo sapiens GN=PLS3 
PE=1 SV=4 
PLST_HUMAN 0.58 10 9 9 6 6 16 11 8 
sp|P45877|PPIC_HUMAN Peptidyl-
prolyl cis-trans isomerase C 
OS=Homo sapiens GN=PPIC... 
sp|P45877|PPIC_HUMAN Peptidyl-prolyl cis-
trans isomerase C OS=Homo sapiens GN=PPIC... 
0.35 14 19 9 12 12 15 13 15 
Sphingomyelin phosphodiesterase 
OS=Homo sapiens GN=SMPD1 PE=1 
SV=4 
ASM_HUMAN 0.47 0 0 12 15 15 0 21 0 
Aspartate aminotransferase 
OS=Homo sapiens GN=GOT1 PE=2 
SV=1 
B7Z7E9_HUMAN 0.34 11 24 16 12 12 12 21 16 
Isoform 2 of Glutathione reductase, 
mitochondrial OS=Homo sapiens 
GN=GSR 
sp|P00390-3|GSHR_HUMAN 0.42 1 1 26 21 21 0 28 0 
Isoform 2 of Probable phospholipid-
transporting ATPase IIB OS=Homo 
sapiens GN=ATP9B 
ATP9B_HUMAN 0.52 2 3 4 0 1 9 1 3 
sp|O43278|SPIT1_HUMAN Kunitz-
type protease inhibitor 1 OS=Homo 
sapiens GN=SPINT1... 
sp|O43278|SPIT1_HUMANKunitz-type protease 
inhibitor 1 OS=Homo sapiens GN=SPINT1 PE=1 
SV=2 
0.16 9 16 0 0 17 23 23 1 
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Neurogenic locus notch homolog 
protein 4 OS=Homo sapiens 
GN=NOTCH4 PE=1 SV=2 
sp|Q99466|NOTC4_HUMANNeurogenic locus 
notch homolog protein 4 OS=Homo sapiens 
GN=NOTCH4 PE=1 SV=2-DECOY 
0.75 1 0 0 1 1 0 2 0 
Isoform 3 of Ras-related protein Rap-
1b OS=Homo sapiens GN=RAP1B 
sp|P61224-3|RAP1B_HUMAN 0.33 34 20 19 18 18 21 27 19 
Talin-1 OS=Homo sapiens GN=TLN1 
PE=1 SV=3 
TLN1_HUMAN 0.28 11 2 10 0 0 2 2 0 
Isoform 2 of Syntaxin-binding protein 
2 OS=Homo sapiens GN=STXBP2 
STXB2_HUMAN 0.25 4 9 4 9 9 0 8 6 
Protein unc-13 homolog B OS=Homo 
sapiens GN=UNC13B PE=2 SV=1 
B1AM27_HUMAN 0.84 3 3 0 0 0 4 0 3 
UMP-CMP kinase OS=Homo sapiens 
GN=CMPK1 PE=1 SV=3 
KCY_HUMAN 0.73 23 25 0 8 8 21 21 16 
Suppressor of tumorigenicity 14 
protein OS=Homo sapiens GN=ST14 
PE=1 SV=2 
ST14_HUMAN 0.85 2 2 0 6 6 2 0 1 
Hexokinase-1 OS=Homo sapiens 
GN=HK1 PE=2 SV=1 
E7ENR4_HUMAN 0.88 4 10 1 10 10 8 10 6 
Isoform 2 of Plectin OS=Homo 
sapiens GN=PLEC 
sp|Q15149-2|PLEC_HUMAN 0.26 5 0 1 0 0 0 0 2 
Isoform 4 of Protein MON2 homolog 
OS=Homo sapiens GN=MON2 
sp|Q7Z3U7-4|MON2_HUMAN 0.71 1 1 2 0 0 3 3 5 
sp|Q9P2K2|TXD16_HUMAN 
Thioredoxin domain-containing 
protein 16 OS=Homo sapiens 
GN=TXNDC16 PE=2 SV=4 
sp|Q9P2K2|TXD16_HUMANThioredoxin domain-
containing protein 16 OS=Homo sapiens 
GN=TXNDC16 PE=2 SV=4 
0.54 4 13 0 0 2 0 11 15 
sp|Q99832|TCPH_HUMAN T-
complex protein 1 subunit eta 
OS=Homo sapiens GN=CCT7 PE=1... 
sp|Q99832|TCPH_HUMAN T-complex protein 1 
subunit eta OS=Homo sapiens GN=CCT7 PE=1... 
0.28 45 20 14 6 6 23 23 20 
Isoform 3 of DCC-interacting protein 
13-beta OS=Homo sapiens 
GN=APPL2 
sp|Q8NEU8-3|DP13B_HUMAN 0.36 0 0 7 1 1 0 1 0 
sp|Q8TDW7|FAT3_HUMAN 
Protocadherin Fat 3 OS=Homo 
sapiens GN=FAT3 PE=2 SV=2 
sp|Q8TDW7|FAT3_HUMAN Protocadherin Fat 3 
OS=Homo sapiens GN=FAT3 PE=2 SV=2-DECOY 
0.36 0 0 2 0 0 0 0 0 
sp|P34096|RNAS4_HUMAN 
Ribonuclease 4 OS=Homo sapiens 
GN=RNASE4 PE=1 SV=3 
sp|P34096|RNAS4_HUMANRibonuclease 4 
OS=Homo sapiens GN=RNASE4 PE=1 SV=3 
0.86 31 9 0 15 15 14 17 17 
Zinc finger protein 469 OS=Homo 
sapiens GN=ZNF469 PE=2 SV=1 
H3BS19_HUMAN 0.36 0 4 0 0 0 0 0 0 
Plasminogen OS=Homo sapiens 
GN=PLG PE=1 SV=2 
PLMN_HUMAN 0.44 8 13 6 4 4 16 11 7 
Arylsulfatase A OS=Homo sapiens 
GN=ARSA PE=1 SV=3 
sp|P15289|ARSA_HUMAN 0.36 21 20 18 28 28 24 24 20 
Stellenbosch University  https://scholar.sun.ac.za




OS=Homo sapiens GN=APEH PE=1 
SV=4 
ACPH_HUMAN 0.77 10 18 0 0 0 10 0 11 
Plasma serine protease inhibitor 
OS=Homo sapiens GN=SERPINA5 
PE=1 SV=3 
IPSP_HUMAN 0.88 0 2 1 2 2 0 2 0 
sp|P29966|MARCS_HUMAN 
Myristoylated alanine-rich C-kinase 
substrate OS=Homo sapiens 
GN=MARCKS PE=1 SV=4 
sp|P29966|MARCS_HUMANMyristoylated 
alanine-rich C-kinase substrate OS=Homo sapiens 
GN=MARCKS PE=1 SV=4 
0.68 24 10 5 0 14 15 18 0 
EH domain-containing protein 4 
OS=Homo sapiens GN=EHD4 PE=1 
SV=1 
EHD4_HUMAN 0.43 6 12 5 6 6 10 10 9 
Proteasome subunit beta type-4 
OS=Homo sapiens GN=PSMB4 PE=1 
SV=4 
PSB4_HUMAN 0.73 16 30 0 0 0 31 0 30 
Phosphoglucomutase-2 OS=Homo 
sapiens GN=PGM2 PE=1 SV=4 
PGM2_HUMAN 0.36 7 16 6 21 21 9 12 12 
Antigen KI-67 OS=Homo sapiens 
GN=MKI67 PE=1 SV=2 
sp|P46013|KI67_HUMAN 0.36 8 0 0 0 0 0 0 0 
Translin OS=Homo sapiens GN=TSN 
PE=2 SV=1 
E9PGT1_HUMAN 0.55 7 17 10 11 11 20 37 21 
Isoform 2 of Ester hydrolase 
C11orf54 OS=Homo sapiens 
GN=C11orf54 
sp|Q9H0W9-2|CK054_HUMAN 0.25 15 17 13 15 15 8 9 12 
sp|P18136|KV313_HUMAN Ig kappa 
chain V-III region HIC OS=Homo 
sapiens PE=2 SV=2 
sp|P18136|KV313_HUMANIg kappa chain V-III 
region HIC OS=Homo sapiens PE=2 SV=2 
0.34 13 14 14 15 15 0 13 25 
sp|P47895|AL1A3_HUMAN 
Aldehyde dehydrogenase family 1 
member A3 OS=Homo sapiens 
GN=ALDH1A3 PE=1 SV=2 
sp|P47895|AL1A3_HUMANAldehyde 
dehydrogenase family 1 member A3 OS=Homo 
sapiens GN=ALDH1A3 PE=1 SV=2 
0.75 29 22 0 0 19 1 27 15 
sp|O75503|CLN5_HUMAN Ceroid-
lipofuscinosis neuronal protein 5 
OS=Homo sapiens GN=CLN5... 
sp|O75503|CLN5_HUMAN Ceroid-lipofuscinosis 
neuronal protein 5 OS=Homo sapiens GN=CLN5... 
0.37 12 17 19 18 18 19 19 14 
Isoform 2 of Sodium-dependent 
phosphate transport protein 2B 
OS=Homo sapiens GN=SLC34A2 
NPT2B_HUMAN 0.36 0 0 0 0 0 0 0 2 
sp|P05109|S10A8_HUMAN Protein 
S100-A8 OS=Homo sapiens 
GN=S100A8 PE=1 SV=1 
sp|P05109|S10A8_HUMANProtein S100-A8 
OS=Homo sapiens GN=S100A8 PE=1 SV=1 
0.43 15 19 0 9 9 10 4 6 
sp|P04406|G3P_HUMAN 
Glyceraldehyde-3-phosphate 
dehydrogenase OS=Homo sapiens 
GN=GAPDH... 
sp|P04406|G3P_HUMAN Glyceraldehyde-3-
phosphate dehydrogenase OS=Homo sapiens 
GN=GAPDH... 
0.32 20 28 28 18 18 28 26 15 
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Fructose-bisphosphate aldolase C 
OS=Homo sapiens GN=ALDOC PE=1... 
sp|P09972|ALDOC_HUMANFructose-
bisphosphate aldolase C OS=Homo sapiens 
GN=ALDOC PE=1 SV=2 
0.86 21 27 1 0 13 0 20 13 
sp|P12110|CO6A2_HUMAN 
Collagen alpha-2(VI) chain OS=Homo 
sapiens GN=COL6A2 PE=1 SV=4 
sp|P12110|CO6A2_HUMANCollagen alpha-2(VI) 
chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 
0.29 9 12 7 22 22 0 10 14 
Alpha-soluble NSF attachment 
protein OS=Homo sapiens GN=NAPA 
PE=1 SV=3 
SNAA_HUMAN 0.4 0 0 16 11 11 0 19 0 
Isoform 2 of Heterogeneous nuclear 
ribonucleoprotein M OS=Homo 
sapiens GN=HNRNPM 
HNRPM_HUMAN 0.36 65 0 0 0 0 0 0 0 
Isoform 5 of Seizure 6-like protein 2 
OS=Homo sapiens GN=SEZ6L2 
sp|Q6UXD5-5|SE6L2_HUMAN 0.27 6 13 6 6 6 4 7 6 
Apolipoprotein E OS=Homo sapiens 
GN=APOE PE=1 SV=1 
APOE_HUMAN 0.29 10 25 15 15 15 13 9 14 
Isoform C of Protein CutA OS=Homo 
sapiens GN=CUTA 
sp|O60888-3|CUTA_HUMAN 0.35 17 10 8 8 8 10 20 8 
Glycogen phosphorylase, liver form 
OS=Homo sapiens GN=PYGL PE=1 
SV=4 
sp|P06737|PYGL_HUMAN 0.18 18 18 11 4 4 4 2 12 
sp|P60953|CDC42_HUMAN Cell 
division control protein 42 homolog 
OS=Homo sapiens GN=CDC42 PE=1 
SV=2 
sp|P60953|CDC42_HUMANCell division control 
protein 42 homolog OS=Homo sapiens 
GN=CDC42 PE=1 SV=2 
0.25 21 20 0 0 20 23 15 15 
T-complex protein 1 subunit epsilon 
OS=Homo sapiens GN=CCT5 PE=2 
SV=1 
E9PCA1_HUMAN 0.47 0 0 14 7 7 0 15 0 
Isoform 4 of E3 ubiquitin-protein 
ligase UBR2 OS=Homo sapiens 
GN=UBR2 
sp|Q8IWV8-4|UBR2_HUMAN 0.33 0 2 2 0 0 0 0 0 
60S ribosomal protein L7 OS=Homo 
sapiens GN=RPL7 PE=2 SV=1 
A8MUD9_HUMAN 0.39 12 9 11 4 4 20 5 14 
Alpha-L-iduronidase OS=Homo 
sapiens GN=IDUA PE=1 SV=2 
IDUA_HUMAN 0.5 3 7 11 16 16 9 15 15 
sp|Q14697|GANAB_HUMAN Neutral 
alpha-glucosidase AB OS=Homo 
sapiens GN=GANAB PE=1 SV=3 
sp|Q14697|GANAB_HUMANNeutral alpha-
glucosidase AB OS=Homo sapiens GN=GANAB 
PE=1 SV=3 
0.36 15 12 2 0 17 0 22 24 
Glypican-4 OS=Homo sapiens 
GN=GPC4 PE=1 SV=4 
GPC4_HUMAN 0.61 5 7 0 1 1 9 6 2 
Isoform 2 of UPF0577 protein 
KIAA1324 OS=Homo sapiens 
GN=KIAA1324 
sp|Q6UXG2-2|K1324_HUMAN 0.36 0 0 0 0 0 5 0 0 
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Selenoprotein P (Fragment) 
OS=Homo sapiens GN=SEPP1 PE=4 
SV=1 
D6REX5_HUMAN 0.33 19 16 12 16 16 20 14 16 
Xaa-Pro aminopeptidase 1 OS=Homo 
sapiens GN=XPNPEP1 PE=1 SV=3 
sp|Q9NQW7|XPP1_HUMAN 0.33 8 6 7 1 1 11 1 2 
Calcyphosin OS=Homo sapiens 
GN=CAPS PE=4 SV=1 
K7EL21_HUMAN 0.33 16 12 16 16 16 12 11 9 
Proteasome subunit alpha type 
OS=Homo sapiens GN=PSMA6 PE=2 
SV=1 
G3V5Z7_HUMAN 0.62 17 23 2 0 0 23 0 30 
sp|Q9UQ35|SRRM2_HUMAN 
Serine/arginine repetitive matrix 
protein 2 OS=Homo sapiens 
GN=SRRM2 PE=1 SV=2 
sp|Q9UQ35|SRRM2_HUMANSerine/arginine 
repetitive matrix protein 2 OS=Homo sapiens 
GN=SRRM2 PE=1 SV=2 
0.36 29 0 0 0 0 0 0 0 
Macrophage migration inhibitory 
factor OS=Homo sapiens GN=MIF 
PE=1 SV=4 
MIF_HUMAN 0.27 29 32 15 13 13 16 16 12 
Isoform 2 of Threonine--tRNA ligase, 
cytoplasmic OS=Homo sapiens 
GN=TARS 
sp|P26639-2|SYTC_HUMAN 0.39 0 0 0 1 1 0 3 0 
sp|Q9HC38|GLOD4_HUMAN 
Glyoxalase domain-containing 
protein 4 OS=Homo sapiens 
GN=GLOD4... 
sp|Q9HC38|GLOD4_HUMANGlyoxalase domain-
containing protein 4 OS=Homo sapiens 
GN=GLOD4 PE=1 SV=1 
0.66 21 30 0 0 23 28 14 0 
sp|Q9BR76|COR1B_HUMAN 
Coronin-1B OS=Homo sapiens 
GN=CORO1B PE=1 SV=1 
sp|Q9BR76|COR1B_HUMANCoronin-1B 
OS=Homo sapiens GN=CORO1B PE=1 SV=1 
0.27 11 14 13 10 10 8 10 6 
Insulin-like growth factor-binding 
protein 4 OS=Homo sapiens 
GN=IGFBP4 PE=1 SV=2 
IBP4_HUMAN 0.29 17 22 15 9 9 2 13 9 
Cullin-3 OS=Homo sapiens GN=CUL3 
PE=1 SV=2 
sp|Q13618|CUL3_HUMAN 0.72 1 1 4 0 0 6 11 4 
Isoform 2 of Signal peptide, CUB and 
EGF-like domain-containing protein 2 
OS=Homo sapiens GN=SCUBE2 
sp|Q9NQ36-2|SCUB2_HUMAN 0.59 0 2 0 0 0 0 0 5 
sp|Q5JWF2|GNAS1_HUMAN 
Guanine nucleotide-binding protein 
G(s) subunit alpha isoforms XLas 
OS=Homo sapiens GN=GNAS PE=1 
SV=2 
sp|Q5JWF2|GNAS1_HUMANGuanine nucleotide-
binding protein G(s) subunit alpha isoforms XLas 
OS=Homo sapiens GN=GNAS PE=1 SV=2 
0.67 0 11 3 0 13 7 11 11 
Hypoxanthine-guanine 
phosphoribosyltransferase OS=Homo 
sapiens GN=HPRT1 PE=1 SV=2 
HPRT_HUMAN 0.42 13 21 10 15 15 25 21 22 
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associated protein AHNAK 
OS=Homo... 
sp|Q09666|AHNK_HUMAN Neuroblast 
differentiation-associated protein AHNAK 
OS=Homo... 
0.37 100 7 0 1 1 6 2 5 
Isoform 3 of Probable phospholipid-
transporting ATPase IA OS=Homo 
sapiens GN=ATP8A1 
sp|Q9Y2Q0-3|AT8A1_HUMAN 0.36 0 0 9 5 5 0 3 0 
sp|P13667|PDIA4_HUMAN Protein 
disulfide-isomerase A4 OS=Homo 
sapiens GN=PDIA4 PE=1 SV=2 
sp|P13667|PDIA4_HUMANProtein disulfide-
isomerase A4 OS=Homo sapiens GN=PDIA4 PE=1 
SV=2 
0.69 7 12 0 0 9 0 0 15 
Serpin B5 OS=Homo sapiens 
GN=SERPINB5 PE=1 SV=2 
sp|P36952|SPB5_HUMAN 0.45 0 2 5 4 4 6 2 3 
sp|Q86X29-4|LSR_HUMAN Isoform 
4 of Lipolysis-stimulated lipoprotein 
receptor OS=Homo... 
sp|Q86X29-4|LSR_HUMANIsoform 4 of Lipolysis-
stimulated lipoprotein receptor OS=Homo 
sapiens GN=LSR 
0.65 2 12 3 0 11 8 11 13 
Isoform 2 of UTP--glucose-1-
phosphate uridylyltransferase 
OS=Homo sapiens GN=UGP2 
sp|Q16851-2|UGPA_HUMAN 0.44 0 0 15 16 16 0 18 0 
Ribonuclease inhibitor OS=Homo 
sapiens GN=RNH1 PE=1 SV=2 
RINI_HUMAN 0.39 10 13 12 8 8 8 18 15 
N(4)-(beta-N-acetylglucosaminyl)-L-
asparaginase OS=Homo sapiens 
GN=AGA PE=1 SV=2 
ASPG_HUMAN 0.39 1 0 8 0 0 1 7 1 
Isoform 3 of SEC14-like protein 2 
OS=Homo sapiens GN=SEC14L2 
sp|O76054-5|S14L2_HUMAN 0.42 5 11 4 8 8 8 9 11 
sp|Q92484|ASM3A_HUMAN Acid 
sphingomyelinase-like 
phosphodiesterase 3a OS=Homo 
sapiens GN=SMPDL3A PE=1 SV=2 
sp|Q92484|ASM3A_HUMANAcid 
sphingomyelinase-like phosphodiesterase 3a 
OS=Homo sapiens GN=SMPDL3A PE=1 SV=2 
0.37 9 11 1 0 12 18 11 0 
Glutathione peroxidase 3 OS=Homo 
sapiens GN=GPX3 PE=1 SV=2 
GPX3_HUMAN 0.29 18 11 6 11 11 10 7 13 
Heat shock protein 105 kDa 
OS=Homo sapiens GN=HSPH1 PE=2 
SV=1 
B4DY72_HUMAN 0.33 4 2 6 0 0 1 2 3 
Reticulocalbin-1 OS=Homo sapiens 
GN=RCN1 PE=1 SV=1 
RCN1_HUMAN 0.59 4 10 8 3 3 10 12 19 
sp|Q96BQ1|FAM3D_HUMAN 
Protein FAM3D OS=Homo sapiens 
GN=FAM3D PE=1 SV=1 
sp|Q96BQ1|FAM3D_HUMANProtein FAM3D 
OS=Homo sapiens GN=FAM3D PE=1 SV=1 
0.42 20 32 0 20 20 16 9 0 
Protein lifeguard 3 OS=Homo sapiens 
GN=TMBIM1 PE=1 SV=2 
LFG3_HUMAN 0.44 15 12 13 12 12 23 17 16 
sp|Q96C24|SYTL4_HUMAN 
Synaptotagmin-like protein 4 
OS=Homo sapiens GN=SYTL4 PE=1... 
sp|Q96C24|SYTL4_HUMANSynaptotagmin-like 
protein 4 OS=Homo sapiens GN=SYTL4 PE=1 SV=2 
0.82 19 0 3 0 12 0 5 18 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
146 
 
Isoform 3 of Ataxin-2-like protein 
OS=Homo sapiens GN=ATXN2L 
sp|Q8WWM7-3|ATX2L_HUMAN 0.36 17 0 0 0 0 0 0 0 
sp|O75326|SEM7A_HUMAN 
Semaphorin-7A OS=Homo sapiens 
GN=SEMA7A PE=1 SV=1 
sp|O75326|SEM7A_HUMANSemaphorin-7A 
OS=Homo sapiens GN=SEMA7A PE=1 SV=1 
0.25 5 7 5 4 4 4 5 3 
sp|Q12913|PTPRJ_HUMAN 
Receptor-type tyrosine-protein 
phosphatase eta OS=Homo sapiens... 
sp|Q12913|PTPRJ_HUMANReceptor-type 
tyrosine-protein phosphatase eta OS=Homo 
sapiens GN=PTPRJ PE=1 SV=3 
0.31 5 0 0 0 3 0 3 9 
Isoform 3 of G-protein coupled 
receptor 56 OS=Homo sapiens 
GN=GPR56 
sp|Q9Y653-3|GPR56_HUMAN 0.97 4 15 0 0 0 7 0 12 
sp|Q9BY14|TX101_HUMAN Testis-
expressed sequence 101 protein 
OS=Homo sapiens GN=TEX101... 
sp|Q9BY14|TX101_HUMANTestis-expressed 
sequence 101 protein OS=Homo sapiens 
GN=TEX101 PE=2 SV=2 
0.34 8 34 0 0 23 30 27 0 
sp|O60664|PLIN3_HUMAN Perilipin-
3 OS=Homo sapiens GN=PLIN3 PE=1 
SV=3 
sp|O60664|PLIN3_HUMANPerilipin-3 OS=Homo 
sapiens GN=PLIN3 PE=1 SV=3 
0.25 27 9 4 2 2 5 11 12 
sp|Q9H3Z4|DNJC5_HUMAN DnaJ 
homolog subfamily C member 5 
OS=Homo sapiens GN=DNAJC5... 
sp|Q9H3Z4|DNJC5_HUMANDnaJ homolog 
subfamily C member 5 OS=Homo sapiens 
GN=DNAJC5 PE=1 SV=1 
0.37 11 18 1 2 22 19 18 0 
sp|Q7L266|ASGL1_HUMAN 
Isoaspartyl peptidase/L-asparaginase 
OS=Homo sapiens GN=ASRGL1 PE=1 
SV=2 
sp|Q7L266|ASGL1_HUMANIsoaspartyl 
peptidase/L-asparaginase OS=Homo sapiens 
GN=ASRGL1 PE=1 SV=2 
0.13 13 18 0 0 7 36 25 16 
Isoform 2 of Spectrin beta chain, 
non-erythrocytic 1 OS=Homo sapiens 
GN=SPTBN1 
sp|Q01082-3|SPTB2_HUMAN 0.36 0 0 3 0 0 0 0 0 
Proteasome subunit alpha type-3 
OS=Homo sapiens GN=PSMA3 PE=1 
SV=2 
sp|P25788|PSA3_HUMAN 0.97 35 26 0 0 0 27 0 36 
Cathepsin S OS=Homo sapiens 
GN=CTSS PE=1 SV=3 
sp|P25774|CATS_HUMAN 0.35 2 6 7 2 2 5 4 2 
sp|Q86SF2|GALT7_HUMAN N-
acetylgalactosaminyltransferase 7 
OS=Homo sapiens GN=GALNT7 PE=1 
SV=1 
sp|Q86SF2|GALT7_HUMANN-
acetylgalactosaminyltransferase 7 OS=Homo 
sapiens GN=GALNT7 PE=1 SV=1 
0.16 5 11 0 0 17 9 5 8 
Myomegalin OS=Homo sapiens 
GN=PDE4DIP PE=2 SV=1 
F8WAP3_HUMAN 0.64 0 4 0 0 0 8 0 0 
sp|P35609|ACTN2_HUMAN Alpha-
actinin-2 OS=Homo sapiens 
GN=ACTN2 PE=1 SV=1 
sp|P35609|ACTN2_HUMANAlpha-actinin-2 
OS=Homo sapiens GN=ACTN2 PE=1 SV=1 
0.13 0 0 0 0 0 0 6 0 
DNA damage-binding protein 1 
OS=Homo sapiens GN=DDB1 PE=1 
SV=1 
DDB1_HUMAN 0.41 2 3 8 2 2 5 3 6 
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Isoform 2 of Tryptophan--tRNA 
ligase, cytoplasmic OS=Homo sapiens 
GN=WARS 
sp|P23381-2|SYWC_HUMAN 0.42 0 0 10 11 11 0 9 0 
Cytoplasmic FMR1-interacting 
protein 2 OS=Homo sapiens 
GN=CYFIP2 PE=2 SV=1 
F5H583_HUMAN 0.53 0 0 2 1 1 0 5 0 
Isoform 7 of Protein PRRC2C 
OS=Homo sapiens GN=PRRC2C 
sp|Q9Y520|PRC2C_HUMANProtein PRRC2C 
OS=Homo sapiens GN=PRRC2C PE=1 SV=4 
0.39 18 0 0 1 1 0 0 2 
sp|Q9UK41|VPS28_HUMAN 
Vacuolar protein sorting-associated 
protein 28 homolog OS=Homo 
sapiens GN=VPS28 PE=1 SV=1 
sp|Q9UK41|VPS28_HUMANVacuolar protein 
sorting-associated protein 28 homolog OS=Homo 
sapiens GN=VPS28 PE=1 SV=1 
0.66 18 16 0 1 28 0 21 0 
Isoform 2 of Cysteine--tRNA ligase, 
cytoplasmic OS=Homo sapiens 
GN=CARS 
sp|P49589-2|SYCC_HUMAN 0.2 1 10 3 1 1 2 1 1 
Afamin OS=Homo sapiens GN=AFM 
PE=1 SV=1 
AFAM_HUMAN 0.24 16 10 5 6 6 5 7 15 
Isoform B of AP-1 complex subunit 
beta-1 OS=Homo sapiens GN=AP1B1 
sp|Q10567-2|AP1B1_HUMAN 0.79 8 10 0 0 0 11 0 5 
sp|P01768|HV307_HUMAN Ig heavy 
chain V-III region CAM OS=Homo 
sapiens PE=1 SV=1 
sp|P01768|HV307_HUMANIg heavy chain V-III 
region CAM OS=Homo sapiens PE=1 SV=1 
0.47 2 1 4 1 1 4 5 0 
sp|Q99816|TS101_HUMAN Tumor 
susceptibility gene 101 protein 
OS=Homo sapiens GN=TSG101... 
sp|Q99816|TS101_HUMANTumor susceptibility 
gene 101 protein OS=Homo sapiens GN=TSG101 
PE=1 SV=2 
0.79 10 15 8 0 27 19 11 21 
Isoform 5 of Tropomyosin alpha-3 
chain OS=Homo sapiens GN=TPM3 
sp|P06753-5|TPM3_HUMAN 0.04 15 16 2 3 3 5 7 2 
sp|P21399|ACOC_HUMAN 
Cytoplasmic aconitate hydratase 
OS=Homo sapiens GN=ACO1 PE=1... 
sp|P21399|ACOC_HUMAN Cytoplasmic 
aconitate hydratase OS=Homo sapiens GN=ACO1 
PE=1... 
0.37 14 19 12 10 10 21 12 18 
sp|Q9BTY2|FUCO2_HUMAN Plasma 
alpha-L-fucosidase OS=Homo sapiens 
GN=FUCA2 PE=1 SV=2 
sp|Q9BTY2|FUCO2_HUMANPlasma alpha-L-
fucosidase OS=Homo sapiens GN=FUCA2 PE=1 
SV=2 
0.38 13 15 14 10 10 9 14 23 
sp|Q9Y5P6|GMPPB_HUMAN 
Mannose-1-phosphate 
guanyltransferase beta OS=Homo 
sapiens... 
sp|Q9Y5P6|GMPPB_HUMANMannose-1-
phosphate guanyltransferase beta OS=Homo 
sapiens GN=GMPPB PE=1 SV=2 
0.21 18 22 9 0 5 11 7 0 
Thrombospondin-2 OS=Homo 
sapiens GN=THBS2 PE=1 SV=2 
TSP2_HUMAN 0.14 0 0 0 0 0 1 6 2 
Leukemia inhibitory factor receptor 
OS=Homo sapiens GN=LIFR PE=1 
SV=1 
LIFR_HUMAN 0.75 11 14 0 0 0 13 1 17 
Proto-oncogene tyrosine-protein 
kinase receptor Ret OS=Homo 
sapiens GN=RET PE=1 SV=3 
RET_HUMAN 0.89 0 1 0 3 3 2 0 0 
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OS=Homo sapiens GN=QDPR PE=2 
SV=1 
B3KW71_HUMAN 0.34 15 16 12 11 11 17 13 12 
Junction plakoglobin OS=Homo 
sapiens GN=JUP PE=1 SV=3 
PLAK_HUMAN 0.43 0 7 0 11 11 8 11 3 
Isoform Short of Glucosylceramidase 
OS=Homo sapiens GN=GBA 
sp|P04062-2|GLCM_HUMAN 0.36 12 6 4 0 0 1 17 1 
sp|Q9Y5Z4|HEBP2_HUMAN Heme-
binding protein 2 OS=Homo sapiens 
GN=HEBP2 PE=1 SV=1 
sp|Q9Y5Z4|HEBP2_HUMANHeme-binding 
protein 2 OS=Homo sapiens GN=HEBP2 PE=1 
SV=1 
0.19 17 28 0 0 16 39 20 18 
Isoform 2 of Histone H2B type 2-F 
OS=Homo sapiens GN=HIST2H2BF 
H2B2F_HUMAN 0.29 74 24 0 9 9 0 12 10 
sp|P15907|SIAT1_HUMAN Beta-
galactoside alpha-2,6-
sialyltransferase 1 OS=Homo sapiens 
GN=ST6GAL1 PE=1 SV=1 
sp|P15907|SIAT1_HUMANBeta-galactoside 
alpha-2,6-sialyltransferase 1 OS=Homo sapiens 
GN=ST6GAL1 PE=1 SV=1 








acetylglucosaminyltransferase OS=Homo sapiens 
GN=B3GNT1 PE=1 SV=1 
0.63 12 17 11 0 15 18 13 15 
Proteasome subunit alpha type-4 
OS=Homo sapiens GN=PSMA4 PE=1 
SV=1 
sp|P25789|PSA4_HUMAN 0.37 0 0 19 15 15 0 14 0 
sp|P36969-2|GPX4_HUMAN Isoform 
Cytoplasmic of Phospholipid 
hydroperoxide glutathione... 
sp|P36969-2|GPX4_HUMAN Isoform 
Cytoplasmic of Phospholipid hydroperoxide 
glutathione... (+1) 
0.43 11 9 12 10 10 18 33 11 
sp|O75629|CREG1_HUMAN Protein 
CREG1 OS=Homo sapiens GN=CREG1 
PE=1 SV=1 
sp|O75629|CREG1_HUMANProtein CREG1 
OS=Homo sapiens GN=CREG1 PE=1 SV=1 
0.75 12 18 3 12 12 16 14 21 
sp|Q8N335|GPD1L_HUMAN 
Glycerol-3-phosphate 
dehydrogenase 1-like protein 
OS=Homo sapiens GN=GPD1L PE=1 
SV=1 
sp|Q8N335|GPD1L_HUMANGlycerol-3-
phosphate dehydrogenase 1-like protein 
OS=Homo sapiens GN=GPD1L PE=1 SV=1 
0.36 15 19 7 0 7 12 12 10 
Isoform 2 of Transmembrane 
channel-like protein 5 OS=Homo 
sapiens GN=TMC5 
sp|Q6UXY8-2|TMC5_HUMAN (+1) 0.61 4 1 0 3 3 2 4 2 
sp|O43396|TXNL1_HUMAN 
Thioredoxin-like protein 1 OS=Homo 
sapiens GN=TXNL1 PE=1 SV=3 
sp|O43396|TXNL1_HUMANThioredoxin-like 
protein 1 OS=Homo sapiens GN=TXNL1 PE=1 
SV=3 
0.39 4 4 5 3 3 5 9 0 
Acetyl-CoA acetyltransferase, 
mitochondrial OS=Homo sapiens 
GN=ACAT1 PE=1 SV=1 
THIL_HUMAN 0.16 0 0 0 0 0 1 2 0 
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Kinesin heavy chain isoform 5C 
OS=Homo sapiens GN=KIF5C PE=2 
SV=2 
E9PET8_HUMAN 0.38 0 0 7 0 0 0 4 0 
sp|P26371|KRA59_HUMAN Keratin-
associated protein 5-9 OS=Homo 
sapiens GN=KRTAP5-9 PE=1 SV=1 
sp|P26371|KRA59_HUMANKeratin-associated 
protein 5-9 OS=Homo sapiens GN=KRTAP5-9 
PE=1 SV=1-DECOY 
0.42 0 2 2 1 1 3 1 0 
sp|P31946|1433B_HUMAN 14-3-3 
protein beta/alpha OS=Homo 
sapiens GN=YWHAB PE=1 SV=3 
sp|P31946|1433B_HUMAN14-3-3 protein 
beta/alpha OS=Homo sapiens GN=YWHAB PE=1 
SV=3 
0.32 12 12 10 7 7 18 10 13 
Isoform 6 of Myosin-14 OS=Homo 
sapiens GN=MYH14 
sp|Q7Z406-6|MYH14_HUMAN 0.39 1 5 1 0 0 2 1 0 
sp|P17612|KAPCA_HUMAN cAMP-
dependent protein kinase catalytic 
subunit alpha OS=Homo sapiens 
GN=PRKACA PE=1 SV=2 
sp|P17612|KAPCA_HUMANcAMP-dependent 
protein kinase catalytic subunit alpha OS=Homo 
sapiens GN=PRKACA PE=1 SV=2 
0.29 15 19 0 0 10 12 14 22 
Heterogeneous nuclear 
ribonucleoproteins A2/B1 OS=Homo 
sapiens GN=HNRNPA2B1 PE=1 SV=2 
sp|P22626|ROA2_HUMAN 0.36 114 0 0 0 0 2 0 0 
sp|P01781|HV320_HUMAN Ig heavy 
chain V-III region GAL OS=Homo 
sapiens PE=1 SV=1 
sp|P01781|HV320_HUMANIg heavy chain V-III 
region GAL OS=Homo sapiens PE=1 SV=1 
0.35 0 3 0 0 0 0 4 5 
sp|P01861|IGHG4_HUMAN Ig 
gamma-4 chain C region OS=Homo 
sapiens GN=IGHG4 PE=1 SV=1 
sp|P01861|IGHG4_HUMANIg gamma-4 chain C 
region OS=Homo sapiens GN=IGHG4 PE=1 SV=1 
0.45 2 13 5 9 9 2 6 11 
sp|P60842|IF4A1_HUMAN 
Eukaryotic initiation factor 4A-I 
OS=Homo sapiens GN=EIF4A1 PE=1 
SV=1 
sp|P60842|IF4A1_HUMANEukaryotic initiation 
factor 4A-I OS=Homo sapiens GN=EIF4A1 PE=1 
SV=1 
0.47 15 3 3 0 1 8 13 0 
Tyrosine-protein kinase Yes 
OS=Homo sapiens GN=YES1 PE=1 
SV=3 
YES_HUMAN 0.54 2 3 3 1 1 3 5 3 
Isoform 6 of Dynactin subunit 1 
OS=Homo sapiens GN=DCTN1 
sp|Q14203-6|DCTN1_HUMAN 0.54 3 1 4 0 0 9 5 0 
Argininosuccinate synthase 
OS=Homo sapiens GN=ASS1 PE=1 
SV=2 
ASSY_HUMAN 0.36 5 17 20 1 1 5 12 12 
sp|P55259-3|GP2_HUMAN Isoform 
Alpha of Pancreatic secretory 
granule membrane major 
glycoprotein GP2 OS=Homo sapiens 
GN=GP2 
sp|P55259-3|GP2_HUMANIsoform Alpha of 
Pancreatic secretory granule membrane major 
glycoprotein GP2 OS=Homo sapiens GN=GP2 
0.99 1 4 4 0 9 0 13 7 
sp|Q9UL46|PSME2_HUMAN 
Proteasome activator complex 
subunit 2 OS=Homo sapiens 
GN=PSME2 PE=1 SV=4 
sp|Q9UL46|PSME2_HUMANProteasome 
activator complex subunit 2 OS=Homo sapiens 
GN=PSME2 PE=1 SV=4 
0.063 11 0 0 0 9 17 21 5 
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Bleomycin hydrolase OS=Homo 
sapiens GN=BLMH PE=1 SV=1 
BLMH_HUMAN 0.4 2 1 3 4 4 3 3 1 
Methionine aminopeptidase 2 
OS=Homo sapiens GN=METAP2 PE=1 
SV=1 
MAP2_HUMAN 0.24 3 1 2 1 1 1 1 1 
Zinc finger CCCH domain-containing 
protein 4 (Fragment) OS=Homo 
sapiens GN=ZC3H4 PE=4 SV=1 
M0QY97_HUMAN 0.36 4 0 0 0 0 0 0 0 
sp|Q8IZ41|RASEF_HUMAN Ras and 
EF-hand domain-containing protein 
OS=Homo sapiens GN=RASEF PE=1 
SV=1 
sp|Q8IZ41|RASEF_HUMANRas and EF-hand 
domain-containing protein OS=Homo sapiens 
GN=RASEF PE=1 SV=1 
0.2 0 4 0 0 1 0 6 5 
sp|Q00839|HNRPU_HUMAN 
Heterogeneous nuclear 
ribonucleoprotein U OS=Homo 
sapiens GN=HNRNPU PE=1 SV=6 
sp|Q00839|HNRPU_HUMANHeterogeneous 
nuclear ribonucleoprotein U OS=Homo sapiens 
GN=HNRNPU PE=1 SV=6 
0.36 88 0 0 0 0 0 0 0 
Serine incorporator 5 OS=Homo 
sapiens GN=SERINC5 PE=2 SV=1 
D6RHG7_HUMAN 0.65 3 0 1 1 1 4 0 3 
sp|O14672|ADA10_HUMAN 
Disintegrin and metalloproteinase 
domain-containing protein 10 
OS=Homo sapiens GN=ADAM10 
PE=1 SV=1 
sp|O14672|ADA10_HUMANDisintegrin and 
metalloproteinase domain-containing protein 10 
OS=Homo sapiens GN=ADAM10 PE=1 SV=1 
0.096 3 1 0 0 5 10 6 0 
sp|P20073|ANXA7_HUMAN Annexin 
A7 OS=Homo sapiens GN=ANXA7 
PE=1 SV=3 
sp|P20073|ANXA7_HUMANAnnexin A7 
OS=Homo sapiens GN=ANXA7 PE=1 SV=3 
0.53 5 10 7 0 10 10 13 0 
Isoform 6 of Calpastatin OS=Homo 
sapiens GN=CAST 
sp|P20810-6|ICAL_HUMAN 0.11 23 10 1 1 1 1 3 9 
Arachidonate 15-lipoxygenase B 
OS=Homo sapiens GN=ALOX15B 
PE=2 SV=1 
I3L1D5_HUMAN 0.48 0 0 8 17 17 0 11 0 
sp|Q9Y230|RUVB2_HUMAN RuvB-
like 2 OS=Homo sapiens GN=RUVBL2 
PE=1 SV=3 
sp|Q9Y230|RUVB2_HUMANRuvB-like 2 
OS=Homo sapiens GN=RUVBL2 PE=1 SV=3 
0.91 12 5 5 7 7 24 25 0 
sp|P31150|GDIA_HUMAN Rab GDP 
dissociation inhibitor alpha 
OS=Homo sapiens GN=GDI1... 
sp|P31150|GDIA_HUMAN Rab GDP dissociation 
inhibitor alpha OS=Homo sapiens GN=GDI1... 
0.44 11 12 11 12 12 22 16 16 
sp|Q16348|S15A2_HUMAN Solute 
carrier family 15 member 2 
OS=Homo sapiens GN=SLC15A2 PE=2 
SV=2 
sp|Q16348|S15A2_HUMANSolute carrier family 
15 member 2 OS=Homo sapiens GN=SLC15A2 
PE=2 SV=2 
0.67 3 0 4 0 5 10 3 0 
sp|Q13263|TIF1B_HUMAN 
Transcription intermediary factor 1-
beta OS=Homo sapiens GN=TRIM28 
PE=1 SV=5 
sp|Q13263|TIF1B_HUMANTranscription 
intermediary factor 1-beta OS=Homo sapiens 
GN=TRIM28 PE=1 SV=5 
0.42 15 0 0 0 0 0 2 0 
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sapiens GN=GGCT PE=1... 
sp|O75223|GGCT_HUMAN Gamma-
glutamylcyclotransferase OS=Homo sapiens 
GN=GGCT PE=1... 
0.37 16 9 14 18 18 13 21 18 
sp|P49419|AL7A1_HUMAN Alpha-
aminoadipic semialdehyde 
dehydrogenase OS=Homo sapiens 
GN=ALDH7A1 PE=1 SV=5 
sp|P49419|AL7A1_HUMANAlpha-aminoadipic 
semialdehyde dehydrogenase OS=Homo sapiens 
GN=ALDH7A1 PE=1 SV=5 
0.71 8 10 1 0 4 9 16 0 
Cytochrome b561 OS=Homo sapiens 
GN=CYB561 PE=2 SV=1 
F5H757_HUMAN 0.38 9 14 17 13 13 19 15 15 
sp|Q6UX06|OLFM4_HUMAN 
Olfactomedin-4 OS=Homo sapiens 
GN=OLFM4 PE=1 SV=1 
sp|Q6UX06|OLFM4_HUMANOlfactomedin-4 
OS=Homo sapiens GN=OLFM4 PE=1 SV=1 
0.13 20 19 5 16 16 0 20 15 
Isoform 2 of Syntaxin-binding protein 
1 OS=Homo sapiens GN=STXBP1 
STXB1_HUMAN 0.97 2 4 0 2 2 2 0 4 
Capping protein (Actin filament) 
muscle Z-line, beta, isoform CRA_d 
OS=Homo sapiens GN=CAPZB PE=2 
SV=1 
B1AK88_HUMAN 0.68 20 25 0 2 2 31 0 32 
Myeloperoxidase OS=Homo sapiens 
GN=MPO PE=1 SV=1 
sp|P05164|PERM_HUMAN 0.15 11 2 4 9 9 4 0 1 
sp|P19012|K1C15_HUMAN Keratin, 
type I cytoskeletal 15 OS=Homo 
sapiens GN=KRT15 PE=1... 
sp|P19012|K1C15_HUMANKeratin, type I 
cytoskeletal 15 OS=Homo sapiens GN=KRT15 
PE=1 SV=3 
0.12 0 1 0 0 1 0 0 4 
Platelet-activating factor 
acetylhydrolase OS=Homo sapiens 
GN=PLA2G7 PE=1 SV=1 
PAFA_HUMAN 0.46 2 9 0 1 1 8 0 15 
ADP-ribosylation factor 4 OS=Homo 
sapiens GN=ARF4 PE=1 SV=3 






phosphate dehydrogenase, testis-specific 
OS=Homo... 
0.16 2 6 3 14 14 16 40 22 
Inorganic pyrophosphatase 
OS=Homo sapiens GN=PPA1 PE=1 
SV=2 
IPYR_HUMAN 0.79 0 17 1 3 3 8 23 4 
sp|Q14055|CO9A2_HUMAN 
Collagen alpha-2(IX) chain OS=Homo 
sapiens GN=COL9A2 PE=1 SV=2 
sp|Q14055|CO9A2_HUMANCollagen alpha-2(IX) 
chain OS=Homo sapiens GN=COL9A2 PE=1 SV=2 
0.14 15 2 4 0 0 0 3 0 
sp|P20827|EFNA1_HUMAN Ephrin-
A1 OS=Homo sapiens GN=EFNA1 
PE=1 SV=2 
sp|P20827|EFNA1_HUMANEphrin-A1 OS=Homo 
sapiens GN=EFNA1 PE=1 SV=2 
0.11 11 21 0 0 17 21 10 24 
Ketimine reductase mu-crystallin 
OS=Homo sapiens GN=CRYM PE=2 
SV=1 
H9KVC2_HUMAN 0.44 11 18 12 8 8 19 21 17 
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Thioredoxin OS=Homo sapiens 
GN=TXN PE=1 SV=3 
sp|P10599|THIO_HUMAN (+1) 0.33 10 17 15 13 13 9 15 6 
sp|TRY1_BOVIN| sp|TRY1_BOVIN| 0.69 2 0 0 1 1 3 7 3 
Sortilin OS=Homo sapiens GN=SORT1 
PE=1 SV=3 
sp|Q99523|SORT_HUMAN 0.97 3 9 0 5 5 5 3 4 
Isoform 2 of Bifunctional purine 
biosynthesis protein PURH OS=Homo 
sapiens GN=ATIC 
sp|P31939-2|PUR9_HUMAN 0.19 9 18 1 0 0 6 0 3 
Transcobalamin-2 OS=Homo sapiens 
GN=TCN2 PE=1 SV=3 
sp|P20062|TCO2_HUMAN 0.33 1 9 3 1 1 1 1 8 
Alpha-amylase 1 OS=Homo sapiens 
GN=AMY1A PE=1 SV=2 
AMY1_HUMAN 0.93 1 21 0 13 13 0 4 17 
Fibrinogen alpha chain OS=Homo 
sapiens GN=FGA PE=1 SV=2 
sp|P02671|FIBA_HUMAN 0.35 7 0 6 1 1 8 0 1 
Isoform C of Fibulin-1 OS=Homo 
sapiens GN=FBLN1 
sp|P23142-4|FBLN1_HUMAN 0.59 0 2 1 2 2 5 3 6 
Isoform 8 of Eukaryotic translation 
initiation factor 4 gamma 1 
OS=Homo sapiens GN=EIF4G1 




OS=Homo sapiens GN=GALNT18 
PE=2 SV=2 
sp|Q6P9A2|GLT18_HUMANPolypeptide N-
acetylgalactosaminyltransferase 18 OS=Homo 
sapiens GN=GALNT18 PE=2 SV=2 
0.21 0 1 0 0 7 2 1 0 
Anion exchange protein 2 OS=Homo 
sapiens GN=SLC4A2 PE=1 SV=4 
sp|P04920|B3A2_HUMAN 0.36 2 0 0 0 0 0 0 0 
sp|P61106|RAB14_HUMAN Ras-
related protein Rab-14 OS=Homo 
sapiens GN=RAB14 PE=1 SV=4 
sp|P61106|RAB14_HUMANRas-related protein 
Rab-14 OS=Homo sapiens GN=RAB14 PE=1 SV=4 
0.31 20 15 9 5 5 17 19 10 
Adenosylhomocysteinase OS=Homo 
sapiens GN=AHCYL2 PE=2 SV=1 
D7UEQ7_HUMAN 0.54 5 3 2 2 2 4 4 6 
Translationally-controlled tumor 
protein OS=Homo sapiens GN=TPT1 
PE=1 SV=1 
TCTP_HUMAN 0.7 29 18 0 0 0 14 0 19 
Isoform 4 of Myosin-10 OS=Homo 
sapiens GN=MYH10 
sp|P35580-4|MYH10_HUMAN 0.35 0 3 1 0 0 2 3 0 
Lysosomal protective protein 
OS=Homo sapiens GN=CTSA PE=1 
SV=2 
PPGB_HUMAN 0.38 3 7 3 2 2 7 5 4 
sp|P56851|EP3B_HUMAN 
Epididymal secretory protein E3-beta 
OS=Homo sapiens GN=EDDM3B... 
sp|P56851|EP3B_HUMAN Epididymal secretory 
protein E3-beta OS=Homo sapiens 
GN=EDDM3B... 
0.35 13 15 6 12 12 17 17 7 
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OS=Homo sapiens GN=NAGK PE=1 
SV=4 
sp|Q9UJ70|NAGK_HUMAN 0.4 4 2 5 4 4 6 4 3 
5'-3' exoribonuclease 2 OS=Homo 
sapiens GN=XRN2 PE=2 SV=1 
B4DZC3_HUMAN 0.36 10 0 0 0 0 0 0 0 
Sialic acid synthase OS=Homo 
sapiens GN=NANS PE=1 SV=2 
SIAS_HUMAN 0.35 13 5 17 3 3 8 10 4 
Isoform 2 of Echinoderm 
microtubule-associated protein-like 
2 OS=Homo sapiens GN=EML2 
sp|O95834-2|EMAL2_HUMAN 0.55 4 7 0 0 0 3 0 3 
Biglycan OS=Homo sapiens GN=BGN 
PE=1 SV=2 
PGS1_HUMAN 0.27 2 6 0 5 5 4 4 12 
sp|P09210|GSTA2_HUMAN 
Glutathione S-transferase A2 
OS=Homo sapiens GN=GSTA2 PE=1 
SV=4 
sp|P09210|GSTA2_HUMANGlutathione S-
transferase A2 OS=Homo sapiens GN=GSTA2 
PE=1 SV=4 
0.44 27 55 0 0 10 0 24 0 
Matrilysin OS=Homo sapiens 
GN=MMP7 PE=1 SV=1 
MMP7_HUMAN 0.51 7 3 6 8 8 11 8 18 
sp|Q15286|RAB35_HUMAN Ras-
related protein Rab-35 OS=Homo 
sapiens GN=RAB35 PE=1 SV=1 
sp|Q15286|RAB35_HUMANRas-related protein 
Rab-35 OS=Homo sapiens GN=RAB35 PE=1 SV=1 
0.21 20 19 3 5 5 10 3 23 
sp|P01771|HV310_HUMAN Ig heavy 
chain V-III region HIL OS=Homo 
sapiens PE=1 SV=1 
sp|P01771|HV310_HUMANIg heavy chain V-III 
region HIL OS=Homo sapiens PE=1 SV=1-DECOY 
0.26 0 0 0 0 0 5 0 1 
sp|P21281|VATB2_HUMAN V-type 
proton ATPase subunit B, brain 
isoform OS=Homo sapiens 
GN=ATP6V1B2 PE=1 SV=3 
sp|P21281|VATB2_HUMANV-type proton 
ATPase subunit B, brain isoform OS=Homo 
sapiens GN=ATP6V1B2 PE=1 SV=3 
0.064 0 13 0 0 11 15 9 10 
Pyruvate kinase PKM OS=Homo 
sapiens GN=PKM PE=1 SV=4 
sp|P14618|KPYM_HUMAN 0.29 6 20 10 17 17 12 16 9 
sp|Q9Y678|COPG1_HUMAN 
Coatomer subunit gamma-1 
OS=Homo sapiens GN=COPG1 PE=1 
SV=1 
sp|Q9Y678|COPG1_HUMANCoatomer subunit 
gamma-1 OS=Homo sapiens GN=COPG1 PE=1 
SV=1 
0.44 0 3 6 2 2 4 3 5 
sp|P61026|RAB10_HUMAN Ras-
related protein Rab-10 OS=Homo 
sapiens GN=RAB10 PE=1 SV=1 
sp|P61026|RAB10_HUMANRas-related protein 
Rab-10 OS=Homo sapiens GN=RAB10 PE=1 SV=1 
0.28 9 22 2 12 12 6 10 9 
sp|Q7Z304|MAMC2_HUMAN MAM 
domain-containing protein 2 
OS=Homo sapiens GN=MAMDC2 
PE=2 SV=3 
sp|Q7Z304|MAMC2_HUMANMAM domain-
containing protein 2 OS=Homo sapiens 
GN=MAMDC2 PE=2 SV=3 
0.69 2 9 0 0 2 0 6 0 
Actin-related protein 3 OS=Homo 
sapiens GN=ACTR3 PE=1 SV=3 
ARP3_HUMAN 0.14 12 16 9 4 4 5 0 5 
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regulatory light chain 12B OS=Homo 
sapiens GN=MYL12B PE=1 SV=2 
sp|O14950|ML12B_HUMANMyosin regulatory 
light chain 12B OS=Homo sapiens GN=MYL12B 
PE=1 SV=2 
0.64 10 5 0 0 3 8 4 5 
sp|Q5BJF6|ODFP2_HUMAN Outer 
dense fiber protein 2 OS=Homo 
sapiens GN=ODF2 PE=1 SV=1 
sp|Q5BJF6|ODFP2_HUMANOuter dense fiber 
protein 2 OS=Homo sapiens GN=ODF2 PE=1 SV=1 
0.29 0 2 0 0 0 4 23 0 
sp|P11908|PRPS2_HUMAN Ribose-
phosphate pyrophosphokinase 2 
OS=Homo sapiens GN=PRPS2... 
sp|P11908|PRPS2_HUMANRibose-phosphate 
pyrophosphokinase 2 OS=Homo sapiens 
GN=PRPS2 PE=1 SV=2 
0.86 6 26 0 0 8 0 17 0 
Proteasome subunit alpha type-2 
OS=Homo sapiens GN=PSMA2 PE=1 
SV=2 
PSA2_HUMAN 0.99 11 28 0 0 0 18 0 20 
sp|P54578|UBP14_HUMAN 
Ubiquitin carboxyl-terminal 
hydrolase 14 OS=Homo sapiens 
GN=USP14... 
sp|P54578|UBP14_HUMANUbiquitin carboxyl-
terminal hydrolase 14 OS=Homo sapiens 
GN=USP14 PE=1 SV=3 
0.39 10 0 17 0 7 0 12 0 
Isoform 2 of Partitioning defective 3 
homolog OS=Homo sapiens 
GN=PARD3 
sp|Q8TEW0-2|PARD3_HUMAN 0.38 0 1 2 0 0 0 2 0 
Nicastrin OS=Homo sapiens 
GN=NCSTN PE=1 SV=2 
sp|Q92542|NICA_HUMAN 0.43 3 4 8 2 2 8 3 7 
Protein arginine N-methyltransferase 
5 OS=Homo sapiens GN=PRMT5 
PE=2 SV=1 
B4DX49_HUMAN 0.46 0 0 0 1 1 0 2 0 
sp|O75131|CPNE3_HUMAN Copine-
3 OS=Homo sapiens GN=CPNE3 PE=1 
SV=1 
sp|O75131|CPNE3_HUMANCopine-3 OS=Homo 
sapiens GN=CPNE3 PE=1 SV=1 
0.34 8 7 6 4 4 5 10 6 
sp|P98160|PGBM_HUMAN 
Basement membrane-specific 
heparan sulfate proteoglycan core... 
sp|P98160|PGBM_HUMAN Basement 
membrane-specific heparan sulfate proteoglycan 
core... 
0.68 3 13 5 4 4 25 4 5 
sp|P08754|GNAI3_HUMAN Guanine 
nucleotide-binding protein G(k) 
subunit alpha OS=Homo... 
sp|P08754|GNAI3_HUMANGuanine nucleotide-
binding protein G(k) subunit alpha OS=Homo 
sapiens GN=GNAI3 PE=1 SV=3 
0.56 3 4 5 0 6 0 8 4 
Proteasome subunit beta type-6 
OS=Homo sapiens GN=PSMB6 PE=1 
SV=4 
PSB6_HUMAN 0.37 5 8 9 9 9 8 8 10 
Desmocollin-1 OS=Homo sapiens 
GN=DSC1 PE=1 SV=2 
sp|Q08554|DSC1_HUMAN 0.58 2 0 1 2 2 0 3 2 
sp|O00204|ST2B1_HUMAN 
Sulfotransferase family cytosolic 2B 
member 1 OS=Homo sapiens... 
sp|O00204|ST2B1_HUMANSulfotransferase 
family cytosolic 2B member 1 OS=Homo sapiens 
GN=SULT2B1 PE=1 SV=2 
0.88 0 14 7 0 13 14 15 15 
sp|Q15084|PDIA6_HUMAN Protein 
disulfide-isomerase A6 OS=Homo 
sapiens GN=PDIA6 PE=1... 
sp|Q15084|PDIA6_HUMANProtein disulfide-
isomerase A6 OS=Homo sapiens GN=PDIA6 PE=1 
SV=1 
0.58 13 0 4 0 8 12 13 15 
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OS=Homo sapiens GN=GLB1L PE=2 
SV=1 
sp|Q6UWU2|GLB1L_HUMANBeta-galactosidase-
1-like protein OS=Homo sapiens GN=GLB1L PE=2 
SV=1 
0.34 4 2 0 0 0 5 7 0 
sp|P20933|ASPG_HUMAN N(4)-
(beta-N-acetylglucosaminyl)-L-




0.38 11 7 7 26 26 20 13 26 
Mucin-15 OS=Homo sapiens 
GN=MUC15 PE=2 SV=1 
E9PII6_HUMAN 0.38 8 7 6 6 6 11 3 10 
sp|P49773|HINT1_HUMAN Histidine 
triad nucleotide-binding protein 1 
OS=Homo sapiens GN=HINT1 PE=1 
SV=2 
sp|P49773|HINT1_HUMANHistidine triad 
nucleotide-binding protein 1 OS=Homo sapiens 
GN=HINT1 PE=1 SV=2 
0.9 46 0 0 0 17 18 17 0 
Angiogenin OS=Homo sapiens 
GN=ANG PE=1 SV=1 
ANGI_HUMAN 0.36 16 4 14 18 18 20 6 10 
Isoform 2 of Ras-related protein Rab-
6A OS=Homo sapiens GN=RAB6A 
sp|P20340-2|RAB6A_HUMAN 0.3 13 9 8 2 2 10 6 6 
Junction plakoglobin OS=Homo 
sapiens GN=JUP PE=2 SV=1 
F5GWP8_HUMAN 1 1 0 3 8 8 5 5 2 
Desmoglein-1 OS=Homo sapiens 
GN=DSG1 PE=1 SV=2 
DSG1_HUMAN 0.25 7 6 4 4 4 1 8 3 
C-1-tetrahydrofolate synthase, 
cytoplasmic OS=Homo sapiens 
GN=MTHFD1 PE=2 SV=1 
F5H2F4_HUMAN 0.12 15 5 3 0 0 1 2 2 
Farnesyl pyrophosphate synthase 
OS=Homo sapiens GN=FDPS PE=1 
SV=4 
sp|P14324|FPPS_HUMAN 0.31 12 9 6 5 5 8 9 7 
Isoform 3 of Poly(rC)-binding protein 
2 OS=Homo sapiens GN=PCBP2 
sp|Q15366-3|PCBP2_HUMAN 0.35 7 4 2 2 2 7 4 3 
sp|P09488|GSTM1_HUMAN 
Glutathione S-transferase Mu 1 
OS=Homo sapiens GN=GSTM1 PE=1 
SV=3 
sp|P09488|GSTM1_HUMANGlutathione S-
transferase Mu 1 OS=Homo sapiens GN=GSTM1 
PE=1 SV=3 
0.28 6 10 0 0 8 9 19 0 
sp|P78417|GSTO1_HUMAN 
Glutathione S-transferase omega-1 
OS=Homo sapiens GN=GSTO1... 
sp|P78417|GSTO1_HUMANGlutathione S-
transferase omega-1 OS=Homo sapiens 
GN=GSTO1 PE=1 SV=2 
0.5 1 40 0 0 28 23 17 0 
Moesin OS=Homo sapiens GN=MSN 
PE=1 SV=3 
MOES_HUMAN 0.54 21 0 0 0 0 0 0 2 
Carboxymethylenebutenolidase 
homolog OS=Homo sapiens 
GN=CMBL PE=1 SV=1 
CMBL_HUMAN 0.38 8 5 4 2 2 1 7 12 
Isoform 4 of Protein sidekick-2 
OS=Homo sapiens GN=SDK2 
sp|Q58EX2-4|SDK2_HUMAN 0.15 2 2 1 1 1 1 0 1 
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mannosidase OS=Homo sapiens 
GN=MAN2B2 PE=2 SV=1 
E9PCD7_HUMAN 0.66 0 1 1 2 2 0 4 0 
Solute carrier family 2, facilitated 
glucose transporter member 14 
OS=Homo sapiens GN=SLC2A14 PE=2 
SV=1 
B7ZAC3_HUMAN 0.39 0 0 9 6 6 1 6 0 
Specifically androgen-regulated gene 
protein OS=Homo sapiens GN=SARG 
PE=1 SV=2 
sp|Q9BW04|SARG_HUMAN 0.3 0 2 0 0 0 4 0 3 
sp|Q16706|MA2A1_HUMAN Alpha-
mannosidase 2 OS=Homo sapiens 
GN=MAN2A1 PE=1 SV=2 
sp|Q16706|MA2A1_HUMANAlpha-mannosidase 
2 OS=Homo sapiens GN=MAN2A1 PE=1 SV=2 
0.19 0 5 1 1 1 0 0 2 
Isoform 2 of Sodium/hydrogen 
exchanger 10 OS=Homo sapiens 
GN=SLC9C1 
SL9C1_HUMAN 0.49 4 0 0 0 0 0 1 0 
Elongation factor 1-delta OS=Homo 
sapiens GN=EEF1D PE=2 SV=1 
E9PRY8_HUMAN (+1) 0.24 14 3 5 0 0 6 3 1 
sp|Q12907|LMAN2_HUMAN 
Vesicular integral-membrane protein 
VIP36 OS=Homo sapiens 
GN=LMAN2... 
sp|Q12907|LMAN2_HUMANVesicular integral-
membrane protein VIP36 OS=Homo sapiens 
GN=LMAN2 PE=1 SV=1 
0.66 5 5 3 0 7 12 25 0 
sp|P51854|TKTL1_HUMAN 
Transketolase-like protein 1 
OS=Homo sapiens GN=TKTL1 PE=1 
SV=2 
sp|P51854|TKTL1_HUMANTransketolase-like 
protein 1 OS=Homo sapiens GN=TKTL1 PE=1 
SV=2 
0.015 2 7 0 0 6 9 7 9 
Xaa-Pro dipeptidase OS=Homo 
sapiens GN=PEPD PE=1 SV=3 
sp|P12955|PEPD_HUMAN 0.88 5 2 1 0 0 4 8 2 
V-type proton ATPase subunit S1 
OS=Homo sapiens GN=ATP6AP1 
PE=1 SV=2 
VAS1_HUMAN 0.46 0 0 0 2 2 0 4 0 
sp|P15374|UCHL3_HUMAN 
Ubiquitin carboxyl-terminal 
hydrolase isozyme L3 OS=Homo 
sapiens GN=UCHL3 PE=1 SV=1 
sp|P15374|UCHL3_HUMANUbiquitin carboxyl-
terminal hydrolase isozyme L3 OS=Homo sapiens 
GN=UCHL3 PE=1 SV=1 
0.43 17 8 0 0 8 16 21 0 
sp|P01137|TGFB1_HUMAN 
Transforming growth factor beta-1 
OS=Homo sapiens GN=TGFB1 PE=1 
SV=2 
sp|P01137|TGFB1_HUMANTransforming growth 
factor beta-1 OS=Homo sapiens GN=TGFB1 PE=1 
SV=2 
0.0045 0 0 0 0 6 5 12 15 
E3 UFM1-protein ligase 1 OS=Homo 
sapiens GN=UFL1 PE=1 SV=2 
sp|O94874|UFL1_HUMAN 0.48 15 7 0 0 0 0 2 8 
Proteasome subunit beta type-8 
OS=Homo sapiens GN=PSMB8 PE=1 
SV=3 
sp|P28062|PSB8_HUMAN 0.3 12 9 3 5 5 10 7 8 
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T-cell immunomodulatory protein 
OS=Homo sapiens GN=ITFG1 PE=1 
SV=1 
TIP_HUMAN 0.46 4 5 6 5 5 10 8 4 
sp|Q92743|HTRA1_HUMAN Serine 
protease HTRA1 OS=Homo sapiens 
GN=HTRA1 PE=1 SV=1 
sp|Q92743|HTRA1_HUMANSerine protease 
HTRA1 OS=Homo sapiens GN=HTRA1 PE=1 SV=1 
0.69 0 9 3 1 1 0 12 6 
ATP synthase subunit beta OS=Homo 
sapiens GN=ATP5B PE=2 SV=1 
F8VPV9_HUMAN 0.64 3 7 5 0 0 12 5 7 
Complement component C7 
OS=Homo sapiens GN=C7 PE=1 SV=2 
CO7_HUMAN 0.8 0 3 0 3 3 0 0 2 
Trypsin-3 OS=Homo sapiens 
GN=PRSS3 PE=1 SV=2 
sp|P35030|TRY3_HUMAN 0.71 0 0 0 12 12 0 1 2 
Phosphoacetylglucosamine mutase 
OS=Homo sapiens GN=PGM3 PE=1 
SV=1 
sp|O95394|AGM1_HUMAN 0.95 7 16 0 0 0 10 0 9 
NADP-dependent malic enzyme 
OS=Homo sapiens GN=ME1 PE=1 
SV=1 
MAOX_HUMAN 0.75 0 16 2 1 1 11 9 0 
sp|Q13277|STX3_HUMAN Syntaxin-
3 OS=Homo sapiens GN=STX3 PE=1 
SV=3 
sp|Q13277|STX3_HUMAN Syntaxin-3 OS=Homo 
sapiens GN=STX3 PE=1 SV=3-DECOY 
0.14 0 0 0 0 0 0 4 3 
Acetyl-CoA acetyltransferase, 
cytosolic OS=Homo sapiens 
GN=ACAT2 PE=2 SV=1 
B7Z233_HUMAN 0.65 20 21 0 0 0 12 0 15 
sp|P16949|STMN1_HUMAN 
Stathmin OS=Homo sapiens 
GN=STMN1 PE=1 SV=3 
sp|P16949|STMN1_HUMANStathmin OS=Homo 
sapiens GN=STMN1 PE=1 SV=3 
0.36 122 0 0 0 0 0 0 0 
sp|Q9BXJ1|C1QT1_HUMAN 
Complement C1q tumor necrosis 
factor-related protein 1 OS=Homo... 
sp|Q9BXJ1|C1QT1_HUMANComplement C1q 
tumor necrosis factor-related protein 1 
OS=Homo sapiens GN=C1QTNF1 PE=1 SV=1 
0.6 9 14 8 2 22 1 25 2 
Alpha-crystallin B chain (Fragment) 
OS=Homo sapiens GN=CRYAB PE=2 
SV=1 
E9PR44_HUMAN 0.32 17 25 13 10 10 13 14 16 
sp|P61981|1433G_HUMAN 14-3-3 
protein gamma OS=Homo sapiens 
GN=YWHAG PE=1 SV=2 
sp|P61981|1433G_HUMAN14-3-3 protein 
gamma OS=Homo sapiens GN=YWHAG PE=1 
SV=2 
0.39 13 10 8 0 9 8 15 11 
Processed exostosin-like 2 OS=Homo 
sapiens GN=EXTL2 PE=2 SV=1 
F5GZK1_HUMAN 0.89 0 2 0 3 3 1 2 0 
sp|Q96EU7|C1GLC_HUMAN 
C1GALT1-specific chaperone 1 
OS=Homo sapiens GN=C1GALT1C1 
PE=1 SV=1 
sp|Q96EU7|C1GLC_HUMANC1GALT1-specific 
chaperone 1 OS=Homo sapiens GN=C1GALT1C1 
PE=1 SV=1 
0.62 13 1 0 0 2 0 4 0 
N-sulphoglucosamine 
sulphohydrolase OS=Homo sapiens 
GN=SGSH PE=2 SV=1 
F5H6A3_HUMAN 0.65 2 5 7 6 6 17 7 5 
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Aflatoxin B1 aldehyde reductase 
member 2 OS=Homo sapiens 
GN=AKR7A2... 
sp|O43488|ARK72_HUMANAflatoxin B1 
aldehyde reductase member 2 OS=Homo sapiens 
GN=AKR7A2 PE=1 SV=3 
0.079 5 6 0 0 14 14 16 0 
sp|P61604|CH10_HUMAN 10 kDa 
heat shock protein, mitochondrial 
OS=Homo sapiens GN=HSPE1... 
sp|P61604|CH10_HUMAN 10 kDa heat shock 
protein, mitochondrial OS=Homo sapiens 
GN=HSPE1... 
0.36 130 0 0 0 0 0 0 0 
Alpha-centractin OS=Homo sapiens 
GN=ACTR1A PE=1 SV=1 
ACTZ_HUMAN 0.35 3 11 9 8 8 4 9 9 
Galectin-1 OS=Homo sapiens 
GN=LGALS1 PE=1 SV=2 
LEG1_HUMAN 0.36 95 0 0 0 0 1 0 0 
40S ribosomal protein S12 OS=Homo 
sapiens GN=RPS12 PE=1 SV=3 
RS12_HUMAN 0.16 69 4 4 1 1 7 9 1 
Acrosin OS=Homo sapiens GN=ACR 
PE=2 SV=4 
ACRO_HUMAN 0.43 0 5 2 2 2 4 20 8 
sp|P17050|NAGAB_HUMAN Alpha-
N-acetylgalactosaminidase OS=Homo 
sapiens GN=NAGA PE=1 SV=2 
sp|P17050|NAGAB_HUMANAlpha-N-
acetylgalactosaminidase OS=Homo sapiens 
GN=NAGA PE=1 SV=2 
0.16 0 9 0 0 9 11 9 0 
Isoform SNAP-23b of Synaptosomal-
associated protein 23 OS=Homo 
sapiens GN=SNAP23 
SNP23_HUMAN 0.95 14 5 0 8 8 11 8 0 
Isoform 5 of Radixin OS=Homo 
sapiens GN=RDX 
sp|P35241-5|RADI_HUMAN 0.092 1 4 5 0 0 3 4 1 
Ubiquitin thioesterase OTUB1 
OS=Homo sapiens GN=OTUB1 PE=2 
SV=1 
F5GYN4_HUMAN 0.53 8 14 1 0 0 15 1 9 
Guanine nucleotide-binding protein 
subunit beta-2-like 1 (Fragment) 
OS=Homo sapiens GN=GNB2L1 PE=2 
SV=1 
D6R9L0_HUMAN 0.27 0 1 0 0 0 2 0 2 
Isoform 4 of Protein tweety homolog 
3 OS=Homo sapiens GN=TTYH3 
sp|Q9C0H2-4|TTYH3_HUMAN 0.089 0 0 0 1 1 2 5 1 
sp|Q29RF7|PDS5A_HUMAN Sister 
chromatid cohesion protein PDS5 
homolog A OS=Homo sapiens 
GN=PDS5A PE=1 SV=1 
sp|Q29RF7|PDS5A_HUMANSister chromatid 
cohesion protein PDS5 homolog A OS=Homo 
sapiens GN=PDS5A PE=1 SV=1 
0.36 2 0 0 0 0 0 0 0 
Serine/threonine-protein 
phosphatase 2A 65 kDa regulatory 
subunit A alpha isoform OS=Homo 
sapiens GN=PPP2R1A PE=2 SV=1 
B3KQV6_HUMAN 0.5 2 0 9 5 5 0 24 0 
Isoform 2B of Cytoplasmic dynein 1 
intermediate chain 2 OS=Homo 
sapiens GN=DYNC1I2 
sp|Q13409-2|DC1I2_HUMAN 0.37 0 0 6 1 1 0 2 0 
Tripeptidyl-peptidase 2 OS=Homo 
sapiens GN=TPP2 PE=2 SV=1 
Q5VZU9_HUMAN (+1) 0.43 0 6 9 3 3 6 4 9 
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gamma OS=Homo sapiens GN=GNPTG PE=1 SV=1 
0.2 6 16 0 0 15 5 14 11 
Glutathione peroxidase 1 OS=Homo 
sapiens GN=GPX1 PE=1 SV=4 
sp|P07203|GPX1_HUMAN 0.37 8 6 11 6 6 14 4 8 
sp|Q9Y265|RUVB1_HUMAN RuvB-
like 1 OS=Homo sapiens GN=RUVBL1 
PE=1 SV=1 
sp|Q9Y265|RUVB1_HUMANRuvB-like 1 
OS=Homo sapiens GN=RUVBL1 PE=1 SV=1 
0.29 9 5 9 4 4 0 8 6 
Lipoma-preferred partner OS=Homo 
sapiens GN=LPP PE=1 SV=1 
LPP_HUMAN 0.32 4 5 4 0 0 0 5 0 
sp|Q8WXA2|PATE1_HUMAN 
Prostate and testis expressed protein 
1 OS=Homo sapiens GN=PATE1 PE=2 
SV=1 
sp|Q8WXA2|PATE1_HUMANProstate and testis 
expressed protein 1 OS=Homo sapiens 
GN=PATE1 PE=2 SV=1 
0.95 37 14 0 0 21 21 9 0 
sp|P61978|HNRPK_HUMAN 
Heterogeneous nuclear 
ribonucleoprotein K OS=Homo 
sapiens GN=HNRNPK... 
sp|P61978|HNRPK_HUMANHeterogeneous 
nuclear ribonucleoprotein K OS=Homo sapiens 
GN=HNRNPK PE=1 SV=1 
0.36 51 0 0 0 0 0 1 0 
Desmocollin-2 OS=Homo sapiens 
GN=DSC2 PE=1 SV=1 
sp|Q02487|DSC2_HUMAN 0.42 7 1 2 4 4 7 2 7 
sp|Q7Z794|K2C1B_HUMAN Keratin, 
type II cytoskeletal 1b OS=Homo 
sapiens GN=KRT77 PE=2... 
sp|Q7Z794|K2C1B_HUMANKeratin, type II 
cytoskeletal 1b OS=Homo sapiens GN=KRT77 
PE=2 SV=3 
0.96 0 0 1 3 6 0 0 0 
sp|Q6BCY4|NB5R2_HUMAN NADH-
cytochrome b5 reductase 2 
OS=Homo sapiens GN=CYB5R2 
PE=1... 
sp|Q6BCY4|NB5R2_HUMANNADH-cytochrome 
b5 reductase 2 OS=Homo sapiens GN=CYB5R2 
PE=1 SV=1 
0.74 0 20 0 0 10 0 17 0 
sp|Q9NZV1|CRIM1_HUMAN 
Cysteine-rich motor neuron 1 protein 
OS=Homo sapiens GN=CRIM1 PE=1 
SV=1 
sp|Q9NZV1|CRIM1_HUMANCysteine-rich motor 
neuron 1 protein OS=Homo sapiens GN=CRIM1 
PE=1 SV=1 
0.36 2 0 0 0 0 0 0 0 
sp|P27037|AVR2A_HUMAN Activin 
receptor type-2A OS=Homo sapiens 
GN=ACVR2A PE=1 SV=1 
sp|P27037|AVR2A_HUMANActivin receptor 
type-2A OS=Homo sapiens GN=ACVR2A PE=1 
SV=1 
0.56 0 3 0 0 0 0 1 0 
sp|Q6UWW0|LCN15_HUMAN 
Lipocalin-15 OS=Homo sapiens 
GN=LCN15 PE=1 SV=1 
sp|Q6UWW0|LCN15_HUMANLipocalin-15 
OS=Homo sapiens GN=LCN15 PE=1 SV=1 
0.26 6 4 0 8 8 5 12 7 
Twinfilin-1 OS=Homo sapiens 
GN=TWF1 PE=1 SV=3 
sp|Q12792|TWF1_HUMAN 0.39 2 15 12 3 3 13 7 11 
AGR2 OS=Homo sapiens GN=AGR2 
PE=2 SV=1 
Q4JM47_HUMAN 0.36 9 16 16 6 6 15 12 11 
sp|Q8NFZ8|CADM4_HUMAN Cell 
adhesion molecule 4 OS=Homo 
sapiens GN=CADM4 PE=1 SV=1 
sp|Q8NFZ8|CADM4_HUMANCell adhesion 
molecule 4 OS=Homo sapiens GN=CADM4 PE=1 
SV=1 
0.14 6 9 4 11 11 3 4 0 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
160 
 
Isoform 2 of Transmembrane protein 
2 OS=Homo sapiens GN=TMEM2 
TMEM2_HUMAN 0.22 6 3 2 1 1 0 0 4 
sp|Q8N436|CPXM2_HUMAN 
Inactive carboxypeptidase-like 
protein X2 OS=Homo sapiens 
GN=CPXM2 PE=2 SV=3 
sp|Q8N436|CPXM2_HUMANInactive 
carboxypeptidase-like protein X2 OS=Homo 
sapiens GN=CPXM2 PE=2 SV=3 
0.57 1 5 0 0 1 0 6 3 
Hydroxyacylglutathione hydrolase, 
mitochondrial OS=Homo sapiens 
GN=HAGH PE=1 SV=2 
sp|Q16775|GLO2_HUMAN 0.44 0 0 0 8 8 1 14 0 
sp|Q8N4F0|BPIB2_HUMAN BPI fold-
containing family B member 2 
OS=Homo sapiens GN=BPIFB2 PE=1 
SV=2 
sp|Q8N4F0|BPIB2_HUMANBPI fold-containing 
family B member 2 OS=Homo sapiens GN=BPIFB2 
PE=1 SV=2 
0.18 10 29 16 0 6 0 0 0 
GTP-binding nuclear protein Ran 
OS=Homo sapiens GN=RAN PE=1 
SV=3 
RAN_HUMAN 0.37 9 14 12 5 5 13 20 5 
S-formylglutathione hydrolase 
OS=Homo sapiens GN=ESD PE=1 
SV=2 
ESTD_HUMAN 0.29 7 16 10 8 8 6 13 4 
Delta-aminolevulinic acid 
dehydratase OS=Homo sapiens 
GN=ALAD PE=1 SV=1 
sp|P13716|HEM2_HUMAN 0.41 0 0 19 11 11 0 20 0 
Isoform 3 of Protein phosphatase 1A 
OS=Homo sapiens GN=PPM1A 
sp|P35813-3|PPM1A_HUMAN 0.42 1 4 2 1 1 4 3 1 
Vasorin OS=Homo sapiens GN=VASN 
PE=1 SV=1 
VASN_HUMAN 0.44 2 6 5 3 3 5 6 7 
Calmodulin (Fragment) OS=Homo 
sapiens GN=CALM2 PE=2 SV=1 
H0Y7A7_HUMAN 0.4 12 2 11 5 5 17 10 8 
Asparagine--tRNA ligase, cytoplasmic 
OS=Homo sapiens GN=NARS PE=1 
SV=1 
SYNC_HUMAN 0.5 7 2 3 1 1 2 3 6 
Isoform 2 of Ras-related protein Rab-
18 OS=Homo sapiens GN=RAB18 
sp|Q9NP72-2|RAB18_HUMAN 0.38 7 7 8 7 7 8 9 14 
sp|P06889|LV405_HUMAN Ig 
lambda chain V-IV region MOL 
OS=Homo sapiens PE=1 SV=1 
sp|P06889|LV405_HUMANIg lambda chain V-IV 
region MOL OS=Homo sapiens PE=1 SV=1-DECOY 
0.65 0 2 0 3 3 0 0 0 
Ecto-ADP-ribosyltransferase 3 
OS=Homo sapiens GN=ART3 PE=1 
SV=2 
sp|Q13508|NAR3_HUMAN 0.091 0 6 0 0 0 8 9 12 
sp|P38606|VATA_HUMAN V-type 
proton ATPase catalytic subunit A 
OS=Homo sapiens GN=ATP6V1A... 
sp|P38606|VATA_HUMAN V-type proton ATPase 
catalytic subunit A OS=Homo sapiens 
GN=ATP6V1A... (+1) 
0.45 10 6 18 4 4 19 14 7 
sp|Q5KU26|COL12_HUMAN 
Collectin-12 OS=Homo sapiens 
GN=COLEC12 PE=1 SV=3 
sp|Q5KU26|COL12_HUMANCollectin-12 
OS=Homo sapiens GN=COLEC12 PE=1 SV=3 
0.18 4 10 3 7 7 0 9 0 
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Isoform 2 of Tubulin alpha-1A chain 
OS=Homo sapiens GN=TUBA1A 
TBA1A_HUMAN 0.32 2 19 0 6 6 10 12 16 
sp|O00754|MA2B1_HUMAN 
Lysosomal alpha-mannosidase 
OS=Homo sapiens GN=MAN2B1 
PE=1 SV=3 
sp|O00754|MA2B1_HUMANLysosomal alpha-
mannosidase OS=Homo sapiens GN=MAN2B1 
PE=1 SV=3 
0.87 22 3 0 0 5 5 12 0 
Isoform 2 of Mitogen-activated 
protein kinase 1 OS=Homo sapiens 
GN=MAPK1 
sp|P28482-2|MK01_HUMAN 0.54 10 8 0 0 0 5 0 5 
Glutaminyl-peptide cyclotransferase 
OS=Homo sapiens GN=QPCT PE=1 
SV=1 
sp|Q16769|QPCT_HUMAN 0.45 6 9 4 6 6 7 11 9 
Synaptotagmin-1 OS=Homo sapiens 
GN=SYT1 PE=1 SV=1 
SYT1_HUMAN 0.85 1 3 2 3 3 7 6 2 
D-dopachrome decarboxylase 
OS=Homo sapiens GN=DDT PE=2 
SV=2 
B5MC82_HUMAN 0.27 22 8 7 6 6 8 7 7 
Retinol-binding protein 4 OS=Homo 
sapiens GN=RBP4 PE=1 SV=3 
RET4_HUMAN 0.38 10 10 4 16 16 17 7 12 
sp|O15144|ARPC2_HUMAN Actin-
related protein 2/3 complex subunit 
2 OS=Homo sapiens... 
sp|O15144|ARPC2_HUMANActin-related protein 
2/3 complex subunit 2 OS=Homo sapiens 
GN=ARPC2 PE=1 SV=1 
0.82 9 8 0 0 4 9 4 2 
sp|P29992|GNA11_HUMAN 
Guanine nucleotide-binding protein 
subunit alpha-11 OS=Homo sapiens 
GN=GNA11 PE=1 SV=2 
sp|P29992|GNA11_HUMANGuanine nucleotide-
binding protein subunit alpha-11 OS=Homo 
sapiens GN=GNA11 PE=1 SV=2 
0.27 1 8 0 0 3 2 6 9 
Protein NDRG2 (Fragment) 
OS=Homo sapiens GN=NDRG2 PE=4 
SV=1 
H0YJT9_HUMAN 0.64 1 4 3 1 1 11 1 4 
sp|Q9Y376|CAB39_HUMAN 
Calcium-binding protein 39 
OS=Homo sapiens GN=CAB39 PE=1 
SV=1 
sp|Q9Y376|CAB39_HUMANCalcium-binding 
protein 39 OS=Homo sapiens GN=CAB39 PE=1 
SV=1 
0.036 11 14 2 5 5 0 6 6 
sp|Q9C0J8|WDR33_HUMAN pre-
mRNA 3' end processing protein 
WDR33 OS=Homo sapiens 
GN=WDR33 PE=1 SV=2 
sp|Q9C0J8|WDR33_HUMANpre-mRNA 3' end 
processing protein WDR33 OS=Homo sapiens 
GN=WDR33 PE=1 SV=2 
0.36 2 0 0 0 0 0 0 0 
Destrin OS=Homo sapiens GN=DSTN 
PE=1 SV=3 
sp|P60981|DEST_HUMAN 0.34 6 3 6 2 2 4 5 1 
sp|Q7Z4H3|HDDC2_HUMAN HD 
domain-containing protein 2 
OS=Homo sapiens GN=HDDC2 PE=1 
SV=1 
sp|Q7Z4H3|HDDC2_HUMANHD domain-
containing protein 2 OS=Homo sapiens 
GN=HDDC2 PE=1 SV=1 
0.086 1 5 0 0 7 11 17 0 
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Isoform Gamma-A of Fibrinogen 
gamma chain OS=Homo sapiens 
GN=FGG 
sp|P02679-2|FIBG_HUMAN 0.38 0 0 17 2 2 3 0 3 
sp|Q9P232|CNTN3_HUMAN 
Contactin-3 OS=Homo sapiens 
GN=CNTN3 PE=1 SV=3 
sp|Q9P232|CNTN3_HUMANContactin-3 
OS=Homo sapiens GN=CNTN3 PE=1 SV=3 
0.49 2 2 2 2 2 4 4 0 
sp|P01610|KV118_HUMAN Ig kappa 
chain V-I region WEA OS=Homo 
sapiens PE=1 SV=1 
sp|P01610|KV118_HUMANIg kappa chain V-I 
region WEA OS=Homo sapiens PE=1 SV=1 
0.35 10 15 15 8 8 12 10 12 
Out at first protein homolog 
OS=Homo sapiens GN=OAF PE=2 
SV=1 
OAF_HUMAN 0.48 4 6 0 4 4 1 3 2 
sp|P15259|PGAM2_HUMAN 
Phosphoglycerate mutase 2 
OS=Homo sapiens GN=PGAM2 PE=1 
SV=3 
sp|P15259|PGAM2_HUMANPhosphoglycerate 
mutase 2 OS=Homo sapiens GN=PGAM2 PE=1 
SV=3 
0.84 6 15 0 7 7 0 17 11 
sp|Q99988|GDF15_HUMAN 
Growth/differentiation factor 15 
OS=Homo sapiens GN=GDF15 PE=1 
SV=3 
sp|Q99988|GDF15_HUMANGrowth/differentiati
on factor 15 OS=Homo sapiens GN=GDF15 PE=1 
SV=3 
0.65 19 23 0 0 9 9 10 0 
sp|O75340|PDCD6_HUMAN 
Programmed cell death protein 6 
OS=Homo sapiens GN=PDCD6 PE=1 
SV=1 
sp|O75340|PDCD6_HUMANProgrammed cell 
death protein 6 OS=Homo sapiens GN=PDCD6 
PE=1 SV=1 
0.34 14 0 0 0 28 0 19 0 
Glycine--tRNA ligase OS=Homo 
sapiens GN=GARS PE=1 SV=3 
SYG_HUMAN 0.94 1 2 1 0 0 0 8 2 
sp|Q13214|SEM3B_HUMAN 
Semaphorin-3B OS=Homo sapiens 
GN=SEMA3B PE=2 SV=1 
sp|Q13214|SEM3B_HUMANSemaphorin-3B 
OS=Homo sapiens GN=SEMA3B PE=2 SV=1 
0.62 4 5 1 5 5 0 9 8 
Isoform 3 of Natural resistance-
associated macrophage protein 2 
OS=Homo sapiens GN=SLC11A2 
sp|P49281-3|NRAM2_HUMAN 0.94 0 0 0 2 2 0 0 0 
sp|Q9ULD9|ZN608_HUMAN Zinc 
finger protein 608 OS=Homo sapiens 
GN=ZNF608 PE=1 SV=4 
sp|Q9ULD9|ZN608_HUMANZinc finger protein 
608 OS=Homo sapiens GN=ZNF608 PE=1 SV=4 
0.51 4 4 0 4 4 0 4 0 
sp|Q08629|TICN1_HUMAN 
Testican-1 OS=Homo sapiens 
GN=SPOCK1 PE=1 SV=1 
sp|Q08629|TICN1_HUMANTestican-1 OS=Homo 
sapiens GN=SPOCK1 PE=1 SV=1 
0.82 11 0 0 5 5 5 4 0 
sp|P35625|TIMP3_HUMAN 
Metalloproteinase inhibitor 3 
OS=Homo sapiens GN=TIMP3 PE=1 
SV=2 
sp|P35625|TIMP3_HUMANMetalloproteinase 
inhibitor 3 OS=Homo sapiens GN=TIMP3 PE=1 
SV=2 
0.17 5 17 0 0 15 7 17 9 
Isoform 2 of Protein FAM177A1 
OS=Homo sapiens GN=FAM177A1 
F177A_HUMAN 0.83 5 3 0 9 9 5 7 0 
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sp|P01762|HV301_HUMAN Ig heavy 
chain V-III region TRO OS=Homo 
sapiens PE=1 SV=1 
sp|P01762|HV301_HUMANIg heavy chain V-III 
region TRO OS=Homo sapiens PE=1 SV=1 
0.72 6 4 2 0 2 6 3 6 
Isoform 2 of Nardilysin OS=Homo 
sapiens GN=NRD1 
sp|O43847-2|NRDC_HUMAN 0.69 1 0 1 0 0 3 2 0 
sp|P18065|IBP2_HUMAN Insulin-like 
growth factor-binding protein 2 
OS=Homo sapiens... 
sp|P18065|IBP2_HUMAN Insulin-like growth 
factor-binding protein 2 OS=Homo sapiens... 
0.31 9 14 10 16 16 10 14 16 
Nuclear migration protein nudC 
OS=Homo sapiens GN=NUDC PE=1 
SV=1 
NUDC_HUMAN 0.69 5 8 4 1 1 10 14 10 
Isoform 2 of Delta-like protein 3 
OS=Homo sapiens GN=DLL3 
sp|Q9NYJ7-2|DLL3_HUMAN 0.65 0 0 0 4 4 0 0 4 
sp|Q14990|ODFP1_HUMAN Outer 
dense fiber protein 1 OS=Homo 
sapiens GN=ODF1 PE=2 SV=2 
sp|Q14990|ODFP1_HUMANOuter dense fiber 
protein 1 OS=Homo sapiens GN=ODF1 PE=2 SV=2 
0.39 2 5 0 0 4 0 24 0 
sp|Q9Y4G8|RPGF2_HUMAN Rap 
guanine nucleotide exchange factor 
2 OS=Homo sapiens GN=RAPGEF2 
PE=1 SV=1 
sp|Q9Y4G8|RPGF2_HUMANRap guanine 
nucleotide exchange factor 2 OS=Homo sapiens 
GN=RAPGEF2 PE=1 SV=1 
0.71 0 4 0 0 0 2 0 0 
sp|Q9UQ80|PA2G4_HUMAN 
Proliferation-associated protein 2G4 
OS=Homo sapiens GN=PA2G4 PE=1 
SV=3 
sp|Q9UQ80|PA2G4_HUMANProliferation-
associated protein 2G4 OS=Homo sapiens 
GN=PA2G4 PE=1 SV=3 
0.25 0 10 0 0 2 8 7 6 
Omega-amidase NIT2 OS=Homo 
sapiens GN=NIT2 PE=1 SV=1 






dimethylarginine dimethylaminohydrolase 2 
OS=Homo sapiens GN=DDAH2 PE=1 SV=1 
0.46 12 13 1 0 3 9 9 9 
sp|P37802|TAGL2_HUMAN 
Transgelin-2 OS=Homo sapiens 
GN=TAGLN2 PE=1 SV=3 
sp|P37802|TAGL2_HUMANTransgelin-2 
OS=Homo sapiens GN=TAGLN2 PE=1 SV=3 
0.42 49 3 0 0 3 2 5 0 
Isoform 2 of Tropomyosin alpha-4 
chain OS=Homo sapiens GN=TPM4 
sp|P67936-2|TPM4_HUMAN 0.15 1 6 3 1 1 2 3 5 
Thymidine phosphorylase OS=Homo 
sapiens GN=TYMP PE=1 SV=2 
sp|P19971|TYPH_HUMAN 0.38 3 3 3 1 1 3 4 2 
Isoform 2 of Ig mu chain C region 
OS=Homo sapiens GN=IGHM 
sp|P01871-2|IGHM_HUMAN 0.35 1 4 10 2 2 2 2 3 
Complement C4-A OS=Homo sapiens 
GN=C4A PE=1 SV=2 
sp|P0C0L4|CO4A_HUMAN 0.3 7 8 2 8 8 7 6 4 
Dickkopf-related protein 3 OS=Homo 
sapiens GN=DKK3 PE=2 SV=2 
E7EUD0_HUMAN 0.68 0 2 0 0 0 0 0 1 
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factor 3B subunit 1 OS=Homo 
sapiens GN=SF3B1 PE=1 SV=3 
sp|O75533|SF3B1_HUMANSplicing factor 3B 
subunit 1 OS=Homo sapiens GN=SF3B1 PE=1 
SV=3 
0.36 27 0 0 0 0 0 0 0 
Ras-related protein R-Ras OS=Homo 
sapiens GN=RRAS PE=1 SV=1 
RRAS_HUMAN 0.35 4 13 8 7 7 8 10 7 
sp|Q15365|PCBP1_HUMAN 
Poly(rC)-binding protein 1 OS=Homo 
sapiens GN=PCBP1 PE=1 SV=2 
sp|Q15365|PCBP1_HUMANPoly(rC)-binding 
protein 1 OS=Homo sapiens GN=PCBP1 PE=1 
SV=2 
0.46 13 4 2 0 4 6 2 3 
Protein DPCD OS=Homo sapiens 
GN=DPCD PE=1 SV=2 
DPCD_HUMAN 0.95 7 13 2 7 7 10 17 19 
40S ribosomal protein S8 OS=Homo 
sapiens GN=RPS8 PE=1 SV=2 
RS8_HUMAN 0.27 22 4 9 2 2 6 6 2 
Isoform 3 of Poliovirus receptor-
related protein 3 OS=Homo sapiens 
GN=PVRL3 
sp|Q9NQS3-3|PVRL3_HUMAN 0.22 0 0 0 1 1 0 1 2 
Vitamin D-binding protein OS=Homo 
sapiens GN=GC PE=2 SV=1 
D6RF35_HUMAN 0.35 5 4 5 6 6 9 7 5 
Solute carrier family 2, facilitated 
glucose transporter member 5 
OS=Homo sapiens GN=SLC2A5 PE=2 
SV=1 
B4DU31_HUMAN 0.53 7 6 0 0 0 12 0 11 
sp|P22392-2|NDKB_HUMAN 
Isoform 3 of Nucleoside diphosphate 
kinase B OS=Homo sapiens... 
sp|P22392-2|NDKB_HUMAN Isoform 3 of 
Nucleoside diphosphate kinase B OS=Homo 
sapiens... (+1) 
0.37 18 4 13 15 15 15 14 9 
Isoform 2 of Vigilin OS=Homo 
sapiens GN=HDLBP 
VIGLN_HUMAN 0.49 4 0 0 0 0 5 0 4 
Lysosome-associated membrane 
glycoprotein 2 OS=Homo sapiens 
GN=LAMP2 PE=2 SV=1 
B4E2S7_HUMAN 0.91 17 19 0 0 0 24 0 19 
Sortilin-related receptor OS=Homo 
sapiens GN=SORL1 PE=1 SV=2 
SORL_HUMAN 0.54 0 2 2 1 1 4 2 1 
S-methyl-5'-thioadenosine 
phosphorylase OS=Homo sapiens 
GN=MTAP PE=2 SV=1 
B4DUC8_HUMAN 0.64 6 10 0 0 0 6 0 4 
sp|Q99828|CIB1_HUMAN Calcium 
and integrin-binding protein 1 
OS=Homo sapiens GN=CIB1... 
sp|Q99828|CIB1_HUMAN Calcium and integrin-
binding protein 1 OS=Homo sapiens GN=CIB1... 
0.35 17 9 5 10 10 15 10 14 
Cysteine and glycine-rich protein 1 
OS=Homo sapiens GN=CSRP1 PE=2 
SV=1 
E9PP21_HUMAN 0.22 18 4 3 4 4 9 2 0 
sp|P34931|HS71L_HUMAN Heat 
shock 70 kDa protein 1-like 
OS=Homo sapiens GN=HSPA1L... 
sp|P34931|HS71L_HUMANHeat shock 70 kDa 
protein 1-like OS=Homo sapiens GN=HSPA1L 
PE=1 SV=2 
0.11 5 2 0 0 3 11 7 3 
Sepiapterin reductase OS=Homo 
sapiens GN=SPR PE=1 SV=1 
SPRE_HUMAN 0.35 6 8 14 1 1 5 5 6 
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Importin subunit beta-1 OS=Homo 
sapiens GN=KPNB1 PE=1 SV=2 
IMB1_HUMAN 0.51 12 7 0 9 9 6 14 7 
Tolloid-like protein 1 OS=Homo 
sapiens GN=TLL1 PE=1 SV=1 
sp|O43897|TLL1_HUMAN 0.36 0 0 0 0 0 2 0 0 
sp|P30044|PRDX5_HUMAN 
Peroxiredoxin-5, mitochondrial 
OS=Homo sapiens GN=PRDX5 PE=1 
SV=4 
sp|P30044|PRDX5_HUMANPeroxiredoxin-5, 
mitochondrial OS=Homo sapiens GN=PRDX5 
PE=1 SV=4 
0.53 29 0 0 0 14 17 20 0 
sp|O94886|TM63A_HUMAN 
Transmembrane protein 63A 
OS=Homo sapiens GN=TMEM63A 
PE=2 SV=3 
sp|O94886|TM63A_HUMANTransmembrane 
protein 63A OS=Homo sapiens GN=TMEM63A 
PE=2 SV=3 
0.75 2 1 3 0 4 8 1 4 
sp|P31153|METK2_HUMAN S-
adenosylmethionine synthase 
isoform type-2 OS=Homo sapiens 
GN=MAT2A PE=1 SV=1 
sp|P31153|METK2_HUMANS-
adenosylmethionine synthase isoform type-2 
OS=Homo sapiens GN=MAT2A PE=1 SV=1 
0.54 4 8 4 0 6 0 5 12 
sp|Q92485|ASM3B_HUMAN Acid 
sphingomyelinase-like 
phosphodiesterase 3b OS=Homo 
sapiens GN=SMPDL3B PE=2 SV=2 
sp|Q92485|ASM3B_HUMANAcid 
sphingomyelinase-like phosphodiesterase 3b 
OS=Homo sapiens GN=SMPDL3B PE=2 SV=2 
0.57 0 12 8 0 13 0 14 1 
Tissue-type plasminogen activator 
chain A OS=Homo sapiens GN=PLAT 
PE=2 SV=1 
B4DN26_HUMAN 0.36 0 0 0 0 0 11 0 0 
sp|P30040|ERP29_HUMAN 
Endoplasmic reticulum resident 
protein 29 OS=Homo sapiens 
GN=ERP29 PE=1 SV=4 
sp|P30040|ERP29_HUMANEndoplasmic 
reticulum resident protein 29 OS=Homo sapiens 
GN=ERP29 PE=1 SV=4 
0.59 30 7 0 0 5 7 4 4 
sp|Q92945|FUBP2_HUMAN Far 
upstream element-binding protein 2 
OS=Homo sapiens GN=KHSRP PE=1 
SV=4 
sp|Q92945|FUBP2_HUMANFar upstream 
element-binding protein 2 OS=Homo sapiens 
GN=KHSRP PE=1 SV=4 
0.36 36 0 0 0 0 0 0 0 
sp|O94832|MYO1D_HUMAN 
Unconventional myosin-Id OS=Homo 
sapiens GN=MYO1D PE=1 SV=2 
sp|O94832|MYO1D_HUMANUnconventional 
myosin-Id OS=Homo sapiens GN=MYO1D PE=1 
SV=2 
0.62 1 1 2 1 1 7 1 1 
tr|F5GWE5|F5GWE5_HUMAN 
Phosphatidylinositol transfer protein 
alpha isoform OS=Homo... 
tr|F5GWE5|F5GWE5_HUMAN 
Phosphatidylinositol transfer protein alpha 
isoform OS=Homo... 
0.44 4 8 8 6 6 6 12 10 
sp|P24855|DNAS1_HUMAN 
Deoxyribonuclease-1 OS=Homo 
sapiens GN=DNASE1 PE=1 SV=1 
sp|P24855|DNAS1_HUMANDeoxyribonuclease-1 
OS=Homo sapiens GN=DNASE1 PE=1 SV=1 
0.047 8 7 1 5 5 0 6 0 
Isoform 3 of Calumenin OS=Homo 
sapiens GN=CALU 
sp|O43852-3|CALU_HUMAN 0.42 6 1 7 1 1 5 5 5 
sp|Q14507|EP3A_HUMAN 
Epididymal secretory protein E3-
sp|Q14507|EP3A_HUMAN Epididymal secretory 
protein E3-alpha OS=Homo sapiens 
GN=EDDM3A... 
0.18 11 13 4 13 13 6 6 4 
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alpha OS=Homo sapiens 
GN=EDDM3A... 
Syntaxin-3 OS=Homo sapiens 
GN=STX3 PE=1 SV=3 
sp|Q13277|STX3_HUMAN 0.16 1 6 1 2 2 2 2 1 
WD repeat-containing protein 1 
OS=Homo sapiens GN=WDR1 PE=1 
SV=4 
sp|O75083|WDR1_HUMAN 0.72 0 0 5 14 14 1 19 0 
26S proteasome non-ATPase 
regulatory subunit 14 OS=Homo 
sapiens GN=PSMD14 PE=1 SV=1 
PSDE_HUMAN 0.33 4 3 1 0 0 3 3 1 
Keratin, type II cytoskeletal 4 
OS=Homo sapiens GN=KRT4 PE=1 
SV=4 
K2C4_HUMAN 0.72 2 2 0 5 5 1 0 0 
Isoform 3 of Guanine nucleotide-
binding protein G(i) subunit alpha-2 
OS=Homo sapiens GN=GNAI2 
sp|P04899-3|GNAI2_HUMAN 0.92 11 9 0 0 0 8 0 12 
Dermcidin OS=Homo sapiens 
GN=DCD PE=1 SV=2 
DCD_HUMAN 0.065 6 2 0 0 11 11 26 3 
sp|O14745|NHRF1_HUMAN 
Na(+)/H(+) exchange regulatory 
cofactor NHE-RF1 OS=Homo 
sapiens... 
sp|O14745|NHRF1_HUMANNa(+)/H(+) exchange 
regulatory cofactor NHE-RF1 OS=Homo sapiens 
GN=SLC9A3R1 PE=1 SV=4 
0.62 10 5 0 0 3 0 6 0 
sp|O00160|MYO1F_HUMAN 
Unconventional myosin-If OS=Homo 
sapiens GN=MYO1F PE=1 SV=3 
sp|O00160|MYO1F_HUMANUnconventional 
myosin-If OS=Homo sapiens GN=MYO1F PE=1 
SV=3 
0.36 6 0 0 0 0 0 0 0 
Cathepsin O OS=Homo sapiens 
GN=CTSO PE=2 SV=1 
CATO_HUMAN 0.12 5 10 2 3 3 2 3 0 
Isoform 3 of Retinal dehydrogenase 
2 OS=Homo sapiens GN=ALDH1A2 
sp|O94788-3|AL1A2_HUMAN 0.3 0 1 2 0 0 0 0 0 
sp|Q5R3I4|TTC38_HUMAN 
Tetratricopeptide repeat protein 38 
OS=Homo sapiens GN=TTC38 PE=1 
SV=1 
sp|Q5R3I4|TTC38_HUMANTetratricopeptide 
repeat protein 38 OS=Homo sapiens GN=TTC38 
PE=1 SV=1 
0.7 3 5 0 1 1 0 4 2 
Matrix metalloproteinase-9 
OS=Homo sapiens GN=MMP9 PE=1 
SV=3 
MMP9_HUMAN 0.52 3 0 0 3 3 0 0 0 
sp|CAS1_BOVIN| sp|CAS1_BOVIN| 0.97 6 1 5 8 8 16 13 13 
P2X purinoceptor OS=Homo sapiens 
GN=P2RX4 PE=2 SV=2 
E7EPF7_HUMAN 0.49 0 1 1 2 2 5 2 4 
Soluble interleukin-4 receptor 
subunit alpha OS=Homo sapiens 
GN=IL4R PE=2 SV=1 
B4E076_HUMAN 0.36 0 2 0 0 0 0 0 0 
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Ras-related protein Rab-8A 
OS=Homo sapiens GN=RAB8A PE=2 
SV=1 
B4DEK7_HUMAN 0.27 3 3 0 0 0 0 4 1 
Nucleolar protein 3 OS=Homo 
sapiens GN=NOL3 PE=2 SV=1 
B4DFL0_HUMAN 0.76 0 1 0 5 5 3 1 0 
sp|O15232|MATN3_HUMAN 
Matrilin-3 OS=Homo sapiens 
GN=MATN3 PE=1 SV=2 
sp|O15232|MATN3_HUMANMatrilin-3 
OS=Homo sapiens GN=MATN3 PE=1 SV=2 
0.13 1 1 0 0 0 2 2 2 
sp|Q96N03|VTM2L_HUMAN V-set 
and transmembrane domain-
containing protein 2-like protein... 
sp|Q96N03|VTM2L_HUMANV-set and 
transmembrane domain-containing protein 2-like 
protein OS=Homo sapiens GN=VSTM2L PE=1 
SV=1 
0.065 9 9 0 0 9 7 14 15 
Adenine phosphoribosyltransferase 
OS=Homo sapiens GN=APRT PE=1 
SV=2 
APT_HUMAN 0.92 13 12 0 0 4 12 10 0 
sp|Q96QK1|VPS35_HUMAN 
Vacuolar protein sorting-associated 
protein 35 OS=Homo sapiens 
GN=VPS35 PE=1 SV=2 
sp|Q96QK1|VPS35_HUMANVacuolar protein 
sorting-associated protein 35 OS=Homo sapiens 
GN=VPS35 PE=1 SV=2 
0.88 0 6 0 0 1 0 4 0 
sp|Q96IJ6|GMPPA_HUMAN 
Mannose-1-phosphate 
guanyltransferase alpha OS=Homo 
sapiens... 
sp|Q96IJ6|GMPPA_HUMANMannose-1-
phosphate guanyltransferase alpha OS=Homo 
sapiens GN=GMPPA PE=1 SV=1 
0.58 6 0 7 0 10 10 7 0 
Matrin-3 OS=Homo sapiens 
GN=MATR3 PE=2 SV=1 
A8MXP9_HUMAN (+1) 0.36 12 0 0 0 0 0 0 0 
40S ribosomal protein SA OS=Homo 
sapiens GN=RPSA PE=1 SV=4 
RSSA_HUMAN 0.39 1 9 5 2 2 5 7 4 
Isoform 2 of Actin-related protein 2 
OS=Homo sapiens GN=ACTR2 
sp|P61160-2|ARP2_HUMAN 0.14 5 21 5 5 5 1 2 8 
Fumarylacetoacetase OS=Homo 
sapiens GN=FAH PE=1 SV=2 
FAAA_HUMAN 0.63 0 1 2 2 2 5 2 2 
Alcohol dehydrogenase class-3 
OS=Homo sapiens GN=ADH5 PE=1 
SV=4 
ADHX_HUMAN 0.72 2 8 0 3 3 4 7 2 
Tyrosine--tRNA ligase, cytoplasmic 
OS=Homo sapiens GN=YARS PE=1 
SV=4 
SYYC_HUMAN 0.4 0 0 4 3 3 0 3 0 
sp|Q9BWS9|CHID1_HUMAN 
Chitinase domain-containing protein 
1 OS=Homo sapiens GN=CHID1... 
sp|Q9BWS9|CHID1_HUMANChitinase domain-
containing protein 1 OS=Homo sapiens 
GN=CHID1 PE=1 SV=1 
0.4 11 17 4 0 10 13 0 8 
Isoform 2 of Eukaryotic translation 
initiation factor 5A-1 OS=Homo 
sapiens GN=EIF5A 
IF5A1_HUMAN 0.64 3 0 0 8 8 0 12 0 
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Fibroblast growth factor 19 
OS=Homo sapiens GN=FGF19 PE=1 
SV=1 
sp|O95750|FGF19_HUMANFibroblast growth 
factor 19 OS=Homo sapiens GN=FGF19 PE=1 
SV=1 
0.12 6 11 0 3 3 0 0 0 
sp|Q9H4M9|EHD1_HUMAN EH 
domain-containing protein 1 
OS=Homo sapiens GN=EHD1 PE=1... 
sp|Q9H4M9|EHD1_HUMAN EH domain-
containing protein 1 OS=Homo sapiens GN=EHD1 
PE=1... 
0.43 5 6 16 6 6 7 14 7 
Myoglobin (Fragment) OS=Homo 
sapiens GN=MB PE=2 SV=1 
B0QYF8_HUMAN (+2) 0.35 1 2 7 6 6 1 4 1 
sp|Q07960|RHG01_HUMAN Rho 
GTPase-activating protein 1 
OS=Homo sapiens GN=ARHGAP1 
PE=1 SV=1 
sp|Q07960|RHG01_HUMANRho GTPase-
activating protein 1 OS=Homo sapiens 
GN=ARHGAP1 PE=1 SV=1 
0.029 1 3 0 0 3 4 2 5 
Anoctamin-7 OS=Homo sapiens 
GN=ANO7 PE=1 SV=2 
sp|Q6IWH7|ANO7_HUMAN 0.4 3 1 5 1 1 4 0 5 
sp|P22059|OSBP1_HUMAN 
Oxysterol-binding protein 1 
OS=Homo sapiens GN=OSBP PE=1 
SV=1 
sp|P22059|OSBP1_HUMANOxysterol-binding 
protein 1 OS=Homo sapiens GN=OSBP PE=1 SV=1 
0.58 0 5 1 2 2 0 5 2 
sp|O75110|ATP9A_HUMAN 
Probable phospholipid-transporting 
ATPase IIA OS=Homo sapiens 
GN=ATP9A PE=1 SV=3 
sp|O75110|ATP9A_HUMANProbable 
phospholipid-transporting ATPase IIA OS=Homo 
sapiens GN=ATP9A PE=1 SV=3 
0.42 2 4 5 0 1 0 8 8 
Palmitoyl-protein thioesterase 1 
(Fragment) OS=Homo sapiens 
GN=PPT1 PE=2 SV=1 
E9PMG2_HUMAN 0.4 0 5 0 0 0 3 10 1 
Isoform 4 of Alpha-mannosidase 2C1 
OS=Homo sapiens GN=MAN2C1 
sp|Q9NTJ4-4|MA2C1_HUMAN 0.18 0 0 0 0 0 2 0 1 
Elongation factor 1-beta OS=Homo 
sapiens GN=EEF1B2 PE=1 SV=3 
EF1B_HUMAN 0.39 25 1 0 0 0 1 2 0 
60S ribosomal protein L29 OS=Homo 
sapiens GN=RPL29 PE=1 SV=2 
RL29_HUMAN 0.24 24 6 7 1 1 2 2 3 
sp|Q8TDQ7|GNPI2_HUMAN 
Glucosamine-6-phosphate isomerase 
2 OS=Homo sapiens GN=GNPDA2... 
sp|Q8TDQ7|GNPI2_HUMANGlucosamine-6-
phosphate isomerase 2 OS=Homo sapiens 
GN=GNPDA2 PE=1 SV=1 
0.99 2 11 0 1 1 0 13 0 
sp|Q9H4G4|GAPR1_HUMAN Golgi-
associated plant pathogenesis-
related protein 1 OS=Homo sapiens 
GN=GLIPR2 PE=1 SV=3 
sp|Q9H4G4|GAPR1_HUMANGolgi-associated 
plant pathogenesis-related protein 1 OS=Homo 
sapiens GN=GLIPR2 PE=1 SV=3 
0.52 13 4 0 0 8 8 11 0 
Glycine N-methyltransferase 
OS=Homo sapiens GN=GNMT PE=1 
SV=3 
GNMT_HUMAN 0.71 0 0 5 0 0 13 5 3 
Bcl-2-associated transcription factor 
1 OS=Homo sapiens GN=BCLAF1 
PE=2 SV=1 
E9PK91_HUMAN 0.36 5 0 0 0 0 0 0 0 
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7 of Complement decay-accelerating 
factor OS=Homo sapiens GN=CD55 
sp|P08174-7|DAF_HUMANIsoform 7 of 
Complement decay-accelerating factor OS=Homo 
sapiens GN=CD55 
0.044 2 0 0 0 5 7 2 2 
Isoform 2 of Transmembrane protein 
132A OS=Homo sapiens 
GN=TMEM132A 
sp|Q24JP5-2|T132A_HUMAN 0.39 0 0 0 1 1 3 0 0 
sp|P68402|PA1B2_HUMAN Platelet-
activating factor acetylhydrolase IB 
subunit beta... 
sp|P68402|PA1B2_HUMANPlatelet-activating 
factor acetylhydrolase IB subunit beta OS=Homo 
sapiens GN=PAFAH1B2 PE=1 SV=1 






dependent dihydroxyacetone kinase/FAD-AMP 
lyase... 
0.36 7 10 18 13 13 12 14 7 
Ribosyldihydronicotinamide 
dehydrogenase [quinone] OS=Homo 
sapiens GN=NQO2 PE=1 SV=5 
NQO2_HUMAN 0.32 6 6 3 6 6 7 7 2 
sp|P37837|TALDO_HUMAN 
Transaldolase OS=Homo sapiens 
GN=TALDO1 PE=1 SV=2 
sp|P37837|TALDO_HUMANTransaldolase 
OS=Homo sapiens GN=TALDO1 PE=1 SV=2 
0.64 6 6 4 0 4 12 8 3 
Isoform 2 of Latent-transforming 
growth factor beta-binding protein 3 
OS=Homo sapiens GN=LTBP3 
LTBP3_HUMAN 0.42 0 1 0 1 1 0 3 0 
Melanotransferrin OS=Homo sapiens 
GN=MFI2 PE=1 SV=2 
sp|P08582|TRFM_HUMAN 0.57 12 3 0 3 3 4 4 1 
sp|P50591|TNF10_HUMAN Tumor 
necrosis factor ligand superfamily 
member 10 OS=Homo sapiens 
GN=TNFSF10 PE=1 SV=1 
sp|P50591|TNF10_HUMANTumor necrosis 
factor ligand superfamily member 10 OS=Homo 
sapiens GN=TNFSF10 PE=1 SV=1 
0.61 6 11 0 0 4 7 4 7 
sp|P06314|KV404_HUMAN Ig kappa 
chain V-IV region B17 OS=Homo 
sapiens PE=2 SV=1 
sp|P06314|KV404_HUMANIg kappa chain V-IV 
region B17 OS=Homo sapiens PE=2 SV=1 
0.47 8 13 0 0 9 5 6 9 
Calponin-2 OS=Homo sapiens 
GN=CNN2 PE=1 SV=4 
sp|Q99439|CNN2_HUMAN 0.36 2 0 0 0 0 0 0 0 
Myosin-4 OS=Homo sapiens 
GN=MYH4 PE=1 SV=2 
MYH4_HUMAN 0.9 0 0 0 0 0 0 2 0 
Isoform 2 of Phosphoserine 
aminotransferase OS=Homo sapiens 
GN=PSAT1 
sp|Q9Y617-2|SERC_HUMAN 0.46 4 7 6 11 11 13 7 7 
Phospholipid transfer protein 
OS=Homo sapiens GN=PLTP PE=1 
SV=1 
sp|P55058|PLTP_HUMAN 0.52 0 1 5 2 2 3 8 3 
Aldehyde oxidase OS=Homo sapiens 
GN=AOX1 PE=2 SV=2 
ADO_HUMAN 0.64 0 2 2 0 0 8 0 0 
Histone H3.1 OS=Homo sapiens 
GN=HIST1H3A PE=1 SV=2 
H31_HUMAN 0.41 30 1 0 3 3 4 2 0 
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Isoform 4 of Non-specific lipid-
transfer protein OS=Homo sapiens 
GN=SCP2 
sp|P22307-4|NLTP_HUMAN 0.36 31 0 0 0 0 0 0 0 
tr|D6RI10|D6RI10_HUMAN Serine 
protease inhibitor Kazal-type 2 
OS=Homo sapiens GN=SPINK2... 
tr|D6RI10|D6RI10_HUMAN Serine protease 
inhibitor Kazal-type 2 OS=Homo sapiens 
GN=SPINK2... 
0.35 7 15 11 7 7 13 9 10 
Pyridoxal kinase OS=Homo sapiens 
GN=PDXK PE=1 SV=1 
sp|O00764|PDXK_HUMAN 0.24 9 4 5 6 6 6 3 2 
sp|Q9UPN7|PP6R1_HUMAN 
Serine/threonine-protein 
phosphatase 6 regulatory subunit 1 
OS=Homo sapiens GN=PPP6R1 PE=1 
SV=5 
sp|Q9UPN7|PP6R1_HUMANSerine/threonine-
protein phosphatase 6 regulatory subunit 1 
OS=Homo sapiens GN=PPP6R1 PE=1 SV=5 
0.24 4 1 0 0 0 0 0 0 
sp|P47755|CAZA2_HUMAN F-actin-
capping protein subunit alpha-2 
OS=Homo sapiens GN=CAPZA2 PE=1 
SV=3 
sp|P47755|CAZA2_HUMANF-actin-capping 
protein subunit alpha-2 OS=Homo sapiens 
GN=CAPZA2 PE=1 SV=3 
0.63 17 0 0 0 5 14 9 0 
Ropporin-1B (Fragment) OS=Homo 
sapiens GN=ROPN1B PE=2 SV=1 
D6RCR2_HUMAN 0.041 0 3 0 0 0 9 10 11 
sp|Q9BUF7|CRUM3_HUMAN 
Protein crumbs homolog 3 OS=Homo 
sapiens GN=CRB3 PE=1 SV=3 
sp|Q9BUF7|CRUM3_HUMANProtein crumbs 
homolog 3 OS=Homo sapiens GN=CRB3 PE=1 
SV=3 
0.45 0 3 4 7 7 5 5 1 
sp|Q9NYU2|UGGG1_HUMAN UDP-
glucose:glycoprotein 
glucosyltransferase 1 OS=Homo 
sapiens GN=UGGT1 PE=1 SV=3 
sp|Q9NYU2|UGGG1_HUMANUDP-
glucose:glycoprotein glucosyltransferase 1 
OS=Homo sapiens GN=UGGT1 PE=1 SV=3 
0.39 0 0 6 0 0 0 3 0 
Pigment epithelium-derived factor 
OS=Homo sapiens GN=SERPINF1 
PE=1 SV=4 
PEDF_HUMAN 0.5 0 0 8 8 8 0 15 0 
Isoform 6 of Rho GTPase-activating 
protein 17 OS=Homo sapiens 
GN=ARHGAP17 








acetylglucosaminyltransferase OS=Homo sapiens 
GN=MGAT1 PE=2 SV=2 
0.28 8 8 0 0 8 0 11 15 
Adenylate kinase isoenzyme 1 
OS=Homo sapiens GN=AK1 PE=1 
SV=3 
KAD1_HUMAN 0.73 0 6 2 2 2 12 6 3 
sp|O95460|MATN4_HUMAN 
Matrilin-4 OS=Homo sapiens 
GN=MATN4 PE=1 SV=3 
sp|O95460|MATN4_HUMANMatrilin-4 
OS=Homo sapiens GN=MATN4 PE=1 SV=3 
0.55 4 2 0 0 0 0 6 5 
Kininogen-1 OS=Homo sapiens 
GN=KNG1 PE=1 SV=2 
sp|P01042|KNG1_HUMAN 0.38 1 7 3 0 0 6 2 2 
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Isoform 3 of Oxidoreductase 
HTATIP2 OS=Homo sapiens 
GN=HTATIP2 
sp|Q9BUP3-3|HTAI2_HUMAN 0.097 2 3 0 3 3 5 3 5 
Calsyntenin-1 OS=Homo sapiens 
GN=CLSTN1 PE=2 SV=1 
B4E3Q1_HUMAN 0.71 5 2 0 4 4 1 1 2 
Protein sidekick-1 OS=Homo sapiens 
GN=SDK1 PE=1 SV=3 
sp|Q7Z5N4|SDK1_HUMAN 0.53 2 0 0 0 0 0 7 0 
Rho GTPase-activating protein 4 
OS=Homo sapiens GN=ARHGAP4 
PE=2 SV=1 
F5GZW3_HUMAN 0.36 3 0 0 0 0 0 0 0 
Isoform 2 of Acyl-protein 
thioesterase 1 OS=Homo sapiens 
GN=LYPLA1 






dehalogenase-like hydrolase domain-containing 
protein 2 OS=Homo sapiens GN=HDHD2 PE=1 
SV=1 
0.68 13 11 0 0 12 11 7 0 
40S ribosomal protein S4, X isoform 
OS=Homo sapiens GN=RPS4X PE=1 
SV=2 
RS4X_HUMAN 0.36 14 4 9 3 3 8 13 6 
Serine/threonine-protein 
phosphatase PP1-beta catalytic 
subunit OS=Homo sapiens 
GN=PPP1CB PE=1 SV=3 
PP1B_HUMAN 0.83 0 7 1 9 9 10 8 0 
sp|Q9UKF5|ADA29_HUMAN 
Disintegrin and metalloproteinase 
domain-containing protein 29 
OS=Homo sapiens GN=ADAM29 
PE=1 SV=3 
sp|Q9UKF5|ADA29_HUMANDisintegrin and 
metalloproteinase domain-containing protein 29 
OS=Homo sapiens GN=ADAM29 PE=1 SV=3 
0.94 0 0 0 2 2 0 0 0 
Complement component C9 
OS=Homo sapiens GN=C9 PE=1 SV=2 
CO9_HUMAN 0.41 0 2 4 2 2 3 2 1 
sp|P49257|LMAN1_HUMAN Protein 
ERGIC-53 OS=Homo sapiens 
GN=LMAN1 PE=1 SV=2 
sp|P49257|LMAN1_HUMANProtein ERGIC-53 
OS=Homo sapiens GN=LMAN1 PE=1 SV=2 
0.2 10 6 7 0 0 0 4 0 
sp|Q9UM22|EPDR1_HUMAN 
Mammalian ependymin-related 
protein 1 OS=Homo sapiens 
GN=EPDR1 PE=1 SV=2 
sp|Q9UM22|EPDR1_HUMANMammalian 
ependymin-related protein 1 OS=Homo sapiens 
GN=EPDR1 PE=1 SV=2 
0.0015 0 2 0 0 10 9 8 5 
Insulin-degrading enzyme OS=Homo 
sapiens GN=IDE PE=1 SV=4 
IDE_HUMAN 0.48 3 0 2 0 0 4 1 2 
sp|Q96AG4|LRC59_HUMAN 
Leucine-rich repeat-containing 
protein 59 OS=Homo sapiens 
GN=LRRC59 PE=1 SV=1 
sp|Q96AG4|LRC59_HUMANLeucine-rich repeat-
containing protein 59 OS=Homo sapiens 
GN=LRRC59 PE=1 SV=1 
0.3 17 2 0 0 0 0 0 0 
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Hematopoietic lineage cell-specific 
protein OS=Homo sapiens... 
sp|P14317|HCLS1_HUMANHematopoietic 
lineage cell-specific protein OS=Homo sapiens 
GN=HCLS1 PE=1 SV=3 
0.4 46 0 0 0 0 4 0 0 
Keratin-associated protein 9-1 
OS=Homo sapiens GN=KRTAP9-1 
PE=2 SV=1 
H7BXR9_HUMAN 0.55 0 1 0 0 0 0 0 3 
Cystatin-B OS=Homo sapiens 
GN=CSTB PE=1 SV=2 
CYTB_HUMAN 0.31 21 7 8 3 3 9 8 9 
Isoform 3 of Retinol dehydrogenase 
11 OS=Homo sapiens GN=RDH11 
sp|Q8TC12-3|RDH11_HUMAN 0.41 4 3 3 1 1 7 5 1 
Isoform 4 of Target of Myb protein 1 
OS=Homo sapiens GN=TOM1 
sp|O60784-4|TOM1_HUMAN 0.16 3 4 2 1 1 2 0 2 
40S ribosomal protein S10 OS=Homo 
sapiens GN=RPS10 PE=1 SV=1 
RS10_HUMAN 0.34 16 0 5 4 4 13 3 4 
Lactadherin OS=Homo sapiens 
GN=MFGE8 PE=1 SV=2 
sp|Q08431|MFGM_HUMAN 0.92 0 4 2 4 4 8 4 6 
Isoform 3 of 60S ribosomal protein 
L17 OS=Homo sapiens GN=RPL17 
sp|P18621-3|RL17_HUMAN 0.26 20 3 4 0 0 7 4 1 
sp|Q9GZN4|BSSP4_HUMAN Brain-
specific serine protease 4 OS=Homo 
sapiens GN=PRSS22... 
sp|Q9GZN4|BSSP4_HUMANBrain-specific serine 
protease 4 OS=Homo sapiens GN=PRSS22 PE=1 
SV=1 
0.77 1 3 0 0 0 3 2 0 
Isoform 3 of Transmembrane emp24 
domain-containing protein 4 
OS=Homo sapiens GN=TMED4 
sp|Q7Z7H5-3|TMED4_HUMAN 0.46 0 0 3 10 10 0 14 0 
Reticulon-4 OS=Homo sapiens 
GN=RTN4 PE=1 SV=2 
sp|Q9NQC3|RTN4_HUMAN 0.36 11 0 0 0 0 0 0 0 
Maleylacetoacetate isomerase 
OS=Homo sapiens GN=GSTZ1 PE=1 
SV=3 
sp|O43708|MAAI_HUMAN 0.21 8 15 3 5 5 4 8 4 
Tetraspanin-6 OS=Homo sapiens 
GN=TSPAN6 PE=1 SV=1 
TSN6_HUMAN 0.15 3 7 1 4 4 4 3 4 
Epithelial discoidin domain-
containing receptor 1 OS=Homo 
sapiens GN=DDR1 PE=1 SV=1 
sp|Q08345|DDR1_HUMAN 0.4 6 7 7 4 4 10 2 12 
sp|P48556|PSMD8_HUMAN 26S 
proteasome non-ATPase regulatory 
subunit 8 OS=Homo sapiens... 
sp|P48556|PSMD8_HUMAN26S proteasome 
non-ATPase regulatory subunit 8 OS=Homo 
sapiens GN=PSMD8 PE=1 SV=2 
0.0068 0 0 0 0 2 7 4 4 
sp|P34059|GALNS_HUMAN N-
acetylgalactosamine-6-sulfatase 
OS=Homo sapiens GN=GALNS... 
sp|P34059|GALNS_HUMANN-
acetylgalactosamine-6-sulfatase OS=Homo 
sapiens GN=GALNS PE=1 SV=1 
0.39 12 7 10 0 12 0 13 0 
Nucleolin OS=Homo sapiens GN=NCL 
PE=1 SV=3 
NUCL_HUMAN 0.36 13 0 0 0 0 0 0 0 
Isoform 3 of Protein scribble 
homolog OS=Homo sapiens 
GN=SCRIB 
sp|Q14160-3|SCRIB_HUMAN 0.36 2 0 0 0 0 0 0 0 
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Coatomer protein complex, subunit 
beta 2 (Beta prime), isoform CRA_b 
OS=Homo sapiens GN=COPB2 PE=2 
SV=1 
B4DZI8_HUMAN 0.62 7 0 0 0 0 3 0 0 
ATP-dependent (S)-NAD(P)H-hydrate 
dehydratase OS=Homo sapiens 
GN=CARKD PE=1 SV=1 
sp|Q8IW45|NNRD_HUMAN 0.75 3 6 0 0 0 9 0 3 
sp|Q6P4A8|PLBL1_HUMAN 
Phospholipase B-like 1 OS=Homo 
sapiens GN=PLBD1 PE=1 SV=2 
sp|Q6P4A8|PLBL1_HUMANPhospholipase B-like 
1 OS=Homo sapiens GN=PLBD1 PE=1 SV=2 
0.47 1 0 2 2 2 0 4 2 
Phosphomannomutase 2 OS=Homo 
sapiens GN=PMM2 PE=1 SV=1 
PMM2_HUMAN 0.36 3 11 5 3 3 6 9 4 
Tubulin beta-3 chain OS=Homo 
sapiens GN=TUBB3 PE=1 SV=2 
TBB3_HUMAN 0.49 0 1 3 0 0 1 1 4 
sp|Q9Y2S2|CRYL1_HUMAN Lambda-
crystallin homolog OS=Homo sapiens 
GN=CRYL1 PE=1 SV=3 
sp|Q9Y2S2|CRYL1_HUMANLambda-crystallin 
homolog OS=Homo sapiens GN=CRYL1 PE=1 SV=3 
0.41 3 8 6 0 1 6 11 0 
Isoform B of Annexin A13 OS=Homo 
sapiens GN=ANXA13 
ANX13_HUMAN 0.35 3 4 3 0 1 4 2 1 
Uncharacterized protein OS=Homo 
sapiens PE=2 SV=1 
F8W810_HUMAN 0.49 1 2 3 1 1 4 0 4 
Protocadherin-1 (Fragment) 
OS=Homo sapiens GN=PCDH1 PE=2 
SV=1 
H0Y2Z9_HUMAN 0.36 0 9 0 0 0 0 0 0 
Isoform 2 of Prothymosin alpha 
OS=Homo sapiens GN=PTMA 
sp|P06454-2|PTMA_HUMAN 0.36 62 0 0 0 0 0 0 0 
Glycolipid transfer protein OS=Homo 
sapiens GN=GLTP PE=1 SV=3 
GLTP_HUMAN 0.37 5 3 5 2 2 5 3 7 
Ras-related protein Rab-5A 
OS=Homo sapiens GN=RAB5A PE=2 
SV=1 
B4DJA5_HUMAN 0.33 1 4 2 2 2 3 4 1 
Kallikrein-1 OS=Homo sapiens 
GN=KLK1 PE=1 SV=2 
sp|P06870|KLK1_HUMAN 0.15 1 7 1 5 5 1 2 1 
Protein-glutamine gamma-
glutamyltransferase E OS=Homo 
sapiens GN=TGM3 PE=1 SV=4 
TGM3_HUMAN 0.39 0 2 0 1 1 1 2 1 
sp|P04433|KV309_HUMAN Ig kappa 
chain V-III region VG (Fragment) 
OS=Homo sapiens PE=1 SV=1 
sp|P04433|KV309_HUMANIg kappa chain V-III 
region VG (Fragment) OS=Homo sapiens PE=1 
SV=1 
0.11 9 8 0 0 8 10 8 8 
Exportin-2 OS=Homo sapiens 
GN=CSE1L PE=1 SV=3 
sp|P55060|XPO2_HUMAN 0.44 6 0 0 0 0 0 1 0 
sp|P35080|PROF2_HUMAN Profilin-
2 OS=Homo sapiens GN=PFN2 PE=1 
SV=3 
sp|P35080|PROF2_HUMANProfilin-2 OS=Homo 
sapiens GN=PFN2 PE=1 SV=3 
0.31 7 8 0 0 3 22 14 0 
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Tubulin alpha-4A chain OS=Homo 
sapiens GN=TUBA4A PE=2 SV=1 
A8MUB1_HUMAN 0.42 6 3 6 4 4 2 3 1 
Alpha/beta hydrolase domain-
containing protein 14B OS=Homo 
sapiens GN=ABHD14B PE=2 SV=1 
F8W9U3_HUMAN 0.42 0 1 5 18 18 0 16 0 
Protein AMBP (Fragment) OS=Homo 
sapiens GN=AMBP PE=4 SV=1 
S4R471_HUMAN 0.12 3 9 3 6 6 1 1 1 
sp|Q15389|ANGP1_HUMAN 
Angiopoietin-1 OS=Homo sapiens 
GN=ANGPT1 PE=1 SV=2 
sp|Q15389|ANGP1_HUMANAngiopoietin-1 
OS=Homo sapiens GN=ANGPT1 PE=1 SV=2 
0.43 0 3 2 0 1 0 2 2 
sp|P36543|VATE1_HUMAN V-type 
proton ATPase subunit E 1 OS=Homo 
sapiens GN=ATP6V1E1... 
sp|P36543|VATE1_HUMANV-type proton 
ATPase subunit E 1 OS=Homo sapiens 
GN=ATP6V1E1 PE=1 SV=1 
0.24 7 9 5 0 1 0 7 2 
sp|Q9Y2W1|TR150_HUMAN Thyroid 
hormone receptor-associated 
protein 3 OS=Homo sapiens 
GN=THRAP3 PE=1 SV=2 
sp|Q9Y2W1|TR150_HUMANThyroid hormone 
receptor-associated protein 3 OS=Homo sapiens 
GN=THRAP3 PE=1 SV=2 
0.36 20 0 0 0 0 0 0 0 
Isoform 2 of Protein HID1 OS=Homo 
sapiens GN=HID1 
sp|Q8IV36-2|HID1_HUMAN (+1) 0.46 1 2 3 3 3 4 0 4 
Tartrate-resistant acid phosphatase 
type 5 OS=Homo sapiens GN=ACP5 
PE=1 SV=3 
PPA5_HUMAN 0.51 5 5 5 2 2 11 6 6 
sp|O00469|PLOD2_HUMAN 
Procollagen-lysine,2-oxoglutarate 5-
dioxygenase 2 OS=Homo sapiens... 
sp|O00469|PLOD2_HUMANProcollagen-lysine,2-
oxoglutarate 5-dioxygenase 2 OS=Homo sapiens 
GN=PLOD2 PE=1 SV=2 
0.79 5 6 8 0 17 12 13 0 
40S ribosomal protein S3 OS=Homo 
sapiens GN=RPS3 PE=2 SV=1 
E9PL09_HUMAN 0.5 0 9 3 1 1 7 7 1 
Myosin-6 OS=Homo sapiens 
GN=MYH6 PE=1 SV=5 
MYH6_HUMAN 0.56 4 4 0 0 0 0 3 0 
sp|P05387|RLA2_HUMAN 60S acidic 
ribosomal protein P2 OS=Homo 
sapiens GN=RPLP2 PE=1... 
sp|P05387|RLA2_HUMAN 60S acidic ribosomal 
protein P2 OS=Homo sapiens GN=RPLP2 PE=1... 
0.38 65 0 0 0 0 0 0 4 
sp|P45974-2|UBP5_HUMAN Isoform 
Short of Ubiquitin carboxyl-terminal 
hydrolase 5 OS=Homo... 
sp|P45974-2|UBP5_HUMAN Isoform Short of 
Ubiquitin carboxyl-terminal hydrolase 5 
OS=Homo... (+1) 
0.46 5 13 4 6 6 8 13 12 
Aspartyl aminopeptidase OS=Homo 
sapiens GN=DNPEP PE=2 SV=1 
E7ETB3_HUMAN 0.48 1 1 6 1 1 3 4 4 
sp|Q04917|1433F_HUMAN 14-3-3 
protein eta OS=Homo sapiens 
GN=YWHAH PE=1 SV=4 
sp|Q04917|1433F_HUMAN14-3-3 protein eta 
OS=Homo sapiens GN=YWHAH PE=1 SV=4 
0.29 5 8 3 6 6 2 3 6 
40S ribosomal protein S9 OS=Homo 
sapiens GN=RPS9 PE=2 SV=1 
C9JM19_HUMAN 0.41 2 1 3 3 3 5 4 2 
Isoform 2 of Kinesin light chain 2 
OS=Homo sapiens GN=KLC2 
sp|Q9H0B6-2|KLC2_HUMAN 0.15 4 14 1 1 1 0 0 5 
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COP9 signalosome complex subunit 
4 OS=Homo sapiens GN=COPS4 PE=2 
SV=1 
D6RFN0_HUMAN 0.43 0 0 2 5 5 0 3 0 
Lin-7 homolog C (C. elegans), isoform 
CRA_b OS=Homo sapiens GN=LIN7C 
PE=2 SV=1 
G3V1D4_HUMAN 0.79 6 7 0 0 0 6 0 4 
sp|P12931-2|SRC_HUMAN Isoform 
2 of Proto-oncogene tyrosine-protein 
kinase Src OS=Homo sapiens GN=SRC 
sp|P12931-2|SRC_HUMANIsoform 2 of Proto-
oncogene tyrosine-protein kinase Src OS=Homo 
sapiens GN=SRC 
0.15 0 1 0 0 3 2 2 0 
sp|P12036-2|NFH_HUMAN Isoform 
2 of Neurofilament heavy 
polypeptide OS=Homo sapiens 
GN=NEFH 
sp|P12036-2|NFH_HUMANIsoform 2 of 
Neurofilament heavy polypeptide OS=Homo 
sapiens GN=NEFH 
0.63 0 1 3 0 0 0 11 0 
Complement factor H OS=Homo 
sapiens GN=CFH PE=1 SV=4 
sp|P08603|CFAH_HUMAN 0.31 5 0 7 0 0 1 0 0 
sp|P49755|TMEDA_HUMAN 
Transmembrane emp24 domain-
containing protein 10 OS=Homo 
sapiens GN=TMED10 PE=1 SV=2 
sp|P49755|TMEDA_HUMANTransmembrane 
emp24 domain-containing protein 10 OS=Homo 
sapiens GN=TMED10 PE=1 SV=2 
0.26 8 2 0 0 2 10 9 3 
sp|Q9NRV9|HEBP1_HUMAN Heme-
binding protein 1 OS=Homo sapiens 
GN=HEBP1 PE=1 SV=1 
sp|Q9NRV9|HEBP1_HUMANHeme-binding 
protein 1 OS=Homo sapiens GN=HEBP1 PE=1 
SV=1 
0.8 11 4 0 8 8 13 7 0 
sp|P19022|CADH2_HUMAN 
Cadherin-2 OS=Homo sapiens 
GN=CDH2 PE=1 SV=4 
sp|P19022|CADH2_HUMANCadherin-2 
OS=Homo sapiens GN=CDH2 PE=1 SV=4 
0.68 0 6 0 0 0 2 0 1 
Protein ABHD14A-ACY1 OS=Homo 
sapiens GN=ABHD14A-ACY1 PE=2 
SV=1 
C9JMV9_HUMAN 0.94 0 0 0 5 5 0 0 0 
Isoform 2 of Protein CDV3 homolog 
OS=Homo sapiens GN=CDV3 
sp|Q9UKY7-2|CDV3_HUMAN 0.36 10 0 0 0 0 0 0 0 
sp|Q4G148|GXLT1_HUMAN 
Glucoside xylosyltransferase 1 
OS=Homo sapiens GN=GXYLT1 PE=1 
SV=2 
sp|Q4G148|GXLT1_HUMANGlucoside 
xylosyltransferase 1 OS=Homo sapiens 
GN=GXYLT1 PE=1 SV=2 
0.23 0 2 0 0 2 1 0 3 
Isoform MEF2DA'0 of Myocyte-
specific enhancer factor 2D 
OS=Homo sapiens GN=MEF2D 
sp|Q14814-5|MEF2D_HUMAN 0.36 6 0 0 0 0 0 0 0 
sp|Q9ULC3|RAB23_HUMAN Ras-
related protein Rab-23 OS=Homo 
sapiens GN=RAB23 PE=1 SV=1 
sp|Q9ULC3|RAB23_HUMANRas-related protein 
Rab-23 OS=Homo sapiens GN=RAB23 PE=1 SV=1 
0.99 5 4 0 4 4 8 1 0 
Isoform 3 of V-type proton ATPase 
116 kDa subunit a isoform 1 
OS=Homo sapiens GN=ATP6V0A1 
sp|Q93050-3|VPP1_HUMAN 0.4 0 2 0 0 0 9 0 1 
Dipeptidyl peptidase 1 OS=Homo 
sapiens GN=CTSC PE=1 SV=2 
sp|P53634|CATC_HUMAN 0.23 1 2 0 0 0 2 6 2 
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protease 58 OS=Homo sapiens 
GN=PRSS58 PE=2 SV=1 
sp|Q8IYP2|PRS58_HUMANSerine protease 58 
OS=Homo sapiens GN=PRSS58 PE=2 SV=1 
0.7 6 2 0 2 2 3 2 6 
Iduronate 2-sulfatase OS=Homo 
sapiens GN=IDS PE=1 SV=1 
IDS_HUMAN 0.85 2 8 0 4 4 10 2 0 
Junctional adhesion molecule A 
OS=Homo sapiens GN=F11R PE=1 
SV=1 
JAM1_HUMAN 0.35 0 0 8 5 5 0 2 0 
sp|Q7RTZ1|OVCH2_HUMAN 
Ovochymase-2 OS=Homo sapiens 
GN=OVCH2 PE=2 SV=2 
sp|Q7RTZ1|OVCH2_HUMANOvochymase-2 
OS=Homo sapiens GN=OVCH2 PE=2 SV=2 
0.87 12 2 0 3 3 6 11 0 
Ras-related protein Rab-1B 
OS=Homo sapiens GN=RAB1B PE=2 
SV=1 
E9PLD0_HUMAN 0.38 0 6 1 10 10 9 1 6 
sp|P20338|RAB4A_HUMAN Ras-
related protein Rab-4A OS=Homo 
sapiens GN=RAB4A PE=1 SV=3 
sp|P20338|RAB4A_HUMANRas-related protein 
Rab-4A OS=Homo sapiens GN=RAB4A PE=1 SV=3 
0.26 5 1 1 0 0 3 1 2 
sp|P51153|RAB13_HUMAN Ras-
related protein Rab-13 OS=Homo 
sapiens GN=RAB13 PE=1 SV=1 
sp|P51153|RAB13_HUMANRas-related protein 
Rab-13 OS=Homo sapiens GN=RAB13 PE=1 SV=1 
0.0087 7 6 0 0 6 4 7 6 
Aspartate aminotransferase 
OS=Homo sapiens GN=GOT2 PE=2 
SV=1 
E7ERW2_HUMAN 0.4 0 3 0 0 0 2 2 2 
sp|Q8N9U0|TAC2N_HUMAN 
Tandem C2 domains nuclear protein 
OS=Homo sapiens GN=TC2N PE=1... 
sp|Q8N9U0|TAC2N_HUMANTandem C2 domains 
nuclear protein OS=Homo sapiens GN=TC2N 
PE=1 SV=2 
0.0068 0 0 0 0 1 1 2 3 
Histone H1.4 OS=Homo sapiens 
GN=HIST1H1E PE=1 SV=2 
H14_HUMAN 0.36 67 0 0 0 0 0 1 0 
Cystatin-M OS=Homo sapiens 
GN=CST6 PE=1 SV=1 
CYTM_HUMAN 0.28 5 12 6 7 7 2 4 6 
Isoform 2 of Cell cycle control 
protein 50A OS=Homo sapiens 
GN=TMEM30A 
sp|Q9NV96-2|CC50A_HUMAN 0.44 3 3 4 3 3 0 9 3 
sp|P62906|RL10A_HUMAN 60S 
ribosomal protein L10a OS=Homo 
sapiens GN=RPL10A PE=1 SV=2 
sp|P62906|RL10A_HUMAN60S ribosomal 
protein L10a OS=Homo sapiens GN=RPL10A PE=1 
SV=2 
0.3 10 5 0 0 3 9 6 10 
sp|Q8NEB7|ACRBP_HUMAN 
Acrosin-binding protein OS=Homo 
sapiens GN=ACRBP PE=2 SV=1 
sp|Q8NEB7|ACRBP_HUMANAcrosin-binding 
protein OS=Homo sapiens GN=ACRBP PE=2 SV=1 
0.2 1 0 0 0 0 1 13 4 
Nucleophosmin OS=Homo sapiens 
GN=NPM1 PE=1 SV=2 
NPM_HUMAN 0.38 39 0 0 0 0 2 0 0 
Isoform 2 of Dynactin subunit 2 
OS=Homo sapiens GN=DCTN2 
sp|Q13561-2|DCTN2_HUMAN 0.53 2 0 8 3 3 8 4 6 
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dependent RNA helicase DDX42 
OS=Homo sapiens GN=DDX42 PE=1 
SV=1 
sp|Q86XP3|DDX42_HUMANATP-dependent RNA 
helicase DDX42 OS=Homo sapiens GN=DDX42 
PE=1 SV=1 
0.36 8 0 0 0 0 0 0 0 
sp|Q8TDL5|BPIB1_HUMAN BPI fold-
containing family B member 1 
OS=Homo sapiens GN=BPIFB1 PE=2 
SV=1 
sp|Q8TDL5|BPIB1_HUMANBPI fold-containing 
family B member 1 OS=Homo sapiens GN=BPIFB1 
PE=2 SV=1 
0.43 5 1 1 0 0 0 4 2 
Isoform 2 of Heterogeneous nuclear 
ribonucleoprotein A3 OS=Homo 
sapiens GN=HNRNPA3 
sp|P51991-2|ROA3_HUMAN 0.17 22 0 2 0 0 0 0 0 
Zinc finger protein 207 OS=Homo 
sapiens GN=ZNF207 PE=2 SV=1 
J3QRS9_HUMAN 0.36 15 0 0 0 0 0 0 0 
Isoform 1B of Beta-arrestin-1 
OS=Homo sapiens GN=ARRB1 
ARRB1_HUMAN 0.33 4 2 4 3 3 5 1 2 
Grancalcin OS=Homo sapiens 
GN=GCA PE=1 SV=2 
GRAN_HUMAN 0.18 5 9 1 5 5 6 2 7 
Vacuolar-sorting protein SNF8 
OS=Homo sapiens GN=SNF8 PE=1 
SV=1 
sp|Q96H20|SNF8_HUMAN 0.37 2 1 1 2 2 3 2 0 
sp|Q8NCC3|PAG15_HUMAN Group 
XV phospholipase A2 OS=Homo 
sapiens GN=PLA2G15 PE=1 SV=2 
sp|Q8NCC3|PAG15_HUMANGroup XV 
phospholipase A2 OS=Homo sapiens 
GN=PLA2G15 PE=1 SV=2 
0.23 5 1 2 3 3 4 1 0 
SPARC OS=Homo sapiens GN=SPARC 
PE=1 SV=1 
SPRC_HUMAN 0.72 0 1 1 2 2 1 4 1 
Isoform 4 of EGF-containing fibulin-
like extracellular matrix protein 1 
OS=Homo sapiens GN=EFEMP1 
sp|Q12805-4|FBLN3_HUMAN 0.87 1 3 0 0 0 1 0 2 
Glypican-6 OS=Homo sapiens 
GN=GPC6 PE=1 SV=1 
GPC6_HUMAN 0.45 0 0 0 0 0 4 0 0 
Obg-like ATPase 1 OS=Homo sapiens 
GN=OLA1 PE=2 SV=1 
J3KQ32_HUMAN 0.27 8 5 4 3 3 3 5 6 
sp|P01766|HV305_HUMAN Ig heavy 
chain V-III region BRO OS=Homo 
sapiens PE=1 SV=1 
sp|P01766|HV305_HUMANIg heavy chain V-III 
region BRO OS=Homo sapiens PE=1 SV=1 
0.24 9 5 5 5 5 5 10 0 
sp|P16150|LEUK_HUMAN 
Leukosialin OS=Homo sapiens 
GN=SPN PE=1 SV=1 
sp|P16150|LEUK_HUMAN Leukosialin OS=Homo 
sapiens GN=SPN PE=1 SV=1-DECOY 
0.97 2 0 0 0 0 0 2 0 
Arrestin domain-containing protein 1 
(Fragment) OS=Homo sapiens 
GN=ARRDC1 PE=2 SV=1 
Q5T370_HUMAN 0.83 5 6 0 0 0 6 0 6 
Malate dehydrogenase OS=Homo 
sapiens GN=MDH2 PE=2 SV=1 
G3XAL0_HUMAN 0.55 3 3 4 3 3 5 10 4 
40S ribosomal protein S7 OS=Homo 
sapiens GN=RPS7 PE=1 SV=1 
RS7_HUMAN 0.24 18 1 4 1 1 1 3 0 
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Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-2 
(Fragment) OS=Homo sapiens 
GN=GNB2 PE=2 SV=1 
C9JXA5_HUMAN 0.31 1 3 0 4 4 5 3 4 
sp|Q9H1M3|DB129_HUMAN Beta-
defensin 129 OS=Homo sapiens 
GN=DEFB129 PE=2 SV=1 
sp|Q9H1M3|DB129_HUMANBeta-defensin 129 
OS=Homo sapiens GN=DEFB129 PE=2 SV=1 
0.58 1 8 1 0 0 5 9 0 
COP9 signalosome complex subunit 
5 OS=Homo sapiens GN=COPS5 PE=1 
SV=4 
CSN5_HUMAN 0.3 0 4 0 0 0 1 8 4 
60S ribosomal protein L18 OS=Homo 
sapiens GN=RPL18 PE=2 SV=1 
RL18_HUMAN 0.38 2 1 12 0 0 6 7 2 
sp|Q8NBS9|TXND5_HUMAN 
Thioredoxin domain-containing 
protein 5 OS=Homo sapiens 
GN=TXNDC5 PE=1 SV=2 
sp|Q8NBS9|TXND5_HUMANThioredoxin 
domain-containing protein 5 OS=Homo sapiens 
GN=TXNDC5 PE=1 SV=2 
0.31 7 0 9 0 0 3 1 0 
sp|P05783|K1C18_HUMAN Keratin, 
type I cytoskeletal 18 OS=Homo 
sapiens GN=KRT18 PE=1... 
sp|P05783|K1C18_HUMANKeratin, type I 
cytoskeletal 18 OS=Homo sapiens GN=KRT18 
PE=1 SV=2 
0.87 0 8 2 0 1 0 4 2 
sp|Q9UKJ8|ADA21_HUMAN 
Disintegrin and metalloproteinase 
domain-containing protein 21 
OS=Homo sapiens GN=ADAM21 
PE=2 SV=2 
sp|Q9UKJ8|ADA21_HUMANDisintegrin and 
metalloproteinase domain-containing protein 21 
OS=Homo sapiens GN=ADAM21 PE=2 SV=2-
DECOY 
0.36 0 0 0 0 0 0 2 0 
sp|P61086|UBE2K_HUMAN 
Ubiquitin-conjugating enzyme E2 K 
OS=Homo sapiens GN=UBE2K... 
sp|P61086|UBE2K_HUMANUbiquitin-
conjugating enzyme E2 K OS=Homo sapiens 
GN=UBE2K PE=1 SV=3 
0.029 4 4 0 0 4 6 5 7 
Malectin OS=Homo sapiens 
GN=MLEC PE=1 SV=1 
MLEC_HUMAN 0.18 0 2 0 0 0 2 6 2 
Suprabasin OS=Homo sapiens 
GN=SBSN PE=2 SV=2 
sp|Q6UWP8|SBSN_HUMAN 0.65 0 0 0 2 2 0 2 0 
sp|Q13435|SF3B2_HUMAN Splicing 
factor 3B subunit 2 OS=Homo 
sapiens GN=SF3B2 PE=1 SV=2 
sp|Q13435|SF3B2_HUMANSplicing factor 3B 
subunit 2 OS=Homo sapiens GN=SF3B2 PE=1 
SV=2 
0.36 9 0 0 0 0 0 0 0 
Pumilio homolog 1 (Fragment) 
OS=Homo sapiens GN=PUM1 PE=4 
SV=1 
H0YEH2_HUMAN 0.36 2 0 0 0 0 0 0 0 
sp|Q96CN7|ISOC1_HUMAN 
Isochorismatase domain-containing 
protein 1 OS=Homo sapiens 
GN=ISOC1 PE=1 SV=3 
sp|Q96CN7|ISOC1_HUMANIsochorismatase 
domain-containing protein 1 OS=Homo sapiens 
GN=ISOC1 PE=1 SV=3 
0.92 7 12 0 0 7 0 14 0 
RNA-binding protein FUS OS=Homo 
sapiens GN=FUS PE=2 SV=1 
H3BPE7_HUMAN 0.36 10 0 0 0 0 0 0 0 
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Nucleoside diphosphate kinase 3 
OS=Homo sapiens GN=NME3 PE=1... 
sp|Q13232|NDK3_HUMAN Nucleoside 
diphosphate kinase 3 OS=Homo sapiens 
GN=NME3 PE=1... 
0.34 12 8 12 6 6 10 8 5 
Glutamate--cysteine ligase catalytic 
subunit OS=Homo sapiens GN=GCLC 
PE=1 SV=2 
GSH1_HUMAN 0.57 2 6 0 0 0 3 0 1 
sp|Q9BS86|ZPBP1_HUMAN Zona 
pellucida-binding protein 1 
OS=Homo sapiens GN=ZPBP PE=2... 
sp|Q9BS86|ZPBP1_HUMANZona pellucida-
binding protein 1 OS=Homo sapiens GN=ZPBP 
PE=2 SV=1 
0.46 1 4 4 0 0 0 11 0 
Isoform 3 of Probable ATP-
dependent RNA helicase DDX17 
OS=Homo sapiens GN=DDX17 
sp|Q92841-2|DDX17_HUMAN 0.36 8 0 0 0 0 0 0 0 
Cystatin-SN OS=Homo sapiens 
GN=CST1 PE=1 SV=3 
CYTN_HUMAN 0.4 1 12 6 6 6 13 8 5 
60S ribosomal protein L7a OS=Homo 
sapiens GN=RPL7A PE=1 SV=2 
RL7A_HUMAN 0.16 14 1 1 0 0 2 1 1 
sp|O43813|LANC1_HUMAN LanC-
like protein 1 OS=Homo sapiens 
GN=LANCL1 PE=1 SV=1 
sp|O43813|LANC1_HUMANLanC-like protein 1 
OS=Homo sapiens GN=LANCL1 PE=1 SV=1 
0.56 1 5 0 0 0 2 2 6 
sp|P10809|CH60_HUMAN 60 kDa 
heat shock protein, mitochondrial 
OS=Homo sapiens GN=HSPD1... 
sp|P10809|CH60_HUMAN 60 kDa heat shock 
protein, mitochondrial OS=Homo sapiens 
GN=HSPD1... 
0.32 49 1 1 0 0 1 3 0 
Serine/threonine-protein 
phosphatase 2A activator OS=Homo 
sapiens GN=PPP2R4 PE=1 SV=3 
sp|Q15257|PTPA_HUMAN 0.57 0 0 4 3 3 0 11 0 
sp|Q13438-6|OS9_HUMAN Isoform 
6 of Protein OS-9 OS=Homo sapiens 
GN=OS9 
sp|Q13438-6|OS9_HUMANIsoform 6 of Protein 
OS-9 OS=Homo sapiens GN=OS9 
0.23 6 6 3 3 3 0 11 6 
Treacle protein OS=Homo sapiens 
GN=TCOF1 PE=2 SV=1 
E9PHK9_HUMAN 0.36 2 0 0 0 0 0 0 0 
HCG2044781 OS=Homo sapiens 
GN=TMEM189 PE=2 SV=1 
G3V2F7_HUMAN 0.33 7 0 4 3 3 3 3 2 
Early endosome antigen 1 OS=Homo 
sapiens GN=EEA1 PE=1 SV=2 
EEA1_HUMAN 0.33 1 1 4 0 0 0 1 0 
sp|Q9Y287|ITM2B_HUMAN Integral 
membrane protein 2B OS=Homo 
sapiens GN=ITM2B PE=1 SV=1 
sp|Q9Y287|ITM2B_HUMANIntegral membrane 
protein 2B OS=Homo sapiens GN=ITM2B PE=1 
SV=1 
0.9 5 7 0 3 4 0 12 1 
sp|Q9UNM6|PSD13_HUMAN 26S 
proteasome non-ATPase regulatory 
subunit 13 OS=Homo sapiens 
GN=PSMD13 PE=1 SV=2 
sp|Q9UNM6|PSD13_HUMAN26S proteasome 
non-ATPase regulatory subunit 13 OS=Homo 
sapiens GN=PSMD13 PE=1 SV=2 
0.43 1 4 5 0 1 0 10 0 
Reticulon-3 OS=Homo sapiens 
GN=RTN3 PE=1 SV=2 
sp|O95197|RTN3_HUMAN 1 7 0 0 0 0 6 1 0 
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Eukaryotic translation initiation 
factor 3 subunit D OS=Homo sapiens 
GN=EIF3D PE=2 SV=1 
B4DVY1_HUMAN 0.36 6 0 0 0 0 0 0 0 
sp|P43487|RANG_HUMAN Ran-
specific GTPase-activating protein 
OS=Homo sapiens GN=RANBP1... 
sp|P43487|RANG_HUMAN Ran-specific GTPase-
activating protein OS=Homo sapiens 
GN=RANBP1... 
0.33 36 6 0 4 4 0 3 4 
Isoform 2 of Vesicle-associated 
membrane protein 4 OS=Homo 
sapiens GN=VAMP4 
VAMP4_HUMAN (+1) 0.36 0 0 0 0 0 0 0 7 
Ras-related protein Ral-A OS=Homo 
sapiens GN=RALA PE=1 SV=1 
RALA_HUMAN 0.36 2 3 3 4 4 3 6 3 
Isoform 2 of Gephyrin OS=Homo 
sapiens GN=GPHN 
sp|Q9NQX3-2|GEPH_HUMAN 0.25 3 0 2 1 1 1 0 0 
Corticosteroid-binding globulin 
OS=Homo sapiens GN=SERPINA6 
PE=1 SV=1 
CBG_HUMAN 0.57 0 6 1 3 3 3 6 4 
Tetraspanin-1 OS=Homo sapiens 
GN=TSPAN1 PE=1 SV=2 
TSN1_HUMAN 0.94 0 8 1 2 2 2 3 10 
sp|Q9H9H4|VP37B_HUMAN 
Vacuolar protein sorting-associated 
protein 37B OS=Homo sapiens... 
sp|Q9H9H4|VP37B_HUMANVacuolar protein 
sorting-associated protein 37B OS=Homo sapiens 
GN=VPS37B PE=1 SV=1 
0.47 0 7 0 0 12 1 1 2 
sp|P30626|SORCN_HUMAN Sorcin 
OS=Homo sapiens GN=SRI PE=1 SV=1 
sp|P30626|SORCN_HUMANSorcin OS=Homo 
sapiens GN=SRI PE=1 SV=1 
0.47 3 5 0 4 4 18 3 0 
Extracellular superoxide dismutase 
[Cu-Zn] OS=Homo sapiens GN=SOD3 
PE=1 SV=2 
SODE_HUMAN 0.28 0 0 0 1 1 0 3 0 
sp|Q92734-2|TFG_HUMAN Isoform 
2 of Protein TFG OS=Homo sapiens 
GN=TFG 
sp|Q92734-2|TFG_HUMANIsoform 2 of Protein 
TFG OS=Homo sapiens GN=TFG 
0.64 6 1 0 0 0 2 0 2 
Cornulin OS=Homo sapiens 
GN=CRNN PE=1 SV=1 
CRNN_HUMAN 0.94 0 0 0 4 4 0 0 0 
Zyxin (Fragment) OS=Homo sapiens 
GN=ZYX PE=2 SV=1 




OS=Homo sapiens GN=GALNT6 PE=2 
SV=2 
sp|Q8NCL4|GALT6_HUMANPolypeptide N-
acetylgalactosaminyltransferase 6 OS=Homo 
sapiens GN=GALNT6 PE=2 SV=2 
0.24 1 3 0 0 2 6 3 0 
sp|P40763|STAT3_HUMAN Signal 
transducer and activator of 
transcription 3 OS=Homo sapiens 
GN=STAT3 PE=1 SV=2 
sp|P40763|STAT3_HUMANSignal transducer and 
activator of transcription 3 OS=Homo sapiens 
GN=STAT3 PE=1 SV=2 
0.29 1 10 7 0 1 0 3 4 
Serine--tRNA ligase, cytoplasmic 
OS=Homo sapiens GN=SARS PE=2 
SV=1 
Q5T5C7_HUMAN 0.45 0 0 4 0 0 0 4 0 
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sapiens GN=P4HB PE=1 SV=3 
sp|P07237|PDIA1_HUMANProtein disulfide-
isomerase OS=Homo sapiens GN=P4HB PE=1 
SV=3 
0.27 6 11 4 4 4 0 9 9 
Tubulin-specific chaperone A 
OS=Homo sapiens GN=TBCA PE=1 
SV=3 
TBCA_HUMAN 0.24 21 0 6 4 4 1 1 1 
BRO1 domain-containing protein 
BROX OS=Homo sapiens GN=BROX 
PE=1 SV=1 
BROX_HUMAN 0.39 1 0 2 0 0 0 2 0 
Activator of 90 kDa heat shock 
protein ATPase homolog 1 OS=Homo 
sapiens GN=AHSA1 PE=2 SV=1 
B4DUR9_HUMAN 0.98 3 4 0 0 0 3 0 4 
Gastric inhibitory polypeptide 
receptor OS=Homo sapiens GN=GIPR 
PE=1 SV=1 
sp|P48546|GIPR_HUMAN 0.36 0 0 0 0 0 0 5 0 
sp|P61088|UBE2N_HUMAN 
Ubiquitin-conjugating enzyme E2 N 
OS=Homo sapiens GN=UBE2N PE=1 
SV=1 
sp|P61088|UBE2N_HUMANUbiquitin-
conjugating enzyme E2 N OS=Homo sapiens 
GN=UBE2N PE=1 SV=1 
0.79 17 1 0 0 3 6 4 0 
Synaptogyrin-2 OS=Homo sapiens 
GN=SYNGR2 PE=1 SV=1 
SNG2_HUMAN 0.41 2 1 4 5 5 8 3 3 
Isoform 5 of Four and a half LIM 
domains protein 1 OS=Homo sapiens 
GN=FHL1 
sp|Q13642-5|FHL1_HUMAN 0.89 0 0 1 0 0 5 1 4 
sp|Q9Y5K6|CD2AP_HUMAN CD2-
associated protein OS=Homo sapiens 
GN=CD2AP PE=1 SV=1 
sp|Q9Y5K6|CD2AP_HUMANCD2-associated 
protein OS=Homo sapiens GN=CD2AP PE=1 SV=1 
0.23 2 1 1 1 1 0 2 0 
sp|Q9UL25|RAB21_HUMAN Ras-
related protein Rab-21 OS=Homo 
sapiens GN=RAB21 PE=1 SV=3 
sp|Q9UL25|RAB21_HUMANRas-related protein 
Rab-21 OS=Homo sapiens GN=RAB21 PE=1 SV=3 
0.84 0 5 1 2 2 5 5 0 
sp|Q9BUL8|PDC10_HUMAN 
Programmed cell death protein 10 
OS=Homo sapiens GN=PDCD10 PE=1 
SV=1 
sp|Q9BUL8|PDC10_HUMANProgrammed cell 
death protein 10 OS=Homo sapiens GN=PDCD10 
PE=1 SV=1 
0.52 0 4 0 0 0 3 5 0 
sp|Q14258|TRI25_HUMAN E3 
ubiquitin/ISG15 ligase TRIM25 
OS=Homo sapiens GN=TRIM25 PE=1 
SV=2 
sp|Q14258|TRI25_HUMANE3 ubiquitin/ISG15 
ligase TRIM25 OS=Homo sapiens GN=TRIM25 
PE=1 SV=2 
0.55 3 0 0 0 0 1 0 0 
Histidine--tRNA ligase, cytoplasmic 
OS=Homo sapiens GN=HARS PE=2 
SV=1 
B3KWE1_HUMAN 0.55 0 8 6 0 0 9 5 6 
sp|P09936|UCHL1_HUMAN 
Ubiquitin carboxyl-terminal 
hydrolase isozyme L1 OS=Homo 
sapiens GN=UCHL1 PE=1 SV=2 
sp|P09936|UCHL1_HUMANUbiquitin carboxyl-
terminal hydrolase isozyme L1 OS=Homo sapiens 
GN=UCHL1 PE=1 SV=2 
0.064 0 1 0 0 0 7 8 3 
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CapZ-interacting protein OS=Homo 
sapiens GN=RCSD1 PE=2 SV=1 
B7ZKW8_HUMAN 0.36 8 0 0 0 0 0 0 0 
sp|P31944|CASPE_HUMAN Caspase-
14 OS=Homo sapiens GN=CASP14 
PE=1 SV=2 
sp|P31944|CASPE_HUMANCaspase-14 
OS=Homo sapiens GN=CASP14 PE=1 SV=2 
0.87 0 0 0 14 14 0 6 0 
sp|P01860|IGHG3_HUMAN Ig 
gamma-3 chain C region OS=Homo 
sapiens GN=IGHG3 PE=1 SV=2 
sp|P01860|IGHG3_HUMANIg gamma-3 chain C 
region OS=Homo sapiens GN=IGHG3 PE=1 SV=2 
0.45 1 6 1 3 3 5 5 4 
Isoform 2 of Microfibril-associated 
glycoprotein 4 OS=Homo sapiens 
GN=MFAP4 
MFAP4_HUMAN 0.5 0 4 0 0 0 0 0 1 
sp|O95861|BPNT1_HUMAN 3'(2'),5'-
bisphosphate nucleotidase 1 
OS=Homo sapiens GN=BPNT1 PE=1 
SV=1 
sp|O95861|BPNT1_HUMAN3'(2'),5'-
bisphosphate nucleotidase 1 OS=Homo sapiens 
GN=BPNT1 PE=1 SV=1 
0.17 1 12 1 0 0 1 2 0 
sp|P16562|CRIS2_HUMAN Cysteine-
rich secretory protein 2 OS=Homo 
sapiens GN=CRISP2 PE=1 SV=1 
sp|P16562|CRIS2_HUMANCysteine-rich 
secretory protein 2 OS=Homo sapiens GN=CRISP2 
PE=1 SV=1 
0.59 2 7 0 0 0 0 11 5 
60S acidic ribosomal protein P0 
OS=Homo sapiens GN=RPLP0 PE=1 
SV=1 
RLA0_HUMAN 0.68 2 0 0 0 0 1 0 0 
sp|Q9NZH0|GPC5B_HUMAN G-
protein coupled receptor family C 
group 5 member B OS=Homo sapiens 
GN=GPRC5B PE=2 SV=2 
sp|Q9NZH0|GPC5B_HUMANG-protein coupled 
receptor family C group 5 member B OS=Homo 
sapiens GN=GPRC5B PE=2 SV=2 
0.16 0 0 0 0 3 0 6 0 
Putative gamma-
glutamyltranspeptidase 3 OS=Homo 
sapiens GN=GGT3P PE=5 SV=2 
GGT3_HUMAN 1 13 9 0 0 0 11 0 9 
Desmoglein-2 OS=Homo sapiens 
GN=DSG2 PE=1 SV=2 
DSG2_HUMAN 0.5 1 2 1 3 3 4 2 3 
sp|O00264|PGRC1_HUMAN 
Membrane-associated progesterone 
receptor component 1 OS=Homo 
sapiens GN=PGRMC1 PE=1 SV=3 
sp|O00264|PGRC1_HUMANMembrane-
associated progesterone receptor component 1 
OS=Homo sapiens GN=PGRMC1 PE=1 SV=3 
0.25 2 10 0 0 7 0 14 9 
Isoform 2 of Gamma-
glutamyltranspeptidase 1 OS=Homo 
sapiens GN=GGT1 
sp|P19440-2|GGT1_HUMAN 0.42 0 0 13 10 10 0 13 0 
sp|P26599|PTBP1_HUMAN 
Polypyrimidine tract-binding protein 
1 OS=Homo sapiens GN=PTBP1... 
sp|P26599|PTBP1_HUMANPolypyrimidine tract-
binding protein 1 OS=Homo sapiens GN=PTBP1 
PE=1 SV=1 
0.36 10 0 0 0 0 0 0 0 
Cytochrome c (Fragment) OS=Homo 
sapiens GN=CYCS PE=2 SV=1 
C9JFR7_HUMAN (+2) 0.63 2 5 2 7 7 9 10 6 
Insulin-like growth factor-binding 
protein 5 (Fragment) OS=Homo 
sapiens GN=IGFBP5 PE=2 SV=1 
C9JXX4_HUMAN 0.36 0 0 3 0 0 0 0 0 
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H2B type 1-A OS=Homo sapiens 
GN=HIST1H2BA PE=1 SV=3 
sp|Q96A08|H2B1A_HUMANHistone H2B type 1-
A OS=Homo sapiens GN=HIST1H2BA PE=1 SV=3 
0.33 3 1 0 9 9 0 14 0 
sp|Q9Y696|CLIC4_HUMAN Chloride 
intracellular channel protein 4 
OS=Homo sapiens GN=CLIC4 PE=1 
SV=4 
sp|Q9Y696|CLIC4_HUMANChloride intracellular 
channel protein 4 OS=Homo sapiens GN=CLIC4 
PE=1 SV=4 
0.25 0 3 0 0 1 0 7 0 
sp|P59998|ARPC4_HUMAN Actin-
related protein 2/3 complex subunit 
4 OS=Homo sapiens GN=ARPC4 PE=1 
SV=3 
sp|P59998|ARPC4_HUMANActin-related protein 
2/3 complex subunit 4 OS=Homo sapiens 
GN=ARPC4 PE=1 SV=3 
0.44 14 5 0 0 10 9 14 0 
sp|Q9H9S4|CB39L_HUMAN 
Calcium-binding protein 39-like 
OS=Homo sapiens GN=CAB39L 
PE=1... 
sp|Q9H9S4|CB39L_HUMANCalcium-binding 
protein 39-like OS=Homo sapiens GN=CAB39L 
PE=1 SV=3 
0.88 3 12 0 0 8 0 8 0 
sp|Q9BS26|ERP44_HUMAN 
Endoplasmic reticulum resident 
protein 44 OS=Homo sapiens 
GN=ERP44 PE=1 SV=1 
sp|Q9BS26|ERP44_HUMANEndoplasmic 
reticulum resident protein 44 OS=Homo sapiens 
GN=ERP44 PE=1 SV=1 
0.63 1 3 0 0 1 0 6 0 
Transferrin receptor protein 1 
OS=Homo sapiens GN=TFRC PE=1 
SV=2 
TFR1_HUMAN 0.66 0 1 0 0 0 0 0 2 
sp|Q8IUE6|H2A2B_HUMAN Histone 
H2A type 2-B OS=Homo sapiens 
GN=HIST2H2AB PE=1 SV=3 
sp|Q8IUE6|H2A2B_HUMANHistone H2A type 2-B 
OS=Homo sapiens GN=HIST2H2AB PE=1 SV=3 
0.72 10 0 0 0 6 5 13 0 
Isoform 2 of Insulin-like growth 
factor-binding protein 7 OS=Homo 
sapiens GN=IGFBP7 
sp|Q16270-2|IBP7_HUMAN 0.16 0 0 0 0 0 5 0 3 
sp|P01597|KV105_HUMAN Ig kappa 
chain V-I region DEE OS=Homo 
sapiens PE=1 SV=1 
sp|P01597|KV105_HUMANIg kappa chain V-I 
region DEE OS=Homo sapiens PE=1 SV=1 
0.1 9 8 2 6 6 4 5 1 
Isoform 2 of GDNF family receptor 
alpha-2 OS=Homo sapiens 
GN=GFRA2 
sp|O00451-2|GFRA2_HUMAN 0.38 0 0 8 6 6 4 0 0 
sp|O75610|LFTY1_HUMAN Left-
right determination factor 1 
OS=Homo sapiens GN=LEFTY1 PE=2 
SV=1 
sp|O75610|LFTY1_HUMANLeft-right 
determination factor 1 OS=Homo sapiens 
GN=LEFTY1 PE=2 SV=1 
0.9 0 9 0 0 1 0 5 3 
Lumican OS=Homo sapiens GN=LUM 
PE=1 SV=2 
LUM_HUMAN 0.36 0 6 0 0 0 12 1 5 
sp|Q9NS25|SPNXB_HUMAN Sperm 
protein associated with the nucleus 
on the X chromosome B/F OS=Homo 
sapiens GN=SPANXB1 PE=2 SV=1 
sp|Q9NS25|SPNXB_HUMANSperm protein 
associated with the nucleus on the X 
chromosome B/F OS=Homo sapiens 
GN=SPANXB1 PE=2 SV=1 
0.045 0 0 0 0 8 4 18 3 
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Histone H1.5 OS=Homo sapiens 
GN=HIST1H1B PE=1 SV=3 
H15_HUMAN 0.36 68 0 0 0 0 0 0 0 
ADP-ribosylation factor 6 OS=Homo 
sapiens GN=ARF6 PE=1 SV=2 
ARF6_HUMAN 0.36 6 2 7 1 1 7 3 0 
sp|P25705|ATPA_HUMAN ATP 
synthase subunit alpha, 
mitochondrial OS=Homo sapiens 
GN=ATP5A1... 
sp|P25705|ATPA_HUMAN ATP synthase subunit 
alpha, mitochondrial OS=Homo sapiens 
GN=ATP5A1... 
0.34 32 4 2 1 1 3 12 2 
Rho guanine nucleotide exchange 
factor 2 OS=Homo sapiens 
GN=ARHGEF2 PE=2 SV=1 
Q5VY93_HUMAN 0.36 2 0 0 0 0 0 0 0 
sp|Q5GAN3|RNS13_HUMAN 
Probable inactive ribonuclease-like 
protein 13 OS=Homo sapiens 
GN=RNASE13 PE=2 SV=1 
sp|Q5GAN3|RNS13_HUMANProbable inactive 
ribonuclease-like protein 13 OS=Homo sapiens 
GN=RNASE13 PE=2 SV=1 
0.13 0 10 0 0 0 20 9 15 
Pyridoxine-5'-phosphate oxidase 
OS=Homo sapiens GN=PNPO PE=2 
SV=1 
B4E152_HUMAN 0.54 1 5 0 0 0 11 0 2 
sp|Q8WWA0|ITLN1_HUMAN 
Intelectin-1 OS=Homo sapiens 
GN=ITLN1 PE=1 SV=1 
sp|Q8WWA0|ITLN1_HUMANIntelectin-1 
OS=Homo sapiens GN=ITLN1 PE=1 SV=1 
0.71 0 7 0 0 0 0 2 2 
60S ribosomal protein L4 OS=Homo 
sapiens GN=RPL4 PE=1 SV=5 
RL4_HUMAN 0.16 10 0 1 0 0 0 0 0 
Isoform 2 of 40S ribosomal protein 
S20 OS=Homo sapiens GN=RPS20 
sp|P60866-2|RS20_HUMAN 0.19 23 0 3 3 3 3 3 2 
Isoform 2 of NADH-cytochrome b5 
reductase 3 OS=Homo sapiens 
GN=CYB5R3 
sp|P00387-2|NB5R3_HUMAN 0.49 1 0 1 3 3 4 4 6 
2,4-dienoyl-CoA reductase, 
mitochondrial OS=Homo sapiens 
GN=DECR1 PE=2 SV=1 
B7Z6B8_HUMAN 0.031 0 0 0 2 2 3 3 2 
Muscleblind-like protein 1 OS=Homo 
sapiens GN=MBNL1 PE=2 SV=1 
C9JP00_HUMAN 0.36 2 0 0 0 0 0 0 0 
Glutamine synthetase OS=Homo 
sapiens GN=GLUL PE=1 SV=4 
GLNA_HUMAN 0.49 0 3 1 0 0 1 2 2 
sp|Q15102|PA1B3_HUMAN 
Platelet-activating factor 
acetylhydrolase IB subunit gamma 
OS=Homo sapiens GN=PAFAH1B3 
PE=1 SV=1 
sp|Q15102|PA1B3_HUMANPlatelet-activating 
factor acetylhydrolase IB subunit gamma 
OS=Homo sapiens GN=PAFAH1B3 PE=1 SV=1 
0.99 4 14 0 0 8 0 9 0 
sp|Q7Z5L9|I2BP2_HUMAN 
Interferon regulatory factor 2-
binding protein 2 OS=Homo 
sapiens... 
sp|Q7Z5L9|I2BP2_HUMANInterferon regulatory 
factor 2-binding protein 2 OS=Homo sapiens 
GN=IRF2BP2 PE=1 SV=2 
0.36 21 0 0 0 0 0 0 0 
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70 protein, mitochondrial OS=Homo 
sapiens GN=HSPA9 PE=1 SV=2 
sp|P38646|GRP75_HUMANStress-70 protein, 
mitochondrial OS=Homo sapiens GN=HSPA9 PE=1 
SV=2 
0.44 6 0 0 0 0 0 1 0 
Histidine-rich glycoprotein OS=Homo 
sapiens GN=HRG PE=1 SV=1 
HRG_HUMAN 0.36 0 0 0 0 0 3 0 0 
sp|Q9NS86|LANC2_HUMAN LanC-
like protein 2 OS=Homo sapiens 
GN=LANCL2 PE=1 SV=1 
sp|Q9NS86|LANC2_HUMANLanC-like protein 2 
OS=Homo sapiens GN=LANCL2 PE=1 SV=1 
0.66 0 1 0 0 0 0 2 0 
sp|Q8NC51|PAIRB_HUMAN 
Plasminogen activator inhibitor 1 
RNA-binding protein OS=Homo 
sapiens GN=SERBP1 PE=1 SV=2 
sp|Q8NC51|PAIRB_HUMANPlasminogen 
activator inhibitor 1 RNA-binding protein 
OS=Homo sapiens GN=SERBP1 PE=1 SV=2 
0.36 22 0 0 0 0 0 0 0 
sp|Q8WU79|SMAP2_HUMAN 
Stromal membrane-associated 
protein 2 OS=Homo sapiens 
GN=SMAP2 PE=1 SV=1 
sp|Q8WU79|SMAP2_HUMANStromal 
membrane-associated protein 2 OS=Homo 
sapiens GN=SMAP2 PE=1 SV=1 
0.36 34 0 0 0 0 0 0 0 
Complement factor I OS=Homo 
sapiens GN=CFI PE=1 SV=2 
CFAI_HUMAN 0.61 1 8 3 4 4 2 10 4 
Isoform 3 of Glucose-6-phosphate 1-
dehydrogenase OS=Homo sapiens 
GN=G6PD 
sp|P11413-3|G6PD_HUMAN 0.45 1 0 4 1 1 3 3 0 
Isoform 2 of Tubulin alpha-3C/D 
chain OS=Homo sapiens GN=TUBA3C 
TBA3C_HUMAN 0.26 4 2 0 1 1 7 3 4 
Isoform 2 of N-acetylmuramoyl-L-
alanine amidase OS=Homo sapiens 
GN=PGLYRP2 
PGRP2_HUMAN 0.41 0 5 7 1 1 5 4 2 
sp|P54727|RD23B_HUMAN UV 
excision repair protein RAD23 
homolog B OS=Homo sapiens... 
sp|P54727|RD23B_HUMANUV excision repair 
protein RAD23 homolog B OS=Homo sapiens 
GN=RAD23B PE=1 SV=1 
0.46 10 2 0 0 1 0 3 0 
sp|Q9NZP8|C1RL_HUMAN 
Complement C1r subcomponent-like 
protein OS=Homo sapiens 
GN=C1RL... 
sp|Q9NZP8|C1RL_HUMAN Complement C1r 
subcomponent-like protein OS=Homo sapiens 
GN=C1RL... 
0.53 1 12 3 2 2 11 8 6 
Tubulin beta chain OS=Homo sapiens 
GN=TUBB PE=1 SV=2 
TBB5_HUMAN 0.37 13 2 3 2 2 3 2 2 
Protein NOV homolog OS=Homo 
sapiens GN=NOV PE=1 SV=1 
NOV_HUMAN 0.75 0 3 0 1 1 1 1 0 
sp|Q05639|EF1A2_HUMAN 
Elongation factor 1-alpha 2 
OS=Homo sapiens GN=EEF1A2 PE=1 
SV=1 
sp|Q05639|EF1A2_HUMANElongation factor 1-
alpha 2 OS=Homo sapiens GN=EEF1A2 PE=1 SV=1 
0.83 0 1 2 0 0 0 0 0 
Ras-related protein R-Ras2 OS=Homo 
sapiens GN=RRAS2 PE=2 SV=1 
B7Z5Z2_HUMAN 0.095 0 2 0 1 1 5 3 2 
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Mitochondrial dicarboxylate carrier 
OS=Homo sapiens GN=SLC25A10 
PE=2 SV=1 
B4DLN1_HUMAN 0.36 7 0 0 0 0 0 0 0 
sp|Q92692|PVRL2_HUMAN 
Poliovirus receptor-related protein 2 
OS=Homo sapiens GN=PVRL2 PE=1 
SV=1 
sp|Q92692|PVRL2_HUMANPoliovirus receptor-
related protein 2 OS=Homo sapiens GN=PVRL2 
PE=1 SV=1 
0.66 3 2 0 0 2 1 0 0 
sp|Q9H993|CF211_HUMAN 
UPF0364 protein C6orf211 OS=Homo 
sapiens GN=C6orf211 PE=1 SV=1 
sp|Q9H993|CF211_HUMANUPF0364 protein 
C6orf211 OS=Homo sapiens GN=C6orf211 PE=1 
SV=1 
0.27 1 4 1 0 0 1 1 2 
Isoform 2 of Prominin-2 OS=Homo 
sapiens GN=PROM2 
sp|Q8N271-2|PROM2_HUMAN 0.64 4 2 0 0 0 1 1 2 
GDP-L-fucose synthase OS=Homo 
sapiens GN=TSTA3 PE=1 SV=1 
FCL_HUMAN 0.22 4 3 0 1 1 0 1 1 
sp|Q9NPF2|CHSTB_HUMAN 
Carbohydrate sulfotransferase 11 
OS=Homo sapiens GN=CHST11... 
sp|Q9NPF2|CHSTB_HUMANCarbohydrate 
sulfotransferase 11 OS=Homo sapiens 
GN=CHST11 PE=1 SV=1 
0.93 6 4 0 0 2 4 3 0 
sp|P07864|LDHC_HUMAN L-lactate 
dehydrogenase C chain OS=Homo 
sapiens GN=LDHC PE=1... 
sp|P07864|LDHC_HUMAN L-lactate 
dehydrogenase C chain OS=Homo sapiens 
GN=LDHC PE=1... 
0.88 1 14 1 2 2 13 6 0 
Transmembrane emp24 domain-
containing protein 2 (Fragment) 
OS=Homo sapiens GN=TMED2 PE=2 
SV=2 
E7EQ72_HUMAN 0.36 0 0 0 0 0 9 0 0 
sp|P13645|K1C10_HUMAN Keratin, 
type I cytoskeletal 10 OS=Homo 
sapiens GN=KRT10 PE=1 SV=6 
sp|P13645|K1C10_HUMANKeratin, type I 
cytoskeletal 10 OS=Homo sapiens GN=KRT10 
PE=1 SV=6 
0.14 0 2 0 0 6 0 7 6 
Gamma-enolase OS=Homo sapiens 
GN=ENO2 PE=1 SV=3 
ENOG_HUMAN 0.3 0 2 4 0 0 0 0 0 
sp|Q15654|TRIP6_HUMAN Thyroid 
receptor-interacting protein 6 
OS=Homo sapiens GN=TRIP6 PE=1 
SV=3 
sp|Q15654|TRIP6_HUMANThyroid receptor-
interacting protein 6 OS=Homo sapiens 
GN=TRIP6 PE=1 SV=3 
0.36 18 0 0 0 0 0 0 0 
Calpain-5 OS=Homo sapiens 
GN=CAPN5 PE=2 SV=2 
E7EV01_HUMAN 0.22 0 6 1 1 1 2 1 0 
40S ribosomal protein S3a OS=Homo 
sapiens GN=RPS3A PE=1 SV=2 
RS3A_HUMAN 0.13 17 1 1 2 2 2 1 0 
sp|O75955|FLOT1_HUMAN Flotillin-
1 OS=Homo sapiens GN=FLOT1 PE=1 
SV=3 
sp|O75955|FLOT1_HUMANFlotillin-1 OS=Homo 
sapiens GN=FLOT1 PE=1 SV=3 
0.92 0 1 1 0 0 1 3 2 
sp|P51665|PSMD7_HUMAN 26S 
proteasome non-ATPase regulatory 
subunit 7 OS=Homo sapiens... 
sp|P51665|PSMD7_HUMAN26S proteasome 
non-ATPase regulatory subunit 7 OS=Homo 
sapiens GN=PSMD7 PE=1 SV=2 
0.53 0 5 2 0 1 4 2 3 
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OS=Homo sapiens GN=GALNT2 PE=1 
SV=1 
sp|Q10471|GALT2_HUMANPolypeptide N-
acetylgalactosaminyltransferase 2 OS=Homo 
sapiens GN=GALNT2 PE=1 SV=1 
0.95 0 4 0 0 1 0 1 1 
Isoform 2 of V-type proton ATPase 
subunit H OS=Homo sapiens 
GN=ATP6V1H 
sp|Q9UI12-2|VATH_HUMAN 0.36 0 0 0 0 0 3 0 0 
sp|Q9NRX4|PHP14_HUMAN 14 kDa 
phosphohistidine phosphatase 
OS=Homo sapiens GN=PHPT1 PE=1 
SV=1 
sp|Q9NRX4|PHP14_HUMAN14 kDa 
phosphohistidine phosphatase OS=Homo sapiens 
GN=PHPT1 PE=1 SV=1 
0.036 3 0 0 0 11 13 6 2 
tr|E7ER45|E7ER45_HUMAN 
Maltase-glucoamylase, intestinal 
OS=Homo sapiens GN=MGAM 
PE=4... 
tr|E7ER45|E7ER45_HUMAN Maltase-
glucoamylase, intestinal OS=Homo sapiens 
GN=MGAM PE=4... 
0.7 2 10 0 0 0 17 0 5 
sp|P0CG12|CTF8A_HUMAN 
Chromosome transmission fidelity 
protein 8 homolog isoform 2 
OS=Homo sapiens GN=CHTF8 PE=1 
SV=1 
sp|P0CG12|CTF8A_HUMANChromosome 
transmission fidelity protein 8 homolog isoform 2 
OS=Homo sapiens GN=CHTF8 PE=1 SV=1 
0.36 18 0 0 0 0 0 0 0 
sp|P63313|TYB10_HUMAN 
Thymosin beta-10 OS=Homo sapiens 
GN=TMSB10 PE=1 SV=2 
sp|P63313|TYB10_HUMANThymosin beta-10 
OS=Homo sapiens GN=TMSB10 PE=1 SV=2 
0.36 61 0 0 0 0 0 0 0 
sp|P07225|PROS_HUMAN Vitamin 
K-dependent protein S OS=Homo 
sapiens GN=PROS1 PE=1... 
sp|P07225|PROS_HUMAN Vitamin K-dependent 
protein S OS=Homo sapiens GN=PROS1 PE=1... 
0.57 3 3 2 8 8 3 7 10 
sp|P55786|PSA_HUMAN Puromycin-
sensitive aminopeptidase OS=Homo 
sapiens GN=NPEPPS... 
sp|P55786|PSA_HUMAN Puromycin-sensitive 
aminopeptidase OS=Homo sapiens GN=NPEPPS... 
0.4 4 6 14 4 4 11 7 4 
Isoform 3 of Argininosuccinate lyase 
OS=Homo sapiens GN=ASL 
sp|P04424-3|ARLY_HUMAN 0.42 2 0 6 0 0 3 2 2 
sp|Q13443|ADAM9_HUMAN 
Disintegrin and metalloproteinase 
domain-containing protein... 
sp|Q13443|ADAM9_HUMANDisintegrin and 
metalloproteinase domain-containing protein 9 
OS=Homo sapiens GN=ADAM9 PE=1 SV=1 
0.53 1 8 0 0 5 2 6 1 
Oligoribonuclease, mitochondrial 
OS=Homo sapiens GN=REXO2 PE=1 
SV=3 
ORN_HUMAN 0.71 0 7 0 0 0 0 2 2 
Gamma-glutamyl hydrolase 
OS=Homo sapiens GN=GGH PE=1 
SV=2 
GGH_HUMAN 0.18 2 4 0 0 0 3 13 8 
sp|Q13283|G3BP1_HUMAN Ras 
GTPase-activating protein-binding 
protein 1 OS=Homo sapiens 
GN=G3BP1 PE=1 SV=1 
sp|Q13283|G3BP1_HUMANRas GTPase-
activating protein-binding protein 1 OS=Homo 
sapiens GN=G3BP1 PE=1 SV=1 
0.36 17 0 0 0 0 0 0 0 
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binding protein 14 OS=Homo sapiens 
GN=RBM14 PE=1 SV=2 
sp|Q96PK6|RBM14_HUMANRNA-binding protein 
14 OS=Homo sapiens GN=RBM14 PE=1 SV=2 
0.36 15 0 0 0 0 0 0 0 
Isoform 2 of Serine/threonine-
protein phosphatase 2B catalytic 
subunit alpha isoform OS=Homo 
sapiens GN=PPP3CA 
sp|Q08209-2|PP2BA_HUMAN 0.39 0 0 6 0 0 0 3 0 
40S ribosomal protein S2 OS=Homo 
sapiens GN=RPS2 PE=1 SV=2 
RS2_HUMAN 0.51 1 3 2 3 3 8 4 0 
sp|P08727|K1C19_HUMAN Keratin, 
type I cytoskeletal 19 OS=Homo 
sapiens GN=KRT19 PE=1... 
sp|P08727|K1C19_HUMANKeratin, type I 
cytoskeletal 19 OS=Homo sapiens GN=KRT19 
PE=1 SV=4 
0.17 0 1 1 0 2 0 1 2 
sp|Q5T4F7|SFRP5_HUMAN Secreted 
frizzled-related protein 5 OS=Homo 
sapiens GN=SFRP5 PE=2 SV=3 
sp|Q5T4F7|SFRP5_HUMANSecreted frizzled-
related protein 5 OS=Homo sapiens GN=SFRP5 
PE=2 SV=3 
0.13 2 0 0 0 3 4 2 0 
sp|Q32P51|RA1L2_HUMAN 
Heterogeneous nuclear 
ribonucleoprotein A1-like 2 
OS=Homo sapiens GN=HNRNPA1L2 
PE=2 SV=2 
sp|Q32P51|RA1L2_HUMANHeterogeneous 
nuclear ribonucleoprotein A1-like 2 OS=Homo 
sapiens GN=HNRNPA1L2 PE=2 SV=2 
0.36 16 0 0 0 0 0 0 0 
BAG family molecular chaperone 
regulator 3 OS=Homo sapiens 
GN=BAG3 PE=1 SV=3 
BAG3_HUMAN 0.36 4 0 0 0 0 0 0 0 
sp|Q9H307|PININ_HUMAN Pinin 
OS=Homo sapiens GN=PNN PE=1 
SV=4 
sp|Q9H307|PININ_HUMANPinin OS=Homo 
sapiens GN=PNN PE=1 SV=4 
0.36 9 0 0 0 0 0 0 0 
sp|Q9UIK5|TEFF2_HUMAN 
Tomoregulin-2 OS=Homo sapiens 
GN=TMEFF2 PE=1 SV=1 
sp|Q9UIK5|TEFF2_HUMANTomoregulin-2 
OS=Homo sapiens GN=TMEFF2 PE=1 SV=1 
0.24 0 0 0 0 0 4 0 1 
sp|Q5T754|LCE1F_HUMAN Late 
cornified envelope protein 1F 
OS=Homo sapiens GN=LCE1F PE=2 
SV=1 
sp|Q5T754|LCE1F_HUMANLate cornified 
envelope protein 1F OS=Homo sapiens GN=LCE1F 
PE=2 SV=1 
0.36 0 0 0 0 0 3 0 0 
sp|Q14166|TTL12_HUMAN Tubulin--
tyrosine ligase-like protein 12 
OS=Homo sapiens GN=TTLL12... 
sp|Q14166|TTL12_HUMANTubulin--tyrosine 
ligase-like protein 12 OS=Homo sapiens 
GN=TTLL12 PE=1 SV=2 







member 3 OS=Homo sapiens GN=ENPP3 PE=1 
SV=2 
0.95 2 4 0 0 2 0 2 1 
sp|P30530-2|UFO_HUMAN Isoform 
Short of Tyrosine-protein kinase 
receptor UFO OS=Homo sapiens 
GN=AXL 
sp|P30530-2|UFO_HUMANIsoform Short of 
Tyrosine-protein kinase receptor UFO OS=Homo 
sapiens GN=AXL 
0.56 1 2 0 0 1 0 5 0 
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Pyrroline-5-carboxylate reductase 3 
OS=Homo sapiens GN=PYCRL PE=1 
SV=2 
sp|Q53H96|P5CR3_HUMANPyrroline-5-
carboxylate reductase 3 OS=Homo sapiens 
GN=PYCRL PE=1 SV=2 
0.61 5 2 0 0 5 0 6 0 
sp|O43291|SPIT2_HUMAN Kunitz-
type protease inhibitor 2 OS=Homo 
sapiens GN=SPINT2 PE=1 SV=2 
sp|O43291|SPIT2_HUMANKunitz-type protease 
inhibitor 2 OS=Homo sapiens GN=SPINT2 PE=1 
SV=2 
0.91 5 12 0 0 9 8 0 0 
Isoform 6 of Splicing factor 1 
OS=Homo sapiens GN=SF1 
sp|Q15637-6|SF01_HUMAN 0.36 19 0 0 0 0 0 0 0 
Putative hydroxypyruvate isomerase 
OS=Homo sapiens GN=HYI PE=1 
SV=2 
HYI_HUMAN 0.18 5 12 0 0 0 0 0 0 
Aldose 1-epimerase OS=Homo 
sapiens GN=GALM PE=1 SV=1 
GALM_HUMAN 0.15 5 7 3 4 4 3 1 2 
60S ribosomal protein L11 OS=Homo 
sapiens GN=RPL11 PE=1 SV=2 
sp|P62913|RL11_HUMAN 0.36 1 1 8 5 5 3 1 4 
Ferritin light chain OS=Homo sapiens 
GN=FTL PE=1 SV=2 
FRIL_HUMAN 0.38 1 4 5 1 1 4 2 5 
Immunoglobulin J chain (Fragment) 
OS=Homo sapiens GN=IGJ PE=2 SV=1 
D6RD17_HUMAN 0.4 0 0 6 2 2 0 8 0 
ADP/ATP translocase 4 OS=Homo 
sapiens GN=SLC25A31 PE=2 SV=1 
ADT4_HUMAN 0.36 0 0 0 0 0 0 3 0 
sp|P67809|YBOX1_HUMAN 
Nuclease-sensitive element-binding 
protein 1 OS=Homo sapiens... 
sp|P67809|YBOX1_HUMANNuclease-sensitive 
element-binding protein 1 OS=Homo sapiens 
GN=YBX1 PE=1 SV=3 
0.36 21 0 0 0 0 0 0 0 
Hematological and neurological-
expressed 1-like protein OS=Homo 
sapiens GN=HN1L PE=2 SV=1 
B4DLH4_HUMAN 0.38 23 0 0 0 0 0 1 0 
sp|P04207|KV308_HUMAN Ig kappa 
chain V-III region CLL OS=Homo 
sapiens PE=1 SV=2 
sp|P04207|KV308_HUMANIg kappa chain V-III 
region CLL OS=Homo sapiens PE=1 SV=2 
0.31 4 3 2 2 2 3 3 2 
sp|O43915|VEGFD_HUMAN 
Vascular endothelial growth factor D 
OS=Homo sapiens GN=FIGF PE=1 
SV=1 
sp|O43915|VEGFD_HUMANVascular endothelial 
growth factor D OS=Homo sapiens GN=FIGF PE=1 
SV=1 
0.15 0 0 0 0 0 0 3 2 
sp|Q86VR7|VS10L_HUMAN V-set 
and immunoglobulin domain-
containing protein 10-like... 
sp|Q86VR7|VS10L_HUMANV-set and 
immunoglobulin domain-containing protein 10-
like OS=Homo sapiens GN=VSIG10L PE=2 SV=2 
0.76 0 5 0 0 0 2 1 0 
sp|Q5VWZ2|LYPL1_HUMAN 
Lysophospholipase-like protein 1 
OS=Homo sapiens GN=LYPLAL1... 
sp|Q5VWZ2|LYPL1_HUMANLysophospholipase-
like protein 1 OS=Homo sapiens GN=LYPLAL1 
PE=1 SV=3 
0.91 2 4 0 0 4 2 0 0 
sp|Q9Y2W2|WBP11_HUMAN WW 
domain-binding protein 11 
OS=Homo sapiens GN=WBP11 PE=1 
SV=1 
sp|Q9Y2W2|WBP11_HUMANWW domain-
binding protein 11 OS=Homo sapiens GN=WBP11 
PE=1 SV=1 
0.36 5 0 0 0 0 0 0 0 
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Cytoplasmic of Fumarate hydratase, 
mitochondrial OS=Homo... (+1) 
0.56 1 6 2 6 6 6 8 9 
Isoform 3 of Selenium-binding 
protein 1 OS=Homo sapiens 
GN=SELENBP1 
sp|Q13228-3|SBP1_HUMAN 0.36 0 2 3 6 6 2 2 3 
sp|O60513|B4GT4_HUMAN Beta-
1,4-galactosyltransferase 4 
OS=Homo sapiens GN=B4GALT4... 
sp|O60513|B4GT4_HUMANBeta-1,4-
galactosyltransferase 4 OS=Homo sapiens 
GN=B4GALT4 PE=1 SV=1 




family member 5 OS=Homo sapiens 
GN=ENPP5 PE=1 SV=1 
sp|Q9UJA9|ENPP5_HUMANEctonucleotide 
pyrophosphatase/phosphodiesterase family 
member 5 OS=Homo sapiens GN=ENPP5 PE=1 
SV=1 
0.68 4 2 0 0 1 2 1 0 
sp|O75556|SG2A1_HUMAN 
Mammaglobin-B OS=Homo sapiens 
GN=SCGB2A1 PE=1 SV=1 
sp|O75556|SG2A1_HUMANMammaglobin-B 
OS=Homo sapiens GN=SCGB2A1 PE=1 SV=1 
0.55 4 21 0 0 5 4 2 0 
sp|Q99733|NP1L4_HUMAN 
Nucleosome assembly protein 1-like 
4 OS=Homo sapiens GN=NAP1L4 
PE=1 SV=1 
sp|Q99733|NP1L4_HUMANNucleosome 
assembly protein 1-like 4 OS=Homo sapiens 
GN=NAP1L4 PE=1 SV=1 
0.31 4 1 0 0 0 1 0 0 
Heterogeneous nuclear 
ribonucleoprotein H OS=Homo 
sapiens GN=HNRNPH1 PE=2 SV=1 
G8JLB6_HUMAN 0.36 15 0 0 0 0 0 0 0 
sp|Q9UQB8|BAIP2_HUMAN Brain-
specific angiogenesis inhibitor 1-
associated protein 2 OS=Homo 
sapiens GN=BAIAP2 PE=1 SV=1 
sp|Q9UQB8|BAIP2_HUMANBrain-specific 
angiogenesis inhibitor 1-associated protein 2 
OS=Homo sapiens GN=BAIAP2 PE=1 SV=1 
0.31 5 10 0 0 6 0 10 6 
sp|P0C7P4|UCRIL_HUMAN Putative 
cytochrome b-c1 complex subunit 
Rieske-like protein 1 OS=Homo 
sapiens GN=UQCRFS1P1 PE=5 SV=1 
sp|P0C7P4|UCRIL_HUMANPutative cytochrome 
b-c1 complex subunit Rieske-like protein 1 
OS=Homo sapiens GN=UQCRFS1P1 PE=5 SV=1 
0.46 5 0 0 0 0 0 1 0 
sp|P49223|SPIT3_HUMAN Kunitz-
type protease inhibitor 3 OS=Homo 
sapiens GN=SPINT3 PE=2 SV=3 
sp|P49223|SPIT3_HUMANKunitz-type protease 
inhibitor 3 OS=Homo sapiens GN=SPINT3 PE=2 
SV=3 
0.74 9 0 0 0 1 8 0 4 
Granulins OS=Homo sapiens 
GN=GRN PE=1 SV=2 
GRN_HUMAN 0.42 7 0 0 0 1 0 8 0 
cAMP-dependent protein kinase 
type I-alpha regulatory subunit 
OS=Homo sapiens GN=PRKAR1A 
PE=1 SV=1 
KAP0_HUMAN 0.18 4 6 1 2 2 5 3 1 
General vesicular transport factor 
p115 OS=Homo sapiens GN=USO1 
PE=2 SV=1 
F5H4X1_HUMAN 0.98 1 5 0 0 0 2 0 6 
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dependent anion-selective channel 
protein 2 OS=Homo... 
sp|P45880|VDAC2_HUMANVoltage-dependent 
anion-selective channel protein 2 OS=Homo 
sapiens GN=VDAC2 PE=1 SV=2 
0.24 0 1 0 0 0 2 15 2 
Calcyclin-binding protein OS=Homo 
sapiens GN=CACYBP PE=1 SV=2 
sp|Q9HB71|CYBP_HUMAN 0.68 5 0 0 1 1 2 1 0 
sp|Q9H2U9|ADAM7_HUMAN 
Disintegrin and metalloproteinase 
domain-containing protein 7 
OS=Homo sapiens GN=ADAM7 PE=1 
SV=3 
sp|Q9H2U9|ADAM7_HUMANDisintegrin and 
metalloproteinase domain-containing protein 7 
OS=Homo sapiens GN=ADAM7 PE=1 SV=3 
0.46 6 6 0 0 4 0 9 6 
sp|P40429|RL13A_HUMAN 60S 
ribosomal protein L13a OS=Homo 
sapiens GN=RPL13A PE=1 SV=2 
sp|P40429|RL13A_HUMAN60S ribosomal 
protein L13a OS=Homo sapiens GN=RPL13A PE=1 
SV=2 
0.75 3 5 0 0 0 6 2 2 
Isoform 1 of Testican-3 OS=Homo 
sapiens GN=SPOCK3 
sp|Q9BQ16-1|TICN3_HUMAN 0.67 0 0 0 0 0 8 0 0 
sp|Q9UBS3|DNJB9_HUMAN DnaJ 
homolog subfamily B member 9 
OS=Homo sapiens GN=DNAJB9 PE=1 
SV=1 
sp|Q9UBS3|DNJB9_HUMANDnaJ homolog 
subfamily B member 9 OS=Homo sapiens 
GN=DNAJB9 PE=1 SV=1 
0.29 0 4 0 0 0 0 7 8 
sp|Q9H1E3|NUCKS_HUMAN Nuclear 
ubiquitous casein and cyclin-
dependent kinase substrate 1 
OS=Homo sapiens GN=NUCKS1 PE=1 
SV=1 
sp|Q9H1E3|NUCKS_HUMANNuclear ubiquitous 
casein and cyclin-dependent kinase substrate 1 
OS=Homo sapiens GN=NUCKS1 PE=1 SV=1 
0.36 22 0 0 0 0 0 0 0 
Quinone oxidoreductase PIG3 
OS=Homo sapiens GN=TP53I3 PE=1 
SV=2 
sp|Q53FA7|QORX_HUMAN 0.077 3 6 1 1 1 2 2 0 
sp|OVAL_CHICK| sp|OVAL_CHICK| 0.2 0 0 0 0 0 1 0 3 
Adenylate kinase 2, mitochondrial 
OS=Homo sapiens GN=AK2 PE=2 
SV=1 
F8W1A4_HUMAN 0.36 18 0 0 0 0 0 0 0 
sp|O60216|RAD21_HUMAN Double-
strand-break repair protein rad21 
homolog OS=Homo sapiens 
GN=RAD21 PE=1 SV=2 
sp|O60216|RAD21_HUMANDouble-strand-break 
repair protein rad21 homolog OS=Homo sapiens 
GN=RAD21 PE=1 SV=2 
0.36 3 0 0 0 0 0 0 0 
Lipocalin-1 OS=Homo sapiens 
GN=LCN1 PE=1 SV=1 
LCN1_HUMAN 0.46 2 3 2 8 8 5 2 8 
40S ribosomal protein S18 OS=Homo 
sapiens GN=RPS18 PE=1 SV=3 
RS18_HUMAN 0.29 11 1 2 1 1 3 5 3 
Carboxypeptidase O OS=Homo 
sapiens GN=CPO PE=2 SV=1 
CBPO_HUMAN 0.99 0 4 0 1 1 0 1 3 
Syndecan-1 OS=Homo sapiens 
GN=SDC1 PE=1 SV=3 
SDC1_HUMAN 0.41 0 2 0 0 0 3 2 0 
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complex protein 1 subunit beta 
OS=Homo sapiens GN=CCT2 PE=1... 
sp|P78371|TCPB_HUMAN T-complex protein 1 
subunit beta OS=Homo sapiens GN=CCT2 PE=1... 
0.29 13 11 2 1 1 7 8 3 
Salivary acidic proline-rich 
phosphoprotein 1/2 OS=Homo 
sapiens GN=PRH1 PE=1 SV=2 
PRPC_HUMAN 0.25 1 7 2 1 1 2 2 0 
Quinone oxidoreductase OS=Homo 
sapiens GN=CRYZ PE=1 SV=1 
QOR_HUMAN 0.31 6 5 3 0 0 1 7 3 
sp|Q9BQT9|CSTN3_HUMAN 
Calsyntenin-3 OS=Homo sapiens 
GN=CLSTN3 PE=1 SV=1 
sp|Q9BQT9|CSTN3_HUMANCalsyntenin-3 
OS=Homo sapiens GN=CLSTN3 PE=1 SV=1 (+1) 
0.36 0 1 0 0 1 0 2 0 
60S ribosomal protein L10 OS=Homo 
sapiens GN=RPL10 PE=1 SV=4 
RL10_HUMAN 0.42 14 1 0 0 0 2 1 0 
Proline-rich protein PRCC OS=Homo 
sapiens GN=PRCC PE=2 SV=1 
A6NG79_HUMAN 0.27 11 0 4 0 0 0 0 0 
Isoform 2 of Caprin-1 OS=Homo 
sapiens GN=CAPRIN1 
CAPR1_HUMAN (+1) 0.36 10 0 0 0 0 0 0 0 
Interferon-induced transmembrane 
protein 1 OS=Homo sapiens 
GN=IFITM1 PE=1 SV=3 
IFM1_HUMAN 0.83 5 3 1 3 3 5 6 10 
60S ribosomal protein L6 OS=Homo 
sapiens GN=RPL6 PE=1 SV=3 
RL6_HUMAN 0.35 6 1 3 0 0 1 7 0 
Isoform Short of Eukaryotic 
translation initiation factor 4H 
OS=Homo sapiens GN=EIF4H 
sp|Q15056-2|IF4H_HUMAN 0.3 25 6 0 2 2 2 2 1 
sp|P68400|CSK21_HUMAN Casein 
kinase II subunit alpha OS=Homo 
sapiens GN=CSNK2A1 PE=1... 
sp|P68400|CSK21_HUMANCasein kinase II 
subunit alpha OS=Homo sapiens GN=CSNK2A1 
PE=1 SV=1 
0.34 0 1 0 3 3 5 2 0 
sp|O95025|SEM3D_HUMAN 
Semaphorin-3D OS=Homo sapiens 
GN=SEMA3D PE=2 SV=2 
sp|O95025|SEM3D_HUMANSemaphorin-3D 
OS=Homo sapiens GN=SEMA3D PE=2 SV=2 
0.98 0 7 0 0 0 0 2 1 
Calnexin OS=Homo sapiens 
GN=CANX PE=2 SV=1 






acetylgalactosaminyltransferase 12 OS=Homo 
sapiens GN=GALNT12 PE=1 SV=3 
0.44 4 5 0 0 2 0 2 0 
Isoform 3 of Basic leucine zipper and 
W2 domain-containing protein 1 
OS=Homo sapiens GN=BZW1 
sp|Q7L1Q6-3|BZW1_HUMAN 0.79 0 6 0 0 0 1 0 3 
Isoform 9 of G-protein coupled 
receptor 64 OS=Homo sapiens 
GN=GPR64 
sp|Q8IZP9-9|GPR64_HUMAN 0.97 1 8 2 0 0 4 0 11 
Double-stranded RNA-binding 
protein Staufen homolog 1 
Q5JW30_HUMAN 0.36 2 0 0 0 0 0 0 0 
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OS=Homo sapiens GN=STAU1 PE=2 
SV=1 
GDP-mannose 4,6 dehydratase 
OS=Homo sapiens GN=GMDS PE=1 
SV=1 
sp|O60547|GMDS_HUMAN 0.36 8 0 0 0 0 0 0 0 
sp|Q12904|AIMP1_HUMAN 
Aminoacyl tRNA synthase complex-
interacting multifunctional protein 1 
OS=Homo sapiens GN=AIMP1 PE=1 
SV=2 
sp|Q12904|AIMP1_HUMANAminoacyl tRNA 
synthase complex-interacting multifunctional 
protein 1 OS=Homo sapiens GN=AIMP1 PE=1 
SV=2 
0.2 5 2 0 0 0 0 0 0 
Biliverdin reductase A OS=Homo 
sapiens GN=BLVRA PE=1 SV=2 
BIEA_HUMAN 0.17 1 8 2 1 1 0 0 3 
sp|Q8NI22|MCFD2_HUMAN 
Multiple coagulation factor 
deficiency protein 2 OS=Homo 
sapiens GN=MCFD2 PE=1 SV=1 
sp|Q8NI22|MCFD2_HUMANMultiple coagulation 
factor deficiency protein 2 OS=Homo sapiens 
GN=MCFD2 PE=1 SV=1 
0.32 7 2 1 0 0 5 2 2 
Citrate synthase (Fragment) 
OS=Homo sapiens GN=CS PE=2 SV=1 
H0YIC4_HUMAN 0.14 0 0 0 0 0 0 7 9 
sp|P39687|AN32A_HUMAN Acidic 
leucine-rich nuclear phosphoprotein 
32 family member... 
sp|P39687|AN32A_HUMANAcidic leucine-rich 
nuclear phosphoprotein 32 family member A 
OS=Homo sapiens GN=ANP32A PE=1 SV=1 
0.36 32 0 0 0 0 0 0 0 
PCTP-like protein OS=Homo sapiens 
GN=STARD10 PE=2 SV=1 
F5H8H3_HUMAN 0.66 2 2 2 2 2 4 3 6 
sp|P36507|MP2K2_HUMAN Dual 
specificity mitogen-activated protein 
kinase kinase 2 OS=Homo sapiens 
GN=MAP2K2 PE=1 SV=1 
sp|P36507|MP2K2_HUMANDual specificity 
mitogen-activated protein kinase kinase 2 
OS=Homo sapiens GN=MAP2K2 PE=1 SV=1 
0.32 2 3 1 0 1 1 3 0 
sp|O14657|TOR1B_HUMAN Torsin-
1B OS=Homo sapiens GN=TOR1B 
PE=1 SV=2 
sp|O14657|TOR1B_HUMANTorsin-1B OS=Homo 
sapiens GN=TOR1B PE=1 SV=2 
0.64 2 3 0 7 7 0 9 2 
Catechol O-methyltransferase 
OS=Homo sapiens GN=COMT PE=1 
SV=2 
sp|P21964|COMT_HUMAN 0.36 0 0 0 1 1 0 5 0 
Isoform 3 of Malignant T-cell-
amplified sequence 1 OS=Homo 
sapiens GN=MCTS1 
sp|Q9ULC4-3|MCTS1_HUMAN 0.81 7 2 0 0 0 4 0 3 
sp|P31949|S10AB_HUMAN Protein 
S100-A11 OS=Homo sapiens 
GN=S100A11 PE=1 SV=2 
sp|P31949|S10AB_HUMANProtein S100-A11 
OS=Homo sapiens GN=S100A11 PE=1 SV=2 
0.4 7 1 0 0 2 6 4 3 
sp|P46926|GNPI1_HUMAN 
Glucosamine-6-phosphate isomerase 
1 OS=Homo sapiens GN=GNPDA1... 
sp|P46926|GNPI1_HUMANGlucosamine-6-
phosphate isomerase 1 OS=Homo sapiens 
GN=GNPDA1 PE=1 SV=1 
0.73 0 0 3 0 1 0 3 9 
sp|O15145|ARPC3_HUMAN Actin-
related protein 2/3 complex subunit 
3 OS=Homo sapiens... 
sp|O15145|ARPC3_HUMANActin-related protein 
2/3 complex subunit 3 OS=Homo sapiens 
GN=ARPC3 PE=1 SV=3 
0.88 9 3 0 0 8 4 0 1 
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protein 57 (Fragment) OS=Homo 
sapiens GN=LRRC57 PE=2 SV=1 
H3BSW0_HUMAN 0.79 2 6 0 0 0 2 0 4 
sp|P36959|GMPR1_HUMAN GMP 
reductase 1 OS=Homo sapiens 
GN=GMPR PE=1 SV=1 
sp|P36959|GMPR1_HUMANGMP reductase 1 
OS=Homo sapiens GN=GMPR PE=1 SV=1 
0.34 0 1 0 0 0 0 1 6 
sp|Q04695|K1C17_HUMAN Keratin, 
type I cytoskeletal 17 OS=Homo 
sapiens GN=KRT17 PE=1... 
sp|Q04695|K1C17_HUMANKeratin, type I 
cytoskeletal 17 OS=Homo sapiens GN=KRT17 
PE=1 SV=2 
0.4 1 0 0 0 3 0 0 8 
sp|Q01638|ILRL1_HUMAN 
Interleukin-1 receptor-like 1 
OS=Homo sapiens GN=IL1RL1 PE=1... 
sp|Q01638|ILRL1_HUMANInterleukin-1 
receptor-like 1 OS=Homo sapiens GN=IL1RL1 
PE=1 SV=4 
0.36 0 0 0 0 0 0 10 0 
sp|P43686|PRS6B_HUMAN 26S 
protease regulatory subunit 6B 
OS=Homo sapiens GN=PSMC4 PE=1 
SV=2 
sp|P43686|PRS6B_HUMAN26S protease 
regulatory subunit 6B OS=Homo sapiens 
GN=PSMC4 PE=1 SV=2 
0.14 0 0 0 1 2 1 2 0 
sp|P0C8F1|PATE4_HUMAN Prostate 
and testis expressed protein 4 
OS=Homo sapiens GN=PATE4 PE=2 
SV=2 
sp|P0C8F1|PATE4_HUMANProstate and testis 
expressed protein 4 OS=Homo sapiens 
GN=PATE4 PE=2 SV=2 
0.81 6 4 0 0 6 1 0 0 
Isoform 2 of AP-2 complex subunit 
alpha-2 OS=Homo sapiens 
GN=AP2A2 
sp|O94973-2|AP2A2_HUMAN 0.96 0 2 0 0 0 1 0 1 
Isoform 2 of Calpain-2 catalytic 
subunit OS=Homo sapiens 
GN=CAPN2 
sp|P17655-2|CAN2_HUMAN 0.71 0 0 1 0 0 4 0 0 
Guanine nucleotide-binding protein 
subunit beta-2-like 1 (Fragment) 
OS=Homo sapiens GN=GNB2L1 PE=2 
SV=1 
D6REE5_HUMAN 0.44 0 5 0 0 0 0 0 0 
Tropomyosin alpha-1 chain 
OS=Homo sapiens GN=TPM1 PE=1 
SV=2 
sp|P09493|TPM1_HUMAN 0.62 1 4 0 0 0 0 2 0 
sp|Q14204|DYHC1_HUMAN 
Cytoplasmic dynein 1 heavy chain 1 
OS=Homo sapiens GN=DYNC1H1... 
sp|Q14204|DYHC1_HUMANCytoplasmic dynein 
1 heavy chain 1 OS=Homo sapiens 
GN=DYNC1H1... 
0.36 0 0 23 0 0 0 0 0 
sp|P62942|FKB1A_HUMAN Peptidyl-
prolyl cis-trans isomerase FKBP1A 
OS=Homo sapiens GN=FKBP1A PE=1 
SV=2 
sp|P62942|FKB1A_HUMANPeptidyl-prolyl cis-
trans isomerase FKBP1A OS=Homo sapiens 
GN=FKBP1A PE=1 SV=2 
0.9 4 6 0 2 2 9 0 2 
Acyl-CoA-binding protein OS=Homo 
sapiens GN=DBI PE=1 SV=2 
sp|P07108|ACBP_HUMAN 0.45 10 2 2 0 0 9 2 8 
sp|Q14344|GNA13_HUMAN 
Guanine nucleotide-binding protein 
sp|Q14344|GNA13_HUMANGuanine nucleotide-
binding protein subunit alpha-13 OS=Homo 
sapiens GN=GNA13 PE=1 SV=2 
0.29 1 3 0 0 6 0 1 4 
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subunit alpha-13 OS=Homo sapiens 
GN=GNA13 PE=1 SV=2 
sp|A5D8V6|VP37C_HUMAN 
Vacuolar protein sorting-associated 
protein 37C OS=Homo sapiens 
GN=VPS37C PE=1 SV=2 
sp|A5D8V6|VP37C_HUMANVacuolar protein 
sorting-associated protein 37C OS=Homo sapiens 
GN=VPS37C PE=1 SV=2 
0.43 0 6 0 0 8 4 1 0 
sp|O75348|VATG1_HUMAN V-type 
proton ATPase subunit G 1 OS=Homo 
sapiens GN=ATP6V1G1 PE=1 SV=3 
sp|O75348|VATG1_HUMANV-type proton 
ATPase subunit G 1 OS=Homo sapiens 
GN=ATP6V1G1 PE=1 SV=3 
0.56 13 4 0 0 3 0 3 3 
Superoxide dismutase [Mn], 
mitochondrial (Fragment) OS=Homo 
sapiens GN=SOD2 PE=2 SV=1 
F5GYZ5_HUMAN 0.31 1 1 0 0 0 3 0 3 
sp|P30520|PURA2_HUMAN 
Adenylosuccinate synthetase 
isozyme 2 OS=Homo sapiens 
GN=ADSS PE=1 SV=3 
sp|P30520|PURA2_HUMANAdenylosuccinate 
synthetase isozyme 2 OS=Homo sapiens 
GN=ADSS PE=1 SV=3 
0.49 0 1 0 0 0 0 0 4 
Isoform 3 of Drebrin-like protein 
OS=Homo sapiens GN=DBNL 
sp|Q9UJU6-3|DBNL_HUMAN 0.24 4 1 0 0 0 0 0 0 
sp|P01613|KV121_HUMAN Ig kappa 
chain V-I region Ni OS=Homo sapiens 
PE=1 SV=1 
sp|P01613|KV121_HUMANIg kappa chain V-I 
region Ni OS=Homo sapiens PE=1 SV=1 
0.15 0 0 0 0 0 3 5 0 
sp|Q92838-3|EDA_HUMAN Isoform 
3 of Ectodysplasin-A OS=Homo 
sapiens GN=EDA 
sp|Q92838-3|EDA_HUMANIsoform 3 of 
Ectodysplasin-A OS=Homo sapiens GN=EDA 
0.69 0 1 0 1 1 2 0 0 
Suppressor of G2 allele of SKP1 
homolog OS=Homo sapiens 
GN=SUGT1 PE=2 SV=1 
F5H5A9_HUMAN 0.37 0 0 0 1 1 0 4 0 
sp|P68036|UB2L3_HUMAN 
Ubiquitin-conjugating enzyme E2 L3 
OS=Homo sapiens GN=UBE2L3... 
sp|P68036|UB2L3_HUMANUbiquitin-conjugating 
enzyme E2 L3 OS=Homo sapiens GN=UBE2L3 
PE=1 SV=1 
0.87 18 1 0 0 5 0 5 6 
Isoform 2 of Signal recognition 
particle receptor subunit alpha 
OS=Homo sapiens GN=SRPR 
sp|P08240-2|SRPR_HUMAN 0.36 0 0 0 0 0 0 3 0 
sp|Q9H361|PABP3_HUMAN 
Polyadenylate-binding protein 3 
OS=Homo sapiens GN=PABPC3 
PE=1... 
sp|Q9H361|PABP3_HUMANPolyadenylate-
binding protein 3 OS=Homo sapiens GN=PABPC3 
PE=1 SV=2 
0.27 0 0 2 0 0 0 0 0 
Alpha-endosulfine OS=Homo sapiens 
GN=ENSA PE=2 SV=1 
Q5T5H1_HUMAN 0.36 32 0 0 0 0 0 0 0 
sp|Q14894|CRYM_HUMAN Ketimine 
reductase mu-crystallin OS=Homo 
sapiens GN=CRYM PE=1... 
sp|Q14894|CRYM_HUMAN Ketimine reductase 
mu-crystallin OS=Homo sapiens GN=CRYM 
PE=1... 
0.41 7 5 5 4 4 4 3 7 
sp|P51993-2|FUT6_HUMAN Isoform 
2 of Alpha-(1,3)-fucosyltransferase 6 
OS=Homo sapiens... 
sp|P51993-2|FUT6_HUMAN Isoform 2 of Alpha-
(1,3)-fucosyltransferase 6 OS=Homo sapiens... 
(+1) 
0.64 0 2 4 4 4 13 4 3 
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40S ribosomal protein S13 OS=Homo 
sapiens GN=RPS13 PE=2 SV=1 
J3KMX5_HUMAN 0.31 11 1 3 1 1 7 2 2 
sp|Q9NPR2|SEM4B_HUMAN 
Semaphorin-4B OS=Homo sapiens 
GN=SEMA4B PE=1 SV=3 
sp|Q9NPR2|SEM4B_HUMANSemaphorin-4B 
OS=Homo sapiens GN=SEMA4B PE=1 SV=3 
0.79 1 2 1 0 3 0 5 0 
sp|Q9UNF0|PACN2_HUMAN Protein 
kinase C and casein kinase substrate 
in neurons protein... 
sp|Q9UNF0|PACN2_HUMANProtein kinase C and 
casein kinase substrate in neurons protein 2 
OS=Homo sapiens GN=PACSIN2 PE=1 SV=2 
0.51 3 4 1 0 2 0 0 6 
Gamma-soluble NSF attachment 
protein OS=Homo sapiens GN=NAPG 
PE=1 SV=1 
SNAG_HUMAN 0.21 0 1 0 0 0 4 0 3 
sp|O15143|ARC1B_HUMAN Actin-
related protein 2/3 complex subunit 
1B OS=Homo sapiens GN=ARPC1B 
PE=1 SV=3 
sp|O15143|ARC1B_HUMANActin-related protein 
2/3 complex subunit 1B OS=Homo sapiens 
GN=ARPC1B PE=1 SV=3 
0.36 4 0 0 0 0 0 0 0 
sp|Q9Y3P9|RBGP1_HUMAN Rab 
GTPase-activating protein 1 
OS=Homo sapiens GN=RABGAP1... 
sp|Q9Y3P9|RBGP1_HUMANRab GTPase-
activating protein 1 OS=Homo sapiens 
GN=RABGAP1 PE=1 SV=3 
0.36 0 0 0 0 0 3 0 0 
sp|P20849|CO9A1_HUMAN 
Collagen alpha-1(IX) chain OS=Homo 
sapiens GN=COL9A1 PE=1 SV=3 
sp|P20849|CO9A1_HUMANCollagen alpha-1(IX) 
chain OS=Homo sapiens GN=COL9A1 PE=1 SV=3 
0.63 0 2 4 0 0 0 7 10 
sp|O43242|PSMD3_HUMAN 26S 
proteasome non-ATPase regulatory 
subunit 3 OS=Homo sapiens 
GN=PSMD3 PE=1 SV=2 
sp|O43242|PSMD3_HUMAN26S proteasome 
non-ATPase regulatory subunit 3 OS=Homo 
sapiens GN=PSMD3 PE=1 SV=2 
0.2 2 0 0 0 0 0 8 6 
Cathepsin G OS=Homo sapiens 
GN=CTSG PE=1 SV=2 
CATG_HUMAN 0.25 17 0 2 0 0 8 0 0 
sp|P49902|5NTC_HUMAN Cytosolic 
purine 5'-nucleotidase OS=Homo 
sapiens GN=NT5C2 PE=1... 
sp|P49902|5NTC_HUMAN Cytosolic purine 5'-
nucleotidase OS=Homo sapiens GN=NT5C2 
PE=1... 
0.41 2 1 6 2 2 4 4 3 
sp|Q9H0E2|TOLIP_HUMAN Toll-
interacting protein OS=Homo 
sapiens GN=TOLLIP PE=1 SV=1 
sp|Q9H0E2|TOLIP_HUMANToll-interacting 
protein OS=Homo sapiens GN=TOLLIP PE=1 SV=1 
0.3 5 0 2 2 2 4 1 0 
sp|P61020|RAB5B_HUMAN Ras-
related protein Rab-5B OS=Homo 
sapiens GN=RAB5B PE=1 SV=1 
sp|P61020|RAB5B_HUMANRas-related protein 
Rab-5B OS=Homo sapiens GN=RAB5B PE=1 SV=1 
0.4 4 4 0 0 3 3 5 3 
sp|Q15008|PSMD6_HUMAN 26S 
proteasome non-ATPase regulatory 
subunit 6 OS=Homo sapiens 
GN=PSMD6 PE=1 SV=1 
sp|Q15008|PSMD6_HUMAN26S proteasome 
non-ATPase regulatory subunit 6 OS=Homo 
sapiens GN=PSMD6 PE=1 SV=1 
0.35 2 4 5 0 0 2 5 0 
Myosin light chain 3 OS=Homo 
sapiens GN=MYL3 PE=1 SV=3 
MYL3_HUMAN 0.68 7 8 0 0 0 0 5 1 
sp|Q9UHY7|ENOPH_HUMAN 
Enolase-phosphatase E1 OS=Homo 
sapiens GN=ENOPH1 PE=1 SV=1 
sp|Q9UHY7|ENOPH_HUMANEnolase-
phosphatase E1 OS=Homo sapiens GN=ENOPH1 
PE=1 SV=1 
0.77 1 2 2 0 0 7 8 1 
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Myotrophin OS=Homo sapiens 
GN=MTPN PE=1 SV=2 
MTPN_HUMAN 0.55 12 2 0 1 1 2 1 4 
sp|O43854|EDIL3_HUMAN EGF-like 
repeat and discoidin I-like domain-
containing protein 3 OS=Homo 
sapiens GN=EDIL3 PE=1 SV=1 
sp|O43854|EDIL3_HUMANEGF-like repeat and 
discoidin I-like domain-containing protein 3 
OS=Homo sapiens GN=EDIL3 PE=1 SV=1 
0.66 1 0 4 0 5 10 5 10 
26S protease regulatory subunit 10B 
(Fragment) OS=Homo sapiens 
GN=PSMC6 PE=4 SV=1 
H0YJC0_HUMAN 0.39 0 0 3 0 0 0 2 0 
sp|P51888|PRELP_HUMAN Prolargin 
OS=Homo sapiens GN=PRELP PE=1 
SV=1 
sp|P51888|PRELP_HUMANProlargin OS=Homo 
sapiens GN=PRELP PE=1 SV=1 
0.41 2 0 0 1 1 8 1 0 
sp|Q14151|SAFB2_HUMAN Scaffold 
attachment factor B2 OS=Homo 
sapiens GN=SAFB2 PE=1 SV=1 
sp|Q14151|SAFB2_HUMANScaffold attachment 
factor B2 OS=Homo sapiens GN=SAFB2 PE=1 
SV=1 
0.12 2 0 0 1 1 0 0 0 
sp|Q9BRA2|TXD17_HUMAN 
Thioredoxin domain-containing 
protein 17 OS=Homo sapiens 
GN=TXNDC17 PE=1 SV=1 
sp|Q9BRA2|TXD17_HUMANThioredoxin domain-
containing protein 17 OS=Homo sapiens 
GN=TXNDC17 PE=1 SV=1 
0.51 6 3 0 0 6 5 3 0 
sp|Q03167|TGBR3_HUMAN 
Transforming growth factor beta 
receptor type 3 OS=Homo sapiens... 
sp|Q03167|TGBR3_HUMANTransforming growth 
factor beta receptor type 3 OS=Homo sapiens 
GN=TGFBR3 PE=1 SV=3 
0.82 3 5 0 0 3 0 0 8 
sp|Q8N1N4|K2C78_HUMAN Keratin, 
type II cytoskeletal 78 OS=Homo 
sapiens GN=KRT78 PE=2... 
sp|Q8N1N4|K2C78_HUMANKeratin, type II 
cytoskeletal 78 OS=Homo sapiens GN=KRT78 
PE=2 SV=2 
0.3 1 0 0 0 8 0 2 0 
Isoform 5 of Insulin-like growth 
factor 2 mRNA-binding protein 2 
OS=Homo sapiens GN=IGF2BP2 
sp|Q9Y6M1-5|IF2B2_HUMAN 0.36 7 0 0 0 0 0 0 0 
Isoform 2 of WAS/WASL-interacting 
protein family member 1 OS=Homo 
sapiens GN=WIPF1 
sp|O43516-2|WIPF1_HUMAN 0.36 14 0 0 0 0 0 0 0 
40S ribosomal protein S21 OS=Homo 
sapiens GN=RPS21 PE=3 SV=1 
Q8WVC2_HUMAN (+1) 0.36 38 0 0 0 0 0 0 0 
sp|P17096|HMGA1_HUMAN High 
mobility group protein HMG-I/HMG-
Y OS=Homo sapiens GN=HMGA1... 
sp|P17096|HMGA1_HUMANHigh mobility group 
protein HMG-I/HMG-Y OS=Homo sapiens 
GN=HMGA1 PE=1 SV=3 
0.36 30 0 0 0 0 0 0 0 
GTPase HRas OS=Homo sapiens 
GN=HRAS PE=1 SV=1 
sp|P01112|RASH_HUMAN 0.33 5 3 7 2 2 1 0 1 
tr|H0Y8T3|H0Y8T3_HUMAN 
Prostatic acid phosphatase 
(Fragment) OS=Homo sapiens 
GN=ACPP... 
tr|H0Y8T3|H0Y8T3_HUMAN Prostatic acid 
phosphatase (Fragment) OS=Homo sapiens 
GN=ACPP... 
0.29 5 2 4 3 3 8 6 0 
40S ribosomal protein S16 OS=Homo 
sapiens GN=RPS16 PE=1 SV=2 
RS16_HUMAN 0.96 8 1 0 1 1 2 5 2 
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Growth arrest-specific protein 1 
OS=Homo sapiens GN=GAS1 PE=1 
SV=2 
GAS1_HUMAN 0.17 0 0 0 0 0 0 2 1 
sp|CASB_BOVIN| sp|CASB_BOVIN| 0.088 2 0 0 2 2 4 2 7 
sp|Q01469|FABP5_HUMAN Fatty 
acid-binding protein, epidermal 
OS=Homo sapiens GN=FABP5 PE=1 
SV=3 
sp|Q01469|FABP5_HUMANFatty acid-binding 
protein, epidermal OS=Homo sapiens GN=FABP5 
PE=1 SV=3 
0.52 7 8 0 0 0 3 5 0 
Cochlin OS=Homo sapiens GN=COCH 
PE=2 SV=1 
E7EN67_HUMAN 0.21 0 0 0 0 0 3 1 0 
Phosphoglycolate phosphatase 
OS=Homo sapiens GN=PGP PE=1 
SV=1 
PGP_HUMAN 0.59 0 1 1 0 0 2 2 0 
sp|Q96C19|EFHD2_HUMAN EF-hand 
domain-containing protein D2 
OS=Homo sapiens GN=EFHD2... 
sp|Q96C19|EFHD2_HUMANEF-hand domain-
containing protein D2 OS=Homo sapiens 
GN=EFHD2 PE=1 SV=1 
0.35 9 2 0 0 1 0 0 1 
Glutathione S-transferase theta-2B 
OS=Homo sapiens GN=GSTT2 PE=2 
SV=2 
B5MCL2_HUMAN 0.62 0 0 1 0 0 0 8 0 
sp|Q8IYS1|P20D2_HUMAN 
Peptidase M20 domain-containing 
protein 2 OS=Homo sapiens 
GN=PM20D2 PE=1 SV=2 
sp|Q8IYS1|P20D2_HUMANPeptidase M20 
domain-containing protein 2 OS=Homo sapiens 
GN=PM20D2 PE=1 SV=2 
0.92 8 3 0 0 4 0 8 0 
Azurocidin OS=Homo sapiens 
GN=AZU1 PE=1 SV=3 
CAP7_HUMAN 0.94 0 0 0 3 3 0 0 0 
sp|Q9BY77|PDIP3_HUMAN 
Polymerase delta-interacting protein 
3 OS=Homo sapiens GN=POLDIP3 
PE=1 SV=2 
sp|Q9BY77|PDIP3_HUMANPolymerase delta-
interacting protein 3 OS=Homo sapiens 
GN=POLDIP3 PE=1 SV=2 
0.36 3 0 0 0 0 0 0 0 
GTP-binding protein SAR1b 
(Fragment) OS=Homo sapiens 
GN=SAR1B PE=2 SV=1 
D6RD69_HUMAN 0.42 0 0 3 4 4 0 8 0 
sp|Q9Y5Z0|BACE2_HUMAN Beta-
secretase 2 OS=Homo sapiens 
GN=BACE2 PE=1 SV=1 
sp|Q9Y5Z0|BACE2_HUMANBeta-secretase 2 
OS=Homo sapiens GN=BACE2 PE=1 SV=1 
0.29 1 2 3 0 0 1 0 0 
sp|Q96FZ7|CHMP6_HUMAN 
Charged multivesicular body protein 
6 OS=Homo sapiens GN=CHMP6... 
sp|Q96FZ7|CHMP6_HUMANCharged 
multivesicular body protein 6 OS=Homo sapiens 
GN=CHMP6 PE=1 SV=3 
0.43 4 0 3 0 3 1 4 0 
Isoform 3 of Kinesin light chain 4 
OS=Homo sapiens GN=KLC4 
sp|Q9NSK0-3|KLC4_HUMAN (+1) 0.39 0 0 3 2 2 0 0 1 
Nuclear transport factor 2 OS=Homo 
sapiens GN=NUTF2 PE=1 SV=1 
NTF2_HUMAN 0.38 1 0 4 0 0 0 4 0 
60S ribosomal protein L5 OS=Homo 
sapiens GN=RPL5 PE=1 SV=3 
RL5_HUMAN 0.98 0 2 0 2 2 2 0 0 
Stellenbosch University  https://scholar.sun.ac.za




Endonuclease domain-containing 1 
protein OS=Homo sapiens 
GN=ENDOD1 PE=1 SV=2 
sp|O94919|ENDD1_HUMANEndonuclease 
domain-containing 1 protein OS=Homo sapiens 
GN=ENDOD1 PE=1 SV=2 
0.13 3 1 1 0 0 0 0 0 
sp|Q9HBR0|S38AA_HUMAN 
Putative sodium-coupled neutral 
amino acid transporter 10 
OS=Homo... 
sp|Q9HBR0|S38AA_HUMANPutative sodium-
coupled neutral amino acid transporter 10 
OS=Homo sapiens GN=SLC38A10 PE=1 SV=2 
0.49 0 1 0 0 0 0 0 4 
sp|O43395|PRPF3_HUMAN U4/U6 
small nuclear ribonucleoprotein Prp3 
OS=Homo sapiens GN=PRPF3 PE=1 
SV=2 
sp|O43395|PRPF3_HUMANU4/U6 small nuclear 
ribonucleoprotein Prp3 OS=Homo sapiens 
GN=PRPF3 PE=1 SV=2 




sapiens GN=A4GALT PE=2 SV=1 
sp|Q9NPC4|A4GAT_HUMANLactosylceramide 4-
alpha-galactosyltransferase OS=Homo sapiens 
GN=A4GALT PE=2 SV=1 
0.89 0 4 0 0 2 0 0 1 
sp|Q9HCN8|SDF2L_HUMAN Stromal 
cell-derived factor 2-like protein 1 
OS=Homo sapiens GN=SDF2L1 PE=1 
SV=2 
sp|Q9HCN8|SDF2L_HUMANStromal cell-derived 
factor 2-like protein 1 OS=Homo sapiens 
GN=SDF2L1 PE=1 SV=2 
0.36 3 0 0 0 0 0 0 0 
Serpin H1 (Fragment) OS=Homo 
sapiens GN=SERPINH1 PE=2 SV=1 
E9PMI5_HUMAN 0.36 2 0 0 0 0 0 0 0 
sp|Q96E39|RMXL1_HUMAN RNA 
binding motif protein, X-linked-like-1 
OS=Homo sapiens GN=RBMXL1 PE=1 
SV=1 
sp|Q96E39|RMXL1_HUMANRNA binding motif 
protein, X-linked-like-1 OS=Homo sapiens 
GN=RBMXL1 PE=1 SV=1 
0.36 21 0 0 0 0 0 0 0 
sp|P20700|LMNB1_HUMAN Lamin-
B1 OS=Homo sapiens GN=LMNB1 
PE=1 SV=2 
sp|P20700|LMNB1_HUMANLamin-B1 OS=Homo 
sapiens GN=LMNB1 PE=1 SV=2 
0.36 16 0 0 0 0 0 0 0 
sp|P04208|LV106_HUMAN Ig 
lambda chain V-I region WAH 
OS=Homo sapiens PE=1 SV=1 
sp|P04208|LV106_HUMANIg lambda chain V-I 
region WAH OS=Homo sapiens PE=1 SV=1 
0.01 1 1 0 0 3 7 3 4 
sp|Q96HC4|PDLI5_HUMAN PDZ and 
LIM domain protein 5 OS=Homo 
sapiens GN=PDLIM5 PE=1 SV=5 
sp|Q96HC4|PDLI5_HUMANPDZ and LIM domain 
protein 5 OS=Homo sapiens GN=PDLIM5 PE=1 
SV=5 
0.52 0 9 0 0 3 4 4 2 
sp|Q8N1G4|LRC47_HUMAN 
Leucine-rich repeat-containing 
protein 47 OS=Homo sapiens 
GN=LRRC47 PE=1 SV=1 
sp|Q8N1G4|LRC47_HUMANLeucine-rich repeat-
containing protein 47 OS=Homo sapiens 
GN=LRRC47 PE=1 SV=1 
0.39 2 0 0 0 1 0 3 1 
sp|Q8NBX0|SCPDL_HUMAN 
Saccharopine dehydrogenase-like 
oxidoreductase OS=Homo sapiens 
GN=SCCPDH PE=1 SV=1 
sp|Q8NBX0|SCPDL_HUMANSaccharopine 
dehydrogenase-like oxidoreductase OS=Homo 
sapiens GN=SCCPDH PE=1 SV=1 
0.21 0 1 0 0 0 1 4 1 
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Isoform 2 of Prostatic acid 
phosphatase OS=Homo sapiens 
GN=ACPP 
sp|P15309-2|PPAP_HUMAN 0.67 1 0 4 0 0 5 1 7 
sp|Q9NRF8|PYRG2_HUMAN CTP 
synthase 2 OS=Homo sapiens 
GN=CTPS2 PE=1 SV=1 
sp|Q9NRF8|PYRG2_HUMANCTP synthase 2 
OS=Homo sapiens GN=CTPS2 PE=1 SV=1 
0.36 0 3 0 0 0 0 0 0 
Galectin-7 OS=Homo sapiens 
GN=LGALS7 PE=1 SV=2 
LEG7_HUMAN 0.23 0 0 0 2 2 0 7 2 
ADP-ribosylation factor-like protein 3 
OS=Homo sapiens GN=ARL3 PE=1 
SV=2 
ARL3_HUMAN 0.36 0 0 2 0 0 0 0 0 
Isoform 2 of Basigin OS=Homo 
sapiens GN=BSG 
sp|P35613-2|BASI_HUMAN 0.7 5 0 0 0 0 0 1 2 
sp|O00151|PDLI1_HUMAN PDZ and 
LIM domain protein 1 OS=Homo 
sapiens GN=PDLIM1 PE=1 SV=4 
sp|O00151|PDLI1_HUMANPDZ and LIM domain 
protein 1 OS=Homo sapiens GN=PDLIM1 PE=1 
SV=4 
0.77 3 0 0 0 0 0 2 0 
PITH domain-containing protein 1 
OS=Homo sapiens GN=PITHD1 PE=1 
SV=1 
sp|Q9GZP4|PITH1_HUMAN 0.48 0 0 5 0 0 12 0 10 
Serine/threonine-protein kinase PAK 
2 OS=Homo sapiens GN=PAK2 PE=1 
SV=3 
PAK2_HUMAN 0.36 3 0 0 0 0 0 0 0 
sp|Q9UK76-2|HN1_HUMAN Isoform 
2 of Hematological and neurological 
expressed 1 protein OS=Homo 
sapiens GN=HN1 
sp|Q9UK76-2|HN1_HUMANIsoform 2 of 
Hematological and neurological expressed 1 
protein OS=Homo sapiens GN=HN1 
0.36 7 0 0 0 0 0 0 0 
sp|P30153|2AAA_HUMAN 
Serine/threonine-protein 
phosphatase 2A 65 kDa regulatory 
subunit... 
sp|P30153|2AAA_HUMAN Serine/threonine-
protein phosphatase 2A 65 kDa regulatory 
subunit... 
0.53 5 1 3 1 1 3 6 2 
sp|P57735|RAB25_HUMAN Ras-
related protein Rab-25 OS=Homo 
sapiens GN=RAB25 PE=1 SV=2 
sp|P57735|RAB25_HUMANRas-related protein 
Rab-25 OS=Homo sapiens GN=RAB25 PE=1 SV=2 
0.49 5 7 0 0 2 2 9 3 
COP9 signalosome complex subunit 
6 OS=Homo sapiens GN=COPS6 PE=1 
SV=1 
CSN6_HUMAN 0.78 1 1 1 0 0 3 4 0 
sp|Q07812-5|BAX_HUMAN Isoform 
Epsilon of Apoptosis regulator BAX 
OS=Homo sapiens GN=BAX 
sp|Q07812-5|BAX_HUMANIsoform Epsilon of 
Apoptosis regulator BAX OS=Homo sapiens 
GN=BAX 
0.07 0 3 0 0 5 5 0 6 
sp|Q9BYZ2|LDH6B_HUMAN L-
lactate dehydrogenase A-like 6B 
OS=Homo sapiens GN=LDHAL6B 
PE=1 SV=3 
sp|Q9BYZ2|LDH6B_HUMANL-lactate 
dehydrogenase A-like 6B OS=Homo sapiens 
GN=LDHAL6B PE=1 SV=3 
0.079 0 0 0 0 0 0 4 1 
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ribonucleoprotein D0 OS=Homo 
sapiens GN=HNRNPD PE=2 SV=1 
B4DTC3_HUMAN 0.36 4 0 0 0 0 0 0 0 
sp|Q9BRG1|VPS25_HUMAN 
Vacuolar protein-sorting-associated 
protein 25 OS=Homo sapiens 
GN=VPS25 PE=1 SV=1 
sp|Q9BRG1|VPS25_HUMANVacuolar protein-
sorting-associated protein 25 OS=Homo sapiens 
GN=VPS25 PE=1 SV=1 
0.8 0 6 0 0 1 1 2 0 
Protein LYRIC OS=Homo sapiens 
GN=MTDH PE=2 SV=1 
E5RJU9_HUMAN (+1) 0.36 16 0 0 0 0 0 0 0 
Vimentin OS=Homo sapiens GN=VIM 
PE=1 SV=4 
VIME_HUMAN 0.36 20 0 0 0 0 0 0 0 
Uncharacterized protein (Fragment) 
OS=Homo sapiens PE=4 SV=1 
L7N2F9_HUMAN 0.31 4 6 2 1 1 5 3 2 
sp|P49747|COMP_HUMAN Cartilage 
oligomeric matrix protein OS=Homo 
sapiens GN=COMP... 
sp|P49747|COMP_HUMAN Cartilage oligomeric 
matrix protein OS=Homo sapiens GN=COMP... 
(+2) 
0.41 7 10 1 1 1 6 2 4 
Isoform 4 of Low-density lipoprotein 
receptor OS=Homo sapiens GN=LDLR 
sp|P01130-4|LDLR_HUMAN 0.71 3 4 0 0 0 2 0 2 
sp|P19440|GGT1_HUMAN Gamma-
glutamyltranspeptidase 1 OS=Homo 
sapiens GN=GGT1 PE=1... 
sp|P19440|GGT1_HUMAN Gamma-
glutamyltranspeptidase 1 OS=Homo sapiens 
GN=GGT1 PE=1... 
0.93 1 9 0 2 2 4 5 0 
sp|P33908|MA1A1_HUMAN 
Mannosyl-oligosaccharide 1,2-alpha-
mannosidase IA OS=Homo sapiens 
GN=MAN1A1 PE=1 SV=3 
sp|P33908|MA1A1_HUMANMannosyl-
oligosaccharide 1,2-alpha-mannosidase IA 
OS=Homo sapiens GN=MAN1A1 PE=1 SV=3 
0.47 0 5 0 0 0 0 0 1 
sp|Q9HCN3|TMM8A_HUMAN 
Transmembrane protein 8A 
OS=Homo sapiens GN=TMEM8A 
PE=1 SV=3 
sp|Q9HCN3|TMM8A_HUMANTransmembrane 
protein 8A OS=Homo sapiens GN=TMEM8A PE=1 
SV=3 
0.17 4 9 0 0 0 0 0 0 
sp|O76003|GLRX3_HUMAN 
Glutaredoxin-3 OS=Homo sapiens 
GN=GLRX3 PE=1 SV=2 
sp|O76003|GLRX3_HUMANGlutaredoxin-3 
OS=Homo sapiens GN=GLRX3 PE=1 SV=2 
1 1 2 0 0 0 0 2 1 
sp|A6NKL6|T200C_HUMAN 
Transmembrane protein 200C 
OS=Homo sapiens GN=TMEM200C 
PE=2 SV=2 
sp|A6NKL6|T200C_HUMANTransmembrane 
protein 200C OS=Homo sapiens GN=TMEM200C 
PE=2 SV=2 
0.36 0 5 0 0 0 0 0 0 
Isoform 3 of Leucine zipper 
transcription factor-like protein 1 
OS=Homo sapiens GN=LZTFL1 
sp|Q9NQ48-3|LZTL1_HUMAN 0.22 0 2 0 0 0 7 0 5 
sp|Q15459|SF3A1_HUMAN Splicing 
factor 3A subunit 1 OS=Homo 
sapiens GN=SF3A1 PE=1 SV=1 
sp|Q15459|SF3A1_HUMANSplicing factor 3A 
subunit 1 OS=Homo sapiens GN=SF3A1 PE=1 
SV=1 





xylosylprotein 3-beta-glucuronosyltransferase 3 
OS=Homo sapiens GN=B3GAT3 PE=1 SV=2 
0.58 1 1 0 0 0 0 5 0 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
202 
 
OS=Homo sapiens GN=B3GAT3 PE=1 
SV=2 
sp|P07900-2|HS90A_HUMAN 
Isoform 2 of Heat shock protein HSP 
90-alpha OS=Homo sapiens... 
sp|P07900-2|HS90A_HUMAN Isoform 2 of Heat 
shock protein HSP 90-alpha OS=Homo sapiens... 
0.45 0 0 5 0 0 0 0 0 
Muscarinic acetylcholine receptor 
M1 OS=Homo sapiens GN=CHRM1 
PE=1 SV=2 
ACM1_HUMAN 0.36 0 0 0 0 0 0 0 5 
Erlin-2 (Fragment) OS=Homo sapiens 
GN=ERLIN2 PE=2 SV=1 
E5RHW4_HUMAN 0.36 0 0 0 0 0 0 2 0 
Prefoldin subunit 2 OS=Homo 
sapiens GN=PFDN2 PE=1 SV=1 
PFD2_HUMAN 0.17 12 1 2 5 5 2 1 1 
sp|Q9Y277|VDAC3_HUMAN 
Voltage-dependent anion-selective 
channel protein 3 OS=Homo... 
sp|Q9Y277|VDAC3_HUMANVoltage-dependent 
anion-selective channel protein 3 OS=Homo 
sapiens GN=VDAC3 PE=1 SV=1 
0.34 2 0 0 1 1 0 7 2 
sp|Q9BV40|VAMP8_HUMAN 
Vesicle-associated membrane 
protein 8 OS=Homo sapiens 
GN=VAMP8 PE=1 SV=1 
sp|Q9BV40|VAMP8_HUMANVesicle-associated 
membrane protein 8 OS=Homo sapiens 
GN=VAMP8 PE=1 SV=1 
0.85 11 2 0 0 4 6 5 0 
sp|Q01581|HMCS1_HUMAN 
Hydroxymethylglutaryl-CoA 
synthase, cytoplasmic OS=Homo 
sapiens GN=HMGCS1 PE=1 SV=2 
sp|Q01581|HMCS1_HUMANHydroxymethylgluta
ryl-CoA synthase, cytoplasmic OS=Homo sapiens 
GN=HMGCS1 PE=1 SV=2 
0.74 2 0 0 0 1 0 0 2 
sp|Q92520|FAM3C_HUMAN Protein 
FAM3C OS=Homo sapiens 
GN=FAM3C PE=1 SV=1 
sp|Q92520|FAM3C_HUMANProtein FAM3C 
OS=Homo sapiens GN=FAM3C PE=1 SV=1 
0.27 0 2 0 0 2 2 1 0 
sp|P04259|K2C6B_HUMAN Keratin, 
type II cytoskeletal 6B OS=Homo 
sapiens GN=KRT6B PE=1... 
sp|P04259|K2C6B_HUMANKeratin, type II 
cytoskeletal 6B OS=Homo sapiens GN=KRT6B 
PE=1 SV=5 
0.093 0 2 0 0 5 0 5 3 
sp|Q969X5|ERGI1_HUMAN 
Endoplasmic reticulum-Golgi 
intermediate compartment protein 1 
OS=Homo sapiens GN=ERGIC1 PE=1 
SV=1 
sp|Q969X5|ERGI1_HUMANEndoplasmic 
reticulum-Golgi intermediate compartment 
protein 1 OS=Homo sapiens GN=ERGIC1 PE=1 
SV=1 
0.41 0 0 5 0 0 0 4 0 
Uncharacterized protein (Fragment) 
OS=Homo sapiens PE=4 SV=1 
H0YHG0_HUMAN 0.36 14 0 0 0 0 0 0 0 
sp|P52566|GDIR2_HUMAN Rho 
GDP-dissociation inhibitor 2 
OS=Homo sapiens GN=ARHGDIB 
PE=1 SV=3 
sp|P52566|GDIR2_HUMANRho GDP-dissociation 
inhibitor 2 OS=Homo sapiens GN=ARHGDIB PE=1 
SV=3 
0.36 20 0 0 0 0 0 0 0 
Cytoplasmic dynein 1 heavy chain 1 
OS=Homo sapiens GN=DYNC1H1 
PE=1 SV=5 
DYHC1_HUMAN 0.36 0 0 0 0 0 11 0 0 
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sp|P05386|RLA1_HUMAN 60S acidic 
ribosomal protein P1 OS=Homo 
sapiens GN=RPLP1 PE=1... 
sp|P05386|RLA1_HUMAN 60S acidic ribosomal 
protein P1 OS=Homo sapiens GN=RPLP1 PE=1... 
0.2 23 0 3 1 1 3 4 1 
Phosphomevalonate kinase 
OS=Homo sapiens GN=PMVK PE=1 
SV=3 
PMVK_HUMAN 0.33 1 9 7 2 2 2 2 2 
Neutrophil elastase OS=Homo 
sapiens GN=ELANE PE=1 SV=1 
ELNE_HUMAN 0.43 1 0 1 3 3 2 1 1 
sp|P01619|KV301_HUMAN Ig kappa 
chain V-III region B6 OS=Homo 
sapiens PE=1 SV=1 
sp|P01619|KV301_HUMANIg kappa chain V-III 
region B6 OS=Homo sapiens PE=1 SV=1 
0.33 0 2 0 0 6 0 1 1 
Corneodesmosin OS=Homo sapiens 
GN=CDSN PE=2 SV=1 







2,3-sialyltransferase 1 OS=Homo sapiens 
GN=ST3GAL1 PE=2 SV=1 




reductase OS=Homo sapiens... 
sp|Q9UBQ7|GRHPR_HUMANGlyoxylate 
reductase/hydroxypyruvate reductase OS=Homo 
sapiens GN=GRHPR PE=1 SV=1 
0.033 0 3 0 0 3 6 6 2 
60S ribosomal protein L13 OS=Homo 
sapiens GN=RPL13 PE=1 SV=4 
sp|P26373|RL13_HUMAN 0.27 10 1 5 0 0 1 1 0 
Synaptobrevin homolog YKT6 
OS=Homo sapiens GN=YKT6 PE=1 
SV=1 
YKT6_HUMAN 0.49 2 0 0 3 3 0 10 0 
Isoform 7 of Tumor protein D54 
OS=Homo sapiens GN=TPD52L2 
sp|O43399-7|TPD54_HUMAN 0.68 2 0 0 0 0 1 0 0 
sp|O43286|B4GT5_HUMAN Beta-
1,4-galactosyltransferase 5 
OS=Homo sapiens GN=B4GALT5 
PE=2 SV=1 
sp|O43286|B4GT5_HUMANBeta-1,4-
galactosyltransferase 5 OS=Homo sapiens 
GN=B4GALT5 PE=2 SV=1 
0.73 0 0 0 0 1 0 2 0 
sp|Q02543|RL18A_HUMAN 60S 
ribosomal protein L18a OS=Homo 
sapiens GN=RPL18A PE=1 SV=2 
sp|Q02543|RL18A_HUMAN60S ribosomal 
protein L18a OS=Homo sapiens GN=RPL18A PE=1 
SV=2 
0.26 0 0 0 0 0 1 6 0 
sp|O75947|ATP5H_HUMAN ATP 
synthase subunit d, mitochondrial 
OS=Homo sapiens GN=ATP5H PE=1 
SV=3 
sp|O75947|ATP5H_HUMANATP synthase 
subunit d, mitochondrial OS=Homo sapiens 
GN=ATP5H PE=1 SV=3 
0.4 11 0 0 0 0 0 1 0 
Isoform 5 of Prelamin-A/C OS=Homo 
sapiens GN=LMNA 
sp|P02545-5|LMNA_HUMAN 0.36 9 0 0 0 0 0 0 0 
sp|P31146|COR1A_HUMAN 
Coronin-1A OS=Homo sapiens 
GN=CORO1A PE=1 SV=4 
sp|P31146|COR1A_HUMANCoronin-1A 
OS=Homo sapiens GN=CORO1A PE=1 SV=4 
0.36 10 0 0 0 0 0 0 0 
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Prefoldin subunit 1 OS=Homo 
sapiens GN=PFDN1 PE=1 SV=2 
PFD1_HUMAN 0.36 19 0 0 0 0 0 0 0 
sp|P53985|MOT1_HUMAN 
Monocarboxylate transporter 1 
OS=Homo sapiens GN=SLC16A1 
PE=1... 
sp|P53985|MOT1_HUMAN Monocarboxylate 
transporter 1 OS=Homo sapiens GN=SLC16A1 
PE=1... 
0.23 0 2 1 1 1 6 6 13 
sp|Q96EY5|MB12A_HUMAN 
Multivesicular body subunit 12A 
OS=Homo sapiens GN=MVB12A 
PE=1... 
sp|Q96EY5|MB12A_HUMANMultivesicular body 
subunit 12A OS=Homo sapiens GN=MVB12A 
PE=1 SV=1 
0.37 2 1 0 0 3 2 1 0 
Isoform 2 of AP-1 complex subunit 
mu-2 OS=Homo sapiens GN=AP1M2 
AP1M2_HUMAN 0.39 0 1 7 0 0 3 0 1 
sp|P61421|VA0D1_HUMAN V-type 
proton ATPase subunit d 1 OS=Homo 
sapiens GN=ATP6V0D1 PE=1 SV=1 
sp|P61421|VA0D1_HUMANV-type proton 
ATPase subunit d 1 OS=Homo sapiens 
GN=ATP6V0D1 PE=1 SV=1 
0.97 0 4 0 0 0 1 2 1 
Tetranectin OS=Homo sapiens 
GN=CLEC3B PE=1 SV=3 
TETN_HUMAN 0.4 1 2 2 2 2 4 4 0 
Isoform 1 of Retinoic acid receptor 
responder protein 1 OS=Homo 
sapiens GN=RARRES1 
sp|P49788-2|TIG1_HUMAN 0.39 1 6 0 2 2 0 0 2 
Tropomyosin alpha-1 chain 
OS=Homo sapiens GN=TPM1 PE=2 
SV=1 
H0YK48_HUMAN 0.78 0 0 0 1 1 2 4 1 
Protein MENT OS=Homo sapiens 
GN=MENT PE=2 SV=1 
sp|Q9BUN1|MENT_HUMAN 0.17 0 0 0 0 0 0 6 3 
Tryptophan--tRNA ligase, 
cytoplasmic OS=Homo sapiens 
GN=WARS PE=1 SV=2 
sp|P23381|SYWC_HUMAN 0.36 0 0 0 0 0 2 0 0 
sp|Q86UN2|R4RL1_HUMAN 
Reticulon-4 receptor-like 1 OS=Homo 
sapiens GN=RTN4RL1 PE=2 SV=1 
sp|Q86UN2|R4RL1_HUMANReticulon-4 
receptor-like 1 OS=Homo sapiens GN=RTN4RL1 
PE=2 SV=1 
0.33 1 2 0 0 1 1 1 2 
Prefoldin subunit 3 OS=Homo 
sapiens GN=VBP1 PE=1 SV=3 
PFD3_HUMAN 0.29 3 10 0 0 0 1 0 1 
Archain 1, isoform CRA_a OS=Homo 
sapiens GN=ARCN1 PE=2 SV=1 
B0YIW6_HUMAN 0.54 1 0 1 0 0 1 5 0 
sp|O75264|CS077_HUMAN 
Transmembrane protein C19orf77 
OS=Homo sapiens GN=C19orf77 
PE=2 SV=2 
sp|O75264|CS077_HUMANTransmembrane 
protein C19orf77 OS=Homo sapiens 
GN=C19orf77 PE=2 SV=2 








acetylglucosaminyltransferase 9 OS=Homo 
sapiens GN=B3GNT9 PE=2 SV=1 
0.81 1 5 0 0 5 0 2 0 
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Regenerating islet-derived protein 3-
gamma OS=Homo sapiens 
GN=REG3G PE=1 SV=1 
sp|Q6UW15|REG3G_HUMANRegenerating islet-
derived protein 3-gamma OS=Homo sapiens 
GN=REG3G PE=1 SV=1 
0.26 6 0 0 0 6 5 5 0 
Lysine--tRNA ligase OS=Homo 
sapiens GN=KARS PE=1 SV=3 
SYK_HUMAN 0.63 1 0 2 0 0 0 6 0 
Sulfatase-modifying factor 2 
OS=Homo sapiens GN=SUMF2 PE=2 
SV=1 
F8WCW9_HUMAN 0.36 0 0 4 0 0 0 0 0 
Isoform 2 of MOB kinase activator 1B 
OS=Homo sapiens GN=MOB1B 
MOB1B_HUMAN 0.36 0 4 0 0 0 0 0 0 
Nuclear pore complex protein Nup93 
OS=Homo sapiens GN=NUP93 PE=2 
SV=1 
H3BVG0_HUMAN 0.36 5 0 0 0 0 0 0 0 
40S ribosomal protein S30 OS=Homo 
sapiens GN=FAU PE=2 SV=1 
E9PR30_HUMAN 0.36 24 0 0 0 0 0 0 0 
sp|P09429|HMGB1_HUMAN High 
mobility group protein B1 OS=Homo 
sapiens GN=HMGB1 PE=1... 
sp|P09429|HMGB1_HUMANHigh mobility group 
protein B1 OS=Homo sapiens GN=HMGB1 PE=1... 
0.36 31 0 0 0 0 0 0 0 
sp|Q13347|EIF3I_HUMAN 
Eukaryotic translation initiation 
factor 3 subunit I OS=Homo sapiens 
GN=EIF3I PE=1 SV=1 
sp|Q13347|EIF3I_HUMANEukaryotic translation 
initiation factor 3 subunit I OS=Homo sapiens 
GN=EIF3I PE=1 SV=1 
0.66 1 1 0 0 0 1 2 0 
Tetraspanin-8 OS=Homo sapiens 
GN=TSPAN8 PE=1 SV=1 
TSN8_HUMAN 0.5 0 1 1 0 0 2 4 0 
sp|Q99460|PSMD1_HUMAN 26S 
proteasome non-ATPase regulatory 
subunit 1 OS=Homo sapiens 
GN=PSMD1 PE=1 SV=2 
sp|Q99460|PSMD1_HUMAN26S proteasome 
non-ATPase regulatory subunit 1 OS=Homo 
sapiens GN=PSMD1 PE=1 SV=2 
0.35 3 8 3 0 0 6 4 3 
sp|Q9P1F3|ABRAL_HUMAN Costars 
family protein ABRACL OS=Homo 
sapiens GN=ABRACL PE=1 SV=1 
sp|Q9P1F3|ABRAL_HUMANCostars family 
protein ABRACL OS=Homo sapiens GN=ABRACL 
PE=1 SV=1 
0.31 14 0 4 0 6 2 3 0 
Flotillin-2 OS=Homo sapiens 
GN=FLOT2 PE=2 SV=1 
E7EMK3_HUMAN 0.4 0 0 4 0 0 1 1 0 
N-acylethanolamine-hydrolyzing acid 
amidase OS=Homo sapiens 
GN=NAAA PE=1 SV=3 
sp|Q02083|NAAA_HUMAN 0.44 0 0 0 1 1 2 0 0 
Isoform 3 of Spectrin alpha chain, 
non-erythrocytic 1 OS=Homo sapiens 
GN=SPTAN1 
sp|Q13813-3|SPTN1_HUMAN 0.68 1 4 0 0 0 6 0 1 
sp|Q9Y2E5|MA2B2_HUMAN 
Epididymis-specific alpha-
mannosidase OS=Homo sapiens 
GN=MAN2B2... 
sp|Q9Y2E5|MA2B2_HUMANEpididymis-specific 
alpha-mannosidase OS=Homo sapiens 
GN=MAN2B2 PE=1 SV=4 
0.93 7 5 0 0 0 0 1 7 
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Isoform 4 of Clathrin light chain A 
OS=Homo sapiens GN=CLTA 
sp|P09496-4|CLCA_HUMAN 0.36 9 0 0 0 0 0 0 0 
Sperm histone HP2 OS=Homo 
sapiens GN=PRM2 PE=2 SV=1 
Q6ZMM0_HUMAN 0.36 0 0 0 0 0 0 14 0 
sp|P52209|6PGD_HUMAN 6-
phosphogluconate dehydrogenase, 
decarboxylating OS=Homo sapiens... 
sp|P52209|6PGD_HUMAN 6-phosphogluconate 
dehydrogenase, decarboxylating OS=Homo 
sapiens... (+1) 
0.44 3 1 5 1 1 6 2 0 
Claudin-3 OS=Homo sapiens 
GN=CLDN3 PE=1 SV=1 
CLD3_HUMAN 0.3 0 3 2 4 4 0 0 1 
sp|Q7Z6M3|MILR1_HUMAN 
Allergin-1 OS=Homo sapiens 
GN=MILR1 PE=1 SV=2 
sp|Q7Z6M3|MILR1_HUMANAllergin-1 OS=Homo 
sapiens GN=MILR1 PE=1 SV=2-DECOY 
0.36 0 0 0 0 0 0 0 3 
sp|Q9H190|SDCB2_HUMAN 
Syntenin-2 OS=Homo sapiens 
GN=SDCBP2 PE=2 SV=2 
sp|Q9H190|SDCB2_HUMANSyntenin-2 
OS=Homo sapiens GN=SDCBP2 PE=2 SV=2 
0.46 0 2 0 1 1 0 2 1 
Interferon regulatory factor 6 
OS=Homo sapiens GN=IRF6 PE=1 
SV=1 
sp|O14896|IRF6_HUMAN 0.34 0 0 2 1 1 0 0 0 
sp|O43598|DNPH1_HUMAN 2'-
deoxynucleoside 5'-phosphate N-
hydrolase 1 OS=Homo sapiens 
GN=DNPH1 PE=1 SV=1 
sp|O43598|DNPH1_HUMAN2'-deoxynucleoside 
5'-phosphate N-hydrolase 1 OS=Homo sapiens 
GN=DNPH1 PE=1 SV=1 
0.98 7 2 0 0 2 4 3 0 
sp|Q8TAA3|PSA7L_HUMAN 
Proteasome subunit alpha type-7-
like OS=Homo sapiens GN=PSMA8... 
sp|Q8TAA3|PSA7L_HUMANProteasome subunit 
alpha type-7-like OS=Homo sapiens GN=PSMA8 
PE=1 SV=3 
0.24 0 3 0 0 0 1 7 1 
S-phase kinase-associated protein 1 
OS=Homo sapiens GN=SKP1 PE=2 
SV=1 
E5RJR5_HUMAN 0.38 0 0 1 3 3 0 2 0 
60S ribosomal protein L27 OS=Homo 
sapiens GN=RPL27 PE=1 SV=2 
RL27_HUMAN 0.35 3 0 4 0 0 1 2 0 
sp|P07686|HEXB_HUMAN Beta-
hexosaminidase subunit beta 
OS=Homo sapiens GN=HEXB PE=1... 
sp|P07686|HEXB_HUMAN Beta-hexosaminidase 
subunit beta OS=Homo sapiens GN=HEXB PE=1... 
0.83 10 5 0 0 0 1 0 1 
Methylosome protein 50 OS=Homo 
sapiens GN=WDR77 PE=2 SV=1 
B4DP38_HUMAN 0.98 0 2 0 0 0 0 1 1 
Small nuclear ribonucleoprotein-
associated proteins B and B' 
OS=Homo sapiens GN=SNRPB PE=1 
SV=2 
sp|P14678|RSMB_HUMAN 0.36 9 0 0 0 0 0 0 0 
Ig lambda chain V-III region LOI 
OS=Homo sapiens PE=1 SV=1 
LV302_HUMAN 0.3 0 0 6 10 0 0 0 5 
sp|Q12834|CDC20_HUMAN Cell 
division cycle protein 20 homolog 
OS=Homo sapiens GN=CDC20 PE=1 
SV=2 
sp|Q12834|CDC20_HUMANCell division cycle 
protein 20 homolog OS=Homo sapiens 
GN=CDC20 PE=1 SV=2 
0.36 6 0 0 0 0 0 0 0 
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Histidine triad nucleotide-binding 
protein 2, mitochondrial OS=Homo 
sapiens GN=HINT2 PE=1 SV=1 
sp|Q9BX68|HINT2_HUMANHistidine triad 
nucleotide-binding protein 2, mitochondrial 
OS=Homo sapiens GN=HINT2 PE=1 SV=1 
0.36 8 0 0 0 0 0 0 0 
sp|P18859|ATP5J_HUMAN ATP 
synthase-coupling factor 6, 
mitochondrial OS=Homo sapiens 
GN=ATP5J PE=1 SV=1 
sp|P18859|ATP5J_HUMANATP synthase-
coupling factor 6, mitochondrial OS=Homo 
sapiens GN=ATP5J PE=1 SV=1 





containing, RNA-binding, signal transduction-
associated protein 1 OS=Homo sapiens 
GN=KHDRBS1 PE=1 SV=1 
0.36 15 0 0 0 0 0 0 0 
sp|Q96PU8-3|QKI_HUMAN Isoform 
2 of Protein quaking OS=Homo 
sapiens GN=QKI 
sp|Q96PU8-3|QKI_HUMANIsoform 2 of Protein 
quaking OS=Homo sapiens GN=QKI 
0.36 6 0 0 0 0 0 0 0 
sp|P01717|LV403_HUMAN Ig 
lambda chain V-IV region Hil 
OS=Homo sapiens PE=1 SV=1 
sp|P01717|LV403_HUMANIg lambda chain V-IV 
region Hil OS=Homo sapiens PE=1 SV=1 
0.38 2 1 0 0 0 5 3 0 
Isoform 2 of 1,2-dihydroxy-3-keto-5-
methylthiopentene dioxygenase 
OS=Homo sapiens GN=ADI1 
sp|Q9BV57-2|MTND_HUMAN 0.32 4 0 3 1 1 2 0 0 
sp|Q9NZL9|MAT2B_HUMAN 
Methionine adenosyltransferase 2 
subunit beta OS=Homo sapiens 
GN=MAT2B PE=1 SV=1 
sp|Q9NZL9|MAT2B_HUMANMethionine 
adenosyltransferase 2 subunit beta OS=Homo 
sapiens GN=MAT2B PE=1 SV=1 
0.13 2 2 1 0 0 0 0 0 
Isoform Short of Splicing factor, 
proline- and glutamine-rich 
OS=Homo sapiens GN=SFPQ 
sp|P23246-2|SFPQ_HUMAN 0.36 13 0 0 0 0 0 0 0 
Phosphoserine phosphatase 
OS=Homo sapiens GN=PSPH PE=1 
SV=2 
SERB_HUMAN 0.55 1 1 1 1 1 3 2 2 
HCG1745306, isoform CRA_a 
OS=Homo sapiens GN=HBA2 PE=2 
SV=1 
G3V1N2_HUMAN (+2) 0.85 2 6 0 0 0 4 4 1 
sp|Q96I24|FUBP3_HUMAN Far 
upstream element-binding protein 3 
OS=Homo sapiens GN=FUBP3 PE=1 
SV=2 
sp|Q96I24|FUBP3_HUMANFar upstream 
element-binding protein 3 OS=Homo sapiens 
GN=FUBP3 PE=1 SV=2 
0.36 2 0 0 0 0 0 0 0 
sp|Q9BQ61|CS043_HUMAN 
Uncharacterized protein C19orf43 
OS=Homo sapiens GN=C19orf43... 
sp|Q9BQ61|CS043_HUMANUncharacterized 
protein C19orf43 OS=Homo sapiens 
GN=C19orf43 PE=1 SV=1 
0.36 14 0 0 0 0 0 0 0 
sp|Q9UIQ6-2|LCAP_HUMAN Isoform 
2 of Leucyl-cystinyl aminopeptidase 
OS=Homo sapiens... 
sp|Q9UIQ6-2|LCAP_HUMAN Isoform 2 of Leucyl-
cystinyl aminopeptidase OS=Homo sapiens... (+2) 
0.77 0 1 1 7 7 3 2 1 
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Putative peptidyl-tRNA hydrolase 
PTRHD1 OS=Homo sapiens 
GN=PTRHD1 PE=1 SV=1 
sp|Q6GMV3|PTRD1_HUMANPutative peptidyl-
tRNA hydrolase PTRHD1 OS=Homo sapiens 
GN=PTRHD1 PE=1 SV=1 
0.63 8 0 0 0 0 1 2 1 
sp|P27105|STOM_HUMAN 
Erythrocyte band 7 integral 
membrane protein OS=Homo 
sapiens... 
sp|P27105|STOM_HUMAN Erythrocyte band 7 
integral membrane protein OS=Homo sapiens... 
0.57 0 2 0 1 1 5 0 0 
Pyruvate dehydrogenase E1 
component subunit beta, 
mitochondrial OS=Homo sapiens 
GN=PDHB PE=2 SV=1 
C9J634_HUMAN 0.25 0 0 0 0 0 1 5 0 
sp|P38571-2|LICH_HUMAN Isoform 
2 of Lysosomal acid 
lipase/cholesteryl ester hydrolase... 
sp|P38571-2|LICH_HUMAN Isoform 2 of 
Lysosomal acid lipase/cholesteryl ester 
hydrolase... (+1) 
0.66 1 9 0 1 1 1 4 6 
ETF1 protein OS=Homo sapiens 
GN=ETF1 PE=2 SV=1 
Q96CG1_HUMAN 0.42 0 1 2 0 0 4 0 0 
sp|O15511|ARPC5_HUMAN Actin-
related protein 2/3 complex subunit 
5 OS=Homo sapiens GN=ARPC5 PE=1 
SV=3 
sp|O15511|ARPC5_HUMANActin-related protein 
2/3 complex subunit 5 OS=Homo sapiens 
GN=ARPC5 PE=1 SV=3 
0.91 7 0 0 0 2 3 1 0 
sp|O60613|SEP15_HUMAN 15 kDa 
selenoprotein OS=Homo sapiens 
GN=SEP15 PE=1 SV=3 
sp|O60613|SEP15_HUMAN15 kDa selenoprotein 
OS=Homo sapiens GN=SEP15 PE=1 SV=3 
0.72 2 0 0 2 2 1 0 0 
sp|Q15847|ADIRF_HUMAN 
Adipogenesis regulatory factor 
OS=Homo sapiens GN=ADIRF PE=1 
SV=1 
sp|Q15847|ADIRF_HUMANAdipogenesis 
regulatory factor OS=Homo sapiens GN=ADIRF 
PE=1 SV=1 
0.96 0 3 0 0 0 1 1 1 
tr|E9PM69|E9PM69_HUMAN 26S 
protease regulatory subunit 6A 
OS=Homo sapiens GN=PSMC3... 
tr|E9PM69|E9PM69_HUMAN 26S protease 
regulatory subunit 6A OS=Homo sapiens 
GN=PSMC3... (+1) 
0.34 5 0 5 0 0 3 2 0 
Isoform 2 of Secernin-1 OS=Homo 
sapiens GN=SCRN1 
sp|Q12765-2|SCRN1_HUMAN (+1) 0.34 2 0 2 0 0 2 0 0 
sp|P07910|HNRPC_HUMAN 
Heterogeneous nuclear 
ribonucleoproteins C1/C2 OS=Homo 
sapiens GN=HNRNPC PE=1 SV=4 
sp|P07910|HNRPC_HUMANHeterogeneous 
nuclear ribonucleoproteins C1/C2 OS=Homo 
sapiens GN=HNRNPC PE=1 SV=4 
0.36 8 0 0 0 0 0 0 0 
Isoform 9 of Eukaryotic translation 
initiation factor 4 gamma 1 
OS=Homo sapiens GN=EIF4G1 
sp|Q04637-9|IF4G1_HUMAN 0.47 10 0 0 0 0 0 0 0 
sp|O75368|SH3L1_HUMAN SH3 
domain-binding glutamic acid-rich-
like protein OS=Homo sapiens 
GN=SH3BGRL PE=1 SV=1 
sp|O75368|SH3L1_HUMANSH3 domain-binding 
glutamic acid-rich-like protein OS=Homo sapiens 
GN=SH3BGRL PE=1 SV=1 
0.81 1 4 0 1 2 1 1 1 
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Isoform 2 of Isopentenyl-
diphosphate Delta-isomerase 1 
OS=Homo sapiens GN=IDI1 
sp|Q13907-2|IDI1_HUMAN 0.34 1 5 4 0 0 2 2 2 
sp|P35998|PRS7_HUMAN 26S 
protease regulatory subunit 7 
OS=Homo sapiens GN=PSMC2 
PE=1... 
sp|P35998|PRS7_HUMAN 26S protease 
regulatory subunit 7 OS=Homo sapiens 
GN=PSMC2 PE=1... 




sapiens GN=NAMPT PE=1 SV=1 
sp|P43490|NAMPT_HUMANNicotinamide 
phosphoribosyltransferase OS=Homo sapiens 
GN=NAMPT PE=1 SV=1 
0.8 4 1 0 0 0 4 1 1 
60S ribosomal protein L12 OS=Homo 
sapiens GN=RPL12 PE=1 SV=1 
sp|P30050|RL12_HUMAN 0.47 12 0 0 1 1 0 3 0 
sp|Q5SRE7|PHYD1_HUMAN 
Phytanoyl-CoA dioxygenase domain-
containing protein 1 OS=Homo 
sapiens GN=PHYHD1 PE=1 SV=2 
sp|Q5SRE7|PHYD1_HUMANPhytanoyl-CoA 
dioxygenase domain-containing protein 1 
OS=Homo sapiens GN=PHYHD1 PE=1 SV=2 
0.68 0 2 0 0 0 0 0 1 
sp|P30048|PRDX3_HUMAN 
Thioredoxin-dependent peroxide 
reductase, mitochondrial OS=Homo 
sapiens GN=PRDX3 PE=1 SV=3 
sp|P30048|PRDX3_HUMANThioredoxin-
dependent peroxide reductase, mitochondrial 
OS=Homo sapiens GN=PRDX3 PE=1 SV=3 
0.68 2 0 0 0 0 1 0 0 
sp|P42167|LAP2B_HUMAN Lamina-
associated polypeptide 2, isoforms 
beta/gamma OS=Homo... 
sp|P42167|LAP2B_HUMANLamina-associated 
polypeptide 2, isoforms beta/gamma OS=Homo 
sapiens GN=TMPO PE=1 SV=2 
0.36 12 0 0 0 0 0 0 0 
Low molecular weight 
phosphotyrosine protein 
phosphatase OS=Homo sapiens 
GN=ACP1 PE=1 SV=3 
sp|P24666|PPAC_HUMAN 0.36 5 0 0 0 0 0 0 0 
60S ribosomal protein L8 OS=Homo 
sapiens GN=RPL8 PE=1 SV=2 
RL8_HUMAN 0.46 5 0 0 0 0 1 0 0 
sp|P26447|S10A4_HUMAN Protein 
S100-A4 OS=Homo sapiens 
GN=S100A4 PE=1 SV=1 
sp|P26447|S10A4_HUMANProtein S100-A4 
OS=Homo sapiens GN=S100A4 PE=1 SV=1 
0.36 14 0 0 0 0 0 0 0 
sp|P05114|HMGN1_HUMAN Non-
histone chromosomal protein HMG-
14 OS=Homo sapiens GN=HMGN1... 
sp|P05114|HMGN1_HUMANNon-histone 
chromosomal protein HMG-14 OS=Homo sapiens 
GN=HMGN1 PE=1 SV=3 
0.36 18 0 0 0 0 0 0 0 
sp|P51858|HDGF_HUMAN 
Hepatoma-derived growth factor 
OS=Homo sapiens GN=HDGF PE=1... 
sp|P51858|HDGF_HUMAN Hepatoma-derived 
growth factor OS=Homo sapiens GN=HDGF 
PE=1... 
0.36 21 0 0 0 0 0 0 0 
Rho-related GTP-binding protein 
RhoG OS=Homo sapiens GN=RHOG 
PE=1 SV=1 
RHOG_HUMAN 0.39 1 4 1 1 1 2 2 2 
Keratin, type II cytoskeletal 8 
(Fragment) OS=Homo sapiens 
GN=KRT8 PE=2 SV=1 
F8VUG2_HUMAN 0.53 1 5 3 0 0 3 4 1 
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Isoform 4 of 60 kDa SS-A/Ro 
ribonucleoprotein OS=Homo sapiens 
GN=TROVE2 
sp|P10155-4|RO60_HUMAN 0.12 1 1 0 1 1 2 3 1 
sp|P30740|ILEU_HUMAN Leukocyte 
elastase inhibitor OS=Homo sapiens 
GN=SERPINB1 PE=1... 
sp|P30740|ILEU_HUMAN Leukocyte elastase 
inhibitor OS=Homo sapiens GN=SERPINB1 PE=1... 
0.75 2 1 0 3 3 4 0 2 
sp|P60903|S10AA_HUMAN Protein 
S100-A10 OS=Homo sapiens 
GN=S100A10 PE=1 SV=2 
sp|P60903|S10AA_HUMANProtein S100-A10 
OS=Homo sapiens GN=S100A10 PE=1 SV=2 
0.37 4 0 0 1 1 6 2 2 
Vacuolar protein sorting-associated 
protein 29 OS=Homo sapiens 
GN=VPS29 PE=2 SV=1 
F8VXU5_HUMAN 0.37 1 2 3 0 0 3 2 0 
sp|P40189|IL6RB_HUMAN 
Interleukin-6 receptor subunit beta 
OS=Homo sapiens GN=IL6ST PE=1 
SV=2 
sp|P40189|IL6RB_HUMANInterleukin-6 receptor 
subunit beta OS=Homo sapiens GN=IL6ST PE=1 
SV=2 
0.49 0 4 0 0 1 0 0 2 
Beta-centractin OS=Homo sapiens 
GN=ACTR1B PE=1 SV=1 
ACTY_HUMAN 0.35 0 3 2 0 0 1 0 3 
Semenogelin-2 OS=Homo sapiens 
GN=SEMG2 PE=1 SV=1 
SEMG2_HUMAN 0.4 0 0 6 0 0 8 0 0 
40S ribosomal protein S28 OS=Homo 
sapiens GN=RPS28 PE=1 SV=1 
RS28_HUMAN 0.36 19 0 0 0 0 0 0 0 
sp|Q9HAB8|PPCS_HUMAN 
Phosphopantothenate--cysteine 
ligase OS=Homo sapiens GN=PPCS... 
sp|Q9HAB8|PPCS_HUMAN 
Phosphopantothenate--cysteine ligase OS=Homo 
sapiens GN=PPCS... 
0.82 6 2 0 5 5 1 5 1 
sp|Q16401-2|PSMD5_HUMAN 
Isoform 2 of 26S proteasome non-
ATPase regulatory subunit... 
sp|Q16401-2|PSMD5_HUMAN Isoform 2 of 26S 
proteasome non-ATPase regulatory subunit... 
0.32 5 3 9 1 1 0 6 1 
sp|Q15257-2|PTPA_HUMAN Isoform 
1 of Serine/threonine-protein 
phosphatase 2A activator... 
sp|Q15257-2|PTPA_HUMAN Isoform 1 of 
Serine/threonine-protein phosphatase 2A 
activator... (+1) 
0.7 0 5 0 0 0 2 1 5 
Cystatin-A OS=Homo sapiens 
GN=CSTA PE=1 SV=1 







0.35 8 0 2 0 0 4 3 0 
sp|P23193|TCEA1_HUMAN 
Transcription elongation factor A 
protein 1 OS=Homo sapiens 
GN=TCEA1 PE=1 SV=2 
sp|P23193|TCEA1_HUMANTranscription 
elongation factor A protein 1 OS=Homo sapiens 
GN=TCEA1 PE=1 SV=2 
0.36 2 0 0 0 0 0 0 0 
sp|P51688|SPHM_HUMAN N-
sulphoglucosamine sulphohydrolase 
OS=Homo sapiens GN=SGSH... 
sp|P51688|SPHM_HUMAN N-sulphoglucosamine 
sulphohydrolase OS=Homo sapiens GN=SGSH... 
0.68 3 1 2 2 2 5 2 6 
Isoform 2B of GTPase KRas 
OS=Homo sapiens GN=KRAS 
sp|P01116-2|RASK_HUMAN 0.35 2 4 2 1 1 1 1 5 
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60S ribosomal protein L38 OS=Homo 
sapiens GN=RPL38 PE=1 SV=2 
RL38_HUMAN 0.14 19 1 1 0 0 1 1 0 
sp|Q8WWY7|WFD12_HUMAN WAP 
four-disulfide core domain protein 
12 OS=Homo sapiens GN=WFDC12... 
sp|Q8WWY7|WFD12_HUMANWAP four-
disulfide core domain protein 12 OS=Homo 
sapiens GN=WFDC12 PE=2 SV=1 
0.097 2 0 0 0 3 5 3 0 
sp|DHE3_BOVIN| sp|DHE3_BOVIN| 0.65 0 0 2 0 0 5 0 0 
sp|P02538|K2C6A_HUMAN Keratin, 
type II cytoskeletal 6A OS=Homo 
sapiens GN=KRT6A PE=1... 
sp|P02538|K2C6A_HUMANKeratin, type II 
cytoskeletal 6A OS=Homo sapiens GN=KRT6A 
PE=1 SV=3 
0.025 0 0 0 0 1 0 2 3 
Heat shock 70 kDa protein 4L 
OS=Homo sapiens GN=HSPA4L PE=2 
SV=2 
E7ES43_HUMAN 0.5 0 0 0 0 0 5 0 3 
sp|Q8IXA5|SACA3_HUMAN Sperm 
acrosome membrane-associated 
protein 3 OS=Homo sapiens 
GN=SPACA3 PE=1 SV=1 
sp|Q8IXA5|SACA3_HUMANSperm acrosome 
membrane-associated protein 3 OS=Homo 
sapiens GN=SPACA3 PE=1 SV=1 
0.22 1 0 0 0 0 0 3 3 
Protein MAL2 OS=Homo sapiens 
GN=MAL2 PE=1 SV=1 
MAL2_HUMAN 0.25 4 2 3 5 5 2 2 0 
T-complex protein 1 subunit epsilon 
OS=Homo sapiens GN=CCT5 PE=2 
SV=1 
E7ENZ3_HUMAN 0.38 2 1 2 0 0 0 3 1 
sp|Q15427|SF3B4_HUMAN Splicing 
factor 3B subunit 4 OS=Homo 
sapiens GN=SF3B4 PE=1 SV=1 
sp|Q15427|SF3B4_HUMANSplicing factor 3B 
subunit 4 OS=Homo sapiens GN=SF3B4 PE=1 
SV=1 
0.36 5 0 0 0 0 0 0 0 
sp|P51991|ROA3_HUMAN 
Heterogeneous nuclear 
ribonucleoprotein A3 OS=Homo 
sapiens GN=HNRNPA3... 
sp|P51991|ROA3_HUMAN Heterogeneous 
nuclear ribonucleoprotein A3 OS=Homo sapiens 
GN=HNRNPA3... 
0.36 16 0 0 0 0 0 0 0 
sp|P00338|LDHA_HUMAN L-lactate 
dehydrogenase A chain OS=Homo 
sapiens GN=LDHA PE=1... 
sp|P00338|LDHA_HUMAN L-lactate 
dehydrogenase A chain OS=Homo sapiens 
GN=LDHA PE=1... 
0.28 4 2 7 0 0 3 0 2 
40S ribosomal protein S25 OS=Homo 
sapiens GN=RPS25 PE=1 SV=1 
RS25_HUMAN 0.33 11 0 3 0 0 7 3 0 
sp|Q9Y224|CN166_HUMAN 
UPF0568 protein C14orf166 
OS=Homo sapiens GN=C14orf166 
PE=1 SV=1 
sp|Q9Y224|CN166_HUMANUPF0568 protein 
C14orf166 OS=Homo sapiens GN=C14orf166 
PE=1 SV=1 
0.53 2 2 0 0 0 0 2 0 
60S ribosomal protein L23a 
(Fragment) OS=Homo sapiens 
GN=RPL23A PE=3 SV=1 
H7BY10_HUMAN 0.45 6 1 0 0 0 2 0 0 
60S ribosomal protein L9 OS=Homo 
sapiens GN=RPL9 PE=1 SV=1 
RL9_HUMAN 0.35 4 1 0 0 0 0 1 0 
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secretory ribonuclease OS=Homo 
sapiens GN=RNASE2 PE=1 SV=2 
sp|P10153|RNAS2_HUMANNon-secretory 
ribonuclease OS=Homo sapiens GN=RNASE2 
PE=1 SV=2 
0.36 7 0 0 0 0 0 0 0 
THO complex subunit 4 OS=Homo 
sapiens GN=ALYREF PE=2 SV=1 
E9PB61_HUMAN 0.36 13 0 0 0 0 0 0 0 
sp|Q969E4|TCAL3_HUMAN 
Transcription elongation factor A 
protein-like 3 OS=Homo sapiens 
GN=TCEAL3 PE=1 SV=1 
sp|Q969E4|TCAL3_HUMANTranscription 
elongation factor A protein-like 3 OS=Homo 
sapiens GN=TCEAL3 PE=1 SV=1 
0.36 6 0 0 0 0 0 0 0 
sp|P0CW22|RS17L_HUMAN 40S 
ribosomal protein S17-like OS=Homo 
sapiens GN=RPS17L PE=1 SV=1 
sp|P0CW22|RS17L_HUMAN40S ribosomal 
protein S17-like OS=Homo sapiens GN=RPS17L 
PE=1 SV=1 
0.36 10 0 0 0 0 0 0 0 
sp|Q9NVJ2|ARL8B_HUMAN ADP-
ribosylation factor-like protein 8B 
OS=Homo sapiens GN=ARL8B PE=1 
SV=1 
sp|Q9NVJ2|ARL8B_HUMANADP-ribosylation 
factor-like protein 8B OS=Homo sapiens 
GN=ARL8B PE=1 SV=1 
0.95 0 2 0 0 0 1 1 0 
sp|P13073|COX41_HUMAN 
Cytochrome c oxidase subunit 4 
isoform 1, mitochondrial OS=Homo 
sapiens GN=COX4I1 PE=1 SV=1 
sp|P13073|COX41_HUMANCytochrome c 
oxidase subunit 4 isoform 1, mitochondrial 
OS=Homo sapiens GN=COX4I1 PE=1 SV=1 
0.37 2 0 0 0 0 2 5 0 
sp|O00232|PSD12_HUMAN 26S 
proteasome non-ATPase regulatory 
subunit 12 OS=Homo sapiens 
GN=PSMD12 PE=1 SV=3 
sp|O00232|PSD12_HUMAN26S proteasome 
non-ATPase regulatory subunit 12 OS=Homo 
sapiens GN=PSMD12 PE=1 SV=3 
0.36 0 0 9 0 0 0 0 0 
Desmin OS=Homo sapiens GN=DES 
PE=1 SV=3 
DESM_HUMAN 0.2 1 3 0 0 0 0 0 0 
sp|P10916|MLRV_HUMAN Myosin 
regulatory light chain 2, 
ventricular/cardiac muscle... 
sp|P10916|MLRV_HUMAN Myosin regulatory 
light chain 2, ventricular/cardiac muscle... 
0.45 2 11 0 0 0 0 4 0 
sp|Q9GZT8|GTPC1_HUMAN 
Putative GTP cyclohydrolase 1 type 2 
NIF3L1 OS=Homo sapiens... 
sp|Q9GZT8|GTPC1_HUMANPutative GTP 
cyclohydrolase 1 type 2 NIF3L1 OS=Homo sapiens 
GN=NIF3L1 PE=1 SV=2 
0.36 0 0 0 0 0 0 3 0 
Syntaxin-binding protein 2 OS=Homo 
sapiens GN=STXBP2 PE=2 SV=1 
M0R0M7_HUMAN 0.22 0 0 0 0 0 4 0 0 
40S ribosomal protein S6 OS=Homo 
sapiens GN=RPS6 PE=1 SV=1 
RS6_HUMAN 0.3 6 2 2 0 0 6 0 0 
Phosphoglucomutase-1 OS=Homo 
sapiens GN=PGM1 PE=1 SV=3 
sp|P36871|PGM1_HUMAN 0.077 0 0 0 1 1 4 3 1 
Sulfatase-modifying factor 2 
(Fragment) OS=Homo sapiens 
GN=SUMF2 PE=2 SV=1 
H7C3B2_HUMAN 0.82 1 3 0 0 0 2 0 1 
ADP/ATP translocase 2 OS=Homo 
sapiens GN=SLC25A5 PE=1 SV=7 
ADT2_HUMAN 0.79 3 1 0 0 0 0 5 0 
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cell adhesion molecule 1 OS=Homo... 
sp|P13688|CEAM1_HUMANCarcinoembryonic 
antigen-related cell adhesion molecule 1 
OS=Homo sapiens GN=CEACAM1 PE=1 SV=2 
0.46 0 2 0 0 1 0 5 0 
Isoform C of Arachidonate 15-
lipoxygenase B OS=Homo sapiens 
GN=ALOX15B 
sp|O15296-3|LX15B_HUMAN 0.7 3 1 0 0 0 3 0 0 
sp|P09529|INHBB_HUMAN Inhibin 
beta B chain OS=Homo sapiens 
GN=INHBB PE=1 SV=2 
sp|P09529|INHBB_HUMANInhibin beta B chain 
OS=Homo sapiens GN=INHBB PE=1 SV=2 
0.21 0 0 0 0 0 3 1 0 
Dynein light chain roadblock-type 1 
OS=Homo sapiens GN=DYNLRB1 
PE=2 SV=1 
B4DFR2_HUMAN 0.41 10 2 0 0 0 3 0 0 
Isoform 4 of PDZ and LIM domain 
protein 7 OS=Homo sapiens 
GN=PDLIM7 
sp|Q9NR12-4|PDLI7_HUMAN 0.36 5 0 0 0 0 0 0 0 
RNA-binding protein EWS OS=Homo 
sapiens GN=EWSR1 PE=2 SV=1 
B0QYK0_HUMAN (+4) 0.36 7 0 0 0 0 0 0 0 
sp|P53999|TCP4_HUMAN Activated 
RNA polymerase II transcriptional 
coactivator p15... 
sp|P53999|TCP4_HUMAN Activated RNA 
polymerase II transcriptional coactivator p15... 
0.33 11 0 0 2 2 0 0 0 
Isoform 2 of Signal recognition 
particle 9 kDa protein OS=Homo 
sapiens GN=SRP9 
SRP09_HUMAN 0.36 13 0 0 0 0 0 0 0 
DNA-(apurinic or apyrimidinic site) 
lyase (Fragment) OS=Homo sapiens 
GN=APEX1 PE=2 SV=1 
G3V5D9_HUMAN 0.36 14 0 0 0 0 0 0 0 
sp|P25325|THTM_HUMAN 3-
mercaptopyruvate sulfurtransferase 
OS=Homo sapiens GN=MPST... 
sp|P25325|THTM_HUMAN 3-mercaptopyruvate 
sulfurtransferase OS=Homo sapiens GN=MPST... 
(+1) 
0.64 0 2 2 3 3 6 3 1 
sp|P07360|CO8G_HUMAN 
Complement component C8 gamma 
chain OS=Homo sapiens GN=C8G 
PE=1... 
sp|P07360|CO8G_HUMAN Complement 
component C8 gamma chain OS=Homo sapiens 
GN=C8G PE=1... 
0.84 1 5 0 1 1 1 3 1 
40S ribosomal protein S11 OS=Homo 
sapiens GN=RPS11 PE=1 SV=3 
RS11_HUMAN 0.44 6 0 0 0 0 1 0 0 
sp|Q9Y5L4|TIM13_HUMAN 
Mitochondrial import inner 
membrane translocase subunit 
Tim13 OS=Homo sapiens 
GN=TIMM13 PE=1 SV=1 
sp|Q9Y5L4|TIM13_HUMANMitochondrial import 
inner membrane translocase subunit Tim13 
OS=Homo sapiens GN=TIMM13 PE=1 SV=1 
0.36 7 0 0 0 0 0 0 0 
Cellular retinoic acid-binding protein 
2 (Fragment) OS=Homo sapiens 
GN=CRABP2 PE=2 SV=1 
Q5SYZ4_HUMAN (+1) 0.36 0 4 0 0 0 0 0 0 
Histone H1.3 OS=Homo sapiens 
GN=HIST1H1D PE=1 SV=2 
H13_HUMAN 0.36 13 0 0 0 0 0 0 0 
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Microtubule-associated protein 4 
OS=Homo sapiens GN=MAP4 PE=1... 
sp|P27816|MAP4_HUMAN Microtubule-
associated protein 4 OS=Homo sapiens 
GN=MAP4 PE=1... 
0.36 12 0 0 0 0 0 0 0 
sp|Q9NZJ9|NUDT4_HUMAN 
Diphosphoinositol polyphosphate 
phosphohydrolase 2 OS=Homo 
sapiens GN=NUDT4 PE=1 SV=2 
sp|Q9NZJ9|NUDT4_HUMANDiphosphoinositol 
polyphosphate phosphohydrolase 2 OS=Homo 
sapiens GN=NUDT4 PE=1 SV=2 
0.32 0 2 0 0 1 0 1 5 
sp|O15393|TMPS2_HUMAN 
Transmembrane protease serine 2 
OS=Homo sapiens GN=TMPRSS2 
PE=1 SV=3 
sp|O15393|TMPS2_HUMANTransmembrane 
protease serine 2 OS=Homo sapiens 
GN=TMPRSS2 PE=1 SV=3 
0.052 0 0 1 0 6 1 3 0 
sp|P17405-4|ASM_HUMAN Isoform 
4 of Sphingomyelin 
phosphodiesterase OS=Homo 
sapiens GN=SMPD1 
sp|P17405-4|ASM_HUMANIsoform 4 of 
Sphingomyelin phosphodiesterase OS=Homo 
sapiens GN=SMPD1 
0.98 2 2 0 0 0 4 0 0 
sp|P24752|THIL_HUMAN Acetyl-
CoA acetyltransferase, mitochondrial 
OS=Homo sapiens... 
sp|P24752|THIL_HUMAN Acetyl-CoA 
acetyltransferase, mitochondrial OS=Homo 
sapiens... 
0.41 12 0 0 0 0 0 0 2 
40S ribosomal protein S19 OS=Homo 
sapiens GN=RPS19 PE=1 SV=2 
RS19_HUMAN 0.36 8 0 0 0 0 0 0 0 
sp|Q9Y6H1|CHCH2_HUMAN Coiled-
coil-helix-coiled-coil-helix domain-
containing protein 2, mitochondrial 
OS=Homo sapiens GN=CHCHD2 PE=1 
SV=1 
sp|Q9Y6H1|CHCH2_HUMANCoiled-coil-helix-
coiled-coil-helix domain-containing protein 2, 
mitochondrial OS=Homo sapiens GN=CHCHD2 
PE=1 SV=1 
0.36 10 0 0 0 0 0 0 0 
Isoform 2 of U1 small nuclear 
ribonucleoprotein 70 kDa OS=Homo 
sapiens GN=SNRNP70 
sp|P08621-2|RU17_HUMAN 0.36 4 0 0 0 0 0 0 0 
sp|Q86U42|PABP2_HUMAN 
Polyadenylate-binding protein 2 
OS=Homo sapiens GN=PABPN1 PE=1 
SV=3 
sp|Q86U42|PABP2_HUMANPolyadenylate-
binding protein 2 OS=Homo sapiens GN=PABPN1 
PE=1 SV=3 
0.36 20 0 0 0 0 0 0 0 
Isoform 2 of Calcium-dependent 
secretion activator 2 OS=Homo 
sapiens GN=CADPS2 
sp|Q86UW7-2|CAPS2_HUMAN 0.99 3 1 0 0 0 3 0 1 
sp|P13646|K1C13_HUMAN Keratin, 
type I cytoskeletal 13 OS=Homo 
sapiens GN=KRT13 PE=1... 
sp|P13646|K1C13_HUMANKeratin, type I 
cytoskeletal 13 OS=Homo sapiens GN=KRT13 
PE=1 SV=4 
0.38 1 1 0 0 6 0 2 0 
sp|Q96A22|CK052_HUMAN 
Uncharacterized protein C11orf52 
OS=Homo sapiens GN=C11orf52 
PE=2 SV=2 
sp|Q96A22|CK052_HUMANUncharacterized 
protein C11orf52 OS=Homo sapiens 
GN=C11orf52 PE=2 SV=2 
0.4 1 0 0 0 0 1 0 2 
Isoform 3 of Mitogen-activated 
protein kinase 3 OS=Homo sapiens 
GN=MAPK3 
sp|P27361-3|MK03_HUMAN 0.39 0 0 2 0 0 1 0 0 
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KIAA1199 OS=Homo sapiens 
GN=KIAA1199 PE=2 SV=2 
sp|Q8WUJ3|K1199_HUMANProtein KIAA1199 
OS=Homo sapiens GN=KIAA1199 PE=2 SV=2 
0.36 0 0 0 0 0 3 0 0 
sp|Q9NP55|BPIA1_HUMAN BPI fold-
containing family A member 1 
OS=Homo sapiens GN=BPIFA1 PE=1 
SV=1 
sp|Q9NP55|BPIA1_HUMANBPI fold-containing 
family A member 1 OS=Homo sapiens GN=BPIFA1 
PE=1 SV=1 
0.36 0 0 0 0 0 0 2 0 
Histone H2A type 3 OS=Homo 
sapiens GN=HIST3H2A PE=1 SV=3 
H2A3_HUMAN 0.42 4 0 0 0 0 0 0 0 
sp|Q13442|HAP28_HUMAN 28 kDa 
heat- and acid-stable 
phosphoprotein OS=Homo sapiens... 
sp|Q13442|HAP28_HUMAN28 kDa heat- and 
acid-stable phosphoprotein OS=Homo sapiens 
GN=PDAP1 PE=1 SV=1 
0.36 10 0 0 0 0 0 0 0 
sp|O60739|EIF1B_HUMAN 
Eukaryotic translation initiation 
factor 1b OS=Homo sapiens 
GN=EIF1B PE=1 SV=2 
sp|O60739|EIF1B_HUMANEukaryotic translation 
initiation factor 1b OS=Homo sapiens GN=EIF1B 
PE=1 SV=2 
0.36 9 0 0 0 0 0 0 0 
sp|O14602|IF1AY_HUMAN 
Eukaryotic translation initiation 
factor 1A, Y-chromosomal OS=Homo 
sapiens GN=EIF1AY PE=1 SV=4 
sp|O14602|IF1AY_HUMANEukaryotic translation 
initiation factor 1A, Y-chromosomal OS=Homo 
sapiens GN=EIF1AY PE=1 SV=4 
0.36 11 0 0 0 0 0 0 0 
sp|Q15233-2|NONO_HUMAN 
Isoform 2 of Non-POU domain-
containing octamer-binding 
protein... 
sp|Q15233-2|NONO_HUMAN Isoform 2 of Non-
POU domain-containing octamer-binding 
protein... 
0.36 18 0 0 0 0 0 0 0 
sp|P50148|GNAQ_HUMAN Guanine 
nucleotide-binding protein G(q) 
subunit alpha OS=Homo... 
sp|P50148|GNAQ_HUMAN Guanine nucleotide-
binding protein G(q) subunit alpha OS=Homo... 
0.61 3 2 0 1 1 2 1 3 
sp|O95166|GBRAP_HUMAN 
Gamma-aminobutyric acid receptor-
associated protein OS=Homo sapiens 
GN=GABARAP PE=1 SV=1 
sp|O95166|GBRAP_HUMANGamma-
aminobutyric acid receptor-associated protein 
OS=Homo sapiens GN=GABARAP PE=1 SV=1 
0.71 8 0 0 0 1 1 1 2 
sp|Q7KZF4|SND1_HUMAN 
Staphylococcal nuclease domain-
containing protein 1 OS=Homo... 
sp|Q7KZF4|SND1_HUMAN Staphylococcal 
nuclease domain-containing protein 1 
OS=Homo... 
0.41 2 0 1 0 0 0 3 3 
sp|P48739|PIPNB_HUMAN 
Phosphatidylinositol transfer protein 
beta isoform OS=Homo... 
sp|P48739|PIPNB_HUMANPhosphatidylinositol 
transfer protein beta isoform OS=Homo sapiens 
GN=PITPNB PE=1 SV=2 
0.088 0 0 0 0 1 4 0 1 
sp|Q96AE7|TTC17_HUMAN 
Tetratricopeptide repeat protein 17 
OS=Homo sapiens GN=TTC17 PE=2 
SV=1 
sp|Q96AE7|TTC17_HUMANTetratricopeptide 
repeat protein 17 OS=Homo sapiens GN=TTC17 
PE=2 SV=1 
0.66 0 1 0 0 0 0 2 0 
sp|Q8TC12|RDH11_HUMAN Retinol 
dehydrogenase 11 OS=Homo sapiens 
GN=RDH11 PE=1 SV=2 
sp|Q8TC12|RDH11_HUMANRetinol 
dehydrogenase 11 OS=Homo sapiens GN=RDH11 
PE=1 SV=2 
0.13 0 0 0 0 0 2 4 0 
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Ubiquitin domain-containing protein 
2 OS=Homo sapiens GN=UBTD2 PE=1 
SV=2 
sp|Q8WUN7|UBTD2_HUMANUbiquitin domain-
containing protein 2 OS=Homo sapiens 
GN=UBTD2 PE=1 SV=2 
0.36 0 0 0 0 4 0 0 0 
sp|P10606|COX5B_HUMAN 
Cytochrome c oxidase subunit 5B, 
mitochondrial OS=Homo sapiens 
GN=COX5B PE=1 SV=2 
sp|P10606|COX5B_HUMANCytochrome c 
oxidase subunit 5B, mitochondrial OS=Homo 
sapiens GN=COX5B PE=1 SV=2 
0.36 13 0 0 0 0 0 0 0 
Isoform 2 of Leucine-rich repeat 
flightless-interacting protein 1 
OS=Homo sapiens GN=LRRFIP1 
sp|Q32MZ4-2|LRRF1_HUMAN 0.067 4 2 1 1 1 0 0 1 
sp|P17858|K6PL_HUMAN 6-
phosphofructokinase, liver type 
OS=Homo sapiens GN=PFKL PE=1... 
sp|P17858|K6PL_HUMAN 6-
phosphofructokinase, liver type OS=Homo 
sapiens GN=PFKL PE=1... 
0.4 1 3 0 1 1 0 2 0 
sp|P43034|LIS1_HUMAN Platelet-
activating factor acetylhydrolase IB 
subunit alpha... 
sp|P43034|LIS1_HUMAN Platelet-activating 
factor acetylhydrolase IB subunit alpha... 
0.66 0 3 1 0 0 2 2 1 
sp|P07098-3|LIPG_HUMAN Isoform 
3 of Gastric triacylglycerol lipase 
OS=Homo sapiens... 
sp|P07098-3|LIPG_HUMAN Isoform 3 of Gastric 
triacylglycerol lipase OS=Homo sapiens... (+1) 
0.34 0 1 0 0 0 5 0 1 
Isoform 3 of Dynactin subunit 3 
OS=Homo sapiens GN=DCTN3 
sp|O75935-3|DCTN3_HUMAN 0.46 0 0 2 0 0 7 0 0 
sp|O14979|HNRDL_HUMAN 
Heterogeneous nuclear 
ribonucleoprotein D-like OS=Homo 
sapiens... 
sp|O14979|HNRDL_HUMANHeterogeneous 
nuclear ribonucleoprotein D-like OS=Homo 
sapiens GN=HNRNPDL PE=1 SV=3 
0.36 2 0 0 0 0 0 0 0 
sp|Q9H3K6|BOLA2_HUMAN BolA-
like protein 2 OS=Homo sapiens 
GN=BOLA2 PE=1 SV=1 
sp|Q9H3K6|BOLA2_HUMANBolA-like protein 2 
OS=Homo sapiens GN=BOLA2 PE=1 SV=1 
0.36 11 0 0 0 0 0 0 0 
Isoform 5 of Polyglutamine-binding 
protein 1 OS=Homo sapiens 
GN=PQBP1 
sp|O60828-5|PQBP1_HUMAN 0.36 3 0 0 0 0 0 0 0 
60S ribosomal protein L24 OS=Homo 
sapiens GN=RPL24 PE=1 SV=1 
RL24_HUMAN 0.36 3 0 0 0 0 0 0 0 
sp|O14737|PDCD5_HUMAN 
Programmed cell death protein 5 
OS=Homo sapiens GN=PDCD5 PE=1 
SV=3 
sp|O14737|PDCD5_HUMANProgrammed cell 
death protein 5 OS=Homo sapiens GN=PDCD5 
PE=1 SV=3 
0.36 5 0 0 0 0 0 0 0 
Aminoacylase-1 OS=Homo sapiens 
GN=ACY1 PE=2 SV=1 
B4DNW0_HUMAN 0.3 0 3 1 0 0 1 1 1 
60S acidic ribosomal protein P0 
OS=Homo sapiens GN=RPLP0 PE=2 
SV=1 
F8VWS0_HUMAN 0.33 0 1 0 2 2 0 1 2 
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Threonine--tRNA ligase, cytoplasmic 
OS=Homo sapiens GN=TARS PE=1 
SV=3 
sp|P26639|SYTC_HUMAN 0.45 2 3 0 0 0 2 0 3 
sp|P62191|PRS4_HUMAN 26S 
protease regulatory subunit 4 
OS=Homo sapiens GN=PSMC1 
PE=1... 
sp|P62191|PRS4_HUMAN 26S protease 
regulatory subunit 4 OS=Homo sapiens 
GN=PSMC1 PE=1... 
0.42 1 0 2 0 0 3 0 0 
sp|Q9NTM9|CUTC_HUMAN Copper 
homeostasis protein cutC homolog 
OS=Homo sapiens GN=CUTC... 
sp|Q9NTM9|CUTC_HUMAN Copper homeostasis 
protein cutC homolog OS=Homo sapiens 
GN=CUTC... (+1) 
0.42 0 1 0 1 1 0 7 0 
sp|P31151|S10A7_HUMAN Protein 
S100-A7 OS=Homo sapiens 
GN=S100A7 PE=1 SV=4 
sp|P31151|S10A7_HUMANProtein S100-A7 
OS=Homo sapiens GN=S100A7 PE=1 SV=4 
0.14 0 0 0 0 2 0 3 0 
26S proteasome non-ATPase 
regulatory subunit 11 OS=Homo 
sapiens GN=PSMD11 PE=1 SV=3 
sp|O00231|PSD11_HUMAN (+1) 0.13 0 0 0 0 0 5 0 5 
sp|Q9HCU4|CELR2_HUMAN 
Cadherin EGF LAG seven-pass G-type 
receptor 2 OS=Homo sapiens... 
sp|Q9HCU4|CELR2_HUMANCadherin EGF LAG 
seven-pass G-type receptor 2 OS=Homo 
sapiens... 
0.47 1 0 0 0 0 0 5 0 
Cell division cycle-associated protein 
3 OS=Homo sapiens GN=CDCA3 PE=2 
SV=1 
F8WDL1_HUMAN 0.36 5 0 0 0 0 0 0 0 
Prefoldin subunit 6 OS=Homo 
sapiens GN=PFDN6 PE=1 SV=1 
PFD6_HUMAN 0.36 10 0 0 0 0 0 0 0 
Deoxyuridine 5'-triphosphate 
nucleotidohydrolase, mitochondrial 
(Fragment) OS=Homo sapiens 
GN=DUT PE=2 SV=1 
H0YKC5_HUMAN 0.36 8 0 0 0 0 0 0 0 
sp|P20674|COX5A_HUMAN 
Cytochrome c oxidase subunit 5A, 
mitochondrial OS=Homo sapiens... 
sp|P20674|COX5A_HUMANCytochrome c 
oxidase subunit 5A, mitochondrial OS=Homo 
sapiens GN=COX5A PE=1 SV=2 
0.36 10 0 0 0 0 0 0 0 
Isoform 4 of Apoptotic chromatin 
condensation inducer in the nucleus 
OS=Homo sapiens GN=ACIN1 
sp|Q9UKV3-5|ACINU_HUMAN 0.36 2 0 0 0 0 0 0 0 
sp|Q7Z6Z7-3|HUWE1_HUMAN 
Isoform 3 of E3 ubiquitin-protein 
ligase HUWE1 OS=Homo sapiens... 
sp|Q7Z6Z7-3|HUWE1_HUMAN Isoform 3 of E3 
ubiquitin-protein ligase HUWE1 OS=Homo 
sapiens... (+1) 
0.36 4 0 0 0 0 0 0 0 
sp|Q7Z2W4|ZCCHV_HUMAN Zinc 
finger CCCH-type antiviral protein 1 
OS=Homo sapiens GN=ZC3HAV1 
PE=1 SV=3 
sp|Q7Z2W4|ZCCHV_HUMANZinc finger CCCH-
type antiviral protein 1 OS=Homo sapiens 
GN=ZC3HAV1 PE=1 SV=3 
0.82 4 1 0 0 0 1 0 3 
GTP-binding protein Rheb OS=Homo 
sapiens GN=RHEB PE=1 SV=1 
RHEB_HUMAN 0.31 2 0 1 0 0 0 1 0 
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isozyme OS=Homo sapiens... 
sp|P05186|PPBT_HUMAN Alkaline phosphatase, 
tissue-nonspecific isozyme OS=Homo sapiens... 
0.54 0 5 0 0 0 7 0 3 
sp|P55145|MANF_HUMAN 
Mesencephalic astrocyte-derived 
neurotrophic factor OS=Homo... 
sp|P55145|MANF_HUMAN Mesencephalic 
astrocyte-derived neurotrophic factor 
OS=Homo... 
0.91 6 0 0 0 0 6 0 1 
Histone H2A.Z OS=Homo sapiens 
GN=H2AFZ PE=1 SV=2 
H2AZ_HUMAN (+1) 0.55 11 0 0 0 0 1 0 0 
sp|Q53H82|LACB2_HUMAN Beta-
lactamase-like protein 2 OS=Homo 
sapiens GN=LACTB2 PE=1 SV=2 
sp|Q53H82|LACB2_HUMANBeta-lactamase-like 
protein 2 OS=Homo sapiens GN=LACTB2 PE=1 
SV=2 
0.36 0 0 0 0 0 0 2 0 
Acetyl-CoA acetyltransferase, 
mitochondrial (Fragment) OS=Homo 
sapiens GN=ACAT1 PE=3 SV=1 
H0YEL7_HUMAN 0.36 11 0 0 0 0 0 0 0 
sp|Q14019|COTL1_HUMAN 
Coactosin-like protein OS=Homo 
sapiens GN=COTL1 PE=1 SV=3 
sp|Q14019|COTL1_HUMANCoactosin-like 
protein OS=Homo sapiens GN=COTL1 PE=1 SV=3 
0.96 0 1 0 2 2 1 0 0 
Isoform 5 of Thioredoxin reductase 
1, cytoplasmic OS=Homo sapiens 
GN=TXNRD1 
sp|Q16881-5|TRXR1_HUMAN 0.51 0 0 1 4 4 0 1 0 
Isoform 4 of Disintegrin and 
metalloproteinase domain-
containing protein 15 OS=Homo 
sapiens GN=ADAM15 
sp|Q13444-4|ADA15_HUMAN 0.37 1 0 1 0 0 0 0 5 
sp|P14550|AK1A1_HUMAN Alcohol 
dehydrogenase [NADP(+)] OS=Homo 
sapiens GN=AKR1A1 PE=1... 
sp|P14550|AK1A1_HUMANAlcohol 
dehydrogenase [NADP(+)] OS=Homo sapiens 
GN=AKR1A1 PE=1... 
0.31 0 0 11 2 0 0 0 0 
sp|Q9H299|SH3L3_HUMAN SH3 
domain-binding glutamic acid-rich-
like protein 3 OS=Homo... 
sp|Q9H299|SH3L3_HUMANSH3 domain-binding 
glutamic acid-rich-like protein 3 OS=Homo 
sapiens GN=SH3BGRL3 PE=1 SV=1 
0.33 9 0 0 2 2 0 0 0 
sp|O75340-2|PDCD6_HUMAN 
Isoform 2 of Programmed cell death 
protein 6 OS=Homo sapiens... 
sp|O75340-2|PDCD6_HUMAN Isoform 2 of 
Programmed cell death protein 6 OS=Homo 
sapiens... 
0.42 0 0 8 0 0 1 0 2 
sp|Q12929|EPS8_HUMAN 
Epidermal growth factor receptor 
kinase substrate 8 OS=Homo... 
sp|Q12929|EPS8_HUMAN Epidermal growth 
factor receptor kinase substrate 8 OS=Homo... 
0.47 0 5 0 0 0 0 0 1 
Collagen alpha-1(VI) chain OS=Homo 
sapiens GN=COL6A1 PE=1 SV=3 
CO6A1_HUMAN 0.57 0 4 0 0 0 6 0 0 
sp|P62195-2|PRS8_HUMAN Isoform 
2 of 26S protease regulatory subunit 
8 OS=Homo sapiens... 
sp|P62195-2|PRS8_HUMAN Isoform 2 of 26S 
protease regulatory subunit 8 OS=Homo 
sapiens... 
0.26 0 0 0 0 0 3 0 0 
sp|Q92688|AN32B_HUMAN Acidic 
leucine-rich nuclear phosphoprotein 
32 family member B OS=Homo 
sapiens GN=ANP32B PE=1 SV=1 
sp|Q92688|AN32B_HUMANAcidic leucine-rich 
nuclear phosphoprotein 32 family member B 
OS=Homo sapiens GN=ANP32B PE=1 SV=1 
0.36 5 0 0 0 0 0 0 0 
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dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 7 OS=Homo 
sapiens GN=NDUFA7 PE=1 SV=3 
sp|O95182|NDUA7_HUMANNADH 
dehydrogenase [ubiquinone] 1 alpha subcomplex 
subunit 7 OS=Homo sapiens GN=NDUFA7 PE=1 
SV=3 
0.36 3 0 0 0 0 0 0 0 
sp|P78527-2|PRKDC_HUMAN 
Isoform 2 of DNA-dependent protein 
kinase catalytic subunit... 
sp|P78527-2|PRKDC_HUMAN Isoform 2 of DNA-
dependent protein kinase catalytic subunit... (+1) 
0.36 4 0 0 0 0 0 0 0 
sp|Q14847-2|LASP1_HUMAN 
Isoform 2 of LIM and SH3 domain 
protein 1 OS=Homo sapiens... 
sp|Q14847-2|LASP1_HUMAN Isoform 2 of LIM 
and SH3 domain protein 1 OS=Homo sapiens... 
(+2) 
0.36 12 0 0 0 0 0 0 0 
tr|C9J8S2|C9J8S2_HUMAN Retinoic 
acid receptor responder protein 2 
(Fragment) OS=Homo... 
tr|C9J8S2|C9J8S2_HUMAN Retinoic acid 
receptor responder protein 2 (Fragment) 
OS=Homo... 
0.8 3 1 0 1 1 1 2 2 
sp|O95394|AGM1_HUMAN 
Phosphoacetylglucosamine mutase 
OS=Homo sapiens GN=PGM3 PE=1... 
sp|O95394|AGM1_HUMAN 
Phosphoacetylglucosamine mutase OS=Homo 
sapiens GN=PGM3 PE=1... 
0.66 0 0 1 3 3 0 4 0 
sp|Q969H8|CS010_HUMAN 
UPF0556 protein C19orf10 OS=Homo 
sapiens GN=C19orf10 PE=1 SV=1 
sp|Q969H8|CS010_HUMANUPF0556 protein 
C19orf10 OS=Homo sapiens GN=C19orf10 PE=1 
SV=1 
0.33 2 0 0 0 0 4 0 3 
sp|P21283|VATC1_HUMAN V-type 
proton ATPase subunit C 1 OS=Homo 
sapiens GN=ATP6V1C1 PE=1 SV=4 
sp|P21283|VATC1_HUMANV-type proton 
ATPase subunit C 1 OS=Homo sapiens 
GN=ATP6V1C1 PE=1 SV=4 
0.36 0 0 0 0 0 0 0 4 
Apolipoprotein A-I OS=Homo sapiens 
GN=APOA1 PE=1 SV=1 
APOA1_HUMAN 0.36 0 0 9 0 0 0 0 0 
IgGFc-binding protein OS=Homo 
sapiens GN=FCGBP PE=1 SV=3 
FCGBP_HUMAN 0.36 0 0 0 0 0 3 0 0 
Laminin subunit alpha-5 OS=Homo 
sapiens GN=LAMA5 PE=1 SV=8 
LAMA5_HUMAN 0.36 0 0 0 0 0 9 0 0 
sp|O60869-2|EDF1_HUMAN Isoform 
2 of Endothelial differentiation-
related factor 1... 
sp|O60869-2|EDF1_HUMAN Isoform 2 of 
Endothelial differentiation-related factor 1... (+1) 
0.36 12 0 0 0 0 0 0 0 
sp|O75475-2|PSIP1_HUMAN 
Isoform 2 of PC4 and SFRS1-
interacting protein OS=Homo 
sapiens... 
sp|O75475-2|PSIP1_HUMAN Isoform 2 of PC4 
and SFRS1-interacting protein OS=Homo 
sapiens... (+2) 
0.36 13 0 0 0 0 0 0 0 
Ras GTPase-activating-like protein 
IQGAP1 OS=Homo sapiens 
GN=IQGAP1 PE=2 SV=1 
H0YLE8_HUMAN 0.36 0 0 3 0 0 0 0 0 
Isoform 2 of Semenogelin-1 
OS=Homo sapiens GN=SEMG1 
sp|P04279-2|SEMG1_HUMAN 0.36 0 0 0 0 0 7 0 0 
sp|Q8WW22-2|DNJA4_HUMAN 
Isoform 2 of DnaJ homolog subfamily 
A member 4 OS=Homo sapiens... 
sp|Q8WW22-2|DNJA4_HUMAN Isoform 2 of 
DnaJ homolog subfamily A member 4 OS=Homo 
sapiens... (+1) 
0.94 1 0 1 0 0 4 1 1 
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receptor type substrate 1 OS=Homo 
sapiens GN=SIRPA PE=1 SV=2 
sp|P78324|SHPS1_HUMANTyrosine-protein 
phosphatase non-receptor type substrate 1 
OS=Homo sapiens GN=SIRPA PE=1 SV=2 
0.082 0 1 0 0 2 4 2 0 
Isoform 2 of Calcineurin-like 
phosphoesterase domain-containing 
protein 1 OS=Homo sapiens 
GN=CPPED1 
CPPED_HUMAN 0.77 0 0 1 0 1 0 2 2 
sp|P48047|ATPO_HUMAN ATP 
synthase subunit O, mitochondrial 
OS=Homo sapiens GN=ATP5O... 
sp|P48047|ATPO_HUMAN ATP synthase subunit 
O, mitochondrial OS=Homo sapiens GN=ATP5O... 
0.83 4 1 0 0 0 1 3 0 
sp|Q9UL26|RB22A_HUMAN Ras-
related protein Rab-22A OS=Homo 
sapiens GN=RAB22A PE=1 SV=2 
sp|Q9UL26|RB22A_HUMANRas-related protein 
Rab-22A OS=Homo sapiens GN=RAB22A PE=1 
SV=2 
0.53 2 2 0 0 0 0 2 0 
Isoform 3 of Neuronal cell adhesion 
molecule OS=Homo sapiens 
GN=NRCAM 
sp|Q92823-3|NRCAM_HUMAN 0.55 0 3 0 0 0 0 0 1 
Chromobox protein homolog 5 
OS=Homo sapiens GN=CBX5 PE=1 
SV=1 
CBX5_HUMAN 0.36 2 0 0 0 0 0 0 0 
sp|O95757|HS74L_HUMAN Heat 
shock 70 kDa protein 4L OS=Homo 
sapiens GN=HSPA4L PE=1 SV=3 
sp|O95757|HS74L_HUMANHeat shock 70 kDa 
protein 4L OS=Homo sapiens GN=HSPA4L PE=1 
SV=3 
0.31 0 0 0 0 0 0 6 0 
sp|P56211|ARP19_HUMAN cAMP-
regulated phosphoprotein 19 
OS=Homo sapiens GN=ARPP19 PE=1 
SV=2 
sp|P56211|ARP19_HUMANcAMP-regulated 
phosphoprotein 19 OS=Homo sapiens 
GN=ARPP19 PE=1 SV=2 
0.36 8 0 0 0 0 0 0 0 
sp|A6NEL2|SWAHB_HUMAN 
Ankyrin repeat domain-containing 
protein SOWAHB OS=Homo 
sapiens... 
sp|A6NEL2|SWAHB_HUMANAnkyrin repeat 
domain-containing protein SOWAHB OS=Homo 
sapiens... 
0.36 0 0 0 0 0 0 5 0 
sp|P56385|ATP5I_HUMAN ATP 
synthase subunit e, mitochondrial 
OS=Homo sapiens GN=ATP5I PE=1 
SV=2 
sp|P56385|ATP5I_HUMANATP synthase subunit 
e, mitochondrial OS=Homo sapiens GN=ATP5I 
PE=1 SV=2 
0.36 10 0 0 0 0 0 0 0 
sp|Q13573|SNW1_HUMAN SNW 
domain-containing protein 1 
OS=Homo sapiens GN=SNW1 PE=1... 
sp|Q13573|SNW1_HUMAN SNW domain-
containing protein 1 OS=Homo sapiens 
GN=SNW1 PE=1... (+1) 
0.36 8 0 0 0 0 0 0 0 
Small acidic protein OS=Homo 
sapiens GN=SMAP PE=1 SV=1 
SMAP_HUMAN 0.36 6 0 0 0 0 0 0 0 
Receptor-type tyrosine-protein 
phosphatase eta OS=Homo sapiens 
GN=PTPRJ PE=1 SV=3 
sp|Q12913|PTPRJ_HUMAN 0.36 0 0 0 0 0 4 0 0 
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Isoform 2 of Programmed cell death 
6-interacting protein... 
sp|Q8WUM4-2|PDC6I_HUMAN Isoform 2 of 
Programmed cell death 6-interacting protein... 
0.15 0 0 0 0 0 5 1 0 
sp|P11216|PYGB_HUMAN Glycogen 
phosphorylase, brain form OS=Homo 
sapiens GN=PYGB PE=1... 
sp|P11216|PYGB_HUMAN Glycogen 
phosphorylase, brain form OS=Homo sapiens 
GN=PYGB PE=1... 
0.31 1 7 0 0 0 0 0 1 
sp|O60282|KIF5C_HUMAN Kinesin 
heavy chain isoform 5C OS=Homo 
sapiens GN=KIF5C PE=1... 
sp|O60282|KIF5C_HUMANKinesin heavy chain 
isoform 5C OS=Homo sapiens GN=KIF5C PE=1 
SV=1 
0.93 0 2 0 0 0 0 0 0 
sp|Q9C005|DPY30_HUMAN Protein 
dpy-30 homolog OS=Homo sapiens 
GN=DPY30 PE=1 SV=1 
sp|Q9C005|DPY30_HUMANProtein dpy-30 
homolog OS=Homo sapiens GN=DPY30 PE=1 
SV=1 
0.36 2 0 0 0 0 0 0 0 
60S ribosomal protein L31 OS=Homo 
sapiens GN=RPL31 PE=1 SV=1 
sp|P62899|RL31_HUMAN 0.36 8 0 0 0 0 0 0 0 
sp|O43447|PPIH_HUMAN Peptidyl-
prolyl cis-trans isomerase H 
OS=Homo sapiens GN=PPIH... 
sp|O43447|PPIH_HUMAN Peptidyl-prolyl cis-
trans isomerase H OS=Homo sapiens GN=PPIH... 
0.36 4 0 0 0 0 0 0 0 
Isoform 2 of Transcription and mRNA 
export factor ENY2 OS=Homo 
sapiens GN=ENY2 






phosphohistidine inorganic pyrophosphate 
phosphatase... 
0.26 1 3 1 1 1 1 2 0 
5'(3')-deoxyribonucleotidase, 
cytosolic type OS=Homo sapiens 
GN=NT5C PE=2 SV=1 
J3KRC4_HUMAN 0.69 1 2 0 0 0 1 0 1 
sp|P14868|SYDC_HUMAN 
Aspartate--tRNA ligase, cytoplasmic 
OS=Homo sapiens GN=DARS... 
sp|P14868|SYDC_HUMAN Aspartate--tRNA 
ligase, cytoplasmic OS=Homo sapiens GN=DARS... 
(+1) 
0.46 0 0 3 0 0 0 2 1 
V-type proton ATPase subunit D 
OS=Homo sapiens GN=ATP6V1D 
PE=2 SV=1 
G3V2S6_HUMAN 0.64 0 1 0 0 0 2 0 0 
sp|O75531|BAF_HUMAN Barrier-to-
autointegration factor OS=Homo 
sapiens GN=BANF1 PE=1... 
sp|O75531|BAF_HUMAN Barrier-to-
autointegration factor OS=Homo sapiens 
GN=BANF1 PE=1... 
0.42 8 0 0 0 0 0 1 0 
sp|Q9BXV9|CN142_HUMAN 
Uncharacterized protein C14orf142 
OS=Homo sapiens GN=C14orf142 
PE=1 SV=2 
sp|Q9BXV9|CN142_HUMANUncharacterized 
protein C14orf142 OS=Homo sapiens 
GN=C14orf142 PE=1 SV=2 
0.36 4 0 0 0 0 0 0 0 
sp|P23246|SFPQ_HUMAN Splicing 
factor, proline- and glutamine-rich 
OS=Homo sapiens... 
sp|P23246|SFPQ_HUMAN Splicing factor, 
proline- and glutamine-rich OS=Homo sapiens... 
0.36 6 0 0 0 0 0 0 0 
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Transmembrane protein 238 
OS=Homo sapiens GN=TMEM238 
PE=1 SV=1 
sp|C9JI98|TM238_HUMANTransmembrane 
protein 238 OS=Homo sapiens GN=TMEM238 
PE=1 SV=1 
0.36 0 0 0 0 0 3 0 0 
sp|Q96C90|PP14B_HUMAN Protein 
phosphatase 1 regulatory subunit 
14B OS=Homo sapiens 
GN=PPP1R14B PE=1 SV=3 
sp|Q96C90|PP14B_HUMANProtein phosphatase 
1 regulatory subunit 14B OS=Homo sapiens 
GN=PPP1R14B PE=1 SV=3 
0.36 4 0 0 0 0 0 0 0 
NHP2-like protein 1 OS=Homo 
sapiens GN=NHP2L1 PE=2 SV=1 





interacting RNA-binding protein, mitochondrial 
OS=Homo sapiens GN=SLIRP PE=1 SV=1 
0.36 8 0 0 0 0 0 0 0 
sp|Q8TD19|NEK9_HUMAN 
Serine/threonine-protein kinase 
Nek9 OS=Homo sapiens GN=NEK9... 
sp|Q8TD19|NEK9_HUMAN Serine/threonine-
protein kinase Nek9 OS=Homo sapiens 
GN=NEK9... 
0.36 4 0 0 0 0 0 0 0 
sp|Q9NPH2-2|INO1_HUMAN 
Isoform 2 of Inositol-3-phosphate 
synthase 1 OS=Homo sapiens... 
sp|Q9NPH2-2|INO1_HUMAN Isoform 2 of 
Inositol-3-phosphate synthase 1 OS=Homo 
sapiens... (+5) 
0.73 0 2 0 1 1 0 5 0 
sp|Q9Y6E0|STK24_HUMAN 
Serine/threonine-protein kinase 24 
OS=Homo sapiens GN=STK24 PE=1 
SV=1 
sp|Q9Y6E0|STK24_HUMANSerine/threonine-
protein kinase 24 OS=Homo sapiens GN=STK24 
PE=1 SV=1 
0.64 1 1 0 0 1 0 2 0 
sp|Q9Y2Q0|AT8A1_HUMAN 
Probable phospholipid-transporting 
ATPase IA OS=Homo sapiens... 
sp|Q9Y2Q0|AT8A1_HUMANProbable 
phospholipid-transporting ATPase IA OS=Homo 
sapiens GN=ATP8A1 PE=1 SV=1 
0.5 1 2 0 0 0 0 0 2 
sp|P0C5Z0|H2AB2_HUMAN Histone 
H2A-Bbd type 2/3 OS=Homo sapiens 
GN=H2AFB2 PE=2 SV=1 
sp|P0C5Z0|H2AB2_HUMANHistone H2A-Bbd 
type 2/3 OS=Homo sapiens GN=H2AFB2 PE=2 
SV=1 
0.21 0 0 0 0 0 0 3 1 
Isoform 5 of Protein transport 
protein Sec16A OS=Homo sapiens 
GN=SEC16A 
sp|O15027-5|SC16A_HUMAN 0.36 6 0 0 0 0 0 0 0 
sp|P62310|LSM3_HUMAN U6 
snRNA-associated Sm-like protein 
LSm3 OS=Homo sapiens GN=LSM3... 
sp|P62310|LSM3_HUMAN U6 snRNA-associated 
Sm-like protein LSm3 OS=Homo sapiens 
GN=LSM3... 
0.36 3 0 0 0 0 0 0 0 
sp|P38159|RBMX_HUMAN RNA-
binding motif protein, X 
chromosome OS=Homo sapiens 
GN=RBMX... 
sp|P38159|RBMX_HUMAN RNA-binding motif 
protein, X chromosome OS=Homo sapiens 
GN=RBMX... (+2) 
0.36 6 0 0 0 0 0 0 0 
sp|Q8IYB3|SRRM1_HUMAN 
Serine/arginine repetitive matrix 
protein 1 OS=Homo sapiens 
GN=SRRM1 PE=1 SV=2 
sp|Q8IYB3|SRRM1_HUMANSerine/arginine 
repetitive matrix protein 1 OS=Homo sapiens 
GN=SRRM1 PE=1 SV=2 
0.36 9 0 0 0 0 0 0 0 
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shock protein HSP 90-beta OS=Homo 
sapiens GN=HSP90AB1... 
sp|P08238|HS90B_HUMANHeat shock protein 
HSP 90-beta OS=Homo sapiens GN=HSP90AB1... 
0.36 0 0 8 0 0 0 0 0 
Spondin-2 OS=Homo sapiens 
GN=SPON2 PE=1 SV=3 
SPON2_HUMAN 0.36 0 0 0 0 0 7 0 0 
sp|P05198|IF2A_HUMAN Eukaryotic 
translation initiation factor 2 subunit 
1 OS=Homo... 
sp|P05198|IF2A_HUMAN Eukaryotic translation 
initiation factor 2 subunit 1 OS=Homo... 
0.48 2 0 1 1 1 1 2 0 
sp|P63151|2ABA_HUMAN 
Serine/threonine-protein 
phosphatase 2A 55 kDa regulatory 
subunit... 
sp|P63151|2ABA_HUMAN Serine/threonine-
protein phosphatase 2A 55 kDa regulatory 
subunit... 
0.27 1 4 1 0 0 1 0 1 
Small VCP/p97-interacting protein 
OS=Homo sapiens GN=SVIP PE=3 
SV=1 
SVIP_HUMAN 0.4 0 0 1 2 2 0 2 0 
sp|O95816|BAG2_HUMAN BAG 
family molecular chaperone 
regulator 2 OS=Homo sapiens 
GN=BAG2... 
sp|O95816|BAG2_HUMAN BAG family molecular 
chaperone regulator 2 OS=Homo sapiens 
GN=BAG2... 
0.44 0 1 2 0 0 4 1 0 
Ethanolamine-phosphate 
cytidylyltransferase (Fragment) 
OS=Homo sapiens GN=PCYT2 PE=2 
SV=1 
I3L1L9_HUMAN 0.55 0 2 0 0 0 0 0 1 
Immunoglobulin superfamily 
member 21 OS=Homo sapiens 
GN=IGSF21 PE=2 SV=1 
IGS21_HUMAN 0.52 0 0 1 0 0 5 0 0 
SAFB-like transcription modulator 
OS=Homo sapiens GN=SLTM PE=2 
SV=1 
H0YMR6_HUMAN 0.36 3 0 0 0 0 0 0 0 
sp|P29762|RABP1_HUMAN Cellular 
retinoic acid-binding protein 1 
OS=Homo sapiens GN=CRABP1 PE=2 
SV=2 
sp|P29762|RABP1_HUMANCellular retinoic acid-
binding protein 1 OS=Homo sapiens GN=CRABP1 
PE=2 SV=2 
0.36 3 0 0 0 0 0 0 0 
Ribosomal protein L19 OS=Homo 
sapiens GN=RPL19 PE=2 SV=1 
J3KTE4_HUMAN (+2) 0.36 3 0 0 0 0 0 0 0 
Isoform 2 of Ubiquitin-associated 
protein 2-like OS=Homo sapiens 
GN=UBAP2L 
sp|Q14157-1|UBP2L_HUMAN 0.36 6 0 0 0 0 0 0 0 
sp|P12956|XRCC6_HUMAN X-ray 
repair cross-complementing protein 
6 OS=Homo sapiens GN=XRCC6 PE=1 
SV=2 
sp|P12956|XRCC6_HUMANX-ray repair cross-
complementing protein 6 OS=Homo sapiens 
GN=XRCC6 PE=1 SV=2 
0.36 3 0 0 0 0 0 0 0 
sp|Q8WW12|PCNP_HUMAN PEST 
proteolytic signal-containing nuclear 
protein OS=Homo sapiens... 
sp|Q8WW12|PCNP_HUMAN PEST proteolytic 
signal-containing nuclear protein OS=Homo 
sapiens... 
0.36 6 0 0 0 0 0 0 0 
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Isoform 2 of UDP-
glucose:glycoprotein 
glucosyltransferase 1 OS=Homo 
sapiens GN=UGGT1 
sp|Q9NYU2-2|UGGG1_HUMAN 0.36 0 0 0 0 0 2 0 0 
sp|O43242|PSMD3_HUMAN 26S 
proteasome non-ATPase regulatory 
subunit 3 OS=Homo sapiens... 
sp|O43242|PSMD3_HUMAN26S proteasome 
non-ATPase regulatory subunit 3 OS=Homo 
sapiens... 
0.36 0 0 4 0 0 0 0 0 
Probable phospholipid-transporting 
ATPase IC OS=Homo sapiens 
GN=ATP8B1 PE=1 SV=3 
AT8B1_HUMAN 0.36 0 0 0 0 0 4 0 0 
sp|P13667|PDIA4_HUMAN Protein 
disulfide-isomerase A4 OS=Homo 
sapiens GN=PDIA4 PE=1... 
sp|P13667|PDIA4_HUMANProtein disulfide-
isomerase A4 OS=Homo sapiens GN=PDIA4 
PE=1... 
0.55 0 0 2 0 0 0 2 0 
Keratin, type I cytoskeletal 12 
OS=Homo sapiens GN=KRT12 PE=1 
SV=1 
K1C12_HUMAN 0.87 0 0 0 0 0 5 0 0 
sp|CYB5_HUMAN| sp|CYB5_HUMAN| 0.37 0 0 2 0 0 0 0 1 
sp|P33240|CSTF2_HUMAN Cleavage 
stimulation factor subunit 2 
OS=Homo sapiens GN=CSTF2 PE=1 
SV=1 
sp|P33240|CSTF2_HUMANCleavage stimulation 
factor subunit 2 OS=Homo sapiens GN=CSTF2 
PE=1 SV=1 
0.36 5 0 0 0 0 0 0 0 
tr|G3V4I0|G3V4I0_HUMAN 
Ectonucleoside triphosphate 
diphosphohydrolase 5 OS=Homo 
sapiens... 
tr|G3V4I0|G3V4I0_HUMAN Ectonucleoside 
triphosphate diphosphohydrolase 5 OS=Homo 
sapiens... 
0.36 0 0 5 0 0 0 0 0 
Isoform 2 of Protein phosphatase 1 
regulatory subunit 21 OS=Homo 
sapiens GN=PPP1R21 
sp|Q6ZMI0-2|PPR21_HUMAN 0.36 0 3 0 0 0 0 0 0 
sp|Q13813-2|SPTN1_HUMAN 
Isoform 2 of Spectrin alpha chain, 
non-erythrocytic 1 OS=Homo... 
sp|Q13813-2|SPTN1_HUMAN Isoform 2 of 
Spectrin alpha chain, non-erythrocytic 1 
OS=Homo... (+1) 
0.36 0 0 3 0 0 0 0 0 
tr|E7ES35|E7ES35_HUMAN 
Tetratricopeptide repeat protein 38 
OS=Homo sapiens GN=TTC38... 
tr|E7ES35|E7ES35_HUMAN Tetratricopeptide 
repeat protein 38 OS=Homo sapiens GN=TTC38... 
0.36 0 0 3 0 0 0 0 0 
sp|Q9Y4Z0|LSM4_HUMAN U6 
snRNA-associated Sm-like protein 
LSm4 OS=Homo sapiens GN=LSM4... 
sp|Q9Y4Z0|LSM4_HUMAN U6 snRNA-associated 
Sm-like protein LSm4 OS=Homo sapiens 
GN=LSM4... 
0.36 4 0 0 0 0 0 0 0 
Transcriptional repressor p66-alpha 
(Fragment) OS=Homo sapiens 
GN=GATAD2A PE=2 SV=1 
C9JHD7_HUMAN 0.36 7 0 0 0 0 0 0 0 
tr|J3KNL6|J3KNL6_HUMAN Protein 
transport protein Sec16A OS=Homo 
sapiens GN=SEC16A... 
tr|J3KNL6|J3KNL6_HUMAN Protein transport 
protein Sec16A OS=Homo sapiens GN=SEC16A... 
0.36 7 0 0 0 0 0 0 0 
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Nucleosome assembly protein 1-like 
1 OS=Homo sapiens GN=NAP1L1 
PE=2 SV=1 
B3KV44_HUMAN 0.35 0 0 4 1 1 0 0 0 
sp|P33121|ACSL1_HUMAN Long-
chain-fatty-acid--CoA ligase 1 
OS=Homo sapiens GN=ACSL1 PE=1 
SV=1 
sp|P33121|ACSL1_HUMANLong-chain-fatty-acid-
-CoA ligase 1 OS=Homo sapiens GN=ACSL1 PE=1 
SV=1 
0.34 0 1 0 0 0 0 4 1 
sp|P20042|IF2B_HUMAN Eukaryotic 
translation initiation factor 2 subunit 
2 OS=Homo... 
sp|P20042|IF2B_HUMAN Eukaryotic translation 
initiation factor 2 subunit 2 OS=Homo... 
0.26 3 0 3 0 0 0 0 0 
sp|P13647|K2C5_HUMAN Keratin, 
type II cytoskeletal 5 OS=Homo 
sapiens GN=KRT5 PE=1... 
sp|P13647|K2C5_HUMAN Keratin, type II 
cytoskeletal 5 OS=Homo sapiens GN=KRT5 
PE=1... 
0.93 0 0 3 0 0 0 3 0 
tr|F8W7I2|F8W7I2_HUMAN 
Prostaglandin-H2 D-isomerase 
OS=Homo sapiens GN=PTGDS PE=2... 
tr|F8W7I2|F8W7I2_HUMAN Prostaglandin-H2 D-
isomerase OS=Homo sapiens GN=PTGDS PE=2... 
0.14 0 0 0 0 0 3 0 1 
sp|P56282|DPOE2_HUMAN DNA 
polymerase epsilon subunit 2 
OS=Homo sapiens GN=POLE2 PE=1... 
sp|P56282|DPOE2_HUMANDNA polymerase 
epsilon subunit 2 OS=Homo sapiens GN=POLE2 
PE=1 SV=2 
0.36 0 3 0 0 0 0 0 0 
Isoform 4 of Heterochromatin 
protein 1-binding protein 3 
OS=Homo sapiens GN=HP1BP3 
sp|Q5SSJ5-5|HP1B3_HUMAN 0.36 3 0 0 0 0 0 0 0 
Alcohol dehydrogenase [NADP(+)] 
OS=Homo sapiens GN=AKR1A1 PE=1 
SV=3 
AK1A1_HUMAN 0.36 0 6 0 0 0 0 0 0 
sp|P35606|COPB2_HUMAN 
Coatomer subunit beta' OS=Homo 
sapiens GN=COPB2 PE=1 SV=2 
sp|P35606|COPB2_HUMANCoatomer subunit 
beta' OS=Homo sapiens GN=COPB2 PE=1 SV=2 
0.36 0 0 0 0 0 0 2 0 
SMARCA4 isoform 2 OS=Homo 
sapiens GN=SMARCA4 PE=2 SV=1 
Q9HBD4_HUMAN (+1) 0.36 3 0 0 0 0 0 0 0 
sp|Q9BUJ2|HNRL1_HUMAN 
Heterogeneous nuclear 
ribonucleoprotein U-like protein 1 
OS=Homo sapiens GN=HNRNPUL1 
PE=1 SV=2 
sp|Q9BUJ2|HNRL1_HUMANHeterogeneous 
nuclear ribonucleoprotein U-like protein 1 
OS=Homo sapiens GN=HNRNPUL1 PE=1 SV=2 
0.36 4 0 0 0 0 0 0 0 
sp|P56381|ATP5E_HUMAN ATP 
synthase subunit epsilon, 
mitochondrial OS=Homo sapiens 
GN=ATP5E PE=1 SV=2 
sp|P56381|ATP5E_HUMANATP synthase subunit 
epsilon, mitochondrial OS=Homo sapiens 
GN=ATP5E PE=1 SV=2 
0.36 5 0 0 0 0 0 0 0 
sp|P55036|PSMD4_HUMAN 26S 
proteasome non-ATPase regulatory 
subunit 4 OS=Homo sapiens 
GN=PSMD4 PE=1 SV=1 
sp|P55036|PSMD4_HUMAN26S proteasome 
non-ATPase regulatory subunit 4 OS=Homo 
sapiens GN=PSMD4 PE=1 SV=1 
0.36 5 0 0 0 0 0 0 0 
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Contactin-associated protein-like 2 
OS=Homo sapiens GN=CNTNAP2 
PE=1 SV=1 
sp|Q9UHC6|CNTP2_HUMAN 0.36 0 0 0 0 0 2 0 0 
tr|J3QRP6|J3QRP6_HUMAN 
Na(+)/H(+) exchange regulatory 
cofactor NHE-RF1 (Fragment)... 
tr|J3QRP6|J3QRP6_HUMAN Na(+)/H(+) 
exchange regulatory cofactor NHE-RF1 
(Fragment)... 
0.36 0 0 0 0 0 2 0 0 
sp|Q8TDI8|TMC1_HUMAN 
Transmembrane channel-like protein 
1 OS=Homo sapiens GN=TMC1... 
sp|Q8TDI8|TMC1_HUMAN Transmembrane 
channel-like protein 1 OS=Homo sapiens 
GN=TMC1... 
0.94 0 0 0 2 2 0 0 0 
sp|P21281|VATB2_HUMAN V-type 
proton ATPase subunit B, brain 
isoform OS=Homo sapiens... 
sp|P21281|VATB2_HUMANV-type proton 
ATPase subunit B, brain isoform OS=Homo 
sapiens... 
0.27 1 0 2 0 0 0 0 0 
tr|D6REA1|D6REA1_HUMAN 
Nucleotide exchange factor SIL1 
OS=Homo sapiens GN=SIL1 PE=2... 
tr|D6REA1|D6REA1_HUMAN Nucleotide 
exchange factor SIL1 OS=Homo sapiens GN=SIL1 
PE=2... 
0.36 0 0 0 0 0 0 2 0 
Isoform 2 of Eukaryotic translation 
initiation factor 2A OS=Homo 
sapiens GN=EIF2A 
EIF2A_HUMAN 0.36 4 0 0 0 0 0 0 0 
sp|P36543-2|VATE1_HUMAN 
Isoform 2 of V-type proton ATPase 
subunit E 1 OS=Homo sapiens... 
sp|P36543-2|VATE1_HUMAN Isoform 2 of V-
type proton ATPase subunit E 1 OS=Homo 
sapiens... 
0.36 0 0 0 0 0 4 0 0 
sp|Q96KP4|CNDP2_HUMAN 
Cytosolic non-specific dipeptidase 
OS=Homo sapiens GN=CNDP2... 
sp|Q96KP4|CNDP2_HUMANCytosolic non-
specific dipeptidase OS=Homo sapiens 
GN=CNDP2... 
0.36 0 0 2 0 0 0 0 0 
sp|O60885|BRD4_HUMAN 
Bromodomain-containing protein 4 
OS=Homo sapiens GN=BRD4 PE=1... 
sp|O60885|BRD4_HUMAN Bromodomain-
containing protein 4 OS=Homo sapiens GN=BRD4 
PE=1... 
0.36 2 0 0 0 0 0 0 0 
sp|Q03167-2|TGBR3_HUMAN 
Isoform 2 of Transforming growth 
factor beta receptor type... 
sp|Q03167-2|TGBR3_HUMAN Isoform 2 of 
Transforming growth factor beta receptor type... 
0.42 0 0 1 0 0 0 2 0 
sp|P18440|ARY1_HUMAN 
Arylamine N-acetyltransferase 1 
OS=Homo sapiens GN=NAT1 PE=1... 
sp|P18440|ARY1_HUMAN Arylamine N-
acetyltransferase 1 OS=Homo sapiens GN=NAT1 
PE=1... (+1) 
0.16 0 0 0 0 0 1 2 0 
tr|E9PET8|E9PET8_HUMAN Kinesin 
heavy chain isoform 5C OS=Homo 
sapiens GN=KIF5C PE=2... 
tr|E9PET8|E9PET8_HUMAN Kinesin heavy chain 
isoform 5C OS=Homo sapiens GN=KIF5C PE=2... 
0.36 0 0 0 0 0 3 0 0 
sp|P30049|ATPD_HUMAN ATP 
synthase subunit delta, 
mitochondrial OS=Homo sapiens 
GN=ATP5D... 
sp|P30049|ATPD_HUMAN ATP synthase subunit 
delta, mitochondrial OS=Homo sapiens 
GN=ATP5D... 
0.36 2 0 0 0 0 0 0 0 
sp|O75746|CMC1_HUMAN Calcium-
binding mitochondrial carrier protein 
Aralar1 OS=Homo... 
sp|O75746|CMC1_HUMAN Calcium-binding 
mitochondrial carrier protein Aralar1 OS=Homo... 
(+1) 
0.36 3 0 0 0 0 0 0 0 
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Transcription initiation factor IIA 
subunit 1 OS=Homo sapiens 
GN=GTF2A1 PE=1 SV=1 
sp|P52655|TF2AA_HUMANTranscription 
initiation factor IIA subunit 1 OS=Homo sapiens 
GN=GTF2A1 PE=1 SV=1 
0.36 2 0 0 0 0 0 0 0 
MAM domain-containing protein 2 
OS=Homo sapiens GN=MAMDC2 
PE=2 SV=3 
sp|Q7Z304|MAMC2_HUMAN 0.36 0 0 0 0 0 0 0 2 
tr|E5RIU9|E5RIU9_HUMAN Charged 
multivesicular body protein 7 
(Fragment) OS=Homo sapiens... 
tr|E5RIU9|E5RIU9_HUMAN Charged 
multivesicular body protein 7 (Fragment) 
OS=Homo sapiens... 
0.36 0 0 0 0 0 0 0 2 
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